Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer, January 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 2884 articles:
HTML format


 

Single Articles

  1. XING B, Pu C, Chen Y, Sheng Y, et al
    Insights into the characteristics of primary radioresistant cervical cancer using single-cell transcriptomics.
    Hum Cell. 2023 Mar 3. doi: 10.1007/s13577-023-00882.
    Abstract

  2. KAVITHA R, Jothi DK, Saravanan K, Swain MP, et al
    Ant Colony Optimization-Enabled CNN Deep Learning Technique for Accurate Detection of Cervical Cancer.
    Biomed Res Int. 2023;2023:1742891.
    Abstract

  3. MERCADEL AJ, Holloway SB, Saripella M, Lea JS, et al
    Risk Factors for Catheter-Associated Urinary Tract Infections Following Radical Hysterectomy for Cervical Cancer.
    Am J Obstet Gynecol. 2023 Feb 28:S0002-9378(23)00135.
    Abstract

  4. ZHOU J, Zhang R, Tang X, Liu S, et al
    Urinary retention between nerve-sparing radical hysterectomy and radical hysterectomy for cervical cancer: A meta-analysis.
    Medicine (Baltimore). 2023;102:e32985.
    Abstract

  5. CADENA IA, Buchanan MR, Harris CG, Jenne MA, et al
    Engineering high throughput screening platforms of cervical cancer.
    J Biomed Mater Res A. 2023 Mar 2. doi: 10.1002/jbm.a.37522.
    Abstract

  6. PALLED SR, Venugopal BK, Nihanthy DS, Khanum H, et al
    Clinical profile and outcomes in cervical cancer: An audit from a tertiary cancer center.
    Indian J Cancer. 2022 Sep 5. doi: 10.4103.
    Abstract

  7. LI MJ, Xiong D, Wang S, Huang H, et al
    Tra2beta Enhances Cell Proliferation by Inducing the Expression of Transcription Factor SP1 in Cervical Cancer.
    Biomed Environ Sci. 2023;36:146-159.
    Abstract

  8. KIM SI, Yoo JG, Lee SJ, Park DC, et al
    Robot-assisted versus conventional laparoscopic radical hysterectomy in cervical cancer stage IB1.
    Int J Med Sci. 2023;20:287-291.
    Abstract

  9. HINGMIRE S, Tshomo U, Dendrup T, Patel A, et al
    Cervical Cancer HPV Vaccination and Bhutan.
    South Asian J Cancer. 2023;12:41-43.
    Abstract

  10. SINGH T, Aggarwal N, Thakur K, Chhokar A, et al
    Evaluation of Therapeutic Potential of Selected Plant-Derived Homeopathic Medicines for their Action against Cervical Cancer.
    Homeopathy. 2023 Mar 1. doi: 10.1055/s-0042-1756436.
    Abstract

  11. WILDING S, Wighton S, West R, Conner M, et al
    A randomised controlled trial of volitional and motivational interventions to improve cervical cancer screening uptake.
    Soc Sci Med. 2023;322:115800.
    Abstract

  12. TURNER K, Tabriz AA, Hong YR, Arredondo B, et al
    Rapid adaptation of cancer screening practices during COVID-19: A multi-state qualitative study.
    Ann Fam Med. 2022;.
    Abstract

  13. EL KHOURY C, Crespo Albiac L, O'Dwyer MC, Haro E, et al
    Patient-centered home cancer screening attitudes during SARS-CoV-2 pandemic.
    Ann Fam Med. 2022;.
    Abstract

  14. BERGER L, Wolf-Breitinger M, Weiss C, Tuschy B, et al
    Prevalence of higher-grade dysplasia in persistently high-risk human papillomavirus positive, cytology negative women after introduction of the new cervical cancer screening in Germany.
    Cancer Causes Control. 2023 Feb 28. doi: 10.1007/s10552-023-01677.
    Abstract

  15. REICH O, Regauer S
    Elimination of Reserve Cells for Prevention of HPV-associated Cervical Cancer.
    Virus Res. 2023 Feb 26:199068. doi: 10.1016/j.virusres.2023.199068.
    Abstract

  16. BALLI C, Kenfack B, Horo A, Jeronimo J, et al
    Transformation Zone Assessment Using Visual Inspection With Acetic Acid Before and After Thermal Ablation: Implications for Follow-Up.
    JCO Glob Oncol. 2023;9:e2200241.
    Abstract

  17. ZHANG X, Yao J, Niu N, Li X, et al
    SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas.
    Mod Pathol. 2023;36:100001.
    Abstract

  18. BHAT MP, Nayaka S
    Cave Soil Streptomyces sp. strain YC69 Antagonistic to Chilli Fungal Pathogens Exhibits In Vitro Anticancer Activity Against Human Cervical Cancer Cells.
    Appl Biochem Biotechnol. 2023 Feb 28. doi: 10.1007/s12010-023-04388.
    Abstract

  19. PLOYSAWANG P, Pitakkarnkul S, Kolaka W, Ratanasrithong P, et al
    Acceptability and Preference for Human Papilloma Virus Self-Sampling among Thai Women Attending National Cancer Institute.
    Asian Pac J Cancer Prev. 2023;24:607-612.
    Abstract

  20. SOMERA LP, Diaz T, Mummert A, Badowski G, et al
    Cervical Cancer and HPV Knowledge and Awareness: An Educational Intervention among College Students in Guam.
    Asian Pac J Cancer Prev. 2023;24:443-449.
    Abstract

  21. ANDALIB KMS, Rahman MH, Habib A
    Bioinformatics and cheminformatics approaches to identify pathways, molecular mechanisms and drug substances related to genetic basis of cervical cancer.
    J Biomol Struct Dyn. 2023 Feb 28:1-16. doi: 10.1080/07391102.2023.2179542.
    Abstract

  22. VINK MD, Hofstra G, Koolman X, Bekkers RL, et al
    Identification of over- and undertreatment in the Dutch national cervical cancer screening program: A data linkage study at the hospital level.
    Prev Med Rep. 2023;32:102134.
    Abstract

  23. AL SAD S, Pandit R, Alhashim N, Abdel-Rasoul M, et al
    Primary care Providers' approaches to cervical cancer screening in Muslim females.
    Prev Med Rep. 2023;32:102126.
    Abstract

  24. UDDIN AFMK, Sumon MA, Pervin S, Sharmin F, et al
    Cervical Cancer in Bangladesh.
    South Asian J Cancer. 2023;12:36-38.
    Abstract

  25. PARIKH PM, Mullapally SK, Hingmire S, Kamal Uddin AFM, et al
    Cervical Cancer in SAARC Countries.
    South Asian J Cancer. 2023;12:1-8.
    Abstract

  26. MULLAPALLY SK, Basu P, Parikh P
    Prevention of Cervical Cancer through HPV Vaccination and Screening in Maldives.
    South Asian J Cancer. 2023;12:44-46.
    Abstract

  27. IQBAL A, Joseph N
    Cervical Cancer in Sri Lanka.
    South Asian J Cancer. 2023;12:39-40.
    Abstract

  28. BARAL G
    Cervical Cancer Screening and HPV Vaccination in Nepal.
    South Asian J Cancer. 2023;12:53-54.
    Abstract

  29. KAUR S, Sharma LM, Mishra V, Goyal MGB, et al
    Challenges in Cervical Cancer Prevention: Real-World Scenario in India.
    South Asian J Cancer. 2023;12:9-16.
    Abstract

  30. BURNEY A, Zafar R
    HPV Vaccination as a Mode of Cervical Cancer Prevention in Pakistan.
    South Asian J Cancer. 2023;12:51-52.
    Abstract

  31. GANESHKUMAR P
    Audio-Visual Training Improves Awareness and Willingness of Cervical Cancer Screening among Healthy Indian Women: Findings from a Survey.
    South Asian J Cancer. 2022;12:23-29.
    Abstract

  32. SAFI AJ
    Cervical Cancer in Afganistan.
    South Asian J Cancer. 2023;12:49-50.
    Abstract

  33. SHAMAUN S, Jaleel R, Gull Y, Shahid A, et al
    Knowledge and Attitude of Cervical Cancer Screening and Vaccination in Patients Attending Gynecology Outpatient Clinic at a Tertiary Care Hospital in Pakistan.
    South Asian J Cancer. 2022;12:17-22.
    Abstract

  34. THINN MM, Aung S, Aung A, Tun NM, et al
    Current Status of Cervical Cancer Prevention and Screening in Myanmar.
    South Asian J Cancer. 2023;12:47-48.
    Abstract

  35. ORTIZ-PEDRAZA Y, Munoz-Bello JO, Ramos-Chavez LA, Martinez-Ramirez I, et al
    HPV16 E6 and E7 Oncoproteins Stimulate the Glutamine Pathway Maintaining Cell Proliferation in a SNAT1-Dependent Fashion.
    Viruses. 2023;15:324.
    Abstract

  36. FENG J, Liu Y, Zhuang N, Chai Z, et al
    EDA-E7 Activated DCs Induces Cytotoxic T Lymphocyte Immune Responses against HPV Expressing Cervical Cancer in Human Setting.
    Vaccines (Basel). 2023;11:320.
    Abstract

  37. FARAG CM, Antar R, Akosman S, Ng M, et al
    What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP's prognostic ability in different cancer types.
    Oncotarget. 2023;14:153-172.
    Abstract

  38. HU J, Liao D, Sun Z, Ren W, et al
    The HPV16 E6, E7/miR-23b-3p/ICAT signaling axis promotes proliferation, migration, invasion and EMT of cervical cancer cells.
    Carcinogenesis. 2023 Feb 27:bgad008. doi: 10.1093.
    Abstract

  39. CARRERA-MARTINEZ M, Mora-Garcia ML, Garcia-Rocha R, Weiss-Steider B, et al
    Inhibition of CD73 expression or A2AR blockade reduces MRP1 expression and increases the sensitivity of cervical cancer cells to cisplatin.
    Cell Biochem Funct. 2023 Feb 27. doi: 10.1002/cbf.3784.
    Abstract

  40. FENG X, Song Z, Tao A, Gong P, et al
    Prediction of active marker of seabuckthorn polysaccharides for prevention and treatment of cervical cancer and mechanism study.
    Front Nutr. 2023;10:1136590.
    Abstract

  41. MORALES-RODRIGUEZ M, Paniagua-Garcia L, Narayanan J, Zamudio-Meza H, et al
    Insulin‑like growth factor axis: A potential nanotherapy target for resistant cervical cancer tumors (Review).
    Oncol Lett. 2023;25:128.
    Abstract

  42. ZHANG K, Ni X, Ma X, Sun R, et al
    LINC01012 upregulation promotes cervical cancer proliferation and migration via downregulation of CDKN2D.
    Oncol Lett. 2023;25:124.
    Abstract

  43. GUO M, Qiao Y, Lu Y, Zhu L, et al
    Squalene epoxidase facilitates cervical cancer progression by modulating tumor protein p53 signaling pathway.
    J Obstet Gynaecol Res. 2023 Feb 26. doi: 10.1111/jog.15576.
    Abstract

  44. BOGANI G, Coleman RL, Vergote I, Raspagliesi F, et al
    Tisotumab vedotin in recurrent or metastatic cervical cancer.
    Curr Probl Cancer. 2023;47:100952.
    Abstract

  45. WANG X, Gu Y, Zhang L, Ma J, et al
    Long noncoding RNAs regulate intrauterine adhesion and cervical cancer development and progression.
    Semin Cell Dev Biol. 2023 Feb 23:S1084-9521(23)00036.
    Abstract

  46. BAI Z, Zuo Y, Huang W, Yao L, et al
    Prevalence and Risk Factors of Urinary Retention in Patients With Cervical Cancer: A Meta-analysis and Systematic Review.
    Cancer Nurs. 2023 Feb 16. doi: 10.1097/NCC.0000000000001198.
    Abstract

  47. FIRDAUS FZ, Bartlett S, Hussein WM, Lu L, et al
    Liposomal Formulations of a Polyleucine-Antigen Conjugate as Therapeutic Vaccines against Cervical Cancer.
    Pharmaceutics. 2023;15:602.
    Abstract

  48. CHOI S, Ismail A, Pappas-Gogos G, Boussios S, et al
    HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK.
    Pathogens. 2023;12:298.
    Abstract

  49. CHEN T, Wang J, Li M, Wu Q, et al
    Genistein Inhibits Proliferation and Metastasis in Human Cervical Cancer Cells through the Focal Adhesion Kinase Signaling Pathway: A Network Pharmacology-Based In Vitro Study in HeLa Cells.
    Molecules. 2023;28:1919.
    Abstract

  50. DE FELICE F, Vicenzi L, Macchia G, Vavassori A, et al
    Vaginal Toxicity Management in Patients with Locally Advanced Cervical Cancer following Exclusive Chemoradiation-A Nationwide Survey on Knowledge and Attitudes by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gynecology Study Gr
    Medicina (Kaunas). 2023;59:385.
    Abstract

  51. JIN QQ, Mei J, Hong L, Wang R, et al
    Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
    Medicina (Kaunas). 2023;59:358.
    Abstract

  52. CONTE C, Della Corte L, Pelligra S, Bifulco G, et al
    Assessment of Salvage Surgery in Persistent Cervical Cancer after Definitive Radiochemotherapy: A Systematic Review.
    Medicina (Kaunas). 2023;59:192.
    Abstract

  53. NAVOLOKIN N, Lomova M, Bucharskaya A, Godage O, et al
    Antitumor Effects of Microencapsulated Gratiola officinalis Extract on Breast Carcinoma and Human Cervical Cancer Cells In Vitro.
    Materials (Basel). 2023;16:1470.
    Abstract

  54. FU Q, Xie X, Xu Y, Zuo J, et al
    Applying Multi-Metric Deformable Image Registration for Dose Accumulation in Combined Cervical Cancer Radiotherapy.
    J Pers Med. 2023;13:323.
    Abstract

  55. MONTERO-MACIAS R, Coronado PJ, Robillard N, Veyer D, et al
    HPV Molecular Genotyping as a Differential Diagnosis Tool in Cervical Cancer Metastasis.
    J Pers Med. 2023;13:177.
    Abstract

  56. NYGARD M, Nygard S
    The Future of Cervical Cancer Prevention: From "One-Size-Fits-All" to Personalized Screening.
    J Pers Med. 2023;13:161.
    Abstract

  57. ZAMULAEVA I, Matchuk O, Selivanova E, Mkrtchian L, et al
    Effects of Fractionated Radiation Exposure on Vimentin Expression in Cervical Cancers: Analysis of Association with Cancer Stem Cell Response and Short-Term Prognosis.
    Int J Mol Sci. 2023;24:3271.
    Abstract

  58. MEMBRILLA-BELTRAN L, Cardona D, Camara-Roca L, Aparicio-Mota A, et al
    Impact of Cervical Cancer on Quality of Life and Sexuality in Female Survivors.
    Int J Environ Res Public Health. 2023;20:3751.
    Abstract

  59. WU YH, Lai CH, Chien L, Pan YC, et al
    Economic Burden of Cervical and Head and Neck Cancer in Taiwan from a Societal Perspective.
    Int J Environ Res Public Health. 2023;20:3717.
    Abstract

  60. SHEN CT, Tai SY, Tsao YH, Chen FM, et al
    Abortion and Female Cancer Risks among Women Aged 20 to 45 Years: A 10-Year Longitudinal Population-Based Cohort Study in Taiwan.
    Int J Environ Res Public Health. 2023;20:3682.
    Abstract

  61. AKER SS, Agar E, Tinelli A, Hatirnaz S, et al
    The Impact of HPV Diagnosis and Abnormal Cervical Cytology Results on Sexual Dysfunction and Anxiety.
    Int J Environ Res Public Health. 2023;20:3630.
    Abstract

  62. CHIOFALO B, Lagana AS, Ghezzi F, Certelli C, et al
    Beyond Sentinel Lymph Node: Outcomes of Indocyanine Green-Guided Pelvic Lymphadenectomy in Endometrial and Cervical Cancer.
    Int J Environ Res Public Health. 2023;20:3476.
    Abstract

  63. JUAREZ-RENDON KJ, Castro-Garcia MA, Prada-Ortega DG, Rivera G, et al
    Variants Identified in the HOXC13 and HOXD13 Genes Suggest Association with Cervical Cancer in a Cohort of Mexican Women.
    Genes (Basel). 2023;14:358.
    Abstract

  64. FEKRI-ERSHAD S, Alsaffar MF
    Developing a Tuned Three-Layer Perceptron Fed with Trained Deep Convolutional Neural Networks for Cervical Cancer Diagnosis.
    Diagnostics (Basel). 2023;13:686.
    Abstract

  65. KAKOTKIN VV, Semina EV, Zadorkina TG, Agapov MA, et al
    Prevention Strategies and Early Diagnosis of Cervical Cancer: Current State and Prospects.
    Diagnostics (Basel). 2023;13:610.
    Abstract

  66. BIZZARRI N, Biscione A, Moro F, Pedone Anchora L, et al
    Prognostic Significance of Ultrasound Characteristics and Body Mass Index in Patients with Apparent Early-Stage Cervical Cancer: A Single-Center, Retrospective, Cohort Study.
    Diagnostics (Basel). 2023;13:583.
    Abstract

  67. AVILA JP, Carvalho BM, Coimbra EC
    A Comprehensive View of the Cancer-Immunity Cycle (CIC) in HPV-Mediated Cervical Cancer and Prospects for Emerging Therapeutic Opportunities.
    Cancers (Basel). 2023;15:1333.
    Abstract

  68. SANTORO A, Inzani F, Angelico G, Arciuolo D, et al
    Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors.
    Cancers (Basel). 2023;15:1137.
    Abstract

  69. WU CT, Chiu LT
    The Impact of Psychological Distress on Cervical Cancer.
    Cancers (Basel). 2023;15:1100.
    Abstract

  70. BIZZARRI N, Arciuolo D, Certelli C, Pedone Anchora L, et al
    Ultrastaging of the Parametrium in Cervical Cancer: A Clinicopathological Study.
    Cancers (Basel). 2023;15:1099.
    Abstract

  71. ZANI AP, Zani CP, Din ZU, Rodrigues-Filho E, et al
    Dibenzylideneacetone Induces Apoptosis in Cervical Cancer Cells through Ros-Mediated Mitochondrial Damage.
    Antioxidants (Basel). 2023;12:317.
    Abstract

  72. DIZENDORF E, Sturdza A, Tagliaferri L, Russo L, et al
    Implementation of online workshops on image-guided adaptive brachytherapy (interventional radiotherapy) in locally advanced cervical cancer: Experience of BrachyAcademy.
    Brachytherapy. 2023 Feb 22:S1538-4721(23)00006.
    Abstract

  73. ZENG J, Zuo J, Li N, Yao H, et al
    Clinical analysis of 312 patients with stage IB1-IIA2 cervical squamous cell carcinoma and research on the influencing factors of postoperative recurrence.
    BMC Womens Health. 2023;23:82.
    Abstract

  74. SOLNAES JV, Njor SH, Tranberg M
    Does full HPV genotyping perform similarly well in clinician-collected cervical samples and self-collected vaginal samples when using the CLART HPV4S assay?
    BMC Womens Health. 2023;23:78.
    Abstract

  75. HAN B, Yuan M, Gong Y, Qi D, et al
    The clinical course of untreated CIN2 (HPV16/18+) under active monitoring: A protocol of systematic reviews and meta-analysis.
    Medicine (Baltimore). 2023;102:e32855.
    Abstract

  76. DONG Y, Wen W, Yuan T, Liu L, et al
    Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
    Dis Markers. 2023;2023:1766080.
    Abstract

  77. NAEGELE K, Weissbach FH, Leuzinger K, Gosert R, et al
    Impact of nucleic acid extraction procedures on human papillomavirus (HPV) detection and genotyping.
    J Med Virol. 2023;95:e28583.
    Abstract

  78. NI X, Hu J, Huang Y, Tao J, et al
    Higher clearance rates of multiple HPV infections may explain their lower risk of HSIL: A retrospective study in Wenzhou, China.
    J Med Virol. 2023;95:e28526.
    Abstract

  79. WANG C, Li L, Wang F, Li X, et al
    Single-cell transcriptomics dissects epithelial heterogeneity in HPV(+) cervical adenocarcinoma.
    J Med Virol. 2023;95:e28480.
    Abstract

  80. FU Y, Li Y, Li X, Wang X, et al
    Risk stratification for cervical precancer and cancer by DH3-HPV partial genotyping and cytology in women attending cervical screening: A retrospective cohort study.
    J Med Virol. 2023;95:e28482.
    Abstract

  81. PARK Y, Ki M, Lee H, Lee JK, et al
    Parental Factors Affecting Decision to Vaccinate Their Daughters against Human Papillomavirus.
    Cancer Prev Res (Phila). 2023;16:133-138.
    Abstract

  82. CHEN J, Huang S, Li H, Li Y, et al
    STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration.
    Clin Transl Oncol. 2023;25:662-672.
    Abstract

  83. CHACHAGE M, Parikh AP, Mahenge A, Bahemana E, et al
    High-risk human papillomavirus (HPV) genotype distribution among women living with and at risk for HIV in the African cohort study.
    AIDS. 2022 Nov 21. pii: 00002030-990000000-00153.
    Abstract

  84. NOUEL J, White EA
    ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins.
    mBio. 2022;13:e0203322.
    Abstract

  85. KURIYAMA S, Yano M, Kusaba T, Zaitsu S, et al
    Immunohistochemical and molecular analysis of an alpha-fetoprotein-producing cervical adenocarcinoma with clear cell morphology.
    Med Mol Morphol. 2023;56:20-27.
    Abstract

  86. MATSUO K, Vallejo A, Barakzai SK, Nusbaum DJ, et al
    Secondary ovarian cancer after external beam radiotherapy for nonovarian pelvic malignancy.
    Eur J Surg Oncol. 2023;49:461-467.
    Abstract

  87. MILLAR MM, Edwards SL, Herget KA, Orleans B, et al
    Adherence to Guideline-Recommended cancer screening among Utah cancer survivors.
    Cancer Med. 2023;12:3543-3554.
    Abstract

  88. WEMRELL M, Vicente RP, Merlo J
    Mapping sociodemographic and geographical differences in human papillomavirus non-vaccination among young girls in Sweden.
    Scand J Public Health. 2023;51:288-295.
    Abstract

  89. YU L, Zheng ZM
    Human Papillomavirus Type 16 Circular RNA Is Barely Detectable for the Claimed Biological Activity.
    mBio. 2022;13:e0359421.
    Abstract

  90. HOLT HK, Peterson CE, MacLaughlan David S, Abdelaziz A, et al
    Mediation of Racial and Ethnic Inequities in the Diagnosis of Advanced-Stage Cervical Cancer by Insurance Status.
    JAMA Netw Open. 2023;6:e232985.
    Abstract

  91. DI SALVO I, Mnzava D, Nicoletti GJ, Senkoro E, et al
    Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
    BMC Health Serv Res. 2023;23:234.
    Abstract

  92. CHITHA W, Sibulawa S, Funani I, Swartbooi B, et al
    A cross-sectional study of knowledge, attitudes, barriers and practices of cervical cancer screening among nurses in selected hospitals in the Eastern Cape Province, South Africa.
    BMC Womens Health. 2023;23:94.
    Abstract

  93. FIGUEIREDO D, Ribeiro I, Penedones A, Mendes D, et al
    Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis.
    BMC Womens Health. 2023;23:96.
    Abstract

  94. LUCIA F, Bourbonne V, Pleyers C, Dupre PF, et al
    Multicentric development and evaluation of (18)F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer.
    Eur J Nucl Med Mol Imaging. 2023 Mar 9. doi: 10.1007/s00259-023-06180.
    Abstract

  95. SUI HY, Cui XY, Shi CX, Yan ZP, et al
    LRRC75A-AS1 delivered by M2 macrophage exosomes promotes cervical cancer progression via enhancing SIX1 expression.
    Cancer Sci. 2023 Mar 9. doi: 10.1111/cas.15780.
    Abstract

  96. WANG L, Liu Z
    Bilateral cervical cancer in a complete septate uterus with a double cervix and vagina: a case report.
    J Int Med Res. 2023;51:3000605231154395.
    Abstract

  97. BEGLIARZADE S, Beilerli A, Sufianov A, Tamrazov R, et al
    Long non-coding RNAs as promising biomarkers and therapeutic targets in cervical cancer.
    Noncoding RNA Res. 2023;8:233-239.
    Abstract

  98. LEE JY, Lee YY, Park JY, Shim SH, et al
    Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3.
    J Gynecol Oncol. 2023;34:e51.
    Abstract

  99. XIONG S, Song H
    LncRNA CERS6-AS1 Is a Tumor Promoter in Cervical Cancer by Sponging miR-195-5p.
    Ann Clin Lab Sci. 2023;53:30-41.
    Abstract

  100. JIA C, Chen F, Li W, Zhu X, et al
    CircCCNB1 Knockdown Blocks the Progression of Cervical Cancer by Acting as Competing Endogenous RNA in the miR-370-3p/SOX4 Pathway.
    Ann Clin Lab Sci. 2023;53:94-105.
    Abstract

  101. ZHANG M, Wei Z, Zhao H, Zhang S, et al
    The role of APOBEC3A in cervical cancer development and progression: A retrospective study.
    Drug Discov Ther. 2023 Mar 9. doi: 10.5582/ddt.2022.01095.
    Abstract

  102. MA X, Fang J, Zhang L, Huang Y, et al
    Efficacy and Safety of Adjuvant Chemotherapy for Locally Advanced Cervical Cancer: A Systematic Review and Meta-Analysis.
    Crit Rev Oncol Hematol. 2023 Mar 6:103953. doi: 10.1016/j.critrevonc.2023.103953
    Abstract

  103. MORENO-ACOSTA P, Gamboa O, Gonzalez-Prieto C, Romero-Rojas A, et al
    hTERT and IGF-1R Proteins Expression in Response to Treatment in Patients with HPV Alpha 9-Positive Cervical Cancer.
    Radiat Res. 2023 Mar 7. doi: 10.1667/RADE-22-00121.
    Abstract

  104. JONES NC, Fusani AU, Cox KM, Martinez VP, et al
    Assessing Spanish Health Literacy and Cervical Cancer Knowledge, Attitudes, and Behaviors in a Student-Run Free Clinic.
    J Cancer Educ. 2023 Mar 8. doi: 10.1007/s13187-023-02278.
    Abstract

  105. QIU H, Su N, Yan S, Li J, et al
    Real-world Efficacy Data on Anti-Angiogenic Drugs in Recurrent Small Cell Cervical Carcinoma: A Retrospective Study.
    Technol Cancer Res Treat. 2023;22:15330338231160393.
    Abstract

  106. YARANDI F, Aghili M, Ramhormozian S, Shirali E, et al
    Endocervical adenocarcinoma implantation in episiotomy scar: a case report and review of the literature.
    J Med Case Rep. 2023;17:100.
    Abstract

  107. VAN DAMME A, Rombaut J, Makar A, De Jaeghere E, et al
    Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer: long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort.
    World J Surg Oncol. 2023;21:84.
    Abstract

  108. ORJI AF, Sodeyi MY, Anoke CI, Cevasco KE, et al
    Disparities in Cervical Cancer Screening by Disability Types: a Systematic Review.
    J Cancer Educ. 2023 Mar 7. doi: 10.1007/s13187-023-02280.
    Abstract

  109. BINDAL A, Mittal P, Shinghal A, Scaria L, et al
    Sigmoid dose accumulation and reporting for multifractionated brachytherapy for cervical cancer: Methodological development of sigmoid points through virtual endoscopic method.
    Brachytherapy. 2023 Mar 5:S1538-4721(23)00003.
    Abstract

  110. ZHU Y, Feldman S, Leung SOA, Creer MH, et al
    AACC Guidance Document on Cervical Cancer Detection: Screening, Surveillance, and Diagnosis.
    J Appl Lab Med. 2023;8:382-406.
    Abstract

  111. HE Y, Shi J, Zhao H, Wang Y, et al
    p16(INK4A) flow cytometry of exfoliated cervical cells: Its role in quantitative pathology and clinical diagnosis of squamous intraepithelial lesions.
    Clin Transl Med. 2023;13:e1209.
    Abstract

  112. YIN M, Weng Y
    Eight Aging-Related Genes Prognostic Signature for Cervical Cancer.
    Int J Genomics. 2023;2023:4971345.
    Abstract

  113. SONG S, Han D, Zhang N, Mao Z, et al
    The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy fraction in one application for the cervical cancer: a retrospective study.
    Radiat Oncol. 2023;18:46.
    Abstract

  114. SHUKLA V, Mallya S, Adiga D, Sriharikrishnaa S, et al
    Bioinformatic Analysis of miR-200b/429 and Hub Gene Network in Cervical Cancer.
    Biochem Genet. 2023 Mar 7. doi: 10.1007/s10528-023-10356.
    Abstract

  115. TEIXEIRA JC, Vale DB, Discacciati MG, Campos CS, et al
    Cervical Cancer Screening with DNA-HPV Testing and Precancerous Lesions Detection: A Brazilian Population-based Demonstration Study.
    Rev Bras Ginecol Obstet. 2023;45:21-30.
    Abstract

  116. MONK BJ, Tewari KS, Dubot C, Caceres MV, et al
    Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet Oncol. 2023 Mar 3:S1470-2045(23)00052.
    Abstract

  117. DHANAWORAVIBUL K, Leetanaporn K, Wattanapaisal P, Deevongkij K, et al
    Association between resting heart rate and oncological outcomes in patients with early-stage cervical cancer who have undergone radical hysterectomy with pelvic lymphadenectomy.
    Oncol Res Treat. 2023 Mar 6. doi: 10.1159/000529969.
    Abstract

  118. YANG XL, Yang FL, Wang N, Zhang YE, et al
    A Scoring System to Select the Candidates for Adjuvant Chemotherapy Alone in High-Risk Early-Stage Cervical Cancer Patients With Pelvic Lymph Node Metastases After Surgery.
    Am J Clin Oncol. 2023 Mar 6. doi: 10.1097/COC.0000000000000996.
    Abstract

  119. LOTFI F, Khodabandeh F, Jafari A, Rezaee M, et al
    Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective.
    Expert Rev Pharmacoecon Outcomes Res. 2023.
    Abstract

  120. PENG X, Woodhouse I, Hancock G, Parker R, et al
    Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer.
    iScience. 2023;26:106101.
    Abstract

  121. GUO J, Guo S, Dong S
    Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: A meta-analysis.
    Front Public Health. 2023;11:1128717.
    Abstract

  122. DE SANCTIS V, Facondo G, Vullo G, Anzellini D, et al
    Clinical Outcomes and Toxicity of CT-guided High Dose-rate Brachytherapy in Women With Locally-advanced Cervical Cancer.
    Cancer Diagn Progn. 2023;3:194-200.
    Abstract

  123. ZHENG X, Gu H, Cao X, Pan B, et al
    Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers.
    Front Immunol. 2023;14:1113369.
    Abstract

  124. VARLOTTO JM, Cardarelli GA
    Editorial: Recent advances in cervical cancer radiotherapy.
    Front Oncol. 2023;13:1144797.
    Abstract

  125. WANG J, Mao Y, Gao X, Zhang Y, et al
    Recurrence risk stratification for locally advanced cervical cancer using multi-modality transformer network.
    Front Oncol. 2023;13:1100087.
    Abstract

  126. OLA IO, Okunowo AA, Habeebu MY, Miao Jonasson J, et al
    Clinical and non-clinical determinants of cervical cancer mortality: A retrospective cohort study in Lagos, Nigeria.
    Front Oncol. 2023;13:1105649.
    Abstract

  127. GU Y, Cheng H, Cang W, Chen L, et al
    Comparison of oncological outcomes in elderly early-stage cervical cancer patients treated with radical surgery or radiotherapy: A real-world retrospective study with propensity score matching.
    Front Oncol. 2023;13:1019254.
    Abstract

  128. LIU K, Zhu Y, Zhou Y, Zhu H, et al
    Cemiplimab as Second-Line Therapy for Patients with Recurrent Cervical Cancer: A United States-based Cost-effectiveness Analysis.
    Adv Ther. 2023 Mar 4. doi: 10.1007/s12325-023-02472.
    Abstract

  129. DOGHISH AS, Ali MA, Elyan SS, Elrebehy MA, et al
    miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay.
    Pathol Res Pract. 2023;244:154386.
    Abstract

  130. KABIR A, Karim MN, Billah B
    The capacity of primary healthcare facilities in Bangladesh to prevent and control non-communicable diseases.
    BMC Prim Care. 2023;24:60.
    Abstract

  131. WAHAB MT, Tan RKJ, Cook AR, Prem K, et al
    Impact of including boys in the national school-based human papillomavirus vaccination programme in Singapore: A modelling-based cost-effectiveness analysis.
    Vaccine. 2023 Feb 14:S0264-410X(23)00160-3. doi: 10.1016/j.vaccine.2023.
    Abstract

  132. LI C, Hall TG, Hall JJ, He WQ, et al
    Effectiveness of quadrivalent HPV vaccination in reducing vaccine-type and nonvaccine-type high risk HPV infection.
    Epidemiol Infect. 2023;151:e37.
    Abstract

  133. WITTENBORN J, Kupec T, Iborra S, Najjari L, et al
    CIN2 + detection in high-risk HPV patients with no or minor cervical cytologic abnormalities: a clinical approach validated by machine learning.
    Arch Gynecol Obstet. 2023;307:881-890.
    Abstract

  134. WU D, Yuan X, Zhou R, Chen W, et al
    Aqueous extract of Sanghuangporus baumii induces autophagy to inhibit cervical carcinoma growth.
    Food Funct. 2023;14:2374-2384.
    Abstract

  135. KAJIMOTO Y, Honda K, Suzuki S, Mori M, et al
    Association between financial toxicity and health-related quality of life of patients with gynecologic cancer.
    Int J Clin Oncol. 2023;28:454-467.
    Abstract

  136. JONES M, Subramanian S, Jose R
    Cancer screening behaviors and preferences among women in southern India.
    J Cancer Policy. 2023;35:100401.
    Abstract

  137. CHANBOUR H, Suryateja Gangavarapu L, Chen JW, Bendfeldt GA, et al
    Unplanned Readmission After Surgery for Cervical Spine Metastases.
    World Neurosurg. 2023;171:e768-e776.
    Abstract

  138. YEN A, Choi B, Inam E, Yeh A, et al
    Spare the Bowel, Don't Spoil the Target: Optimal Margin Assessment for Online Cone Beam Adaptive Radiation Therapy (OnC-ART) of the Cervix.
    Pract Radiat Oncol. 2023;13:e176-e183.
    Abstract

  139. SHI W, Chen L, Guan D
    Lymphoma-like lesion of the uterine cervix: A case report.
    Asian J Surg. 2023;46:1368-1369.
    Abstract

  140. AKCA G, Akca U
    Turkish mothers' knowledge and attitude about HPV vaccine.
    J Pediatr Nurs. 2022;67:83-87.
    Abstract

  141. XIE Z, Chen G, Suk R, Dixon B, et al
    Limited English Proficiency and Screening for Cervical, Breast, and Colorectal Cancers among Asian American Adults.
    J Racial Ethn Health Disparities. 2023;10:977-985.
    Abstract

  142. WASHINGTON A, Randall J
    "We're Not Taken Seriously": Describing the Experiences of Perceived Discrimination in Medical Settings for Black Women.
    J Racial Ethn Health Disparities. 2023;10:883-891.
    Abstract

  143. KUCUKYILDIZ I, Karaca M, Akgor U, Turkyilmaz M, et al
    Endocervical polyps in high risk human papillomavirus infections.
    Ginekol Pol. 2022;93:7-10.
    Abstract

  144. ZHU HT, Xia R, Zhang X
    Clinical characteristics and prognostic factors of cervical adenocarcinoma.
    Asian J Surg. 2021;44:1283-1285.
    Abstract

  145. WILSON R
    HPV vaccine acceptance in West Africa: A systematic literature review.
    Vaccine. 2021;39:5277-5284.
    Abstract

  146. SULLIVAN BG, Qazi A, Senthil M
    Cancer Screening Programs in Low- and Middle-Income Countries: Strategies for Success.
    Ann Surg Oncol. 2021;28:6918-6919.
    Abstract

  147. LINERTOVA R, Guirado-Fuentes C, Mar Medina J, Imaz-Iglesia I, et al
    Cost-effectiveness of extending the HPV vaccination to boys: a systematic review.
    J Epidemiol Community Health. 2021;75:910-916.
    Abstract

  148. KIM N, Park W, Cho WK, Bae DS, et al
    Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features.
    J Gynecol Oncol. 2021;32:e72.
    Abstract

  149. IKEDA M, Mikami M, Yasaka M, Enomoto T, et al
    Association of menopause, aging and treatment procedures with positive margins after therapeutic cervical conization for CIN 3: a retrospective study of 8,856 patients by the Japan Society of Obstetrics and Gynecology.
    J Gynecol Oncol. 2021;32:e68.
    Abstract

  150. LEE YY, Choi MC, Park JY, Suh DH, et al
    Major clinical research advances in gynecologic cancer in 2020.
    J Gynecol Oncol. 2021;32:e53.
    Abstract

  151. MABUCHI S, Sasano T
    Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers.
    Cells. 2021;10:1073.
    Abstract

  152. DHANDAPANI H, Seetharaman A, Jayakumar H, Ganeshrajah S, et al
    Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro.
    J Gynecol Oncol. 2021;32:e59.
    Abstract

  153. YUE Z, Ding S, Li X, Yang S, et al
    Automatic Acetowhite Lesion Segmentation via Specular Reflection Removal and Deep Attention Network.
    IEEE J Biomed Health Inform. 2021;25:3529-3540.
    Abstract

  154. BADMAN SG, Vallely AJ, Pardo C, Mhango LP, et al
    A comparison of ThinPrep against four non-volatile transport media for HPV testing at or near the point of care.
    Pathology. 2021;53:264-266.
    Abstract

  155. STEWART CJR, Moses J
    NKX3.1 expression in cervical 'adenoid basal cell carcinoma': another gynaecological lesion with prostatic differentiation?
    Pathology. 2021;53:193-198.
    Abstract

  156. PASSOS CM, Sales JB, Maia EG, Caldeira TCM, et al
    Trends in access to female cancer screening in Brazil, 2007-16.
    J Public Health (Oxf). 2021;43:632-638.
    Abstract

  157. GU F, Xu F, Pan Z, Shi L, et al
    An integrative pan-cancer analysis illustrating the key role of LRP11 in cervical cancer.
    Medicine (Baltimore). 2023;102:e33201.
    Abstract

  158. CHANG H, Wang M, Liu Y, Wu Y, et al
    Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer.
    J Gynecol Oncol. 2023 Mar 13. doi: 10.3802/jgo.2023.
    Abstract

  159. MURAKAWA Y, Dobashi H, Kondo M, Nishiyama S, et al
    Questionnaire Survey On The Prevention And Development Of Cervical Cancer In Patients With Systemic Lupus Erythematosus In Japan.
    Mod Rheumatol. 2023 Mar 16:road028. doi: 10.1093.
    Abstract

  160. WU Y, Wang S, Chen Y, Liao Y, et al
    A Multicenter Study on Preoperative Assessment of Lymphovascular Space Invasion in Early-Stage Cervical Cancer Based on Multimodal MR Radiomics.
    J Magn Reson Imaging. 2023 Mar 16. doi: 10.1002/jmri.28676.
    Abstract

  161. KOEL M, Vosa U, Joeloo M, Lall K, et al
    GWAS meta-analyses clarify genetics of cervical phenotypes and inform risk stratification for cervical cancer.
    Hum Mol Genet. 2023 Mar 16:ddad043. doi: 10.1093.
    Abstract

  162. NAKAZAWA H, Yamaguchi S, Onuki M, Kitai M, et al
    Age at first sexual intercourse among young women with invasive cervical cancer: implications for routine vaccination against human papillomavirus in Japan.
    Jpn J Clin Oncol. 2023 Mar 16:hyad017. doi: 10.1093.
    Abstract

  163. SHAN Y, Ding Z, Cui Z, Chen A, et al
    Incidence, prognostic factors and a nomogram of cervical cancer with distant organ metastasis: a SEER-based study.
    J Obstet Gynaecol. 2023;43:2181690.
    Abstract

  164. LI N, Zhang Y, Qu W, Zhang C, et al
    Analysis of systemic inflammatory and coagulation biomarkers in advanced cervical cancer: Prognostic and predictive significance.
    Int J Biol Markers. 2023 Mar 16:3936155231163599. doi: 10.1177/03936155231163599
    Abstract

  165. CASTANEDA KM, Sidorenkov GA, de Waard J, Greuter MJW, et al
    The effect of extended participation windows on attendance at cervical cancer screening.
    Prev Med Rep. 2023;32:102166.
    Abstract

  166. LIU J, Guan W, Sun Y, Wang Y, et al
    Early detection of the impact of combined taxane and carboplatin treatment on autonomic nerves in patients with cervical cancer: Measurement of heart rate variability.
    Front Physiol. 2023;14:1126057.
    Abstract

  167. MA CY, Zhao J, Gan GH, He XL, et al
    Establishment of a prediction model for severe acute radiation enteritis associated with cervical cancer radiotherapy.
    World J Gastroenterol. 2023;29:1344-1358.
    Abstract

  168. XIN T, Jiang Y, Li C, Ding X, et al
    Using planned behavior theory to understand cervical cancer screening intentions in Chinese women.
    Front Public Health. 2023;11:1063694.
    Abstract

  169. HIGASHI RT, Tiro JA, Winer RL, Ornelas IJ, et al
    Understanding the effect of new U.S. cervical cancer screening guidelines and modalities on patients' comprehension and reporting of their cervical cancer screening behavior.
    Prev Med Rep. 2023;32:102169.
    Abstract

  170. ABDURAHMAN A, Li Y, Jia SZ, Xu XW, et al
    Knockdown of the SELENOK gene induces ferroptosis in cervical cancer cells.
    Metallomics. 2023 Mar 15:mfad019. doi: 10.1093.
    Abstract

  171. VIDRINE JI, Sutton SK, Wetter DW, Shih YT, et al
    Efficacy of a Smoking Cessation Intervention for Survivors of Cervical Intraepithelial Neoplasia or Cervical Cancer: A Randomized Controlled Trial.
    J Clin Oncol. 2023 Mar 15:JCO2201228. doi: 10.1200/JCO.22.01228.
    Abstract

  172. CHEN F, Shen L, Wang Y, Chen Y, et al
    Signatures of immune cell infiltration for predicting immune escape and immunotherapy in cervical cancer.
    Aging (Albany NY). 2023;15.
    Abstract

  173. YE Y, Li Z, Kang S, Zhan X, et al
    Impact of different postoperative adjuvant therapies on the survival of early-stage cervical cancer patients with one intermediate-risk factor: A multicenter study of 14 years.
    J Obstet Gynaecol Res. 2023 Mar 14. doi: 10.1111/jog.15632.
    Abstract

  174. DU R, Xiong S
    Hsa_circ_0084912 Drives the Progression of Cervical Cancer Via Regulating miR-429/SOX2 Pathway.
    Mol Biotechnol. 2023 Mar 13. doi: 10.1007/s12033-023-00701.
    Abstract

  175. WANG Y, Li JQ, Qiang WM, Wang SR, et al
    Can chronoradiotherapy offer benefits to cervical cancer patients? A scoping review.
    Chronobiol Int. 2023 Mar 13:1-8. doi: 10.1080/07420528.2023.2174880.
    Abstract

  176. LI G, Cheng M, Hong K, Jiang Y, et al
    Clinical Efficacy and Safety of Immunotherapy Retreatment in Metastatic Cervical Cancer: A Retrospective Study.
    Onco Targets Ther. 2023;16:157-163.
    Abstract

  177. YANG X, Zhu W
    ERBB3 mediates the PI3K/AKT/mTOR pathway to alter the epithelial‑mesenchymal transition in cervical cancer and predict immunity filtration outcome.
    Exp Ther Med. 2023;25:146.
    Abstract

  178. BURHAN A, Elmalaika Husian N, Yahia R, Abbasher L, et al
    Locally advanced cervical cancer complicating early pregnancy: A case of multiple challenges in a limited-resource setting.
    Gynecol Oncol Rep. 2023;46:101154.
    Abstract

  179. SHELLEY CE, Bolt MA, Hollingdale R, Chadwick SJ, et al
    Implementing cone-beam computed tomography-guided online adaptive radiotherapy in cervical cancer.
    Clin Transl Radiat Oncol. 2023;40:100596.
    Abstract

  180. CHANG L, Qiu L, Lei N, Zhou J, et al
    Characterization of fecal microbiota in cervical cancer patients associated with tumor stage and prognosis.
    Front Cell Infect Microbiol. 2023;13:1145950.
    Abstract

  181. WANG W, Liu L, Tian Y
    miR-19-3p Targets PTEN to Regulate Cervical Cancer Cell Proliferation, Invasion, and Autophagy.
    Genet Res (Camb). 2023;2023:4784500.
    Abstract

  182. GUO L, Wang W, Xie X, Wang S, et al
    Machine learning for genetic prediction of chemotherapy toxicity in cervical cancer.
    Biomed Pharmacother. 2023;161:114518.
    Abstract

  183. DADIPOOR S, Alavi A, Kader Z, Eshaghi Sani Kakhaki H, et al
    Utilization of cervical cancer screening services and its associated factors in Iran: a case-control study.
    Infect Agent Cancer. 2023;18:17.
    Abstract

  184. NISHIMURA Y, Matsuura M, Terada N, Nagao S, et al
    Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan.
    BMC Public Health. 2023;23:473.
    Abstract

  185. ZOU D, Liang A
    A bibliometric analysis on research hot spot and publication trends on immunotherapy for cervical cancer after surgery.
    Asian J Surg. 2023 Mar 9:S1015-9584(23)00281.
    Abstract

  186. GEORGE N, Bhandari P, Shruptha P, Jayaram P, et al
    Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis.
    Mol Cell Biochem. 2023 Mar 11:1-26. doi: 10.1007/s11010-023-04686.
    Abstract

  187. TADESSE F, Megerso A, Mohammed E, Nigatu D, et al
    Cervical Cancer Screening Practice Among Women: A Community Based Cross-Sectional Study Design.
    Inquiry. 2023;60:469580231159743.
    Abstract

  188. RAD A, Sorbye SW, Brenn T, Tiwari S, et al
    13-Type HPV DNA Test versus 5-Type HPV mRNA Test in Triage of Women Aged 25-33 Years with Minor Cytological Abnormalities-6 Years of Follow-Up.
    Int J Environ Res Public Health. 2023;20:4119.
    Abstract

  189. VOIDAZAN TS, Uzun CC, Kovacs Z, Rosznayai FF, et al
    The Hybrid Capture 2 Results in Correlation with the Pap Test, Sexual Behavior, and Characteristics of Romanian Women.
    Int J Environ Res Public Health. 2023;20:3839.
    Abstract

  190. KASHIMA Y, Murakami K, Miyagawa C, Takaya H, et al
    Treatment for Locally Resectable Stage IIIC1 Cervical Cancer: A Retrospective, Single-Institution Study.
    Healthcare (Basel). 2023;11:632.
    Abstract

  191. SHENG Y, Zhang B, Xing B, Liu Z, et al
    Cancer-Associated Fibroblasts Exposed to High-Dose Ionizing Radiation Promote M2 Polarization of Macrophages, Which Induce Radiosensitivity in Cervical Cancer.
    Cancers (Basel). 2023;15:1620.
    Abstract

  192. SEROUART B, Cordoba A, Martinez-Gomez C, Bogart E, et al
    Results of a 20 Year Retrospective Analysis of Early-Stage Cervical Cancer: Should 3 cm Be Considered the New Ariadne's Thread in Early Cervical Cancer Treatment?
    Cancers (Basel). 2023;15:1570.
    Abstract

  193. VINALS R, Jonnalagedda M, Petignat P, Thiran JP, et al
    Artificial Intelligence-Based Cervical Cancer Screening on Images Taken during Visual Inspection with Acetic Acid: A Systematic Review.
    Diagnostics (Basel). 2023;13:836.
    Abstract

  194. WU N, Jia D, Zhang C, Li Z, et al
    Cervical cell extraction network based on optimized yolo.
    Math Biosci Eng. 2023;20:2364-2381.
    Abstract

  195. LIU Y, Dong C, He X, Wu P, et al
    Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report.
    BMC Nephrol. 2023;24:51.
    Abstract

  196. KALLIS K, Moore L, Cortes KG, Brown D, et al
    Automated treatment planning framework for brachytherapy of cervical cancer using 3D dose predictions.
    Phys Med Biol. 2023 Mar 10. doi: 10.1088/1361-6560.
    Abstract

  197. DA ROSA P, Rekabdarkolaee HM, Koenecke L, Gudgeon L, et al
    Trends in Eligibility and Geographic Variations in Breast Cancer Screening Participation Among Underserved Women in South Dakota.
    S D Med. 2023;76:76-79.
    Abstract

  198. EUN BW, Bahar E, Xavier S, Kim H, et al
    Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017-2021).
    Hum Vaccin Immunother. 2023;19:2184756.
    Abstract

  199. DYKENS JA, Peterson CE, Holt HK, Harper DM, et al
    Gender neutral HPV vaccination programs: Reconsidering policies to expand cancer prevention globally.
    Front Public Health. 2023;11:1067299.
    Abstract

  200. ZHANG Q, Yang L, Gao H, Kuang X, et al
    APE1 promotes non-homologous end joining by initiating DNA double-strand break formation and decreasing ubiquitination of artemis following oxidative genotoxic stress.
    J Transl Med. 2023;21:183.
    Abstract

  201. OLIVEIRA SP, Montezuma D, Moreira A, Oliveira D, et al
    A CAD system for automatic dysplasia grading on H&E cervical whole-slide images.
    Sci Rep. 2023;13:3970.
    Abstract

  202. JIN WY, Zhang Y, Tian J, Xu LK, et al
    HOXA5 inhibits the proliferation and metastasis of cervical squamous cell carcinoma by suppressing the beta-catenin/Snail signaling.
    Neoplasma. 2023;70:82-93.
    Abstract

  203. BLOMBERG K, Halleberg-Nyman M
    Experiences of human papillomavirus self-sampling by women >60 years old: A qualitative study.
    Health Expect. 2023;26:818-826.
    Abstract

  204. CHOPRA S, Mulani J, Mittal P, Singh M, et al
    Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic.
    Brachytherapy. 2023;22:125-131.
    Abstract

  205. LI JY, Tien CJ, Kassick M, Peters GW, et al
    Implementing a simulation-based curriculum for hybrid intracavitary/interstitial brachytherapy using a new, commercially available, US/MR/CT-compatible gynecologic phantom.
    Brachytherapy. 2023;22:157-165.
    Abstract

  206. ZHAO T, Chen Y, Qiu B, Zhang J, et al
    Evaluating the accumulated dose distribution of organs at risk in combined radiotherapy for cervical carcinoma based on deformable image registration.
    Brachytherapy. 2023;22:174-180.
    Abstract

  207. CARPENTER DJ, Stephens SJ, Ayala-Peacock DN, Shenker RF, et al
    What is appropriate target delineation for MRI-based brachytherapy for medically inoperable endometrial cancer?
    Brachytherapy. 2023;22:181-187.
    Abstract

  208. KREIMER AR, Cernuschi T, Rees H, Brotherton JML, et al
    Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule.
    J Natl Cancer Inst. 2022 Oct 4. pii: 6747964. doi: 10.1093.
    Abstract

  209. LIU S, Chu R, Xie J, Song K, et al
    Differentiating single cervical cells by mitochondrial fluorescence imaging and deep learning-based label-free light scattering with multi-modal static cytometry.
    Cytometry A. 2023;103:240-250.
    Abstract

  210. HAMMERLE MH, Lu LH, Thomas LC, Swan AA, et al
    Possible autonomic or cranial nerve symptoms triggered during sustained neck rotation in persistent headache post-concussion: a retrospective observational cross-sectional study.
    J Man Manip Ther. 2023;31:113-123.
    Abstract

  211. ROCHA MA, de Campos Vidal B, Mello MLS
    Sodium Valproate Modulates the Methylation Status of Lysine Residues 4, 9 and 27 in Histone H3 of HeLa Cells.
    Curr Mol Pharmacol. 2023;16:197-210.
    Abstract

  212. XU P, Zhang H, Guo L, Huang X, et al
    Cervical cancer metastasis to ureter: A case report and literature review.
    Asian J Surg. 2023 Mar 23:S1015-9584(23)00337.
    Abstract

  213. SINGH KUSHWAH A, Srivastava K, Banerjee M
    Differential expression of DNA repair genes and treatment outcome of chemoradiotherapy (CRT) in cervical cancer.
    Gene. 2023 Mar 22:147389. doi: 10.1016/j.gene.2023.147389.
    Abstract

  214. BANO N, Ansari MI, Kainat KM, Singh VK, et al
    Chloroquine synergizes doxorubicin efficacy in cervical cancer cells through flux impairment and down regulation of proteins involved in the fusion of autophagosomes to lysosomes.
    Biochem Biophys Res Commun. 2023;656:131-138.
    Abstract

  215. KWETE XJ, Kane K, Liu YA, Krakauer EL, et al
    Frequency and duration of suffering of cervical cancer patients and caregivers: Results from an international Delphi study.
    PLOS Glob Public Health. 2023;3:e0001642.
    Abstract

  216. MEKONNEN AG, Mittiku YM
    Early-onset of sexual activity as a potential risk of cervical cancer in Africa: A review of literature.
    PLOS Glob Public Health. 2023;3:e0000941.
    Abstract

  217. CHONGSUWAT T, Ibrahim AO, Evensen AE, Conway JH, et al
    Health facility assessments of cervical cancer prevention, early diagnosis, and treatment services in Gulu, Uganda.
    PLOS Glob Public Health. 2023;3:e0000785.
    Abstract

  218. STANKUNAS M, Parna K, Tisler A, Kivite-Urtane A, et al
    Population Health Management Involving a Personalized Health Care Approach: An Example with Cervical Cancer Screening.
    Popul Health Manag. 2023 Mar 24. doi: 10.1089/pop.2023.0023.
    Abstract

  219. TIN KN, Ngamjarus C, Rattanakanokchai S, Sothornwit J, et al
    Interventions to increase the uptake of cervical cancer screening in low- and middle-income countries: a systematic review and meta-analysis.
    BMC Womens Health. 2023;23:120.
    Abstract

  220. NAKAMURA K, Shigeyasu K, Okamoto K, Matsuoka H, et al
    ADAR1 has an oncogenic function and can be a prognostic factor in cervical cancer.
    Sci Rep. 2023;13:4720.
    Abstract

  221. TSAOUSIDIS G, Zitzelsberger U, Papathemelis T
    Crossed fused renal ectopia during paraaortic lymphadenectomy for cervical cancer.
    J Minim Invasive Gynecol. 2023 Mar 21:S1553-4650(23)00110.
    Abstract

  222. ZHANG Y, Liu P, Wen D, Xiong H, et al
    Regulation of Cervical Cancer Development by a Novel Circ_0000212/miR-1236-3p/GREM1 ceRNA Crosstalk.
    Mol Biotechnol. 2023 Mar 23. doi: 10.1007/s12033-023-00721.
    Abstract

  223. GIGLIO AG, de Brito Rangel J, Cardozo CL, Bergmann A, et al
    Answer to the Letter to the Editor of Yu Toda, et al. concerning "Incidence and risk factors associated with the development of metastatic spinal cord compression due to bone metastasis in women with cervical cancer" by A. G. Giglio, et al. (Eur Spine
    Eur Spine J. 2023 Mar 22. doi: 10.1007/s00586-023-07657.
    Abstract

  224. MEENAN RT, Troja C, Buist DSM, Tiro JA, et al
    Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening.
    JAMA Netw Open. 2023;6:e234052.
    Abstract

  225. HU C, Liu T, Zhang W, Sun Y, et al
    miR-145 inhibits aerobic glycolysis and cell proliferation of cervical cancer by acting on MYC.
    FASEB J. 2023;37:e22839.
    Abstract

  226. MAO J, Yang W, Guo H, Dong R, et al
    [A cervical cancer tissue-derived decellularized extracellular matrix scaffold for cervical cancer tissue reconstruction in vitro].
    Nan Fang Yi Ke Da Xue Xue Bao. 2023;43:157-165.
    Abstract


  227. Update Management of Cervical Precancer Lesion.
    J Obstet Gynaecol Res. 2023;49 Suppl 1:191-202.
    Abstract

  228. ZHANG MX, Wang JH, Zhang L, Yan JX, et al
    [The characteristics and correlations of vaginal flora in women with cervical lesions].
    Zhonghua Zhong Liu Za Zhi. 2023;45:253-258.
    Abstract

  229. YUAN M, Zhao X, Wang H, Hu S, et al
    Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006-2030: a Bayesian Age-period-cohort Modeling Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Mar 21:EPI-22-0674.
    Abstract

  230. ELASBALI AM, Al-Soud WA, Mousa Elayyan AE, Al-Oanzi ZH, et al
    Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
    J Biomol Struct Dyn. 2023 Mar 21:1-17. doi: 10.1080/07391102.2023.2191719.
    Abstract

  231. GAO X, Kang J, Li X, Chen C, et al
    Deletion of the tyrosine phosphatase Shp2 in cervical cancer cells promotes reprogramming of glutamine metabolism.
    FASEB J. 2023;37:e22880.
    Abstract

  232. JAGER L, Senn O, Rosemann T, Plate A, et al
    Assessment of Human Papillomavirus Vaccination in Primary Care Among Swiss University Students.
    JAMA Netw Open. 2023;6:e233949.
    Abstract

  233. NONBOE MH, Napolitano G, Schroll JB, Vejborg I, et al
    Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study.
    Elife. 2023;12:e81605.
    Abstract

  234. STEVENS MJ, Ko F, Martland J, Brown R, et al
    Safety and efficacy of single insertion accelerated MR-image guided brachytherapy following chemo-radiation in locally advanced cervix cancer: modifying our EMBRACE during the COVID pandemic.
    Radiat Oncol. 2023;18:54.
    Abstract

  235. REN A, Gong F, Liu G, Fan W, et al
    NR1H4-mediated circRHOBTB3 modulates the proliferation, metastasis, and Warburg effects of cervical cancer through interacting with IGF2BP3.
    Mol Cell Biochem. 2023 Mar 20. doi: 10.1007/s11010-023-04692.
    Abstract

  236. FURTADO FS, Catalano OA
    Editorial for "A Multi-Center Study on Preoperative Assessment of Lymphovascular Space Invasion in Early-Stage Cervical Cancer Based on Multimodal MR Radiomics".
    J Magn Reson Imaging. 2023 Mar 20. doi: 10.1002/jmri.28678.
    Abstract

  237. ZENG W, Liang Y, Zhou J, Lin H, et al
    Vaginal microecological changes of different degrees of cervical lesions in Hakka women in Meizhou City.
    J Obstet Gynaecol. 2023;43:2186780.
    Abstract

  238. ARRIVILLAGA M, Bermudez PC, Garcia-Cifuentes JP, Rodriguez-Lopez M, et al
    Women's critical experiences with the pap smear for the development of cervical cancer screening devices.
    Heliyon. 2023;9:e14289.
    Abstract

  239. BARAL G, Baral R
    Erratum: Cervical Cancer Screening and HPV Vaccination in Nepal.
    South Asian J Cancer. 2023;12:e1.
    Abstract

  240. MAHAPATRA BR, Muraleedharan A, Badajena A, Das Majumdar SK, et al
    Cutaneous Metastasis in a Treated Case of Cervical Cancer With Extraordinary Response to Chemotherapy: A Case Report of a Rare Event and Review of the Literature.
    Cureus. 2023;15:e35083.
    Abstract

  241. WANG HB, Xu XT, Tian MX, Ding CC, et al
    Prognostic values of the prognostic nutritional index, geriatric nutritional risk index, and systemic inflammatory indexes in patients with stage IIB-III cervical cancer receiving radiotherapy.
    Front Nutr. 2023;10:1000326.
    Abstract

  242. ZHOU Y, Zhu J, Gu M, Gu K, et al
    Prognosis and Characterization of Microenvironment in Cervical Cancer Influenced by Fatty Acid Metabolism-Related Genes.
    J Oncol. 2023;2023:6851036.
    Abstract

  243. GJYSHI O, Grippin A, Andring L, Jhingran A, et al
    Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer.
    Clin Transl Radiat Oncol. 2023;39:100578.
    Abstract

  244. TANG Y, Tong Q, Dai N, Xu C, et al
    Evaluation of the clinical efficacy of vaginal treatment options for persistent high-risk human papillomavirus infection after excisional treatment of cervical high-grade squamous intraepithelial lesions: a systematic review and Bayesian network meta-
    Virol J. 2023;20:47.
    Abstract

  245. KUANG T, Li L, Chen Y, Wang J, et al
    Effects of miR-9-5p on the migration, invasion and epithelial-mesenchymal transition process in cervical squamous cell carcinoma.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48:15-23.
    Abstract

  246. SAWAYA GF, Saraiya M, Soman A, Gopalani SV, et al
    Accelerating Cervical Cancer Screening With Human Papillomavirus Genotyping.
    Am J Prev Med. 2023;64:552-555.
    Abstract

  247. XIANG Y, Wang F, Zhao M, Ling X, et al
    Nomograms prediction for young and middle-aged patients (aged under 50) with metastatic cervical cancer: Based on SEER database.
    Asian J Surg. 2023 Mar 16:S1015-9584(23)00319.
    Abstract

  248. GRABINSKI E, Dunsmoor-Su R
    Pap smear recommendations in older women, does the data support stopping?
    Curr Opin Obstet Gynecol. 2023;35:160-163.
    Abstract

  249. SHAFIEE G, Mousavian AH, Sheidaei A, Ebrahimi M, et al
    The 15-year national trends of genital cancer incidence among Iranian men and women; 2005-2020.
    BMC Public Health. 2023;23:495.
    Abstract

  250. GAO Y, Jiang Y, Tie YQ, Yu D, et al
    [Application of multiplex PCR capillary electrophoresis and analysis of distribution characteristics of HPV infection subtypes].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2023;57:393-399.
    Abstract

  251. VALCARCEL B, Enriquez-Vera D, De-la-Cruz-Ku G, Chambergo-Michilot D, et al
    Epidemiological Features and Outcomes of HTLV-1 Carriers Diagnosed With Cancer: A Retrospective Cohort Study in an Endemic Country.
    JCO Glob Oncol. 2023;9:e2200369.
    Abstract

  252. OYOUNI AAA
    Human papillomavirus in cancer: Infection, disease transmission, and progress in vaccines.
    J Infect Public Health. 2023;16:626-631.
    Abstract

  253. AZIZ H, Sattar AA, Mahmood H, Fatima S, et al
    Prevalence of HPV types in HIV-positive and negative females with normal cervical cytology or dysplasia.
    J Clin Lab Anal. 2023;37:e24851.
    Abstract

  254. ALMOTAIRY A, Alyahya M, Althobaiti A, Almutairi M, et al
    Disulfiram 3D printed film produced via hot-melt extrusion techniques as a potential anticervical cancer candidate.
    Int J Pharm. 2023;635:122709.
    Abstract

  255. SHING JZ, Corbin J, Kreimer AR, Carvajal LJ, et al
    Human papillomavirus-associated cancer incidence by disaggregated Asian American, Native Hawaiian, and other Pacific Islander ethnicity.
    JNCI Cancer Spectr. 2023;7:pkad012.
    Abstract

  256. BARAKZAI SK, Nguyen A, Sehgal S, Matsuo K, et al
    The clinical relevance of human papillomavirus negative status in unsatisfactory cervical cytology.
    Arch Gynecol Obstet. 2023;307:1021-1025.
    Abstract

  257. GUTIERREZ MIGUELEZ C, Rodriguez Villalba S, Villafranca Iturre E, Fuentemilla Urio N, et al
    Recommendations of the Spanish brachytherapy group of the Spanish Society of Radiation Oncology and the Spanish Society of Medical Physics for interstitial high-dose-rate brachytherapy for gynaecologic malignancies.
    Clin Transl Oncol. 2023;25:912-932.
    Abstract

  258. ZHANG B, Zhang S, Sun L, Wu Y, et al
    Characteristics of preplan-based three-dimensional individual template-guided brachytherapy compared to freehand implantation.
    J Appl Clin Med Phys. 2023;24:e13840.
    Abstract

  259. HANCZUK T, Weiss M, Henes L, Engler T, et al
    Certification as dysplasia unit and its impact on large loop electrosurgical excision (LEEP).
    Arch Gynecol Obstet. 2023;307:1177-1184.
    Abstract

  260. CAO Y, Ma H, Fan Y, Liu Y, et al
    A deep learning-based method for cervical transformation zone classification in colposcopy images.
    Technol Health Care. 2023;31:527-538.
    Abstract

  261. LIEB JA, Mondal A, Lieb L, Fehm TN, et al
    Pregnancy outcome and risk of recurrence after tissue-preserving loop electrosurgical excision procedure (LEEP).
    Arch Gynecol Obstet. 2023;307:1137-1143.
    Abstract

  262. NEIS F, Holleczek B, Henes M, Juhasz-Boss I, et al
    Proposal for a descriptive and differentiated presentation of the longitudinal impact of the new organized cancer screening guideline and HPV vaccination in Germany.
    Arch Gynecol Obstet. 2023;307:1125-1136.
    Abstract

  263. ZHAO J, Zheng W, Wang L, Jiang H, et al
    Human papillomavirus (HPV) integration signature in cervical lesions: identification of MACROD2 gene as HPV hot spot integration site.
    Arch Gynecol Obstet. 2023;307:1115-1123.
    Abstract

  264. PAPASTAMELOS C, Linder M
    Human papillomavirus anogenital screening in solid organ transplant recipients: a narrative review.
    Arch Gynecol Obstet. 2023;307:1277-1283.
    Abstract

  265. ERDEN F, Karagoz H
    Human papillomavirus and vaccination.
    J Am Acad Dermatol. 2023;88:e175.
    Abstract

  266. NOFAL A, Ibrahim AM, Nofal E, Nabil M, et al
    Human papillomavirus and vaccination.
    J Am Acad Dermatol. 2023;88:e177.
    Abstract

  267. AMIN FAS, Un Naher Z, Ali PSS
    Molecular markers predicting the progression and prognosis of human papillomavirus-induced cervical lesions to cervical cancer.
    J Cancer Res Clin Oncol. 2023 Mar 31. doi: 10.1007/s00432-023-04710.
    Abstract

  268. XU X, Shen L, Li W, Liu X, et al
    ITGA5 promotes tumor angiogenesis in cervical cancer.
    Cancer Med. 2023 Mar 31. doi: 10.1002/cam4.5873.
    Abstract

  269. CHENG Y, Geng L, Zhao L, Zuo P, et al
    [Corrigendum] Human papillomavirus E6‑regulated microRNA‑20b promotes invasion in cervical cancer by targeting tissue inhibitor of metalloproteinase 2.
    Mol Med Rep. 2023;27:101.
    Abstract

  270. YU W, Xiao C, Xu J, Jin J, et al
    Direct Dose Prediction With Deep Learning for Postoperative Cervical Cancer Underwent Volumetric Modulated Arc Therapy.
    Technol Cancer Res Treat. 2023;22:15330338231167039.
    Abstract

  271. VISIOLI CB, Giorgi Rossi P, Armaroli P, Iossa A, et al
    The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15-16 years in Italy.
    J Med Screen. 2023 Mar 30:9691413231165237. doi: 10.1177/09691413231165237.
    Abstract

  272. CHARROIS-DURAND C, Beauchemin MC, Barkati M
    A Case of Radiation-Induced Aortitis in a Patient With Cervical Cancer.
    Cureus. 2023;15:e35484.
    Abstract

  273. HAO Y, Guy MM, Liu Q, Li R, et al
    Construction of a prognostic model based on eight ubiquitination-related genes via machine learning and potential therapeutics analysis for cervical cancer.
    Front Genet. 2023;14:1142938.
    Abstract

  274. HE M, Guo M, Zhou Q, Tang Y, et al
    Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103).
    J Gynecol Oncol. 2023 Mar 23. doi: 10.3802/jgo.2023.
    Abstract

  275. LI M, Zhao C, Zhao Y, Li J, et al
    Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China.
    Front Immunol. 2023;14:1112750.
    Abstract

  276. SHISHKOVA K, Gergova R, Tasheva E, Shishkov S, et al
    Molecular Screening for High-Risk Human Papillomaviruses in Patients with Periodontitis.
    Viruses. 2023;15:809.
    Abstract

  277. ACEVEDO-SANCHEZ V, Martinez-Ruiz RS, Aguilar-Ruiz SR, Torres-Aguilar H, et al
    Quantitative Proteomics for the Identification of Differentially Expressed Proteins in the Extracellular Vesicles of Cervical Cancer Cells.
    Viruses. 2023;15:702.
    Abstract

  278. UMAKANTHAN S, Bukelo MM, Ghany S, Gay D, et al
    The Correlation of Papanicolaou Smears and Clinical Features to Identify the Common Risk Factors for Cervical Cancer: A Retrospective and Descriptive Study from a Tertiary Care Hospital in Trinidad.
    Vaccines (Basel). 2023;11:697.
    Abstract

  279. DAU H, Gottschlich A, Metz L, Pineda N, et al
    The role of daughters in relation to their mother's cervical cancer diagnosis and treatment in Guatemala: a descriptive study.
    BMC Womens Health. 2023;23:142.
    Abstract

  280. ZHU B, Yu H, Ni P, Chen X, et al
    A population-based cross-sectional study on the situation of cervical cancer screening in Liaoning, China.
    BMC Womens Health. 2023;23:144.
    Abstract

  281. LIU J, Wu D, Lin X, Hong Y, et al
    Retraction notice to "Long non-coding RNA TUG1 sponges microRNA-381-3p to facilitate cell viability and attenuate apoptosis in cervical cancer by elevating MDM2 expression" [Life Sci. 267 (2021) 118902].
    Life Sci. 2023 Mar 27:121600. doi: 10.1016/j.lfs.2023.121600.
    Abstract

  282. HARIPRASAD R, John A, Abdulkader RS
    Challenges in the Implementation of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in India: A Systematic Review.
    JCO Glob Oncol. 2023;9:e2200401.
    Abstract

  283. KRISHNA A, Hasib AG, Fernandes D, Athiyamaan MS, et al
    Comparison of two high dose rate intracavitary brachytherapy regimens in treatment of cervical cancer: a preliminary report.
    Discov Oncol. 2023;14:33.
    Abstract

  284. LECHER JC, Didier HL, Dickson RL, Slaughter LR, et al
    Utilization of a cell-penetrating peptide-adaptor for delivery of human papillomavirus protein E2 into cervical cancer cells to arrest cell growth and promote cell death.
    Cancer Rep (Hoboken). 2023 Mar 28:e1810. doi: 10.1002/cnr2.1810.
    Abstract

  285. FERREIRA M, Gomes D, Neto M, Passarinha LA, et al
    Development and Characterization of Quercetin-Loaded Delivery Systems for Increasing Its Bioavailability in Cervical Cancer Cells.
    Pharmaceutics. 2023;15:936.
    Abstract

  286. JAYASINGHE YL, Tabrizi SN, Stevens M, Leong TY, et al
    Pre-Vaccination Human Papillomavirus Genotypes and HPV16 Variants among Women Aged 25 Years or Less with Cervical Cancer.
    Pathogens. 2023;12:451.
    Abstract

  287. SHAIKH R, Daniel A, Lyng FM
    Raman Spectroscopy for Early Detection of Cervical Cancer, a Global Women's Health Issue-A Review.
    Molecules. 2023;28:2502.
    Abstract

  288. GARGIULO ISACCO C, Balzanelli MG, Garzone S, Lorusso M, et al
    Alterations of Vaginal Microbiota and Chlamydia trachomatis as Crucial Co-Causative Factors in Cervical Cancer Genesis Procured by HPV.
    Microorganisms. 2023;11:662.
    Abstract

  289. FAN W, Lu Q, Liu G
    A Clinical Prediction Model of Overall Survival for Patients with Cervical Cancer Aged 25-69 Years.
    Medicina (Kaunas). 2023;59:600.
    Abstract

  290. CORTES-SARABIA K, Alarcon-Romero LDC, Mendoza-Catalan MA, Carpio-Pedroza JC, et al
    REST/NRSF Silencing Modifies Neuronal Gene Expression in siRNA-Treated HeLa Cells: A Preliminary Exploration in the Search for Neuronal Biomarkers of Cervical Cancer.
    Medicina (Kaunas). 2023;59:537.
    Abstract

  291. ZENG L, Sun X
    Correlation of INHBA Overexpression with Pathological Features, Antitumor Immune Response and Clinical Prognosis in Cervical Cancer.
    Medicina (Kaunas). 2023;59:495.
    Abstract

  292. JING W, Zhang R, Chen X, Zhang X, et al
    Association of Glycosylation-Related Genes with Different Patterns of Immune Profiles and Prognosis in Cervical Cancer.
    J Pers Med. 2023;13:529.
    Abstract

  293. PADEZNIK T, Oleksy A, Cokan A, Takac I, et al
    Changes in the Extracellular Matrix in Endometrial and Cervical Cancer: A Systematic Review.
    Int J Mol Sci. 2023;24:5463.
    Abstract

  294. AZAGE M, Zewudie S, Goedert MH, Hagos EG, et al
    Epidemiological Characteristics of Cancer Patients Attending at Felege Hiwot Referral Hospital, Northwest Ethiopia.
    Int J Environ Res Public Health. 2023;20:5218.
    Abstract

  295. SKJELDESTAD FE, Wergeland Sorbye S
    May Women with a Negative Co-Test at First Follow-Up Visit Return to 3-Year Screening after Treatment for Cervical Intraepithelial Neoplasia?
    Int J Environ Res Public Health. 2023;20:4739.
    Abstract

  296. CHUA B, Lim LM, Ng JSY, Ma Y, et al
    Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore.
    Cancers (Basel). 2023;15:1812.
    Abstract

  297. CHEN X, Jiang M, Zhou S, Chen H, et al
    PRAME Promotes Cervical Cancer Proliferation and Migration via Wnt/beta-Catenin Pathway Regulation.
    Cancers (Basel). 2023;15:1801.
    Abstract

  298. DAPONTE N, Valasoulis G, Michail G, Magaliou I, et al
    HPV-Based Self-Sampling in Cervical Cancer Screening: An Updated Review of the Current Evidence in the Literature.
    Cancers (Basel). 2023;15:1669.
    Abstract

  299. ZHANG Y, Wu C, Xiao Z, Lv F, et al
    A Deep Learning Radiomics Nomogram to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer: A Two-Center Study.
    Diagnostics (Basel). 2023;13:1073.
    Abstract

  300. JI J, Pang W, Song J, Wang X, et al
    Retrospective Analysis of the Predictive Value of (18)F-FDG PET/CT Metabolic Parameters for PD-L1 Expression in Cervical Cancer.
    Diagnostics (Basel). 2023;13:1015.
    Abstract

  301. HUANG Q, Wang Y, Meng X, Li J, et al
    Amide Proton Transfer-Weighted Imaging Combined with ZOOMit Diffusion Kurtosis Imaging in Predicting Lymph Node Metastasis of Cervical Cancer.
    Bioengineering (Basel). 2023;10:331.
    Abstract

  302. ROCKWELL MS, Armbruster SD, Capucao JC, Russell KB, et al
    Reallocating Cervical Cancer Preventive Service Spending from Low to High-Value Clinical Scenarios.
    Cancer Prev Res (Phila). 2023 Mar 28:CAPR-22-0531.
    Abstract

  303. GAO Z, Zhao M, Yang X, Fu J, et al
    Assessment of Peripheral Platelet to Lymphocyte Ratio and Prognostic Nutritional Index in the Efficacy and Prognosis of Radiotherapy for Cervical Cancer.
    Curr Oncol. 2023;30:2834-2844.
    Abstract

  304. KC H, Gurung A, Katuwal M, Sharma R, et al
    Knowledge, Practice and Barriers on Cervical Cancer Screening among Married Women.
    J Nepal Health Res Counc. 2023;20:755-760.
    Abstract

  305. MIYOSHI AI, Ueda Y, Kurita T, Kimura T, et al
    Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
    Anticancer Res. 2023;43:1397-1405.
    Abstract

  306. TOITA T, Wada K, Sutani S, Umezawa R, et al
    Definitive radiotherapy consisting of external beam radiotherapy without central shielding and 3D image-guided brachytherapy for patients with cervical cancer: feasibility for Japanese patients and dose-response analyses for local control in the low-d
    Jpn J Clin Oncol. 2023 Mar 27:hyad022. doi: 10.1093.
    Abstract

  307. HORIO F, Ikeda T, Zaitsu M, Takebe D, et al
    Knowledge and Awareness of Human Papillomavirus Vaccination and Cervical Cancer among Men and Women in Japan: A Questionnaire Survey.
    Asian Pac J Cancer Prev. 2023;24:1063-1071.
    Abstract

  308. JOHAN SK, Lobo D, Athiyamaan MS, Srinivas C, et al
    In-vivo Comparison of Planned and Measured Rectal Doses during Cobalt-60 HDR CT-based Intracavitary Brachytherapy Applications of Cervical Cancer Using the PTW 9112 Semiconductor Probe.
    Asian Pac J Cancer Prev. 2023;24:897-907.
    Abstract

  309. SURENDRAN S, Foo C, Tan DHY, Tan WH, et al
    Understanding Barriers and Facilitators of Breast and Cervical Cancer Screening among Singapore Women: A Qualitative Approach.
    Asian Pac J Cancer Prev. 2023;24:889-895.
    Abstract

  310. CAMPANER AB, Fernandes GL
    Evaluation of 1,030,482 Cervical Smear Results in Brazilian Population.
    Asian Pac J Cancer Prev. 2023;24:867-872.
    Abstract

  311. LIN Y, Zhang R, Pan H, Li Y, et al
    A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer.
    Med Sci Monit. 2023;29:e938660.
    Abstract

  312. ADEGBOYEGA A, Adeyimika D, Omoadoni O, Mark D, et al
    HPV vaccination and cervical cancer screening promotion among Black individuals: social ecological perspectives from key informants interviews.
    Ethn Health. 2023 Mar 27:1-15. doi: 10.1080/13557858.2023.2193360.
    Abstract

  313. PLAISY MK, Boni SP, Coffie PA, Tanon A, et al
    Barriers to early diagnosis of cervical cancer: a mixed-method study in Cote d'Ivoire, West Africa.
    BMC Womens Health. 2023;23:135.
    Abstract

  314. LIN W, Huang W, Mei C, Liu P, et al
    Associations between the signing status of family doctor contract services and cervical cancer screening behaviors: a cross-sectional study in Shenzhen, China.
    BMC Public Health. 2023;23:573.
    Abstract

  315. TANG FT, Ji J, Ding J, Ke F, et al
    [Cervical gastric-type adenocarcinomas with enteroblastoid characteristic: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2023;52:417-420.
    Abstract

  316. SHI L, Zhang D, Han H, Zhang L, et al
    HOTAIR knockdown impairs metastasis of cervical cancer cells by down-regulating metastasis-related genes.
    J Obstet Gynaecol. 2023;43:2181060.
    Abstract

  317. XU HF, Zhao XL, Zhao S, Hu SY, et al
    Clinical performance of a newly developed domestic urine-based HPV test for cervical cancer screening in China.
    J Med Virol. 2023 Mar 27. doi: 10.1002/jmv.28705.
    Abstract

  318. XIA J, Chen GY, Li YY, Chen L, et al
    Rapid and sensitive detection of superoxide dismutase in serum of the cervical cancer by 4-aminothiophenol-functionalized bimetallic Au-Ag nanoboxs array.
    Front Bioeng Biotechnol. 2023;11:1111866.
    Abstract

  319. MUTYALA S, Smith G, Ansinelli H, Thawani N, et al
    Feasibility of outpatient hybrid brachytherapy for cervical cancer with minimal sedation: Results from a single-institutional protocol.
    J Contemp Brachytherapy. 2023;15:43-47.
    Abstract

  320. FROHLICH G, Vizkeleti J, Nguyen AN, Polgar C, et al
    Are active dwell positions always necessary in the ring/ovoids channel of the cervical applicator in the intracavitary-interstitial brachytherapy of cervical cancer?
    J Contemp Brachytherapy. 2023;15:48-56.
    Abstract

  321. KANANI A, Owrangi A, Yazdi M, Fatemi-Ardekani A, et al
    Development of a multi-purpose quality control phantom for MRI-based treatment planning in high-dose-rate brachytherapy of cervical cancer.
    J Contemp Brachytherapy. 2023;15:57-68.
    Abstract

  322. FAIVRE JC, Jung P, Salleron J, Baumard F, et al
    Prognostic factors of local control and progression-free survival in AJCC stages T1 and T2 cervical cancer patients treated with adjuvant brachytherapy after chemoradiotherapy.
    J Contemp Brachytherapy. 2023;15:27-36.
    Abstract

  323. LI X, Du M, Zuo S, Zhou M, et al
    Deep convolutional neural networks using an active learning strategy for cervical cancer screening and diagnosis.
    Front Bioinform. 2023;3:1101667.
    Abstract

  324. YAO S, Zhao L, Chen S, Wang H, et al
    Cervical cancer immune infiltration microenvironment identification, construction of immune scores, assisting patient prognosis and immunotherapy.
    Front Immunol. 2023;14:1135657.
    Abstract

  325. CRUZ-VALDEZ A, Palacio-Mejia LS, Quezada-Sanchez AD, Hernandez-Avila JE, et al
    Cervical cancer prevention program in Mexico disrupted due to COVID-19 pandemic: Challenges and opportunities.
    Front Oncol. 2023;13:1008560.
    Abstract

  326. KULKARNI SP, Paliwal S, Kosta S
    Genotypic Diversity of Human Papillomavirus (HPV) Types and Its Prevalence With Cervical Cancer (CC) in Central India.
    Cureus. 2023;15:e35227.
    Abstract

  327. CHEN G, Hong X, He W, Ou L, et al
    The construction and analysis of tricarboxylic acid cycle related prognostic model for cervical cancer.
    Front Genet. 2023;14:1092276.
    Abstract

  328. GUO C, Qu X, Tang X, Song Y, et al
    Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: Integrating single-cell RNA-sequencing and spatial transcriptome
    Clin Transl Med. 2023;13:e1219.
    Abstract

  329. AHMED B, Abushama M, Konje JC
    Prevention of spontaneous preterm delivery - an update on where we are today.
    J Matern Fetal Neonatal Med. 2023;36:2183756.
    Abstract

  330. HU K, Wang J, Sparen P, Herweijer E, et al
    Invasive cervical cancer, precancerous lesions, and cervical screening participation among women with mental illness in Sweden: a population-based observational study.
    Lancet Public Health. 2023;8:e266-e275.
    Abstract

  331. BATESON D, Woo YL, Kulkarni J
    Elimination of cervical cancer: ensuring equity.
    Lancet Public Health. 2023;8:e248-e249.
    Abstract

  332. YARANDI F, Shirali E, Feizabad E, Ramhormoziyan S, et al
    Cervical intraepithelial neoplasia in non-16/18 high-risk human papilloma virus positive/cytology negative women: An alternative approach in poor resource areas.
    Taiwan J Obstet Gynecol. 2023;62:299-303.
    Abstract

  333. ZHANG X, Zhu L, Wang X, Zhang H, et al
    Basic research on curcumin in cervical cancer: Progress and perspectives.
    Biomed Pharmacother. 2023;162:114590.
    Abstract

  334. MEGERSA T, Dango S, Kumsa K, Lemma K, et al
    Prevalence of high-risk human papillomavirus infections and associated factors among women living with HIV in Shashemene town public health facilities, Southern Ethiopia.
    BMC Womens Health. 2023;23:125.
    Abstract

  335. KESIC V, Carcopino X, Preti M, Vieira-Baptista P, et al
    The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus S
    J Low Genit Tract Dis. 2023;27:131-145.
    Abstract

  336. CLAY PA, Thompson TD, Markowitz LE, Ekwueme DU, et al
    Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States.
    Vaccine. 2023 Mar 10:S0264-410X(23)00184-6. doi: 10.1016/j.vaccine.2023.
    Abstract

  337. WEI Y, Lin S, Zhi W, Chu T, et al
    Genomic analysis of cervical carcinoma identifies Alpelisib as a therapeutic option for PIK3CA-mutant cervical carcinoma via the PI3K/AKT pathway.
    J Med Virol. 2023;95:e28656.
    Abstract

  338. AL ALAWI S, Al Zaabi O, Heffernan ME, Arulappan J, et al
    Knowledge, attitudes and acceptance toward Human papillomavirus (HPV) vaccination: Perspectives of Muslim women and men.
    Vaccine. 2023 Feb 27:S0264-410X(23)00217-7. doi: 10.1016/j.vaccine.2023.
    Abstract

  339. SKELIN J, Dukic A, Filic V, Hufbauer M, et al
    MAML1-induced HPV E6 oncoprotein stability is required for cellular proliferation and migration of cervical tumor-derived cells.
    J Med Virol. 2023;95:e28624.
    Abstract

  340. LIN G, Li J
    Circulating HPV DNA in HPV-associated cancers.
    Clin Chim Acta. 2023;542:117269.
    Abstract

  341. HUGHES KC, Herring TA, Song JN, Gately RV, et al
    Cervical High-Grade Squamous Intraepithelial Lesion Burden and Standard of Care Treatment Effectiveness and Safety in the United States, 2008-2018: The EACH-WOMAN Project.
    J Low Genit Tract Dis. 2023;27:105-112.
    Abstract

  342. LIANG HY, Chen SL, Cai SH, Zhang SW, et al
    CMTM6 recruits T cells within the endocervical adenocarcinoma microenvironment and suppresses cell proliferation via the p53 pathway.
    J Med Virol. 2023;95:e28605.
    Abstract

  343. LIU Y, Li T, Guo R, Chen T, et al
    The vaginal microbiota among the different status of human papillomavirus infection and bacterial vaginosis.
    J Med Virol. 2023;95:e28595.
    Abstract

  344. MORELLO L, Mancini J, Carcopino X
    Predictors factors of the absence of high-grade intraepithelial lesion in excisional therapy specimen.
    J Gynecol Obstet Hum Reprod. 2023;52:102550.
    Abstract

  345. WATSON CH, Spinosa D, Hayes T, Scott A, et al
    A Pilot Study of a Screening Program for Human Papillomavirus-Related Squamous Intraepithelial Lesion and Malignancy in Gynecologic Oncology Patients.
    J Low Genit Tract Dis. 2023;27:120-124.
    Abstract

  346. DEL VECCHIO NJ, Beaber EF, Garcia MP, Wheeler CM, et al
    Provider- and Facility-Level Variation in Precancerous Cervical Biopsy Diagnoses.
    J Low Genit Tract Dis. 2023;27:113-119.
    Abstract

  347. CHANG X, Miao J
    Ferroptosis: Mechanism and potential applications in cervical cancer.
    Front Mol Biosci. 2023;10:1164398.
    Abstract

  348. HUANG XD, Huo LQ, Luo YS, Chen K, et al
    Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer.
    Ther Adv Med Oncol. 2023;15:17588359231165974.
    Abstract

  349. NICKSON C, Smith MA, Feletto E, Velentzis LS, et al
    A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia.
    Elife. 2023;12:e82818.
    Abstract

  350. LIANG H, Xiang L, Wu H, Liu Y, et al
    Anoikis-related long non-coding RNA signatures to predict prognosis and small molecular drug response in cervical cancer.
    Front Pharmacol. 2023;14:1135626.
    Abstract

  351. CHEN J, Ma N, Sun M, Chen L, et al
    Prognostic value of apparent diffusion coefficient in neuroendocrine carcinomas of the uterine cervix.
    PeerJ. 2023;11:e15084.
    Abstract

  352. SAVAS LS, Loomba P, Shegog R, Alaniz A, et al
    Using Implementation Mapping to increase uptake and use of Salud en Mis Manos: A breast and cervical cancer screening and HPV vaccination intervention for Latinas.
    Front Public Health. 2023;11:966553.
    Abstract

  353. LI T, Feng R, Chen B, Zhou J, et al
    EREG is a risk factor for the prognosis of patients with cervical cancer.
    Front Med (Lausanne). 2023;10:1161835.
    Abstract

  354. WANG Y, Chuan J, Zhu B, Zu Y, et al
    Evaluation of PAX1/ST6GALNAC5 methylation as a triage test for cervical intraepithelial neoplasia and cervical cancer.
    Epigenomics. 2023 Apr 5. doi: 10.2217/epi-2022-0396.
    Abstract

  355. LILLIECREUTZ C, Holm ACS, Dahlgren MA, Blomberg M, et al
    Student-led clinic cervical cancer screening-medical students' views on progression of learning, quality of Pap smears and women s experiences of the visit - a mixed methods study.
    BMC Med Educ. 2023;23:218.
    Abstract

  356. MUTURI D, Mwanzi SN, Riunga FM, Shah J, et al
    HIV Prevalence and Characteristics Among Patients With AIDS-Defining and Non-AIDS-Defining Cancers in a Tertiary Hospital in Kenya.
    JCO Glob Oncol. 2023;9:e2200360.
    Abstract

  357. SSEDYABANE F, Ngonzi J, Kajabwangu R, Najjuma JN, et al
    Association between obesity and cervical intraepithelial neoplasia: results from a case control study in south western Uganda.
    BMC Womens Health. 2023;23:159.
    Abstract

  358. DE RIBAMAR ROSS J, Marinelli NP, Vidal FCB, da Costa Fraga E, et al
    Frequency of human papilomavirus and associated factors in gypsy and quilombola women : Human papillomavirus in gypsy and quilombola women.
    BMC Womens Health. 2023;23:160.
    Abstract

  359. TODA Y, Morimoto T, Hirata H, Yoshihara T, et al
    Letter to the Editor concerning "Incidence and risk factors associated with the development of metastatic spinal cord compression due to bone metastasis in women with cervical cancer" by A. Grasso Giglio, et al. (Eur Spine J [2022]: doi:10.1007/s00586
    Eur Spine J. 2023 Apr 4. doi: 10.1007/s00586-023-07656.
    Abstract

  360. EAKIN A, Wairiri L, Stadtlander W, Bruegl A, et al
    Identifying disparities in brachytherapy delivery for locally advanced cervical cancer.
    Brachytherapy. 2023 Apr 2:S1538-4721(23)00025.
    Abstract

  361. WALTER AE, Cosper PF, Nickel KP, Ramesh S, et al
    Biological Characterization of the Effects of Filtration on the Xoft Axxent(R) Electronic Brachytherapy Source for Cervical Cancer Applications.
    Radiat Res. 2023 Apr 4. doi: 10.1667/RADE-22-00112.
    Abstract

  362. WU PJ, Chiou HL, Hsieh YH, Lin CL, et al
    Induction of immunogenic cell death effect of licoricidin in cervical cancer cells by enhancing endoplasmic reticulum stress-mediated high mobility group box 1 expression.
    Environ Toxicol. 2023 Apr 4. doi: 10.1002/tox.23793.
    Abstract

  363. NINSIIMA M, Nyabigambo A, Kagaayi J
    Acceptability of integration of cervical cancer screening into routine HIV care, associated factors and perceptions among HIV-infected women: a mixed methods study at Mbarara Regional Referral Hospital, Uganda.
    BMC Health Serv Res. 2023;23:333.
    Abstract

  364. QIU J, Chen X
    Acquired vulvar lymphangioma circumscriptum after cervical cancer.
    Pan Afr Med J. 2023;44:29.
    Abstract

  365. SHANG F, Tan Z, Gong T, Tang X, et al
    Evaluation of parametrial infiltration in patients with IB-IIB cervical cancer by a radiomics model integrating features from tumoral and peritumoral regions on (18) F-FDG PET/MRI images.
    NMR Biomed. 2023 Apr 3:e4945. doi: 10.1002/nbm.4945.
    Abstract

  366. OKETCH SY, Ochomo EO, Orwa JA, Mayieka LM, et al
    Communication strategies to improve human papillomavirus (HPV) immunisation uptake among adolescents in sub-Saharan Africa: a systematic review and meta-analysis.
    BMJ Open. 2023;13:e067164.
    Abstract

  367. LIU H, Ma H, Li Y, Zhao H, et al
    Advances in epigenetic modifications and cervical cancer research.
    Biochim Biophys Acta Rev Cancer. 2023 Apr 1:188894.
    Abstract

  368. A D, Bi H, Zhang D, Xiao B, et al
    Association between human papillomavirus infection and common sexually transmitted infections, and the clinical significance of different Mycoplasma subtypes.
    Front Cell Infect Microbiol. 2023;13:1145215.
    Abstract

  369. LIAO D, Liu X, He L, Yao Y, et al
    Comprehensive bioinformatics analysis of the expression, prognostic value, and immune infiltration of chromobox family members in cervical cancer.
    Iran J Basic Med Sci. 2023;26:468-477.
    Abstract

  370. GAO D, Zhao G, Di J, Zhang X, et al
    Knowledge of Cervical Cancer and HPV, and Willingness to Receive HPV Vaccination Among 20-45-Year-Old Women - Six Provinces, China, 2018.
    China CDC Wkly. 2023;5:201-205.
    Abstract

  371. GRAU-BEJAR JF, Garcia-Duran C, Garcia-Illescas D, Mirallas O, et al
    Advances in immunotherapy for cervical cancer.
    Ther Adv Med Oncol. 2023;15:17588359231163836.
    Abstract

  372. LIU J, Li S, Cao Q, Zhang Y, et al
    Risk factors for the recurrence of cervical cancer using MR-based T1 mapping: A pilot study.
    Front Oncol. 2023;13:1133709.
    Abstract

  373. SURYADEVARA A, Gundu DK, Kuppa P, Chinta SK, et al
    The selection of tandem angle and imaging during intracavitary brachytherapy of carcinoma cervix - An experience from a regional cancer center.
    J Cancer Res Ther. 2023;19:235-240.
    Abstract

  374. LI K, Yin R
    Opportunistic cervical cancer screening for elderly women without standardized screening.
    J Cancer Res Ther. 2023;19:92-96.
    Abstract

  375. CHENG H, Wang L, Wang L, Li Q, et al
    Discussion on the necessity of bilateral inguinal lymphatic area irradiation for cervical cancer with invasion of the lower one-third of the vagina.
    J Cancer Res Ther. 2023;19:20-24.
    Abstract

  376. GAUNA F, Verger P, Fressard L, Jardin M, et al
    Vaccine hesitancy about the HPV vaccine among French young women and their parents: a telephone survey.
    BMC Public Health. 2023;23:628.
    Abstract

  377. ZHONG G, Zhao Q, Chen Z, Yao T, et al
    TGF-beta signaling promotes cervical cancer metastasis via CDR1as.
    Mol Cancer. 2023;22:66.
    Abstract

  378. CINTRA FRE, Araujo LM, Dib MI, Brollo LCS, et al
    Cervical Cancer Screening Is a Highly Neglected Procedure Among Women With Systemic Lupus Erythematosus.
    J Rheumatol. 2023 Apr 1:jrheum.230082. doi: 10.3899/jrheum.230082.
    Abstract

  379. AO M, Li P, Sun D, Li X, et al
    Changes in T lymphocyte subsets in peripheral blood of patients with middle-advanced cervical cancer before and after nimotuzumab combined with concurrent chemoradiotherapy.
    J Obstet Gynaecol. 2023;43:2179915.
    Abstract

  380. BURKI TK
    India rolls out HPV vaccination.
    Lancet Oncol. 2023;24:e147.
    Abstract

  381. COLE K, Al-Kadhimi Z, Talmadge JE
    Highlights into historical and current immune interventions for cancer.
    Int Immunopharmacol. 2023;117:109882.
    Abstract

  382. CHEN J, Wang D, Wang Z, Wu K, et al
    Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16.
    J Virol. 2023;97:e0181922.
    Abstract

  383. JORDA P, Hullot J, Crouzet A, Poteau A, et al
    [Psychological impact of the announcement of an abnormal cervical smear: How to improve patient experience and information? COLANX: a multicenter study in Seine-Maritime].
    Gynecol Obstet Fertil Senol. 2023;51:193-199.
    Abstract

  384. POISEUIL M, Moutel G, Cosson M, Quertier MC, et al
    Participation in breast cancer screening and its influence on other cancer screening invitations: study in women aged 56 years old in four French departments.
    Eur J Cancer Prev. 2023;32:238-245.
    Abstract

  385. NISHIO S
    Current status and molecular biology of human papillomavirus-independent gastric-type adenocarcinoma of the cervix.
    J Obstet Gynaecol Res. 2023;49:1106-1113.
    Abstract

  386. QIU J, Qu X, Wang Y, Guo C, et al
    Single-Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus-Associated (HPVA) and Non-HPVA Adenocarcinoma.
    Adv Sci (Weinh). 2023;10:e2204951.
    Abstract

  387. YABUKI Y
    Two lateral parametria in radical hysterectomy: History and outcome.
    J Obstet Gynaecol Res. 2023;49:1069-1078.
    Abstract

  388. ZHEN L, Pan W
    ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via an m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma.
    Clin Exp Pharmacol Physiol. 2023;50:380-392.
    Abstract

  389. ESPINOZA-GUTARRA MR, Rawl SM, Maupome G, O'Leary HA, et al
    Cancer-related knowledge, beliefs, and behaviors among Hispanic/Latino residents of Indiana.
    Cancer Med. 2023;12:7470-7484.
    Abstract

  390. TSAMPAZIS N, Vavoulidis E, Siarkou CM, Siarkou GM, et al
    Diagnostic comparison of electrical impedance spectroscopy with colposcopy and HPV mRNA-testing in the prediction of CIN2+ women in Greece.
    J Obstet Gynaecol Res. 2023;49:1222-1229.
    Abstract

  391. RASOOL S, Naz F, Abdul Wahab T, Khidri FF, et al
    Frequency of abnormal Pap smear in patients presenting with postcoital bleeding in Tertiary Care Hospital, Karachi, Pakistan.
    Trop Doct. 2023;53:267-270.
    Abstract

  392. DENG S, Qian L, Liu L, Liu H, et al
    Circular RNA ARHGAP5 inhibits cisplatin resistance in cervical squamous cell carcinoma by interacting with AUF1.
    Cancer Sci. 2023;114:1582-1595.
    Abstract

  393. EINSTEIN MH, Roden RBS, Ferrall L, Akin M, et al
    Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1.
    Cancer Prev Res (Phila). 2023;16:219-227.
    Abstract

  394. HUANG J, Wei Y, Gu L, Di W, et al
    Feasibility study of 5-aminolevulinic acid mediated photodynamic therapy of persistent vaginal high-risk HPV infection of post-hysterectomy patients.
    Photodiagnosis Photodyn Ther. 2023;41:103250.
    Abstract

  395. LAHLOU ND, Kaibech M, Bakkali T, Zoulati M, et al
    [Intracardiac migration of the ureteral single-J : A case report and removal techniques].
    Ann Cardiol Angeiol (Paris). 2023;72:101577.
    Abstract

  396. FRUMOVITZ M, Chisholm GB, Jhingran A, Ramalingam P, et al
    Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study.
    Am J Obstet Gynecol. 2023;228:445.
    Abstract

  397. LIU A, Garcia-Torres LC, Johnson C, Haver MK, et al
    Cancer screening educational interventions in rural and farmworker communities: a systematic literature review.
    Ethn Health. 2023;28:335-357.
    Abstract

  398. ANSARI B
    Information seeking behaviour differences indicate which US population groups lack information about human papilloma virus and associated cancer risks.
    Health Info Libr J. 2023;40:42-53.
    Abstract

  399. HUANG Y, Wen W, Li X, Xu D, et al
    Prognostic value of lymphovascular space invasion in stage IA to IIB cervical cancer: A meta-analysis.
    Medicine (Baltimore). 2023;102:e33547.
    Abstract

  400. AHN JH, Yun J, Yun CY, Yoo JG, et al
    Is there a relationship between surgical proficiency and oncologic outcome of minimally invasive radical hysterectomy for early-stage cervical cancer?
    Int J Med Sci. 2023;20:551-556.
    Abstract

  401. MENG Y, Yan X, Fan J
    Construction of prediction model of lymph node metastasis of early cervical cancer based on machine learning algorithm and its application: experience of 204 cases in a single center.
    Am J Transl Res. 2023;15:1852-1861.
    Abstract

  402. PING P, Li J, Lei H, Xu X, et al
    Fatty acid metabolism: A new therapeutic target for cervical cancer.
    Front Oncol. 2023;13:1111778.
    Abstract

  403. O PATHAK S, M Manohar S
    Molecular milieu of autophagy in cervical cancer and its therapeutic implications.
    Curr Cancer Drug Targets. 2023 Apr 12. doi: 10.2174/1568009623666230412104913.
    Abstract

  404. ZHAO L, Geng R, Huang Y, Zhang J, et al
    AP2alpha negatively regulates PDHA1 in cervical cancer cells to promote aggressive features and aerobic glycolysis in vitro and in vivo.
    J Gynecol Oncol. 2023 Apr 5. doi: 10.3802/jgo.2023.
    Abstract

  405. ZHANG ZF, Liu F, Zhang HR, Liu B, et al
    Upregulation of TMEM40 is associated with the malignant behavior and promotes tumor progression in cervical cancer.
    Discov Oncol. 2023;14:43.
    Abstract

  406. WANG C, Lester B, Huang L, Sun S, et al
    Patient, disease, and survival outcomes for stage IB to stage IV cervical cancer-A population study.
    Womens Health (Lond). 2023;19:17455057231164551.
    Abstract

  407. CHEN Q, Shen S, Lv N, Tong J, et al
    Role of microRNAs in glycolysis in gynecological tumors (Review).
    Int J Oncol. 2023;62:63.
    Abstract

  408. BAIG E, Furqan A, Abid M
    Do it yourself cervical cancer test: A gateway to increase cervical cancer screening in Pakistan.
    J Pak Med Assoc. 2023;73:955.
    Abstract

  409. TEHRIM M, Kumari B, Memon A
    HPV: take the test, not the risk. Be wise, immunize.
    J Pak Med Assoc. 2023;73:947.
    Abstract

  410. ZOU M, Liu H, Liu H, Wang M, et al
    Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China.
    Front Immunol. 2023;14:1119566.
    Abstract

  411. TERZIC M, Makhadiyeva D, Bila J, Andjic M, et al
    Reproductive and Obstetric Outcomes after Fertility-Sparing Treatments for Cervical Cancer: Current Approach and Future Directions.
    J Clin Med. 2023;12:2614.
    Abstract

  412. CORTES-MORALES VA, Chavez-Sanchez L, Rocha-Zavaleta L, Espindola-Garibay S, et al
    Mesenchymal Stem/Stromal Cells Derived from Cervical Cancer Promote M2 Macrophage Polarization.
    Cells. 2023;12:1047.
    Abstract

  413. ALI H, Traj P, Szebeni GJ, Gemes N, et al
    Investigation of the Antineoplastic Effects of 2-(4-Chlorophenyl)-13alpha-Estrone Sulfamate against the HPV16-Positive Human Invasive Cervical Carcinoma Cell Line SiHa.
    Int J Mol Sci. 2023;24:6625.
    Abstract

  414. DOVNIK A, Poljak M
    The Role of Methylation of Host and/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions.
    Int J Mol Sci. 2023;24:6479.
    Abstract

  415. LEE S, Jung H, Park J, Ahn J, et al
    Accurate Prediction of Cancer Prognosis by Exploiting Patient-Specific Cancer Driver Genes.
    Int J Mol Sci. 2023;24:6445.
    Abstract

  416. RAZLOG R, Kruger CA, Abrahamse H
    Cytotoxic Effects of Combinative ZnPcS(4) Photosensitizer Photodynamic Therapy (PDT) and Cannabidiol (CBD) on a Cervical Cancer Cell Line.
    Int J Mol Sci. 2023;24:6151.
    Abstract

  417. SALMERON-BARCENAS EG, Mendoza-Catalan MA, Ramirez-Bautista AU, Lozano-Santos RA, et al
    Identification of Mir-182-3p/FLI-1 Axis as a Key Signaling in Immune Response in Cervical Cancer: A Comprehensive Bioinformatic Analysis.
    Int J Mol Sci. 2023;24:6032.
    Abstract

  418. DITTO A, Leone Roberti Maggiore U, Evangelisti G, Bogani G, et al
    Diagnostic Accuracy of Magnetic Resonance Imaging in the Pre-Operative Staging of Cervical Cancer Patients Who Underwent Neoadjuvant Treatment: A Clinical-Surgical-Pathologic Comparison.
    Cancers (Basel). 2023;15:2061.
    Abstract

  419. KALBHOR M, Shinde S, Popescu DE, Hemanth DJ, et al
    Hybridization of Deep Learning Pre-Trained Models with Machine Learning Classifiers and Fuzzy Min-Max Neural Network for Cervical Cancer Diagnosis.
    Diagnostics (Basel). 2023;13:1363.
    Abstract

  420. MATTIS A, Beydoun H, Dobrydneva Y, Ganjoo R, et al
    Investigating the Efficacy of HPV Vaccines in Preventing Cervical Cancer from 2006 to 2018 in the US: A SEER Data Set Analysis.
    Rev Recent Clin Trials. 2023 Apr 10. doi: 10.2174/1574887118666230410093715.
    Abstract

  421. CARTWRIGHT K, Kosich M, Gonya M, Kanda D, et al
    Cervical Cancer Knowledge and Screening Patterns in Zuni Pueblo Women in the Southwest United States.
    J Cancer Educ. 2023 Apr 13. doi: 10.1007/s13187-023-02295.
    Abstract

  422. KAUMA G, Ddungu H, Ssewanyana I, Nyesiga S, et al
    Virologic Nonsuppression Among Patients With HIV Newly Diagnosed With Cancer at Uganda Cancer Institute: A Cross-Sectional Study.
    JCO Glob Oncol. 2023;9:e2200262.
    Abstract

  423. WANG Y, Mao Y, Wang C, Jiang X, et al
    RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer.
    Ann Med. 2023;55:2190618.
    Abstract

  424. CAO F, Zhong M, Liu CR
    [Uterine POLE mutant endometrioid carcinoma combined with human papilloma virus-associated cervical adenocarcinoma: A case report and literature review].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2023;55:370-374.
    Abstract

  425. YAKO-SUKETOMO H, Katayama K, Ogihara A, Asai-Sato M, et al
    Process of developing a cervical cancer education program for female university students in a Health and Physical Education teacher training course: an action research.
    BMC Womens Health. 2023;23:169.
    Abstract

  426. VAHABI M, Mishra G, Pimple S, Wong JP, et al
    Effectiveness of family-centred sexual health education and HPV self-sampling in promoting cervical cancer screening among hard-to-reach indian women in rural and tribal areas: a community-based pilot study.
    BMC Public Health. 2023;23:671.
    Abstract

  427. VIJAYAKUMAR S, Nittala MR, Duggar WN, King M, et al
    The Influence of Patient and System Factors on the Radiotherapy Treatment Time in the Treatment of Non-metastatic Cervical Cancer Patients in a Rural and Resource-Lean State's Safety-Net Hospital: Benefits of Strategic Planning.
    Cureus. 2023;15:e35954.
    Abstract

  428. DAHBI Z, Fadila K, Vinh-Hung V
    Brachytherapy Versus Stereotactic Body Radiotherapy for Cervical Cancer Boost: A Dosimetric Comparison.
    Cureus. 2023;15:e37235.
    Abstract


  429. Erratum: Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application.
    Front Oncol. 2023;13:1178841.
    Abstract

  430. LIU H, Liu J, Zhao G
    Retracted: Long non-coding RNA HOTAIR regulates proliferation, migration and invasion of human cervical cancer cells by modulating expression of MAPK1.
    Arch Med Sci. 2023;19:558.
    Abstract

  431. ZHANG SQ, Zhang J, Yu Y, Yu MM, et al
    APOBEC3B expression has prognostic significance in cervical cancer.
    Int J Clin Exp Pathol. 2023;16:48-56.
    Abstract

  432. LE TM, Chong GO, Han HS
    Tumor human papillomavirus: a potential test for cervical cancer prognosis.
    Transl Cancer Res. 2023;12:684-687.
    Abstract

  433. HU XC, Gan CX, Zheng HM, Wu XP, et al
    Immunotherapy in combination with chemotherapy for Peutz-Jeghers syndrome with advanced cervical cancer: A case report.
    World J Gastrointest Surg. 2023;15:480-487.
    Abstract

  434. LULU B, Loha E, Agegnehu A
    Factors affecting cervical cancer screening service uptake among clients visiting the ART clinic at Hawassa University Comprehensive Specialized Hospital, Hawassa, Ethiopia: A cross-sectional study.
    J Cancer Policy. 2023 Apr 7:100422. doi: 10.1016/j.jcpo.2023.100422.
    Abstract

  435. CHEN M, Wang D, Bao Z, Yi Z, et al
    The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy.
    Radiat Oncol. 2023;18:66.
    Abstract

  436. HUANG J, Yang J, Zhang Y, Lu D, et al
    FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.
    Exp Cell Res. 2023;427:113585.
    Abstract

  437. CHEN H, Tian X, Luan Y, Lu H, et al
    Highly expressed circ_0000285 from serum and cervical exfoliated cells as a novel biomarker for the diagnosis of early stage-cervical cancer.
    J Obstet Gynaecol. 2023;43:2196344.
    Abstract

  438. MEI X, Zhang R, Li D, Xie X, et al
    Association between the infections of Trichomonas vaginalis and uterine cervical human papillomavirus: a meta-analysis.
    J Obstet Gynaecol. 2023;43:2194986.
    Abstract

  439. KOJALO U, Tisler A, Parna K, Kivite-Urtane A, et al
    An overview of cervical cancer epidemiology and prevention in the Baltic States.
    BMC Public Health. 2023;23:660.
    Abstract

  440. GUPTA R, Kumar N, Bansal S, Singh S, et al
    Artificial Intelligence-driven Digital Cytology-based Cervical Cancer Screening: Is the Time Ripe to Adopt This Disruptive Technology in Resource-constrained Settings? A Literature Review.
    J Digit Imaging. 2023 Apr 7. doi: 10.1007/s10278-023-00821.
    Abstract

  441. QIAN WL, Chen Q, Zhang JB, Xu JM, et al
    RESOLVE-based radiomics in cervical cancer: improved image quality means better feature reproducibility?
    Clin Radiol. 2023 Mar 21:S0009-9260(23)00093-4. doi: 10.1016/j.crad.2023.
    Abstract

  442. COLE MB, Lee EK, Frogner BK, Wright B, et al
    Changes in Performance Measures and Service Volume at US Federally Qualified Health Centers During the COVID-19 Pandemic.
    JAMA Health Forum. 2023;4:e230351.
    Abstract

  443. ALSANAFI M, Salim NA, Sallam M
    Willingness to get HPV vaccination among female university students in Kuwait and its relation to vaccine conspiracy beliefs.
    Hum Vaccin Immunother. 2023;19:2194772.
    Abstract

  444. ZHAO R, Sekar P, Bennis SL, Kulasingam S, et al
    A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: Implications for prevention strategies.
    Prev Med. 2023;170:107494.
    Abstract

  445. SU A, Liu Y, Cao X, Zhao J, et al
    Direct Virus Gene Detection: A CRISPR/dCas9-Mediated Surface-Enhanced Raman Scattering Strategy with Enzyme-Catalyzed Signal Amplification.
    Anal Chem. 2023;95:5927-5936.
    Abstract

  446. ZHU J, Yang C, Song S, Wang R, et al
    Classification of multiple cancer types by combination of plasma-based near-infrared spectroscopy analysis and machine learning modeling.
    Anal Biochem. 2023;669:115120.
    Abstract

  447. HEER E, Peters C, Knight R, Yang L, et al
    Participation, barriers, and facilitators of cancer screening among LGBTQ+ populations: A review of the literature.
    Prev Med. 2023;170:107478.
    Abstract

  448. YOSHINO A, Kobayashi E, Tsuboyama T, Fukui H, et al
    Novel Strategy for the Management of Cervical Multicystic Diseases.
    Ann Surg Oncol. 2023;30:2964-2973.
    Abstract

  449. SELBY K, Sedki M, Levine E, Kamineni A, et al
    Test performance metrics for breast, cervical, colon and lung cancer screening: a systematic review.
    J Natl Cancer Inst. 2023 Feb 8:djad028. doi: 10.1093.
    Abstract

  450. NICHOLLS EJ, McGowan CR, Miles S, Baxter L, et al
    Provision of cervical screening for transmasculine patients: a review of clinical and programmatic guidelines.
    BMJ Sex Reprod Health. 2023;49:118-128.
    Abstract

  451. BURGER E, Baussano I, Kim JJ, Laprise JF, et al
    Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions.
    Vaccine. 2022 Aug 5. pii: S0264-410X(22)00910.
    Abstract

  452. USMAN IM, Chama N, Aigbogun EO Jr, Kabanyoro A, et al
    Knowledge, Attitude, and Practice Toward Cervical Cancer Screening Among Female University Students in Ishaka Western Uganda.
    Int J Womens Health. 2023;15:611-620.
    Abstract

  453. ZHAO Q, Wang W, Cui J
    Retraction Note: Melatonin enhances TNF-alpha-mediated cervical cancer HeLa cells death via suppressing CaMKII/Parkin/mitophagy axis.
    Cancer Cell Int. 2023;23:78.
    Abstract

  454. NAKAMURA K, Yamashita S, Kigure K, Nishimura T, et al
    Utility of vaginal vault cytology in the local recurrence of cervical cancer.
    BMC Womens Health. 2023;23:186.
    Abstract

  455. SHEN L, Li Y, Hu G, Song X, et al
    Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFbeta/Smad2/3 signaling.
    Funct Integr Genomics. 2023;23:133.
    Abstract

  456. DOVER L, Dulaney C
    PROshot: Mepitel Film, Daily Versus Twice-Daily Radiation Therapy for Small Cell Lung Cancer, POLAR, Decipher, and Patterns of Failure After Magnetic Resonance Imaging-Guided Brachytherapy for Cervical Cancer.
    Pract Radiat Oncol. 2023;13:167-171.
    Abstract

  457. SAND FL, Urbute A, Ring LL, Kjaer AK, et al
    The influence of overweight and obesity on participation in cervical cancer screening: A systematic review and meta-analysis.
    Prev Med. 2023 Apr 18:107519. doi: 10.1016/j.ypmed.2023.107519.
    Abstract

  458. MILESHKIN LR, Moore KN, Barnes EH, Gebski V, et al
    Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
    Lancet Oncol. 2023 Apr 17:S1470-2045(23)00147.
    Abstract

  459. LIU H, Zhang GN, Luo M, Zhang XD, et al
    [Clinicopathological features and prognostic factors of patients with lung metastasis of stage â… a~â…¢b cervical cancer].
    Zhonghua Zhong Liu Za Zhi. 2023;45:340-347.
    Abstract

  460. JIAO S, Guo L, Da F, Gao Q, et al
    Competitive Risk Model Nomogram to Predict Prognosis in Patients Aged Over 65 Years with nonmetastatic Cervical Cancer: A SEER Population-Based Study.
    Technol Cancer Res Treat. 2023;22:15330338231164191.
    Abstract

  461. SHARIFIAN K, Shoja Z, Jalilvand S
    The interplay between human papillomavirus and vaginal microbiota in cervical cancer development.
    Virol J. 2023;20:73.
    Abstract

  462. MAHIOU K, Vincent L, Peignaux-Casasnovas K, Costaz H, et al
    Impact of therapeutic strategy on disease-free and overall survival of early-stage cervical cancer: Surgery alone versus preoperative radiation.
    Cancer Rep (Hoboken). 2023 Apr 19:e1823. doi: 10.1002/cnr2.1823.
    Abstract

  463. QI ZM, Wang X, Liu X, Zhao J, et al
    Asperuloside Promotes Apoptosis of Cervical Cancer Cells through Endoplasmic Reticulum Stress-Mitochondrial Pathway.
    Chin J Integr Med. 2023 Apr 20. doi: 10.1007/s11655-023-3695.
    Abstract

  464. WANG W, Meng Q, Zhou Y, Hu K, et al
    Prophylactic extended-field irradiation versus pelvic irradiation in cervical cancer patients with 2018 FIGO stage IIIC1 disease.
    Pract Radiat Oncol. 2023 Apr 17:S1879-8500(23)00099.
    Abstract

  465. LUIZAGA CTM, Jardim BC, Wunsch Filho V, Eluf Neto J, et al
    Recent changes in trends of mortality from cervical cancer in Southeastern Brazil.
    Rev Saude Publica. 2023;57:25.
    Abstract

  466. CHEN Y, Zheng Y, Wu Y, Dai J, et al
    Local excision as a viable alternative to hysterectomy for early-stage cervical cancer in women of reproductive age: a population-based cohort study.
    Int J Surg. 2023 Apr 20. doi: 10.1097/JS9.0000000000000417.
    Abstract

  467. VOJTISEK R
    Image guided adaptive brachytherapy of cervical cancer - practical recommendations.
    Klin Onkol. 2023;36:96-103.
    Abstract

  468. GHEBRENDRIAS S, Mody S, Washington S, Hussein B, et al
    A Cervical Cancer Screening Toolkit for Somali Women: A Pilot Randomized Controlled Trial.
    J Immigr Minor Health. 2023 Apr 18:1-8. doi: 10.1007/s10903-023-01455.
    Abstract

  469. NGUYEN T, Nougaret S, Castillo P, Paspulati R, et al
    Cervical cancer in the pregnant population.
    Abdom Radiol (NY). 2023 Apr 18. doi: 10.1007/s00261-023-03836.
    Abstract

  470. LUCKETT R, Feldman S, Woo YL, Moscicki AB, et al
    Point of View: COVID-19 as a catalyst for reimagining cervical cancer prevention.
    Elife. 2023;12:e86266.
    Abstract

  471. SIDDIG EE, Ahmed A, Ahmed ES, Mohammed MA, et al
    Knowledge and attitudes towards cervical cancer prevention among women in Khartoum state, Sudan.
    Womens Health (Lond). 2023;19:17455057231166286.
    Abstract

  472. ZHAO XL, Zhao S, Xia CF, Hu SY, et al
    Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study.
    BMC Med. 2023;21:149.
    Abstract

  473. KAMANGA P, Zhang B, Stones W
    Factors associated with low utilisation of cervical cancer screening among urban women in Lilongwe, Malawi: a cross sectional study.
    BMC Womens Health. 2023;23:183.
    Abstract

  474. SY F, Berner-Rodoreda A, Asnake T, Getnet M, et al
    Exploring computer-aided health decision-making on cervical cancer interventions through deliberative interviews in Ethiopia.
    NPJ Digit Med. 2023;6:68.
    Abstract

  475. SOKALE IO, Oluyomi AO, Montealegre JR, Thrift AP, et al
    Racial/ethnic disparities in cervical cancer stage at diagnosis: Mediating effects of neighborhood-level socioeconomic deprivation.
    Cancer Epidemiol Biomarkers Prev. 2023 Apr 17:EPI-23-0038.
    Abstract

  476. ABE M, Toshiyama R, Gotoh K, Sakai K, et al
    [A Case of Sister Mary Joseph's Nodule after Radiation Therapy for Cervical Cancer].
    Gan To Kagaku Ryoho. 2023;50:535-537.
    Abstract

  477. GAO X, Yang L
    HBXIP knockdown inhibits FHL2 to promote cycle arrest and suppress cervical cancer cell proliferation, invasion and migration.
    Oncol Lett. 2023;25:186.
    Abstract

  478. LI XY, Li G, Gong TT, Lv JL, et al
    Non-Genetic Factors and Risk of Cervical Cancer: An Umbrella Review of Systematic Reviews and Meta-Analyses of Observational Studies.
    Int J Public Health. 2023;68:1605198.
    Abstract

  479. SHI H, Xiong L, Yan G, Du S, et al
    Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis.
    Front Mol Biosci. 2023;10:1156062.
    Abstract

  480. YUAN L, Lei H, Zou D, Wen B, et al
    Public health insurance and the risk of cancer-specific mortality in patients with cervical cancer: A Chinese prospective cohort study.
    Front Public Health. 2023;11:1121548.
    Abstract


  481. [Chinese expert consensus on the use of human papillomavirus nucleic acid testing for cervical cancer screening (2022)].
    Zhonghua Yi Xue Za Zhi. 2023;103:1184-1195.
    Abstract

  482. MARCHADIER A, Leleu H, Barre S
    [Budget impact of self-testing in the national cervical cancer screening program].
    Rev Epidemiol Sante Publique. 2023;71:101838.
    Abstract

  483. TERADA S, Tsunetoh S, Tanaka Y, Tanaka T, et al
    Boron uptake of boronophenylalanine and the effect of boron neutron capture therapy in cervical cancer cells.
    Appl Radiat Isot. 2023;197:110792.
    Abstract

  484. MEZA RAMIREZ CA, Greenop M, Almoshawah YA, Martin Hirsch PL, et al
    Advancing cervical cancer diagnosis and screening with spectroscopy and machine learning.
    Expert Rev Mol Diagn. 2023 Apr 19:1-16. doi: 10.1080/14737159.2023.2203816.
    Abstract

  485. DAS S, Babu A, Medha T, Ramanathan G, et al
    Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients.
    Med Oncol. 2023;40:149.
    Abstract

  486. ZHANG Z, Wan X, Lei X, Wu Y, et al
    Intra- and peri-tumoral MRI radiomics features for preoperative lymph node metastasis prediction in early-stage cervical cancer.
    Insights Imaging. 2023;14:65.
    Abstract

  487. KANG Z, Liu J, Ma C, Chen C, et al
    Early screening of cervical cancer based on tissue Raman spectroscopy combined with deep learning algorithms.
    Photodiagnosis Photodyn Ther. 2023 Apr 12:103557.
    Abstract

  488. LI R, Qu W, Liu Q, Tan Y, et al
    Development and validation of a deep learning survival model for cervical adenocarcinoma patients.
    BMC Bioinformatics. 2023;24:146.
    Abstract

  489. LOMBE DC, Mwamba M, Msadabwe S, Bond V, et al
    Delays in seeking, reaching and access to quality cancer care in sub-Saharan Africa: a systematic review.
    BMJ Open. 2023;13:e067715.
    Abstract

  490. GOTTSCHLICH A, Payne BA, Trawin J, Albert A, et al
    Community-integrated self-collected HPV-based cervix screening in a low-resource rural setting: a pragmatic, cluster-randomized trial.
    Nat Med. 2023;29:927-935.
    Abstract

  491. ODAGAMI M, Iwata A, Kubota K, Kurasawa K, et al
    Awareness of Infectious Disease Screening During Early Pregnancy and Knowledge About its Vertical Transmission in Japan: A Report from the Pregnant Women Health Initiative.
    Matern Child Health J. 2023;27:933-943.
    Abstract

  492. FINAN RR, Chemaitelly H, Racoubian E, Aimagambetova G, et al
    Genetic diversity of human papillomavirus (HPV) as specified by the detection method, gender, and year of sampling: a retrospective cross-sectional study.
    Arch Gynecol Obstet. 2023;307:1469-1479.
    Abstract

  493. RUFFIEUX Y, Muchengeti M, Olago V, Dhokotera T, et al
    Age and cancer incidence in 5.2 million people with HIV: the South African HIV Cancer Match study.
    Clin Infect Dis. 2022 Dec 3:ciac925. doi: 10.1093.
    Abstract

  494. MACKENZIE P, Vajdic C, Delaney G, Comans T, et al
    Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review.
    J Geriatr Oncol. 2023;14:101387.
    Abstract

  495. STUEBS FA, Mergel F, Koch MC, Dietl AK, et al
    Cervical intraepithelial neoplasia grade 3: development during pregnancy and postpartum.
    Arch Gynecol Obstet. 2023;307:1567-1572.
    Abstract

  496. LIU Y, Weiss K, Zamudio AR, Hayes MP, et al
    Primary Anal Cancer Screening Results From 381 Women With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:932-938.
    Abstract

  497. ORNSKOV D, Waldstrom M, Thomsen LT, Munk C, et al
    Quality Control of Biospecimens in a Danish Clinical Cytology Biobank.
    Biopreserv Biobank. 2023;21:184-190.
    Abstract

  498. PAPOUTSIS D
    Improving the surgical performance during LLETZ cervical excision to optimise oncological and obstetric outcomes: critical appraisal of a novel high-fidelity simulator.
    Arch Gynecol Obstet. 2023;307:1643-1644.
    Abstract

  499. FRANCA MC, Boyer VE, Gerend MA, Lee M, et al
    College Students' Awareness of the Link Between Human Papillomavirus (HPV) and HPV-Associated Cancers.
    J Cancer Educ. 2023;38:669-676.
    Abstract

  500. YILDIRIM KARACA S, Adiyeke M, Ince O, Ileri A, et al
    Prediction model for residual high-grade cervical intraepithelial lesions.
    Minerva Obstet Gynecol. 2023;75:158-164.
    Abstract

  501. AHMADLOO N, Heidarpourfard M, Najib FS, Shiravani Z, et al
    The Feasibility and Safety of Induction Chemotherapy Followed by Definitive Chemoradiation in Patients with Locally Advanced Cervical Cancer: A Single-Arm Phase II Clinical Trial.
    Asian Pac J Cancer Prev. 2023;24:1321-1330.
    Abstract

  502. ROH S, Lee HY, Jun JS, Lee YS, et al
    Andersen's Behavioral Model to Identify Correlates of Cervical Cancer Knowledge among American Indian Women.
    Asian Pac J Cancer Prev. 2023;24:1151-1157.
    Abstract

  503. LI XY, Wen JY, Huang YH, Wang WW, et al
    Primary Treatment for Clinically Early Cervical Cancer with Lymph Node Metastasis: Radical Surgery or Radiation?
    Curr Med Sci. 2023 Apr 28. doi: 10.1007/s11596-023-2722.
    Abstract

  504. ISLA-ORTIZ D, Torres-Dominguez J, Perez-Peralta L, Jimenez-Barrera H, et al
    Insurance status and access to cervical cancer treatment in a specialized cancer center in Mexico.
    Medicine (Baltimore). 2023;102:e33655.
    Abstract

  505. YEON CHOI H, Park JW
    Survival outcomes of minimally invasive versus open radical hysterectomy in patients with early-stage IB1 to IIA2 cervical cancer: A single-center retrospective study.
    Medicine (Baltimore). 2023;102:e33702.
    Abstract

  506. ZANG Y, Zhao R, Wang T, Gao Y, et al
    Identification of POLQ as a key gene in cervical cancer progression using integrated bioinformatics analysis and experimental validation.
    Mol Med Rep. 2023;27:115.
    Abstract

  507. ISLAM MR, Dhar PS, Akash S, Sharma R, et al
    Public concerns about cervical cancer: outbreak, types, risk factors, etiology, stages, symptoms, prevention, and treatment.
    Ann Med Surg (Lond). 2023;85:1334-1335.
    Abstract

  508. TEKA B, Yoshida-Court K, Firdawoke E, Chanyalew Z, et al
    Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian Women.
    Microorganisms. 2023;11:833.
    Abstract

  509. STUOPELYTE R, Zukiene G, Breiviene R, Rudaitis V, et al
    Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy.
    Medicina (Kaunas). 2023;59:777.
    Abstract

  510. DIMITROVA P, Vasileva-Slaveva M, Shivarov V, Hasan I, et al
    Infiltration by Intratumor and Stromal CD8 and CD68 in Cervical Cancer.
    Medicina (Kaunas). 2023;59:728.
    Abstract

  511. CIANCI S, Tarascio M, Arcieri M, La Verde M, et al
    Post Treatment Sexual Function and Quality of Life of Patients Affected by Cervical Cancer: A Systematic Review.
    Medicina (Kaunas). 2023;59:704.
    Abstract

  512. KORBECKI J, Bosiacki M, Barczak K, Lagocka R, et al
    Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer.
    Int J Mol Sci. 2023;24:7262.
    Abstract

  513. SEKARAN K, Varghese RP, Gopikrishnan M, Alsamman AM, et al
    Unraveling the Dysbiosis of Vaginal Microbiome to Understand Cervical Cancer Disease Etiology-An Explainable AI Approach.
    Genes (Basel). 2023;14:936.
    Abstract

  514. XIANG S, Wei M, Zhao L, Lin A, et al
    Integrated Analyses of the Expression and Prognostic Value of EPHB6 in Cervical Cancer and Its Correlation with Immune Infiltrates.
    J Oncol. 2023;2023:2258906.
    Abstract

  515. CHAUHAN NK, Singh K, Kumar A, Kolambakar SB, et al
    HDFCN: A Robust Hybrid Deep Network Based on Feature Concatenation for Cervical Cancer Diagnosis on WSI Pap Smear Slides.
    Biomed Res Int. 2023;2023:4214817.
    Abstract

  516. LIU M, Lu J, Zhi Y, Ruan Y, et al
    Microendoscopy in vivo for the pathological diagnosis of cervical precancerous lesions and early cervical cancer.
    Infect Agent Cancer. 2023;18:26.
    Abstract

  517. JHA AK, Mithun S, Sherkhane UB, Jaiswar V, et al
    Systematic review and meta-analysis of prediction models used in cervical cancer.
    Artif Intell Med. 2023;139:102549.
    Abstract

  518. XIN X, Jia-Yin Y, Jun-Yang H, Rui W, et al
    Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis.
    Comput Biol Med. 2023;159:106943.
    Abstract

  519. DADIPOOR S, Alavi A, Kader Z, Kakhaki HES, et al
    Correction: Utilization of cervical cancer screening services and its associated factors in Iran: a case-control study.
    Infect Agent Cancer. 2023;18:25.
    Abstract

  520. KIM W, Chun S, Lee SA
    Changes in cervical dysplasia, carcinoma in situ, and cervical cancer after expanding the National Cancer Screening Program to younger women in Korea.
    Int J Qual Health Care. 2023 Apr 25:mzad024. doi: 10.1093.
    Abstract

  521. MIYASAKA Y, Yoshimoto Y, Ando K, Murata K, et al
    CD8-positive Tumor-infiltrating Lymphocytes and Prognosis in Radiotherapy for Uterine Cervical Squamous Cell Carcinoma.
    Anticancer Res. 2023;43:2077-2084.
    Abstract

  522. FIRTINA TUNCER S, Tuncer HA
    Cervical Cancer Screening in Women Aged Older Than 65 Years.
    J Low Genit Tract Dis. 2023 Apr 25. doi: 10.1097/LGT.0000000000000742.
    Abstract

  523. HAN D, Wang J, Cheng G
    Retraction: LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis.
    Oncotarget. 2023;14:363.
    Abstract

  524. JENSEN B, Khan H, Layeequr Rahman R
    Sociodemographic Determinants in Cervical Cancer Screening Among the Underserved West Texas Women.
    Womens Health Rep (New Rochelle). 2023;4:191-201.
    Abstract

  525. XIA WT, Qiu WR, Yu WK, Xu ZC, et al
    Identifying TME signatures for cervical cancer prognosis based on GEO and TCGA databases.
    Heliyon. 2023;9:e15096.
    Abstract

  526. RANGA S, Yadav R, Chhabra R, Chauhan MB, et al
    Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives.
    Apoptosis. 2023 Apr 25:1-18. doi: 10.1007/s10495-023-01840.
    Abstract

  527. CHEN Y, Ma Q, Sun N
    DDX49 Promotes Proliferation and Metastasis of Cervical Cancer by Regulation of AKT and Wnt/beta-Catenin Signalings.
    Ann Clin Lab Sci. 2023;53:271-277.
    Abstract

  528. SONG G, Ren J, Li Y, Cui J, et al
    Interference with XPO1 Suppresses the Stemness and Radioresistance of CD44 Positive Cervical Cancer Cells via Binding with Rad21.
    Ann Clin Lab Sci. 2023;53:278-292.
    Abstract

  529. RUCKRIEGL S, Loris J, Wert K, Bauerschmitz G, et al
    Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells.
    Cancer Genomics Proteomics. 2023;20:281-297.
    Abstract

  530. GOMES D, Passarinha LA, Sousa A
    E6 Tagged Protein Production, Extraction, and Purification from Escherichia coli Lysate.
    Methods Mol Biol. 2023;2652:21-33.
    Abstract

  531. ADDLEY S, Persic M, Kirke R, Abdul S, et al
    Combined direct hysteroscopic and real-time ultrasound guidance facilitating safe insertion of intra-uterine brachytherapy applicator for locally advanced cervical cancer with significant endocervical stenosis: A novel collaborative approach.
    Gynecol Oncol Rep. 2023;47:101178.
    Abstract

  532. DEY T, Mukerjee A, Rai B, Arora M, et al
    Early integration of palliative care in cervical cancer: Experiences from a pilot study.
    J Family Med Prim Care. 2023;12:366-370.
    Abstract

  533. ENDALAMAW A, Alganeh H, Azage M, Atnafu A, et al
    Improving cervical cancer continuum of care towards elimination in Ethiopia: a scoping review.
    Res Sq. 2023 Apr 14:rs.3.rs-2791526. doi: 10.21203/rs.3.rs-2791526.
    Abstract

  534. SHITU BF, Atnafu DD, Agumas Y
    Public School Adolescents Had Increased Odds of Being Willing to Uptake HPV Vaccinations Owing to Sociodemographic and Healthcare Access Features in Bahir Dar City, Ethiopia.
    Biomed Res Int. 2023;2023:2663815.
    Abstract


  535. [Synthesis of evidence and recommendations: guidelines for cervical cancer screening, detection, and treatmentSintese de evidencias e recomendacoes: diretrizes para rastreamento, deteccao e tratamento do cancer do colo do utero].
    Rev Panam Salud Publica. 2023;47:e72.
    Abstract

  536. ZHANG J, Chen J, Yang X, Han J, et al
    Novel risk prediction models, involving coagulation, thromboelastography, stress response, and immune function indicators, for deep vein thrombosis after radical resection of cervical cancer and ovarian cancer.
    J Obstet Gynaecol. 2023;43:2204162.
    Abstract

  537. PIETA E
    Nanoscale insight into biochemical changes in cervical cancer cells exposed to adaptogenic drug.
    Micron. 2023;170:103462.
    Abstract

  538. BOLARINWA OA, Holt N
    Barriers to breast and cervical cancer screening uptake among Black, Asian, and Minority Ethnic women in the United Kingdom: evidence from a mixed-methods systematic review.
    BMC Health Serv Res. 2023;23:390.
    Abstract

  539. GULIASHVILI G, Taboridze I, Mebonia N, Alibegashvili T, et al
    Evaluation of barriers to cervical cancer screening in Georgia.
    Cent Eur J Public Health. 2023;31:9-18.
    Abstract

  540. POLEBOYINA PK, Alagumuthu M, Pasha A, Ravinder D, et al
    Entrectinib a Plausible Inhibitor for Osteopontin (SPP1) in Cervical Cancer-Integrated Bioinformatic Approach.
    Appl Biochem Biotechnol. 2023 Apr 22. doi: 10.1007/s12010-023-04541.
    Abstract

  541. DUCHANGE N, Poiseuil M, Rollet Q, Piette C, et al
    How do women comply with cancer screenings? A study in four regions of France.
    BMC Womens Health. 2023;23:190.
    Abstract

  542. DZOBO M, Dzinamarira T, Maluleke K, Jaya ZN, et al
    Mapping evidence on the acceptability of human papillomavirus self-sampling for cervical cancer screening among women in sub-Saharan Africa: a scoping review.
    BMJ Open. 2023;13:e062090.
    Abstract

  543. MAURY P, Mondini M, Chargari C, Darricau A, et al
    Clinical transfer of AGuIX(R)-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework.
    Nanomedicine. 2023 Apr 19:102676. doi: 10.1016/j.nano.2023.102676.
    Abstract

  544. MAO P, Zhang C, Wang X, Yang H, et al
    Copious vaginal discharge finally diagnosed as cervical adenocarcinoma: A case report.
    Medicine (Baltimore). 2023;102:e33614.
    Abstract

  545. LI LP, Rao DF, Chen XX, Qi XY, et al
    The impact of hospital-family integrated continuation nursing based on information technology on patients unhealthy mood, family function and sexual function after cervical cancer surgery.
    Medicine (Baltimore). 2023;102:e33504.
    Abstract

  546. OGAWA M, Hashimoto K, Kitano S, Yamashita S, et al
    Estrogen induces genomic instability in high-risk HPV-infected cervix and promotes the carcinogenesis of cervical adenocarcinoma.
    Biochem Biophys Res Commun. 2023;659:80-90.
    Abstract

  547. QIU D, Liu Y, Wang Z, Zhang Z, et al
    Precision and correlation of ED(50) and endpoint titer method in measuring HPV vaccine immunogenicity.
    J Virol Methods. 2023;316:114716.
    Abstract

  548. MUNIR MM, Woldesenbet S, Alaimo L, Moazzam Z, et al
    Mediators of county-level racial and economic privilege in cancer screening.
    J Surg Oncol. 2023;127:1212-1222.
    Abstract

  549. EFFAH K, Agbemafle I, Essel NO, Amuah JE, et al
    Comparison of the AmpFire and MA-6000 polymerase chain reaction platforms for high-risk human papillomavirus testing in cervical precancer screening.
    J Virol Methods. 2023;316:114709.
    Abstract

  550. YU J, Kenkre J, Wallace S, Thomas S, et al
    Methodological reflections on the recruitment and engagement of people for cancer screening research in Wales.
    Aust J Prim Health. 2023;29:148-154.
    Abstract

  551. DAVIDESKO S, Meirovitz M, Shaco-Levy R, Wainstock T, et al
    Positive pathological margins after loop electrosurgical excision procedure - Management and outcome.
    Eur J Surg Oncol. 2023;49:1031-1036.
    Abstract

  552. GORDON J, Bail J
    Cancer Prevention Begins in Middle School: The Personal Advantages of HPV Immunization in Males.
    NASN Sch Nurse. 2023;38:114-120.
    Abstract

  553. BROWER JV, Bradley KA, Russo AL
    Management of Radiographically Positive Pelvic and/or Para-aortic Lymph Nodes During Primary Chemoradiation Therapy for Cervix Cancer.
    Pract Radiat Oncol. 2023;13:246-250.
    Abstract

  554. LI Z, Winer RL, Ba S, Sy MP, et al
    Effect of Human Immunodeficiency Virus Infection on Human Papillomavirus Clearance among Women in Senegal, West Africa.
    J Infect Dis. 2022 Oct 31. pii: 6782258. doi: 10.1093.
    Abstract


  555. Correction: The HPV16 E6, E7/miR-23b-3p/ICAT signaling axis promotes proliferation, migration, invasion and EMT of cervical cancer cells.
    Carcinogenesis. 2023 May 5:bgad022. doi: 10.1093.
    Abstract

  556. CIBULA D, Raspollini MR, Planchamp F, Centeno C, et al
    ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
    Virchows Arch. 2023 May 5. doi: 10.1007/s00428-023-03552.
    Abstract

  557. WANG D, Zhang Y, Ren D, Meng C, et al
    Bioinformatics analysis illustrates the functions of miR-377-5p in cervical cancer.
    Biotechnol Genet Eng Rev. 2023 May 5:1-12. doi: 10.1080/02648725.2023.2208453.
    Abstract

  558. SINEQUE A, Catalao C, Ceffa S, Fonseca AM, et al
    Screening approaches for cervical cancer in Mozambique in HIV positive and negative women.
    Eur J Cancer Prev. 2023 May 3. doi: 10.1097/CEJ.0000000000000802.
    Abstract

  559. YIN Z, Hua X, Lu M
    Integrated network pharmacology and metabolomics to dissect the mechanisms of naringin for treating cervical cancer.
    Comb Chem High Throughput Screen. 2023.
    Abstract

  560. LI Q, Liu L, Gu Z, Li M, et al
    Sense of coherence mediates perceived social support and depressive and anxiety symptoms in cervical cancer patients: a cross-sectional study.
    BMC Psychiatry. 2023;23:312.
    Abstract

  561. TAO T, Zhang P, Zeng Z, Wang M, et al
    Advances in autophagy modulation of natural products in cervical cancer.
    J Ethnopharmacol. 2023 May 2:116575. doi: 10.1016/j.jep.2023.116575.
    Abstract

  562. CUI YY, Wen LY, Chen XY, Bai XH, et al
    Pelvic floor dysfunction and its influencing factors during radiotherapy in cervical cancer survivors: A cross-sectional study.
    Eur J Oncol Nurs. 2023;64:102307.
    Abstract

  563. AKOTO EJ, Allsop MJ
    Factors Influencing the Experience of Breast and Cervical Cancer Screening Among Women in Low- and Middle-Income Countries: A Systematic Review.
    JCO Glob Oncol. 2023;9:e2200359.
    Abstract

  564. LIU GF, Zhang SH, Li XF, Cao LY, et al
    Retraction: Overexpression of microRNA-132 enhances the radiosensitivity of cervical cancer cells by down-regulating Bmi-1.
    Oncotarget. 2023;14:398.
    Abstract

  565. KINOSHITA T, Takahashi S, Anada M, Nishide T, et al
    A retrospective study of locally advanced cervical cancer cases treated with CT-based 3D-IGBT compared with 2D-IGBT.
    Jpn J Radiol. 2023 May 4. doi: 10.1007/s11604-023-01439.
    Abstract

  566. LIU G, Li L, Shang D, Zhou C, et al
    BRSK1 confers cisplatin resistance in cervical cancer cells via regulation of mitochondrial respiration.
    J Cancer Res Clin Oncol. 2023 May 4. doi: 10.1007/s00432-023-04821.
    Abstract

  567. XIE K, Liu L, Wang M, Li X, et al
    IMPA2 blocks cervical cancer cell apoptosis and induces paclitaxel resistance through p53-mediated AIFM2 regulation.
    Acta Biochim Biophys Sin (Shanghai). 2023 Apr 25. doi: 10.3724/abbs.2023069.
    Abstract

  568. TANG J, Peng H, Xu F, Luo P, et al
    Demethoxycurcumin represses cervical cancer growth through PPARgamma-regulated proliferation and apoptosis.
    Acta Biochim Biophys Sin (Shanghai). 2023 Feb 25. doi: 10.3724/abbs.2023077.
    Abstract

  569. FILLON M
    Why young patients with cancer refuse the human papillomavirus vaccine.
    CA Cancer J Clin. 2023;73:225-227.
    Abstract

  570. DIAZ JFR
    Cost analysis of three-dimensional radiation therapy versus intensity-modulated chemoradiotherapy for locally advanced cervical cancer in Peruvian citizens.
    Ecancermedicalscience. 2023;17:1531.
    Abstract

  571. OGUNDIPE L, Ojo T, Oluwadare T, Olayemi E, et al
    Cervical cancer screening and vaccination: knowledge, awareness, and attitude of female staff in a Nigerian University.
    BMC Womens Health. 2023;23:218.
    Abstract

  572. ZHANG Y, Ni Z, Wei T, Liu Q, et al
    Persistent HPV infection after conization of cervical intraepithelial neoplasia-- a systematic review and meta-analysis.
    BMC Womens Health. 2023;23:216.
    Abstract

  573. ZHAO M, Pu X, Ma GY, Zhang MJ, et al
    Quality of life in patients with cervical cancer between the Han nationality and ethnic minorities in the Yunnan Province of China.
    BMC Womens Health. 2023;23:217.
    Abstract

  574. ZHANG Z, Zhang N, Cheng G
    Application of three-dimensional multi-imaging combination in brachytherapy of cervical cancer.
    Radiol Med. 2023 May 3. doi: 10.1007/s11547-023-01632.
    Abstract

  575. MO Y, Liang Z, Lan L, Xiong X, et al
    Extracellular vesicles derived from cervical cancer cells carrying MCM3AP-AS1 promote angiogenesis and tumor growth in cervical cancer via the miR-93/p21 axis.
    Exp Cell Res. 2023 May 1:113621. doi: 10.1016/j.yexcr.2023.113621.
    Abstract

  576. CHEN X, Sun Z, Zhou S, Jiang W, et al
    SH3 domain-binding kinase 1 promotes proliferation and inhibits apoptosis of cervical cancer via activating the Wnt/beta-catenin and Raf/ERK1/2 signaling pathways.
    Mol Carcinog. 2023 May 3. doi: 10.1002/mc.23552.
    Abstract

  577. ARORA S, Tuffaha H
    Cost-effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India.
    Asia Pac J Clin Oncol. 2023 May 3. doi: 10.1111/ajco.13962.
    Abstract

  578. SHAO H, Li X, Wu P, Chen Z, et al
    A Cellular Senescence-Related Signature Predicts Cervical Cancer Patient Outcome and Immunotherapy Sensitivity.
    Res Sq. 2023 Apr 20:rs.3.rs-2769887. doi: 10.21203/rs.3.rs-2769887.
    Abstract

  579. QU SX, Ni YH, Qin JF, Chen XY, et al
    Experience and acceptability for HPV self-sampling among women in Jiangsu province, China: a cross-sectional survey.
    J Obstet Gynaecol. 2023;43:2204942.
    Abstract

  580. OLKOV IG, Grishina NK
    [The preferential strategies of programs of cervical virologic screening (publications review)].
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2023;31:233-241.
    Abstract

  581. POP CF, Stanciu-Pop CM, Jungels C, Chintinne M, et al
    Uterine embryonal rhabdomyosarcoma in adult women: a case report on the challenging diagnosis and treatment.
    Rom J Morphol Embryol. 2023;64:83-88.
    Abstract

  582. KROG L, Lycke KD, Christiansen AG, Hammer A, et al
    Insufficient training in colposcopy and loop electrosurgical excision procedure among residents.
    Dan Med J. 2023;70:A11220695.
    Abstract

  583. DING Y, Wu X, Yang X
    Identification of miRNAs and target genes associated with lymph node metastasis in cervical cancer using bioinformatics analysis.
    Toxicol Mech Methods. 2023 Apr 26:1-27. doi: 10.1080/15376516.2023.2207644.
    Abstract

  584. VALSAN A, Meenu MT, Murali VP, Malgija B, et al
    Exploration of Phaeanthine: A Bisbenzylisoquinoline Alkaloid Induces Anticancer Effect in Cervical Cancer Cells Involving Mitochondria-Mediated Apoptosis.
    ACS Omega. 2023;8:14799-14813.
    Abstract

  585. WAHEED DE, Bolio A, Guillaume D, Sidibe A, et al
    Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: What works in the context of low-resource countries?
    Front Public Health. 2023;11:1112981.
    Abstract

  586. CHEN X, Lin L, Wu Q, Li S, et al
    Tumor Necrosis Factor-alpha Promotes the Tumorigenesis, Lymphangiogenesis, and Lymphatic Metastasis in Cervical Cancer via Activating VEGFC-Mediated AKT and ERK Pathways.
    Mediators Inflamm. 2023;2023:5679966.
    Abstract

  587. WANG L, Liu P, Duan H, Li P, et al
    Abdominal type B vs. type C radical hysterectomy in early-stage cervical cancer: A matched single center cohort report.
    Front Surg. 2023;10:1166084.
    Abstract

  588. LEATH CA 3RD, Nysenbaum J, Ting J, Zhang YJ, et al
    Patterns of care and health care resource use among Medicaid-enrolled women with recurrent or metastatic cervical cancer.
    J Manag Care Spec Pharm. 2023;29:490-498.
    Abstract

  589. O'LAUGHLIN DJ, Strelow BA, Fellows NA, Stevens JN, et al
    Papanicolaou test collection with the Papette brush or the spatula with cytobrush: A pragmatic study.
    Womens Health (Lond). 2023;19:17455057231170975.
    Abstract

  590. SHERO AA, Kaso AW, Tafa M, Agero G, et al
    Cervical cancer screening utilization and associated factors among women attending antenatal care at Asella Referral and Teaching Hospital, Arsi zone, South Central Ethiopia.
    BMC Womens Health. 2023;23:199.
    Abstract

  591. MENDULO R, Chiumia IK
    The state of cervical cancer screening in imprisoned women in Malawi: a case of Maula Prison.
    BMC Womens Health. 2023;23:198.
    Abstract

  592. NANG DW, Tukirinawe H, Okello M, Tayebwa B, et al
    Prevalence of high-risk human papillomavirus infection and associated factors among women of reproductive age attending a rural teaching hospital in western Uganda.
    BMC Womens Health. 2023;23:209.
    Abstract

  593. WANG C, Liu L, Cheng Y, Shi H, et al
    Combined GSK-3beta and MEK inhibitors modulate the stemness and radiotherapy sensitivity of cervical cancer stem cells through the Wnt signaling pathway.
    Chem Biol Interact. 2023 Apr 26:110515. doi: 10.1016/j.cbi.2023.110515.
    Abstract

  594. DEVI S, Gaikwad SR, R H
    Prediction and Detection of Cervical Malignancy Using Machine Learning Models.
    Asian Pac J Cancer Prev. 2023;24:1419-1433.
    Abstract

  595. OTHMAN AA, Goreal AA, Pity IS
    Genotyping and Phylogenetic Analysis of Human Papillomaviruses in Formalin Fixed Paraffin Embedded Sections from Cervical Lesions in Duhok-Iraq.
    Asian Pac J Cancer Prev. 2023;24:1313-1319.
    Abstract

  596. UWAMUNGU S, Nigussie B, Muvunyi CM, Hasseus B, et al
    Prevalence of Human Papillomavirus in Different Mucous Membranes in HIV Concordant Couples in Rwanda.
    Viruses. 2023;15:1005.
    Abstract

  597. NICOLO S, Antonelli A, Tanturli M, Baccani I, et al
    Bacterial Species from Vaginal Microbiota Differently Affect the Production of the E6 and E7 Oncoproteins and of p53 and p-Rb Oncosuppressors in HPV16-Infected Cells.
    Int J Mol Sci. 2023;24:7173.
    Abstract

  598. OVESTAD IT, Dalen I, Andersland MS, Vintermyr OK, et al
    Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program-A Prospective Observational Study from Western Norway.
    Int J Mol Sci. 2023;24:7158.
    Abstract

  599. PLOTZKER RE, Vaidya A, Pokharel U, Stier EA, et al
    Sexually Transmitted Human Papillomavirus: Update in Epidemiology, Prevention, and Management.
    Infect Dis Clin North Am. 2023;37:289-310.
    Abstract

  600. CHO H, Park S, Kim HS
    Gastric-type Endocervical Adenocarcinoma: Comprehensive Cytopathological Analysis and Comparison With Usual-type Endocervical Adenocarcinoma.
    In Vivo. 2023;37:1173-1181.
    Abstract

  601. TOLCHER A, Hamilton E, Coleman RL
    The evolving landscape of antibody-drug conjugates in gynecologic cancers.
    Cancer Treat Rev. 2023;116:102546.
    Abstract

  602. MARUYAMA S, Sakabe N, Ito C, Shimoyama Y, et al
    Effect of Specimen Processing Technique on Cell Detection and Classification by Artificial Intelligence.
    Am J Clin Pathol. 2023;159:448-454.
    Abstract

  603. TOLOSKO JA, Beauchesne M, Rancatore E
    Knowledge, attitudes, and practice of the Pap smear test in female college students attending a global university in the United States.
    J Am Assoc Nurse Pract. 2023;35:322-329.
    Abstract

  604. MERGUI JL, Gondry J, Hocquemiller R, Carcopino X, et al
    [Revision of the French colposcopic terminology].
    Gynecol Obstet Fertil Senol. 2023;51:239-248.
    Abstract

  605. WATANABE Y, Ueda Y, Yagi A, Ikeda S, et al
    Disparities among Japanese municipalities in recommendations for routine and catch-up HPV vaccinations.
    Cancer Sci. 2023;114:2139-2144.
    Abstract

  606. CARETTO M, Giannini A, Simoncini T
    The impact of the pandemic on gynecological oncology practice: Three years later.
    Maturitas. 2023;172:69-70.
    Abstract

  607. MCCLYMONT E, Tan DH, Bondy S, Albert A, et al
    HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV.
    Int J STD AIDS. 2023 Jan 26:9564624231154298. doi: 10.1177/09564624231154298.
    Abstract

  608. KUSAKABE M, Taguchi A, Tanikawa M, Hoshi D, et al
    Application of organoid culture from HPV18-positive small cell carcinoma of the uterine cervix for precision medicine.
    Cancer Med. 2023;12:8476-8489.
    Abstract

  609. CHEN X, Pu X, Chen Z, Li L, et al
    Application of EfficientNet-B0 and GRU-based deep learning on classifying the colposcopy diagnosis of precancerous cervical lesions.
    Cancer Med. 2023;12:8690-8699.
    Abstract

  610. LI Y, Cao L, Han X, Ma Y, et al
    Altered vaginal eukaryotic virome is associated with different cervical disease status.
    Virol Sin. 2023;38:184-197.
    Abstract

  611. KIRKEGAARD P, Larsen MB, Andersen B
    "It's cancer screening after all". Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening.
    J Med Screen. 2023;30:74-80.
    Abstract

  612. WANG J, Xi M, Bian C, Yang L, et al
    Mixed spindle and squamous cell carcinoma of the uterine cervix: A case report.
    Asian J Surg. 2023;46:2237-2238.
    Abstract

  613. KOTAKA S, Kondo E, Kawai Y, Okamoto K, et al
    Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer.
    J Gynecol Oncol. 2023 Apr 28. doi: 10.3802/jgo.2023.
    Abstract

  614. XU WY, Raver E, Jung J, Li Y, et al
    Rural-urban disparities in preventive breast and cervical cancer screening among women with early-onset dementia.
    BMC Womens Health. 2023;23:255.
    Abstract

  615. PAK T, Sadowski EA, Patel-Lippmann K
    MR Imaging in Cervical Cancer: Initial Staging and Treatment.
    Radiol Clin North Am. 2023;61:639-649.
    Abstract

  616. HOANG BX, Han BO, Tran HQ, Fang WH, et al
    Successful Phytotherapy for Acute Refractory Radiation Cystitis in a Cervical Cancer Patient: A Case Report.
    Cancer Diagn Progn. 2023;3:383-386.
    Abstract

  617. STVERAKOVA T, Baranova I, Mikyskova P, Gajdosova B, et al
    Selection of endogenous control and identification of significant microRNA deregulations in cervical cancer.
    Front Oncol. 2023;13:1143691.
    Abstract

  618. MITTAL A, Neibart SS, Kulkarni A, Anderson T, et al
    Barriers and facilitators to effective cervical cancer screening in Belize: a qualitative analysis.
    Cancer Causes Control. 2023 May 11. doi: 10.1007/s10552-023-01703.
    Abstract

  619. ZHANG Q, Song J, Cao L, Sun M, et al
    RNF113A targeted by miR-197 promotes proliferation and inhibits autophagy via CXCR4/CXCL12/AKT/ERK/Beclin1 axis in cervical cancer.
    Exp Cell Res. 2023 May 8:113632. doi: 10.1016/j.yexcr.2023.113632.
    Abstract

  620. SOLANKI R, Jangid AK, Jadav M, Kulhari H, et al
    Folate Functionalized and Evodiamine-Loaded Pluronic Nanomicelles for Augmented Cervical Cancer Cell Killing.
    Macromol Biosci. 2023 May 10:e2300077. doi: 10.1002/mabi.202300077.
    Abstract

  621. MARKOWITZ LE, Unger ER
    Human Papillomavirus Vaccination.
    N Engl J Med. 2023;388:1790-1798.
    Abstract

  622. JIN Y, Xie S, Sheng B, Chen M, et al
    The effect of propofol on chemosensitivity of paclitaxel in cervical cancer cells.
    Cancer Med. 2023 May 10. doi: 10.1002/cam4.6064.
    Abstract

  623. WEI B, Li Q, Seery S, Qiao Y, et al
    Endocervical curettage for diagnosing high-grade squamous intraepithelial lesions or worse in women with type 3 transformation zone lesions: a retrospective, observational study.
    BMC Womens Health. 2023;23:245.
    Abstract

  624. MIJITI Y, Yusupu H, Liu H, Zhang X, et al
    Survey on cervical cancer knowledge and its influencing factors among 2,578 women in Shache county, Kashi, China.
    BMC Womens Health. 2023;23:246.
    Abstract

  625. MERKURI L, Kamberi F, Qorri E, Shapo L, et al
    Assessment of the Albanian University female students' knowledge, attitudes, and practices on cervical cancer.
    J Infect Dev Ctries. 2023;17:534-541.
    Abstract

  626. ZHAO Y, Ma Y, Zang A, Cheng Y, et al
    First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors.
    J Hematol Oncol. 2023;16:50.
    Abstract

  627. ZHAO X, Zhang R, Song Z, Yang K, et al
    Curcumin suppressed the proliferation and apoptosis of HPV-positive cervical cancer cells by directly targeting the E6 protein.
    Phytother Res. 2023 May 8. doi: 10.1002/ptr.7868.
    Abstract

  628. YANG G, He Y, Chen Y, Huang Z, et al
    Antitumor activity of galaxamide involved in cell apoptosis and stemness by inhibiting Wnt/beta-catenin pathway in cervical cancer.
    Drug Dev Res. 2023 May 8. doi: 10.1002/ddr.22073.
    Abstract

  629. HAN X, Du S, Chen X, Min X, et al
    Lactate-mediated Fascin protrusions promote cell adhesion and migration in cervical cancer.
    Theranostics. 2023;13:2368-2383.
    Abstract

  630. AN J, Li X, Wang J, Zhu L, et al
    Efficacy and safety of serplulimab plus nab-paclitaxel in previously treated patients with PD-L1-positive advanced cervical cancer: a phase II, single-arm study.
    Front Immunol. 2023;14:1142256.
    Abstract

  631. DENG B, Li A, Zhu Y, Zhou Y, et al
    SHCBP1 contributes to the proliferation and self‑renewal of cervical cancer cells and activation of the NF‑kappaB signaling pathway through EIF5A.
    Oncol Lett. 2023;25:246.
    Abstract

  632. SHASWATI M, Oeishy FH, Mumu SB, Zahid MZI, et al
    Polymorphisms of the interleukin-6 (IL-6) gene contribute to cervical cancer susceptibility in Bangladeshi women: A case-control study.
    Health Sci Rep. 2023;6:e1238.
    Abstract

  633. AKBARI A, Khayamzadeh M, Salmanian R, Moradi A, et al
    Epidemiology and survival of cervical cancer in Iran based on national cancer registry data (2008-2014).
    Front Oncol. 2023;13:1132369.
    Abstract

  634. YANG X, Zhang W, Zhu W
    Profiling of immune responses by lactate modulation in cervical cancer reveals key features driving clinical outcome.
    Heliyon. 2023;9:e14896.
    Abstract

  635. YANG X, Li Z, Zhang L, Li H, et al
    The effect of radiotherapy time and dose on acute hematologic toxicity during concurrent postoperative chemoradiotherapy for early high-risk cervical cancer.
    J Cancer. 2023;14:895-902.
    Abstract

  636. MENG Q, Liu X, Hu K, Hou X, et al
    Image-guided intensity-modulated radiotherapy in patients with FIGO IIIC1 cervical cancer: efficacy, toxicity and prognosis.
    J Cancer. 2023;14:1001-1010.
    Abstract

  637. CHAYO I, Uribe Perez CJ, De Vries E, Pinheiro PS, et al
    The impact of health insurance affiliation and socioeconomic status on cervical cancer survival in Bucaramanga, Colombia.
    Cancer Epidemiol. 2023;85:102375.
    Abstract

  638. PETRIE K, Wells A, Eckert LO
    Human Papillomavirus Vaccine: The Cancer Prevention Moonshot.
    Obstet Gynecol Clin North Am. 2023;50:339-348.
    Abstract

  639. MEHDI HK, Raju K, Sheela SR
    Association of P16, Ki-67, and CD44 expression in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of the cervix.
    J Cancer Res Ther. 2023;19.
    Abstract

  640. SINGH B, Singh G, Oinam AS, Kumar V, et al
    Radiobiological modeling of radiation-induced acute rectal mucositis: A single-institutional study of cervical carcinoma.
    J Cancer Res Ther. 2023;19.
    Abstract

  641. CHUGHTAI N, Perveen K, Gillani SR, Abbas A, et al
    National cervical cancer burden estimation through systematic review and analysis of publicly available data in Pakistan.
    BMC Public Health. 2023;23:834.
    Abstract

  642. XU X, Wang X, Chen Q, Zheng A, et al
    Sp1 promotes tumour progression by remodelling the mitochondrial network in cervical cancer.
    J Transl Med. 2023;21:307.
    Abstract

  643. SPENCER JC, Kim JJ, Tiro JA, Feldman S, et al
    Racial and Ethnic Disparities in Cervical Cancer Screening from Three US Healthcare Settings.
    Am J Prev Med. 2023 May 3:S0749-3797(23)00202.
    Abstract

  644. KARAFEZIEVA BV, Prandzhev GD, Mateva S, Totev T, et al
    Robot-Assisted Hysterectomy for Primary Choriocarcinoma of the Cervix - A Novel Approach.
    Chirurgia (Bucur). 2023;118:202-207.
    Abstract

  645. METE B, Utuk FA, Demirhindi H, Inaltekin A, et al
    Human papillomavirus vaccine administration among women in the Eastern Mediterranean region of Turkey: prevalence and barriers.
    Eur Rev Med Pharmacol Sci. 2023;27:3526-3533.
    Abstract

  646. MACHIDA M, Inoue S
    Patterns of HPV vaccine hesitancy among catch-up generations in Japan: A descriptive study.
    Vaccine. 2023 Apr 4:S0264-410X(23)00355-9. doi: 10.1016/j.vaccine.2023.
    Abstract

  647. MA Y, Li Y, Liu Y, Cao L, et al
    Vaginal Microbiome Dysbiosis is Associated with the Different Cervical Disease Status.
    J Microbiol. 2023;61:423-432.
    Abstract

  648. SETIAWAN D, Annisa AN, Lianawati, Hutubessy RCW, et al
    The Cost Analysis of Human Papillomavirus Vaccination Program in Indonesia.
    Value Health Reg Issues. 2023;35:102-108.
    Abstract

  649. RUEL-LALIBERTE J, Jacob-Wagner M, Bestman-Smith J, Pare J, et al
    Acceptability and Preferences of Dry HR HPV Self-Sampling Mailed Kits Among Canadian Women: A Cross-Sectional Study.
    J Obstet Gynaecol Can. 2023;45:261-266.
    Abstract

  650. RICKFORD R, Rogers M, Halliday A, Lamptey P, et al
    Attitudes to reducing cervical screening frequency among UK women: A qualitative analysis.
    Psychooncology. 2023;32:721-729.
    Abstract

  651. RADU CA, Matos de Melo Fernandes N, Khalfe S, Stordal B, et al
    Awareness of ovarian cancer symptoms and risk factors in a young ethnically diverse British population.
    Cancer Med. 2023;12:9879-9892.
    Abstract

  652. AVILA S, Ruiz MJ, Petereit D, Arya R, et al
    Communicating the Gynecologic Brachytherapy Experience (CoGBE): Clinician perceived benefits of a graphic narrative discussion guide.
    Brachytherapy. 2023;22:352-360.
    Abstract

  653. STOLNICU S, Brito MJ, Karpathiou G, Hoang L, et al
    Villoglandular Pattern in HPV-associated Endocervical Adenocarcinoma is Associated With Excellent Prognosis: A Reappraisal of 31 Cases Using IECC and Silva Pattern Classification.
    Int J Gynecol Pathol. 2023;42:270-277.
    Abstract

  654. STOLNICU S, Hoang L, Zhou Q, Iasonos A, et al
    Cervical Adenosquamous Carcinoma: Detailed Analysis of Morphology, Immunohistochemical Profile, and Outcome in 59 Cases.
    Int J Gynecol Pathol. 2023;42:259-269.
    Abstract

  655. HUANG J, Zhao Y
    E2F Transcription Factor 1 Activates FKBP Prolyl Isomerase 4 to Promote Angiogenesis in Cervical Squamous Cell Carcinoma Via the PI3K/AKT Signaling Pathway.
    Reprod Sci. 2023;30:1229-1240.
    Abstract

  656. THIEL DE BOCANEGRA H, Goliaei Z, Khan N, Banna S, et al
    Refugee Women's Receptiveness for Virtual Engagement on Reproductive Health During the COVID-19 Pandemic.
    Int J Behav Med. 2023;30:366-375.
    Abstract

  657. UMEZAWA R, Tokunaga H, Yamamoto T, Shigeta S, et al
    Retrospective analysis of local recurrence pattern by computed tomography image-guided intracavitary and interstitial brachytherapy for locally advanced cervical cancer in a single Japanese institution.
    Brachytherapy. 2023 May 18:S1538-4721(23)00052.
    Abstract

  658. FRAM R, Fram KM, Saleh S, Muhidat N, et al
    Cervical cancer screening in Jordan; a review of the past and an outlook to the future - facts and figures.
    Prz Menopauzalny. 2023;22:24-29.
    Abstract

  659. CAO H, Yan H, Bai S, Gu B, et al
    Radiation-induced lymphopenia and the survival of women with cervical cancer: a meta-analysis.
    J Obstet Gynaecol. 2023;43:2194991.
    Abstract

  660. SPEES LP, Biddell CB, Smith JS, Des Marais AC, et al
    Cost-effectiveness of human papillomavirus (HPV) self-collection intervention on cervical cancer screening uptake among underscreened US persons with a cervix.
    Cancer Epidemiol Biomarkers Prev. 2023 May 19:EPI-22-1267.
    Abstract

  661. OLWAL CO, Fabius JM, Zuliani-Alvarez L, Eckhardt M, et al
    Network modeling suggests HIV infection phenocopies PI3K-AKT pathway mutations to enhance HPV-associated cervical cancer.
    Mol Omics. 2023 May 19. doi: 10.1039/d3mo00025.
    Abstract

  662. PERKINS R, Mitchell E
    Cervical cancer disparities.
    J Natl Med Assoc. 2023;115.
    Abstract

  663. VOGELSANG TLR, Kast V, Bagnjuk K, Eubler K, et al
    RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation in vitro.
    Front Oncol. 2023;13:1110939.
    Abstract

  664. LIU X, Song J, Liu H, Sun Z, et al
    Endoplasmic Reticulum Stress Could Predict the Prognosis of Cervical Cancer and Regulate the Occurrence of Radiation Mucositis.
    Dose Response. 2023;21:15593258231173199.
    Abstract

  665. ALKHALDI RO, Alzahrani HA, Metwally LA
    Awareness Level About Cervical Cancer, Human Papillomavirus (HPV) and Corresponding Vaccine Among Women Living in the Western Region of Saudi Arabia.
    Cureus. 2023;15:e37512.
    Abstract

  666. ZHANG X, Chen W, Zhu X, Bi H, et al
    Multiple Center Research on Relationship Between Screening Quality and Detection of Cervical Cancer - Six Provinces, China, June-December 2021.
    China CDC Wkly. 2023;5:301-305.
    Abstract

  667. ZHANG J, Liu X
    MRI is more valuable than CT in the diagnosis of cervical cancer.
    Am J Transl Res. 2023;15:2970-2976.
    Abstract

  668. SPEER L
    Majority of Grade 2 Cervical Intraepithelial Neoplasia Lesions Regress in Women 25 to 30 Years of Age.
    Am Fam Physician. 2023;107:Online.
    Abstract

  669. ZHOU KN, Wang Y, Xie Y, Yang SH, et al
    Symptom burden survey and symptom clusters in patients with cervical cancer: a cross-sectional survey.
    Support Care Cancer. 2023;31:338.
    Abstract

  670. LUCAS E, Murillo R, Arrossi S, Barcena M, et al
    Quantification of impact of COVID-19 pandemic on cancer screening programmes - a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand.
    Elife. 2023;12:e86527.
    Abstract

  671. NIE G, Tang B, Lv M, Li D, et al
    HPV E6 promotes cell proliferation of cervical cancer cell by accelerating accumulation of RBM15 dependently of autophagy inhibition.
    Cell Biol Int. 2023 May 16. doi: 10.1002/cbin.12020.
    Abstract

  672. CERTELLI C, Anchora LP, Gallotta V
    Special Issue: "Management of Early Stage Cervical Cancer".
    Cancers (Basel). 2023;15:2343.
    Abstract

  673. PSILOPATIS I, Garmpis N, Garmpi A, Vrettou K, et al
    The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy.
    Cancers (Basel). 2023;15:2222.
    Abstract

  674. APPIDI T, Vakada M, Buddhiraju HS, Chinchulkar SA, et al
    Development of a Point-of-Care Cervico-Vaginal Sampling/Testing Device for the Colorimetric Detection of Cervical Cancer.
    Diagnostics (Basel). 2023;13:1382.
    Abstract

  675. ZHANG CN, Liu XY, Li Q, Song YZ, et al
    [Assessment of the diagnostic value and prognosis of different detection markers in endocervical adenocarcinoma].
    Zhonghua Zhong Liu Za Zhi. 2023;45:402-409.
    Abstract

  676. LI L, Wang LL, Zhou JY
    [Correlation and clinical significance of VISTA expression and cervical squamous cell carcinoma].
    Zhonghua Zhong Liu Za Zhi. 2023;45:396-401.
    Abstract

  677. TIAN T, Hua Z, Kong Y, Wang LZ, et al
    [The mechanism of S100A7 inducing the migration and invasion in cervical cancer cells].
    Zhonghua Zhong Liu Za Zhi. 2023;45:375-381.
    Abstract

  678. GELASSA FR, Nagari SL, Jebena DE, Belgafo D, et al
    Knowledge and practice of cervical cancer screening and its associated factors among women attending maternal health services at public health institutions in Assosa Zone, Benishangul-Gumuz, Northwest Ethiopia, 2022: a cross-sectional study.
    BMJ Open. 2023;13:e068860.
    Abstract

  679. LEE NR, Chang WH, Wang PH
    How big the excision for high-grade intraepithelial neoplasms of the cervix should be done?
    Taiwan J Obstet Gynecol. 2023;62:391-392.
    Abstract

  680. CHUNG SY, Chang JS, Kim YB
    Comprehensive clinical evaluation of deep learning-based auto-segmentation for radiotherapy in patients with cervical cancer.
    Front Oncol. 2023;13:1119008.
    Abstract

  681. HAN S, Wang S, Lv X, Li D, et al
    Ferroptosis-related genes in cervical cancer as biomarkers for predicting the prognosis of gynecological tumors.
    Front Mol Biosci. 2023;10:1188027.
    Abstract

  682. LI G, Lamsisi M, Chenafi S, Moniod L, et al
    Urine-based detection of HPV for cervical cancer screening: Time for standardized tests.
    J Med Virol. 2023;95:e28737.
    Abstract

  683. RAMSHANKAR V, Ravindran S, Arun K, Albert K, et al
    Impact of HPV molecular testing with partial genotyping as a feasibility study in cervical cancer community screening program in South India.
    J Med Virol. 2023;95:e28715.
    Abstract

  684. LAAN JJ, van Lonkhuijzen LRCW, Stokking JA, Barten DLJ, et al
    The Effect of Contemporary Brachytherapy Practices on Prognosis in Women with Locally Advanced Cervical Cancer.
    Curr Oncol. 2023;30:4275-4288.
    Abstract

  685. ZAMMIT C, Creagh N, Nightingale C, McDermott T, et al
    'I'm a bit of a champion for it actually': qualitative insights into practitioner-supported self-collection cervical screening among early adopting Victorian practitioners in Australia.
    Prim Health Care Res Dev. 2023;24:e31.
    Abstract

  686. ZHOU G, Koroukian SM, Navale SM, Schiltz NK, et al
    Cancer burden in women with HIV on Medicaid: A nationwide analysis.
    Womens Health (Lond). 2023;19:17455057231170061.
    Abstract

  687. BABI A, Issa T, Issanov A, Akhanova S, et al
    Knowledge and attitudes of mothers toward HPV vaccination: A cross-sectional study in Kazakhstan.
    Womens Health (Lond). 2023;19:17455057231172355.
    Abstract

  688. ZUO Y, Xiao H, Lv D, Huang M, et al
    Infection pattern and immunological characteristics of Epstein-Barr virus latent infection in cervical squamous cell carcinoma.
    J Med Virol. 2023;95:e28717.
    Abstract

  689. LI S, Liu J, Zhang W, Lu H, et al
    T1 mapping and multimodel diffusion-weighted imaging in the assessment of cervical cancer: a preliminary study.
    Br J Radiol. 2023 May 15:20220952. doi: 10.1259/bjr.20220952.
    Abstract

  690. YU Y, Liu Y, Li Y, Yang X, et al
    Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer.
    Cancer Cell Int. 2023;23:92.
    Abstract

  691. ESTENSON L, Kim N, Jacobson M
    Do age-based discontinuation recommendations influence cervical cancer screening rates? Evidence from the United States' Behavioral Risk Factor Surveillance System, 2016 and 2018.
    Prev Med. 2023;172:107543.
    Abstract

  692. SHARMA K, Machalek DA, Toh ZQ, Amenu D, et al
    No woman left behind: achieving cervical cancer elimination among women living with HIV.
    Lancet HIV. 2023 May 11:S2352-3018(23)00082.
    Abstract

  693. PRETSCH PK, Spees LP, Brewer NT, Hudgens MG, et al
    Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial.
    Lancet Public Health. 2023 May 11:S2468-2667(23)00076.
    Abstract

  694. WANG R, Coleman JS
    The HPV self-collection paradox: boosting cervical cancer screening, struggling with follow-up care.
    Lancet Public Health. 2023 May 11:S2468-2667(23)00094.
    Abstract

  695. WANG L, Liu P, Duan H, Li P, et al
    Evaluation of individualized para-tumor resection of cervical cancer patients based on three-dimensional reconstruction.
    Front Surg. 2023;10:1174490.
    Abstract

  696. BRITTO AMA, Siqueira JD, Curty G, Goes LR, et al
    Microbiome analysis of Brazilian women cervix reveals specific bacterial abundance correlation to RIG-like receptor gene expression.
    Front Immunol. 2023;14:1147950.
    Abstract

  697. YU L, Lanqing G, Huang Z, Xin X, et al
    T cell immunotherapy for cervical cancer: challenges and opportunities.
    Front Immunol. 2023;14:1105265.
    Abstract

  698. NASIRI-AGHDAM M, Garcia-Chagollan M, Pereira-Suarez AL, Aguilar-Lemarroy A, et al
    Splicing Characterization and Isoform Switch Events in Human Keratinocytes Carrying Oncogenes from High-Risk HPV-16 and Low-Risk HPV-84.
    Int J Mol Sci. 2023;24:8347.
    Abstract

  699. POPIEL-KOPACZYK A, Piotrowska A, Sputa-Grzegrzolka P, Smolarz B, et al
    The Immunohistochemical Expression of Epithelial-Mesenchymal Transition Markers in Precancerous Lesions and Cervical Cancer.
    Int J Mol Sci. 2023;24:8063.
    Abstract

  700. HAN X, Fang F, Cui W, Liu Y, et al
    Effect of Ethanol-Induced Methyl Donors Consumption on the State of Hypomethylation in Cervical Cancer.
    Int J Mol Sci. 2023;24:7729.
    Abstract

  701. ASARE M, Elizondo A, Dwumfour-Poku M, Mena C, et al
    Intervention to Increase Cervical Cancer Screening Behavior among Medically Underserved Women: Effectiveness of 3R Communication Model.
    Healthcare (Basel). 2023;11:1323.
    Abstract

  702. BRYAN SJ, Lee J, Gunu R, Jones A, et al
    Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study.
    Cancers (Basel). 2023;15:2590.
    Abstract

  703. KUTLE I, Polten R, Hachenberg J, Klapdor R, et al
    Tumor Organoid and Spheroid Models for Cervical Cancer.
    Cancers (Basel). 2023;15:2518.
    Abstract

  704. XIANG X, Zhang Y, Hua K, Ding J, et al
    Impacts of ovarian preservation on the prognosis of neuroendocrine cervical carcinoma: a retrospective analysis based on machine learning.
    World J Surg Oncol. 2023;21:146.
    Abstract

  705. HOSSEINI Z, Seyrafi N, Homayuni A, Mouseli A, et al
    Predicting cervical cancer screening behavior among women in southern Iran: a cross-sectional study with PEN-3 model.
    BMC Womens Health. 2023;23:260.
    Abstract

  706. QI K, Lin G, Liu H, Zhang X, et al
    Comparison between radical surgery and chemoradiotherapy in patients with cervical esophageal cancer: a propensity score matched analysis.
    BMC Surg. 2023;23:119.
    Abstract

  707. DROUIN E, Classe JM, Hautecoeur P
    125 years of the Wertheim operation. What next?
    J Med Life. 2023;16:341-343.
    Abstract

  708. WENG G, Wang B, Ye Y, Zhang Q, et al
    Application of Microscopic Highly Hydrophilic Silica-Based Nanocomposites with High Surface Exposure in the Efficient Identification of Intact N-Glycopeptides.
    Anal Chem. 2023;95:7735-7742.
    Abstract

  709. RUAN Y, Li H, Liu M, Cao G, et al
    A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine.
    Cancer Epidemiol. 2023;84:102372.
    Abstract

  710. LI N, Cheng C, Liang R, Zhu Q, et al
    Epidemiological analysis of HPV in Sichuan during 2014-2021.
    Cancer Epidemiol. 2023;84:102360.
    Abstract

  711. GOPALANI SV, Soman A, Shapiro JA, Miller JW, et al
    Breast, cervical, and colorectal cancer screening test use in the US territories of Guam, Puerto Rico, and the US Virgin Islands.
    Cancer Epidemiol. 2023;84:102371.
    Abstract

  712. PERKINS RB, Smith DL, Jeronimo J, Campos NG, et al
    Use of risk-based cervical screening programs in resource-limited settings.
    Cancer Epidemiol. 2023;84:102369.
    Abstract

  713. MONDAL K, Muskaan, Mourya A, Choudhary S, et al
    Plan quality score to evaluate the dwell time deviation restricted inverse planning by simulated annealing and graphically optimized treatment plans for template based interstitial brachytherapy.
    Cancer Radiother. 2023;27:196-205.
    Abstract

  714. CONLEY MJ, Epifano I, Kirk A, Stevenson A, et al
    Microwave hyperthermia represses human papillomavirus oncoprotein activity and induces cell death due to cell stress in 3D tissue models of anogenital precancers and cancers.
    EBioMedicine. 2023;91:104577.
    Abstract

  715. MONIST M, Lewkowicz D, Pietak P, Pilewska-Kozak A, et al
    Synchronously occurring endometrioid carcinomas of the uterine corpus and uterine cervix preceded by different precancerous lesions: A case study and a literature review.
    Pathol Res Pract. 2023;245:154452.
    Abstract

  716. AYNAUD O, Huynh B, Bergeron C
    High-grade and low-grade HPV-induced urethral lesions treated by CO(2) laser under colposcopy.
    Sex Transm Infect. 2023 Mar 29:sextrans-2022-055503.
    Abstract

  717. ISHII K, Tabuchi T, Iso H
    Trends in socioeconomic inequalities in cervical, breast, and colorectal cancer screening participation among women in Japan, 2010-2019.
    Cancer Epidemiol. 2023;84:102353.
    Abstract

  718. JIANG YF, Jiang Y, Bi JH, Zhang Y, et al
    Relative survival analysis of gynecological cancers in an urban district of Shanghai during 2002-2013.
    Cancer Epidemiol. 2023;84:102355.
    Abstract

  719. WEYL A, Sanson C, Roumiguie M, Chaynes P, et al
    The lymphatic system of the uterine cervix: towards a more precise definition of the drainage routes.
    Surg Radiol Anat. 2023;45:653-659.
    Abstract

  720. WANG A, Zhou D, Krawczyk E, Li T, et al
    Overexpression of the telomerase holoenzyme induces EMT and tumorigenesis of HPV-immortalized keratinocytes.
    J Med Virol. 2023;95:e28681.
    Abstract

  721. ZENG C, Wu JK, Lu X
    Clinicopathological features and immunophenotype of Silva pattern system in endocervical adenocarcinoma.
    Int J Exp Pathol. 2023;104:140-150.
    Abstract

  722. MCKENZIE KA, Mahnken JD
    Simulating and estimating agreement in the presence of multiple raters and covariates.
    Stat Med. 2023;42:1687-1698.
    Abstract

  723. SHARMA AE, Hodgson AJ, Howitt BE, Olkhov-Mitsel E, et al
    Molecular correlates of invasion pattern in HPV-associated endocervical adenocarcinoma: emergence of two distinct risk-stratified tiers.
    Histopathology. 2023;82:1067-1078.
    Abstract

  724. METZ CK, Skof AS, Sehouli J, Siedentopf JP, et al
    Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study.
    Arch Gynecol Obstet. 2023;308:207-218.
    Abstract

  725. MONTI E, Libutti G, Di Loreto E, Boero V, et al
    High-grade vaginal intraepithelial neoplasia and recurrence risk: analysis of an Italian regional referral center series.
    Arch Gynecol Obstet. 2023;308:201-206.
    Abstract

  726. KOC S, Yuksel D, Kinay T, Burkankulu D, et al
    Histological results of HPV genotyping from a colposcopy center.
    Arch Gynecol Obstet. 2023;308:193-200.
    Abstract

  727. TATAR B
    Incorporating HPV 33 and cytology into HPV 16/18 screening may be feasible. A cross-sectional study.
    Arch Gynecol Obstet. 2023;308:183-191.
    Abstract

  728. ZHANG H, Zhang S
    Prevalence and genotype distribution of human papillomavirus infection among female outpatients in Northeast China: a population-based survey of 110,927 women.
    Arch Gynecol Obstet. 2023;308:35-41.
    Abstract

  729. WARD M, Beltran T, Corbo A, Sevilla M, et al
    Knowledge and Attitudes Regarding Human Papillomavirus Among Active Duty Service Members at a Large Military Base.
    Mil Med. 2023;188.
    Abstract

  730. DAVIDSON T, Yakobi Y, Nayruz K, Levin G, et al
    Early prediction of urinary retention following radical hysterectomy by 18F-FDG PET/CT imaging.
    Minerva Obstet Gynecol. 2023;75:243-250.
    Abstract

  731. CHENG H, Li Y, Cheng J, Zhang Y, et al
    Study on the effect and mechanisms of piperine against cervical cancer based on network pharmacology and experimental validation.
    Biotechnol Genet Eng Rev. 2023 May 26:1-24. doi: 10.1080/02648725.2023.2217611.
    Abstract

  732. LI Y, Gao X, Huang Y, Zhu X, et al
    Tumor microenvironment promotes lymphatic metastasis of cervical cancer: its mechanisms and clinical implications.
    Front Oncol. 2023;13:1114042.
    Abstract

  733. DABI Y, Favier A, Razakamanantsoa L, Suisse S, et al
    Value of non-coding RNAs to assess lymph node status in cervical cancer.
    Front Oncol. 2023;13:1144672.
    Abstract

  734. XIA X, Wang Y, Shao Y, Xu J, et al
    Marine Sulfated Polysaccharide PMGS Synergizes with Paclitaxel in Inhibiting Cervical Cancer In Vitro.
    Mar Drugs. 2023;21:259.
    Abstract

  735. FAYE MD, Petruccelli Araujo M, Wissing MD, Alrabiah K, et al
    Safety and Efficacy of 2D Brachytherapy vs. 3D Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer-A Single Institution Retrospective Study.
    Curr Oncol. 2023;30:4966-4978.
    Abstract

  736. PARKER SL, Deshmukh AA, Chen B, Lairson DR, et al
    Perceived barriers to cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: Results from a telephone survey.
    Elife. 2023;12:e84664.
    Abstract

  737. UEZONO H, Tsujino K, Miyazaki S, Marudai M, et al
    Reduced Risk of Lymphedema With Intensity-modulated Radiation Therapy Compared With 3-dimensional Conformal Radiation Therapy in Patients With Cervical Cancer Who Received Postoperative Pelvic Radiation Therapy.
    Am J Clin Oncol. 2023 May 26. doi: 10.1097/COC.0000000000001018.
    Abstract

  738. GALINDO JF, Formigari GM, Zeferino LC, Carvalho CF, et al
    Social determinants influencing cervical cancer diagnosis: an ecological study.
    Int J Equity Health. 2023;22:102.
    Abstract

  739. SHEN TT, Long CY, Wu MP
    Favorable cervical cancer mortality-to-incidence ratios of countries with good human development index rankings and high health expenditures.
    BMC Womens Health. 2023;23:284.
    Abstract

  740. PAYNE DA, Terraschke A, Yoshida K, Osasah VA, et al
    Aotearoa New Zealand Deaf women's perspectives on breast and cervical cancer screening.
    N Z Med J. 2023;136:40-48.
    Abstract

  741. LI X, Liu L, He J, Yan J, et al
    Analysis of the effectiveness of the application of pelvic floor rehabilitation exercise and the factors influencing its self-efficacy in postoperative patients with cervical cancer.
    Front Oncol. 2023;13:1118794.
    Abstract


  742. Statement of Retraction: Long non-coding RNA SNHG4 promotes cervical cancer progression through regulating c-Met via targeting miR-148a-3p.
    Cell Cycle. 2023 May 25:1. doi: 10.1080/15384101.2023.2211864.
    Abstract

  743. MATSUOKA N, Katsuno T, Tagami G, Ishizuka K, et al
    Granulocyte-colony stimulating factor producing cervical cancer with elevated levels of parathyroid hormone-related protein: a case report and literature review.
    CEN Case Rep. 2023 May 25. doi: 10.1007/s13730-023-00788.
    Abstract

  744. MAN I, Georges D, Bonjour M, Baussano I, et al
    Approximating missing epidemiological data for cervical cancer through Footprinting: A case study in India.
    Elife. 2023;12:e81752.
    Abstract

  745. HAQSHENAS G, Molano M, Phillips S, Balgovind P, et al
    Evaluation of Seegene Anyplex II Performance for Detection of Human Papillomavirus Genotypes in Formalin-Fixed, Paraffin-Embedded Cervical Cancer Specimens.
    Arch Pathol Lab Med. 2023 May 23. doi: 10.5858/arpa.2022-0317.
    Abstract

  746. JEUDIN PP, Sanchez-Covarrubias AP, Thiele AR, Reis IM, et al
    Differences in Cervical Cancer Outcomes by Caribbean Nativity in Black and White Women in Florida.
    Cancer Control. 2023;30:10732748231176642.
    Abstract

  747. ADEYEMI SA, Az-Zamakhshariy Z, Choonara YE
    In Vitro Prototyping of a Nano-Organogel for Thermo-Sonic Intra-Cervical Delivery of 5-Fluorouracil-Loaded Solid Lipid Nanoparticles for Cervical Cancer.
    AAPS PharmSciTech. 2023;24:123.
    Abstract

  748. CEGLA P, Hofheinz F, Burchardt E, Czepczynski R, et al
    Asphericity derived from [(18)F]FDG PET as a new prognostic parameter in cervical cancer patients.
    Sci Rep. 2023;13:8423.
    Abstract

  749. ALBERTON DL, Salcedo MP, Zen RP, Ferreira CF, et al
    Conservative Treatment of Stage IA1 Cervical Carcinoma Without Lymphovascular Space Invasion: A 20-year Retrospective Study in Brazil.
    Rev Bras Ginecol Obstet. 2023;45:201-206.
    Abstract

  750. ZHANG T, Zhuang L, Muaibati M, Wang D, et al
    Identification of cervical cancer stem cells using single-cell transcriptomes of normal cervix, cervical premalignant lesions, and cervical cancer.
    EBioMedicine. 2023;92:104612.
    Abstract

  751. DELGADO-WALDO I, Contreras-Romero C, Salazar-Aguilar S, Pessoa J, et al
    A triple-drug combination induces apoptosis in cervical cancer-derived cell lines.
    Front Oncol. 2023;13:1106667.
    Abstract

  752. ADLER D, Bonham A, Chamberlin S, Fiscella K, et al
    A scalable approach to determine cervical cancer screening needs among emergency department patients in the United States.
    Prev Med Rep. 2023;33:102221.
    Abstract

  753. BENDAHHOU K, Serhier Z, Diouny S, Ouadii K, et al
    Women's Knowledge and Attitudes Towards Cervical Cancer Screening in Morocco.
    Cureus. 2023;15:e37989.
    Abstract

  754. CHEN Y, Huang B, Zheng J, He F, et al
    Prediction study of prognostic nutrition index on the quality of life of patients with cervical cancer undergoing radiotherapy and chemotherapy.
    PeerJ. 2023;11:e15442.
    Abstract

  755. ANDRIKOS D, Andrikos A, Naem A, Ebertz O, et al
    Advanced cervical stump cancer after laparoscopic subtotal hysterectomy: a case report of imaging, laparoscopic staging and treatment approach.
    BMC Womens Health. 2023;23:281.
    Abstract

  756. KIM J, Jo H, Ha MC, Kim H, et al
    Elevated risk of cervical cancer in elderly women with incident ulcerative colitis in South Korea.
    Sci Rep. 2023;13:8323.
    Abstract

  757. DEGIFE EA, Oliveira CR, Znamierowski E, Meyer JP, et al
    Uptake of Cervical Cancer Screening Among Female Patients Using a Mobile Medical Clinic.
    Am J Prev Med. 2023 May 21:S0749-3797(23)00238.
    Abstract

  758. BERGERON C, Orth G
    [The prevention of cervical cancer].
    Med Sci (Paris). 2023;39:423-428.
    Abstract


  759. Retraction statement: Dai, Y., Xie, F. and Chen, Y. (2020), Reduced levels of miR-485-5p in HPV-infected cervical cancer promote cell proliferation and enhance invasion ability. FEBS Open Bio, 10: 1348-1361.
    FEBS Open Bio. 2023 May 23. doi: 10.1002/2211-5463.13622.
    Abstract

  760. TANZI E, Bianchi S, Fappani C, Gori M, et al
    Detection of human papillomavirus in fresh and dried urine through an automated system for cervical cancer screening in low- and middle-income countries.
    J Med Virol. 2023;95:e28802.
    Abstract

  761. ZHANG CY, Zhang L, Wang ZM, Ren DH, et al
    The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers.
    J Obstet Gynaecol. 2023;43:2213764.
    Abstract

  762. SHAFIQ MH, Mansoor M, Arshad A, Mansoor S, et al
    Frequency of human papilloma virus (HPV) vaccination among female health care providers and reasons for non-immunization at a public sector hospital.
    J Pak Med Assoc. 2023;73:1159-1163.
    Abstract

  763. FENG T, Shou HF, Yuan SH, Tang HR, et al
    [Treatment and prognosis analysis of 488 patients with FIGO 2018 stage â…¢c squamous cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2023;58:359-367.
    Abstract

  764. FEYISA JD, Woldegeorgis MA, Zingeta GT, Abegaz KH, et al
    Cervical Cancer Progression in Patients Waiting for Radiotherapy Treatment at a Referral Center in Ethiopia: A Longitudinal Study.
    JCO Glob Oncol. 2023;9:e2200435.
    Abstract

  765. LEE SH, Abdul Rahim N, Ong SK, Abdul Rahman H, et al
    Survival of cervical cancer patients in Brunei Darussalam: 2002-2017.
    Heliyon. 2023;9:e16080.
    Abstract

  766. YE BQ, Zhao CZ, Sun PF
    Variations and effects of bladder and rectal volume following uniform preparation procedure in cervical cancer: Five fractions of 6 Gy.
    J Contemp Brachytherapy. 2023;15:123-129.
    Abstract

  767. XIE H, Wang J, Chen Y, Tu Y, et al
    Automatic reconstruction of interstitial needles using CT images in post-operative cervical cancer brachytherapy based on deep learning.
    J Contemp Brachytherapy. 2023;15:134-140.
    Abstract

  768. XU Y, Sun Y, Song X, Ren J, et al
    The mechanisms and diagnostic potential of lncRNAs, miRNAs, and their related signaling pathways in cervical cancer.
    Front Cell Dev Biol. 2023;11:1170059.
    Abstract

  769. DENG Y, Jiang H, Wu D
    Association of MicroRNA-10b Expression and P16 with Pathological Features in Various Stages of Cervical Precancerous Lesions.
    Cell Mol Biol (Noisy-le-grand). 2023;69:109-113.
    Abstract

  770. ROCKSON L, Btoush R
    Cervical Cancer Screening Among Older Garifuna Women Residing in New York City.
    J Racial Ethn Health Disparities. 2023 May 22. doi: 10.1007/s40615-023-01635.
    Abstract

  771. ROSARIO A, Sousa A, Varandas T, Marinho-Dias J, et al
    Impact of cervicovaginal microbiome on the risk of cervical abnormalities development.
    J Med Virol. 2023;95:e28762.
    Abstract

  772. ZENG X, Wang Y, Liu B, Rao X, et al
    Multi-omics data reveals novel impacts of human papillomavirus integration on the epigenomic and transcriptomic signatures of cervical tumorigenesis.
    J Med Virol. 2023;95:e28789.
    Abstract

  773. TAMURA D, Sako W, Watanabe R, Shitara A, et al
    Distribution of cervical intraepithelial neoplasia is closely associated with HPV status and uterine position.
    J Med Virol. 2023;95:e28777.
    Abstract

  774. MACIOS A, Komerska K, Nowakowski A
    Reasons for truly negative cytology reports preceding the diagnoses of invasive cervical cancer-Results of a false-negative cytology audit in Polish Cervical Cancer Screening Programme.
    Cancer Med. 2023 May 22. doi: 10.1002/cam4.6024.
    Abstract

  775. HARPER DM, Anderson RJ, Baker E, Yu TM, et al
    Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening.
    Cancer Prev Res (Phila). 2023 May 19:CAPR-22-0455.
    Abstract

  776. ADDISU D, Gebeyehu NA, Belachew YY
    Knowledge, attitude, and uptake of human papillomavirus vaccine among adolescent schoolgirls in Ethiopia: a systematic review and meta-analysis.
    BMC Womens Health. 2023;23:279.
    Abstract

  777. GROVER S, Seckar T, Gao L, Bhatia R, et al
    Characterization of HPV subtypes in invasive cervical cancer in Botswana patients using a pan-pathogen microarray technology.
    Tumour Virus Res. 2023 May 18:200262. doi: 10.1016/j.tvr.2023.200262.
    Abstract

  778. ESSOH TA, Adeyanju GC, Adamu AA, Tall H, et al
    Exploring the factors contributing to low vaccination uptake for nationally recommended routine childhood and adolescent vaccines in Kenya.
    BMC Public Health. 2023;23:912.
    Abstract

  779. BROSNAN B, Skarga-Bandurova I, Biloborodova T, Skarha-Bandurov I, et al
    An Integrated Approach to Automated Diagnosis of Cervical Intraepithelial Neoplasia in Digital Histology Images.
    Stud Health Technol Inform. 2023;302:615-616.
    Abstract

  780. ROHR THOMSEN C, Leonhard AK, Strandbo Schmidt Jensen M, Bor P, et al
    Quantitative strain elastography of the uterine cervix assessed by the GE Voluson E10 system in combination with a force-measuring device.
    J Matern Fetal Neonatal Med. 2023;36:2213797.
    Abstract

  781. SEEFOO-JARQUIN P, Sosa-Jurado F, Maycotte-Gonzalez P
    [Epidemiological Panorama of Cervical Dysplasia in a First-Level Care Unit].
    Rev Med Inst Mex Seguro Soc. 2023;61:155-162.
    Abstract

  782. CHEUNG TH, Cheng SSY, Hsu D, Wing-Lei Wong Q, et al
    Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong.
    Hum Vaccin Immunother. 2023;19:2184605.
    Abstract

  783. ZHANG L, Mosquera I, Lucas E, Rol ML, et al
    CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs.
    Nat Med. 2023;29:1135-1145.
    Abstract

  784. VASSILAKOS P, Clarke H, Murtas M, Stegmuller T, et al
    Telecytologic diagnosis of cervical smears for triage of self-sampled human papillomavirus-positive women in a resource-limited setting: concept development before implementation.
    J Am Soc Cytopathol. 2023;12:170-180.
    Abstract

  785. TIAN R, Huang Z, Li L, Yuan J, et al
    HPV integration generates a cellular super-enhancer which functions as ecDNA to regulate genome-wide transcription.
    Nucleic Acids Res. 2023;51:4237-4251.
    Abstract

  786. CHIDAMBARAM S, Chang SH, Sandulache VC, Mazul AL, et al
    Human Papillomavirus Vaccination Prevalence and Disproportionate Cancer Burden Among US Veterans.
    JAMA Oncol. 2023;9:712-714.
    Abstract

  787. KARAASLAN S, Dilcher TL, Abdelsayed M, Goyal A, et al
    Significant outcomes associated with high-risk human papillomavirus negative Papanicolaou tests.
    J Am Soc Cytopathol. 2023;12:189-196.
    Abstract

  788. JOHNSON G, Miquel-Chambers C, Blas Y, Lowery S, et al
    Women's Health Maintenance Efforts at a Student-Run Free Clinic in South Florida Exceeded National Trends During the COVID-19 Pandemic.
    J Community Health. 2023;48:501-507.
    Abstract

  789. VIJAYALAKSHMI K, Goei AHY
    Improved population coverage of the human papillomavirus vaccine after implementation of a school-based vaccination programme: the Singapore experience.
    Singapore Med J. 2023;64:294-301.
    Abstract

  790. HEALTHCARE ENGINEERING JO
    Retracted: Dose Prediction Models Based on Geometric and Plan Optimization Parameter for Adjuvant Radiotherapy Planning Design in Cervical Cancer Radiotherapy.
    J Healthc Eng. 2023;2023:9865373.
    Abstract

  791. ZHU X, Yao Q, Dai W, Ji L, et al
    Cervical cancer screening aided by artificial intelligence, China.
    Bull World Health Organ. 2023;101:381-390.
    Abstract

  792. PARNA K, Nygard M, Tisler A, Toompere K, et al
    Age-specific and genotype-specific carcinogenic human papillomavirus prevalence in a country with a high cervical cancer burden: results of a cross-sectional study in Estonia.
    BMJ Open. 2023;13:e069558.
    Abstract

  793. GOULENOK T, Mendes C, Dayan L, Ferre VM, et al
    Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus.
    J Rheumatol. 2023 Jun 1:jrheum.2022-1335. doi: 10.3899/jrheum.2022-1335.
    Abstract

  794. RONSINI C, Solazzo MC, Molitierno R, De Franciscis P, et al
    Fertility-Sparing Treatment for Early-Stage Cervical Cancer >/= 2 cm: Can One Still Effectively Become a Mother? A Systematic Review of Fertility Outcomes.
    Ann Surg Oncol. 2023 Jun 1. doi: 10.1245/s10434-023-13542.
    Abstract

  795. MORSE RM, Jurczuk M, Brown J, Jara LEC, et al
    "Day or night, no matter what, I will go": Women's perspectives on challenges with follow-up care after cervical cancer screening in Iquitos, Peru: a qualitative study.
    BMC Womens Health. 2023;23:293.
    Abstract

  796. GUO X, Dou Y, Liu S, Du Y, et al
    Elevated Expression of ADAM10 Induced by HPV E6 Influences the Prognosis of Cervical Cancer.
    Genet Test Mol Biomarkers. 2023;27:165-171.
    Abstract

  797. KIM YN, Lee K, Park E, Park J, et al
    Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer.
    Front Oncol. 2023;13:1156973.
    Abstract

  798. FANTIN C, Freitas JB, Teles HFM, Oliveira BAS, et al
    High prevalence of HPV 18 and multiple infections with oncogenic HPV genotypes in women at risk of cervical cancer examined in Manaus, Brazil.
    Braz J Med Biol Res. 2023;56:e12720.
    Abstract

  799. LI B, Hua C, Tian P, Sha Y, et al
    25-hydroxycholesterol inhibits human papillomavirus infection in cervical epithelial cells by perturbing cytoskeletal remodeling.
    J Med Virol. 2023;95:e28834.
    Abstract

  800. MORI AT, Nyabakari CJ
    Cost of image-guided percutaneous nephrostomy among cervical cancer patients at Muhimbili National Hospital in Tanzania.
    Cost Eff Resour Alloc. 2023;21:33.
    Abstract

  801. KARAMAGI HC, Ben Charif A, Afriyie DO, Sy S, et al
    Mapping health service coverage inequalities in Africa: a scoping review protocol.
    BMJ Open. 2023;13:e068903.
    Abstract

  802. CHEN J, Han Y, Hu Y, Feng X, et al
    Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial.
    BMJ Open. 2023;13:e067767.
    Abstract

  803. MOUKHLISSI M, Samba S, Najioui Y, Bennani A, et al
    [A rare case of botryoid sarcoma of the uterine cervix: case report].
    Pan Afr Med J. 2023;44:102.
    Abstract

  804. GUO Y, Jin G, Gao YY, Li K, et al
    Clinical study of interstitial brachytherapy for 72 cases of recurrent cervical cancer.
    Pak J Med Sci. 2023;39:863-869.
    Abstract

  805. JIANG S, Cui Z, Zheng J, Wu Q, et al
    Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity.
    J Inflamm Res. 2023;16:2189-2207.
    Abstract

  806. FINK G, Abdulcadir J, Johnson-Agbakwu CE
    Rates of Cervical Cancer Screening and Dysplasia Among Refugees in a Health Care Safety Net System.
    J Immigr Minor Health. 2023 May 30. doi: 10.1007/s10903-023-01491.
    Abstract

  807. HUANG S, Mai X, Liu H, Sun W, et al
    Plan quality and treatment efficiency assurance of two VMAT optimization for cervical cancer radiotherapy.
    J Appl Clin Med Phys. 2023 May 29:e14050. doi: 10.1002/acm2.14050.
    Abstract

  808. RODRIGUEZ OUTEIRAL R, Gonzalez PJ, Schaake EE, van der Heide UA, et al
    Deep learning for segmentation of the cervical cancer gross tumor volume on magnetic resonance imaging for brachytherapy.
    Radiat Oncol. 2023;18:91.
    Abstract

  809. WANG W, Luo H, Chang J, Yang X, et al
    Circular RNA circ0001955 promotes cervical cancer tumorigenesis and metastasis via the miR-188-3p/NCAPG2 axis.
    J Transl Med. 2023;21:356.
    Abstract

  810. GAO X, Zhang W, Sun J, Adeloye D, et al
    Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta-analysis.
    J Int AIDS Soc. 2023;26:e26090.
    Abstract

  811. DAVIES P, Aluloski I, Aluloski D, Brcanski J, et al
    HPV Vaccination and Cervical Cancer Screening Policies and Practices in 18 Countries, Territories and Entities across Eastern Europe and Central Asia.
    Asian Pac J Cancer Prev. 2023;24:1781-1788.
    Abstract

  812. WANNASIN R, Likitdee N, Kelly M, Thinkhamrop K, et al
    Survival after Diagnosis of Cervical Cancer Patients at a Tertiary Referral Hospital in Northeast Thailand.
    Asian Pac J Cancer Prev. 2023;24:1759-1767.
    Abstract

  813. MAPITIGAMA N, Moonesinghe LN, Punchihewa R, Perera C, et al
    A Descriptive Study of Different Methods of Cervical Cancer Screening among Ever-Married Women in 35-Year and 45-Year Cohorts in Kalutara District, Sri Lanka.
    Asian Pac J Cancer Prev. 2023;24:1487-1493.
    Abstract

  814. KEBAYOON A, Wiwanitkit V
    Comment on Self-Sampling Methodology Impression for Cervical Cancer Screening.
    Asian Pac J Cancer Prev. 2023;24:1449-1451.
    Abstract

  815. TIAN M, Wang H, Liu X, Ye Y, et al
    Delineation of clinical target volume and organs at risk in cervical cancer radiotherapy by deep learning networks.
    Med Phys. 2023 May 29. doi: 10.1002/mp.16468.
    Abstract

  816. ABDUL-LATIF M, Tharmalingam H, Tsang Y, Hoskin PJ, et al
    Functional Magnetic Resonance Imaging in Cervical Cancer Diagnosis and Treatment.
    Clin Oncol (R Coll Radiol). 2023 May 18:S0936-6555(23)00184.
    Abstract

  817. RE GL, Cucinella G, Zaccaria G, Crapanzano A, et al
    Role of MRI in the Assessment of Cervical Cancer.
    Semin Ultrasound CT MR. 2023;44:228-237.
    Abstract

  818. ZHAO W, Liu YK, Li DJ, Zhao XW, et al
    The role of interferon-stimulated gene 15 in the occurence and progression of cervical squamous cell carcinoma.
    J Physiol Pharmacol. 2023;74.
    Abstract

  819. LIANG C, Jiang H, Sun L, Kang S, et al
    Which factors predict parametrial involvement in stage IB cervical cancer? A Chinese multicentre study.
    Eur J Surg Oncol. 2023 May 19:S0748-7983(23)00504.
    Abstract

  820. KOHLER RE, Hemler J, Wagner RB, Sullivan B, et al
    Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy: "The land of the unknown".
    Patient Educ Couns. 2023;114:107810.
    Abstract

  821. DALIANIS T, von Buchwald C, Nasman A, Syrjanen S, et al
    Special Issue "HPV in the Head and Neck Region 2.0".
    Viruses. 2023;15:1119.
    Abstract

  822. PAYANO VJH, Lopes LVA, Peixoto LR, Silva KAD, et al
    Immunostaining of betaA-Activin and Follistatin Is Decreased in HPV(+) Cervical Pre-Neoplastic and Neoplastic Lesions.
    Viruses. 2023;15:1031.
    Abstract

  823. JAGARAN K, Singh M
    Copolymer-Green-Synthesized Copper Oxide Nanoparticles Enhance Folate-Targeting in Cervical Cancer Cells In Vitro.
    Polymers (Basel). 2023;15:2393.
    Abstract

  824. FU J, Lu L, Li M, Guo Y, et al
    A gamma-Glutamyl Transpeptidase (GGT)-Triggered Charge Reversal Drug-Delivery System for Cervical Cancer Treatment: In Vitro and In Vivo Investigation.
    Pharmaceutics. 2023;15:1335.
    Abstract

  825. ANDREIKA L, Vankeviciene K, Plioplyte M, Bitinaityte M, et al
    Multiple Rare Primary Malignancies: A Mixed Squamous Neuroendocrine Adenocarcinoma of the Cervix, Metastasized Carcinosarcoma and Extramammary Vulvar Paget's Disease Case Report.
    Medicina (Kaunas). 2023;59:995.
    Abstract

  826. SCHUBERT M, Bauerschlag DO, Muallem MZ, Maass N, et al
    Challenges in the Diagnosis and Individualized Treatment of Cervical Cancer.
    Medicina (Kaunas). 2023;59:925.
    Abstract

  827. SONG C, Jang TK, Kong S, Kang H, et al
    Robotic Single-Site Radical Hysterectomy for Early Cervical Cancer: A Single Center Experience of 5 Years.
    J Pers Med. 2023;13:733.
    Abstract

  828. PSILOPATIS I, Vrettou K, Giaginis C, Theocharis S, et al
    The Role of Bitter Melon in Breast and Gynecological Cancer Prevention and Therapy.
    Int J Mol Sci. 2023;24:8918.
    Abstract

  829. AVILA E, Noriega-Mejia BJ, Gonzalez-Macias J, Cortes-Hernandez U, et al
    The Preventive Role of the Vitamin D Endocrine System in Cervical Cancer.
    Int J Mol Sci. 2023;24:8665.
    Abstract

  830. ABDULLAH H, Ismail I, Suppian R, Zakaria NM, et al
    Natural Gallic Acid and Methyl Gallate Induces Apoptosis in Hela Cells through Regulation of Intrinsic and Extrinsic Protein Expression.
    Int J Mol Sci. 2023;24:8495.
    Abstract

  831. EVANDE R, Rana A, Biswas-Fiss EE, Biswas SB, et al
    Protein-DNA Interactions Regulate Human Papillomavirus DNA Replication, Transcription, and Oncogenesis.
    Int J Mol Sci. 2023;24:8493.
    Abstract

  832. AASBO G, Hansen BT, Waller J, Nygard M, et al
    Unpacking the Lay Epidemiology of Cervical Cancer: A Focus Group Study on the Perceptions of Cervical Cancer and Its Prevention among Women Late for Screening in Norway.
    Healthcare (Basel). 2023;11:1441.
    Abstract

  833. TOMIC SD, Coric A, Tomic S, Mujicic E, et al
    Cervical Cancer Prevention Knowledge (Cckp-64) among Female Students in Novi Sad, Serbia during COVID-19 Pandemic.
    Healthcare (Basel). 2023;11:1400.
    Abstract

  834. CHEN CY, Kung PT, Chiu LT, Tsai WC, et al
    Comparison of Cervical Cancer Screening Used between Individuals with Disabilities and Individuals without Disabilities.
    Healthcare (Basel). 2023;11:1363.
    Abstract

  835. MUSTAFA WA, Ismail S, Mokhtar FS, Alquran H, et al
    Cervical Cancer Detection Techniques: A Chronological Review.
    Diagnostics (Basel). 2023;13:1763.
    Abstract

  836. NASIOUDIS D, George EM, Tanyi JL
    Controversies in the Staging of Patients with Locally Advanced Cervical Cancer.
    Diagnostics (Basel). 2023;13:1747.
    Abstract

  837. KUTZ JM, Rausche P, Gheit T, Puradiredja DI, et al
    Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review.
    BMC Public Health. 2023;23:974.
    Abstract

  838. AKAKPO PK, Ken-Amoah S, Enyan NIE, Agyare E, et al
    High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting.
    Infect Agent Cancer. 2023;18:33.
    Abstract

  839. XIE S, Zhao J, Wang X, Hu Y, et al
    The distribution pattern of pelvic lymph nodal metastases in cervical cancer.
    J Cancer Res Clin Oncol. 2023 May 26. doi: 10.1007/s00432-023-04810.
    Abstract

  840. ZHANG S, Jin G, Ding F, Zhang J, et al
    A case of endocervical adenocarcinoma of the gastric type that was repeatedly misdiagnosed: A case report and literature review.
    Medicine (Baltimore). 2023;102:e33682.
    Abstract

  841. ZHANG Y, Wang H, Lu J, Lv Q, et al
    Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Int J Immunopathol Pharmacol. 2023;37:3946320231178131.
    Abstract

  842. SU SY
    Mortality trends and disease burdens of cervical, endometrial and ovarian cancers from 1981 to 2020 in Taiwan.
    Prev Med. 2023;172:107551.
    Abstract

  843. VAITSES FONTANARI AM, Bauer GR, Churchill SM, Brandelli Costa A, et al
    Gynecological Care Among Brazilian Women Who Have Sex with Women: A Respondent-Driven Sampling Study.
    LGBT Health. 2023;10:287-295.
    Abstract

  844. ROHRICH M
    Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer.
    PET Clin. 2023;18:315-323.
    Abstract

  845. INCE O, Uysal E, Durak G, Onol S, et al
    Prediction of carcinogenic human papillomavirus types in cervical cancer from multiparametric magnetic resonance images with machine learning-based radiomics models.
    Diagn Interv Radiol. 2023;29:460-468.
    Abstract

  846. MATSUMOTO T, Suzuki T, Nakamura M, Yamamoto M, et al
    Androgen promotes squamous differentiation of atypical cells in cervical intraepithelial neoplasia via an ELF3-dependent pathway.
    Cancer Med. 2023;12:10816-10828.
    Abstract

  847. TSAI YH, Teng YT, Kuan TC, Liu JJ, et al
    Five-year Survival Trends for Young Adult Cancers Diagnosed from 2002 to 2014 in Taiwan and the United States.
    Cancer Epidemiol Biomarkers Prev. 2023;32:834-839.
    Abstract

  848. WANG JC, Peitzmeier S, Reisner SL, Deutsch MB, et al
    Factors Associated with Unsatisfactory Pap Tests Among Sexually Active Trans Masculine Adults.
    LGBT Health. 2023;10:278-286.
    Abstract

  849. XU M, Jiang T
    First report of successful treatment of cervical lymph node metastasis with irreversible electroporation.
    QJM. 2023;116:385-387.
    Abstract

  850. GHANAAT M, Kaboosi H, Negahdari B, Fattahi E, et al
    Heterologous Prime-boost Vaccination Using Adenovirus and Albumin Nanoparticles as Carriers for Human Papillomavirus 16 E7 Epitope.
    Curr Pharm Biotechnol. 2023;24:1195-1203.
    Abstract

  851. KUSAKABE M, Taguchi A, Sone K, Mori M, et al
    Carcinogenesis and management of human papillomavirus-associated cervical cancer.
    Int J Clin Oncol. 2023 Jun 9. doi: 10.1007/s10147-023-02337.
    Abstract

  852. BOLON J, Samson A, Irwin N, Murray L, et al
    An audit of adherence to cervical cancer screening guidelines in a tertiary-level HIV clinic.
    South Afr J HIV Med. 2023;24:1490.
    Abstract

  853. PATEL L, Deng Z, Zhu Z, Lequio M, et al
    Olive: A Potential Suppressor for Cervical Cancer by Upregulation of P21.
    Cureus. 2023;15:e38719.
    Abstract

  854. ZHANG Y, Li X, Zhang J, Mao L, et al
    Development and Validation of the Promising PPAR Signaling Pathway-Based Prognostic Prediction Model in Uterine Cervical Cancer.
    PPAR Res. 2023;2023:4962460.
    Abstract

  855. OIKE T, Osu N, Yoshimoto Y, Obinata H, et al
    Pilot study of plasma creatine riboside as a potential biomarker for cervical cancer.
    Heliyon. 2023;9:e16684.
    Abstract

  856. LIAO D, Liu Y, Li C, He B, et al
    Arctigenin hinders the invasion and metastasis of cervical cancer cells via the FAK/paxillin pathway.
    Heliyon. 2023;9:e16683.
    Abstract

  857. HISHINUMA E, Shimada M, Matsukawa N, Li B, et al
    Identification of predictive biomarkers for diagnosis and radiation sensitivity of uterine cervical cancer using wide-targeted metabolomics.
    J Obstet Gynaecol Res. 2023 Jun 9. doi: 10.1111/jog.15709.
    Abstract

  858. MATOS AS, Invencao MDCV, Moura IA, Freitas AC, et al
    Immunoinformatics applications in the development of therapeutic vaccines against human papillomavirus-related infections and cervical cancer.
    Rev Med Virol. 2023 Jun 8:e2463. doi: 10.1002/rmv.2463.
    Abstract

  859. ZHANG Y, Fan S, Shan M, Zou W, et al
    Propensity score matching analysis to comparing cisplatin versus nedaplatin based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer.
    Sci Rep. 2023;13:9352.
    Abstract

  860. ZHANG W, Ruan Y, Ye L, Liu M, et al
    Definite chemoradiotherapy for early-stage "bulky" cervical cancer.
    J Formos Med Assoc. 2023 Jun 6:S0929-6646(23)00204.
    Abstract

  861. CHINTALA S, Dankoski MA, Anbarasu A, Ramaiah S, et al
    NFX1-123: A potential therapeutic target in cervical cancer.
    J Med Virol. 2023;95:e28856.
    Abstract

  862. YANG L, Tao H, Lin B, He X, et al
    Utilization of PAX1 methylation test for cervical cancer screening of non-HPV16/18 high-risk HPV infection in women.
    Future Oncol. 2023 Jun 8. doi: 10.2217/fon-2023-0226.
    Abstract

  863. ZHANG M, Sit JWH, Choi KC, Chan CWH, et al
    A theory-driven, culture-tailored educational intervention for cervical cancer screening among rural Chinese females: A feasibility and pilot study.
    Asia Pac J Oncol Nurs. 2023;10:100218.
    Abstract

  864. RANGEL V, Fernandez-Deaza GP, Castillo JS, Murillo R, et al
    Is it feasible to enhance quality assurance of cervical cancer screening in Latin America? A regional expert consensus.
    J Med Screen. 2023 Jun 8:9691413231178253. doi: 10.1177/09691413231178253.
    Abstract

  865. LI C, Liu D, Zhao Y, Ding Y, et al
    Diverse intratumoral heterogeneity and immune microenvironment of two HPV-related cervical cancer types revealed by single-cell RNA sequencing.
    J Med Virol. 2023;95:e28857.
    Abstract

  866. SINGH A, Mani N, Aggarwal LM, Agarwal S, et al
    Dose at posterior-inferior border of symphysis point: A predictor for vaginal stricture in cervical cancer.
    Brachytherapy. 2023 Jun 5:S1538-4721(23)00053.
    Abstract

  867. ZHANG L, Li WP
    Retraction notice to "New Cu(II) coordination polymer inhibits cervical cancer development by regulating BRCA1 protein via miR-9-5p" [J. Inorg. Biochem. 226 (2022) 111655].
    J Inorg Biochem. 2023 Jun 5:112270. doi: 10.1016/j.jinorgbio.2023.112270.
    Abstract

  868. ZHANG Z, Peng J, Li B, Wang Z, et al
    HOXA1 promotes aerobic glycolysis and cancer progression in cervical cancer.
    Cell Signal. 2023 Jun 5:110747. doi: 10.1016/j.cellsig.2023.110747.
    Abstract

  869. TSONEVA E, Dimitrova PD, Metodiev M, Shivarov V, et al
    The effects of ROMO1 on cervical cancer progression.
    Pathol Res Pract. 2023;248:154561.
    Abstract

  870. MAO L, Zhang X, Chen T, Li Z, et al
    High-resolution reduced field-of-view diffusion-weighted magnetic resonance imaging in the diagnosis of cervical cancer.
    Quant Imaging Med Surg. 2023;13:3464-3476.
    Abstract

  871. SHEN M, Zou Z, Bao H, Fairley CK, et al
    Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China.
    Lancet Reg Health West Pac. 2023;34:100726.
    Abstract

  872. KOUSAR K, Naseer F, Abduh MS, Anjum S, et al
    CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.
    Front Immunol. 2023;14:1175535.
    Abstract

  873. ZHOU J, Mo J, Tan C, Xie F, et al
    JUND Promotes Tumorigenesis via Specifically Binding on Enhancers of Multiple Oncogenes in Cervical Cancer.
    Onco Targets Ther. 2023;16:347-357.
    Abstract

  874. LI T, Chen S, Li X, Wu Z, et al
    The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening.
    Virol J. 2023;20:116.
    Abstract

  875. TONG Y, Tonui P, Orang'o O, Zhang J, et al
    Association of plasma aflatoxin with persistent detection of oncogenic human papillomaviruses in cervical samples from Kenyan women enrolled in a longitudinal study.
    BMC Infect Dis. 2023;23:377.
    Abstract

  876. HUNTINGTON S, Puri Sudhir K, Schneider V, Sargent A, et al
    Two self-sampling strategies for HPV primary cervical cancer screening compared with clinician-collected sampling: an economic evaluation.
    BMJ Open. 2023;13:e068940.
    Abstract

  877. MA Y, Yang Z, Liu J, Wang D, et al
    CD48 suppresses cell proliferation and migration as a prognostic immune signature in the cervical cancer immune microenvironment.
    Carcinogenesis. 2023 Jun 3:bgad039. doi: 10.1093.
    Abstract

  878. PHUNG MT, An PL, Vinh NN, Le HHTC, et al
    A comparative study on behavior, awareness and belief about cervical cancer among rural and urban women in Vietnam.
    PLOS Glob Public Health. 2023;3:e0001817.
    Abstract

  879. BAETEN IGT, Hoogendam JP, Braat AJAT, de Keizer B, et al
    Learning curve and factors influencing successful robot-assisted bilateral sentinel lymph node mapping in early-stage cervical cancer: an observational cohort study.
    Expert Rev Med Devices. 2023 Jun 5:1-8. doi: 10.1080/17434440.2023.2212157.
    Abstract

  880. BURCHARDT E, Bos-Liedke A, Serkowska K, Cegla P, et al
    Value of [(18)F]FDG PET/CT radiomic parameters in the context of response to chemotherapy in advanced cervical cancer.
    Sci Rep. 2023;13:9092.
    Abstract

  881. BOWDEN SJ, Ellis LB, Kalliala I, Paraskevaidi M, et al
    Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management.
    BMJ Open. 2023;13:e071534.
    Abstract

  882. MKUU R, Salloum RG, Shenkman E, Schaefer N, et al
    Screening for cervical cancer among women with behavioral health conditions-A systematic review.
    Prev Med Rep. 2023;34:102238.
    Abstract

  883. ZHANG H, Wang J, Yang J, He Q, et al
    TMEM33 as a Prognostic Biomarker of Cervical Cancer and Its Correlation with Immune Infiltration.
    Mediators Inflamm. 2023;2023:5542181.
    Abstract

  884. YU B, Li X, Yan W, Ding B, et al
    Post-transcriptional regulation of tumor suppressor gene lncRNA CARMN via m(6)A modification and miRNA regulation in cervical cancer.
    J Cancer Res Clin Oncol. 2023 Jun 5. doi: 10.1007/s00432-023-04893.
    Abstract

  885. SUN J, Mou J, Zhang Y, Yuan K, et al
    Matrix metalloproteinase-2 delivery to extracellular vesicles produced by HPV-positive cervical cancer cells enhances metastasis via the Akt pathway.
    Cell Biol Int. 2023 Jun 5. doi: 10.1002/cbin.12054.
    Abstract

  886. TANG Q, Xu A, Yang Y, Zhang Y, et al
    FOXM1 Contributes to Chemotherapy Sensitivity in Cervical Cancer by Regulating TTK.
    Discov Med. 2023;35:208-220.
    Abstract

  887. BADDAL B, Oktay MN, Bostanci A, Yenen MC, et al
    Prevalence and genotype screening of human papillomavirus among women attending a private hospital in Northern Cyprus: an 11-year retrospective study.
    BMC Womens Health. 2023;23:297.
    Abstract

  888. LV X, Ding B, Xu J, Shen Y, et al
    Effect of modified radical laparoscopic hysterectomy versus open radical hysterectomy on short-term clinical outcomes in early-stage cervical cancer: a single-center, prospective, randomized controlled trial.
    World J Surg Oncol. 2023;21:167.
    Abstract

  889. LIU P, Li Z, Miao J, Kong B, et al
    HPV DNA and p16(INK4a) positivity in vulvar cancer and vulvar intraepithelial neoplasia - Authors' reply.
    Lancet Oncol. 2023;24:e237.
    Abstract

  890. JAYARAJ R, Shetty S, Gothandam KM, Suja S, et al
    HPV DNA and p16(INK4a) positivity in vulvar cancer and vulvar intraepithelial neoplasia.
    Lancet Oncol. 2023;24:e236.
    Abstract

  891. ANIL A, Shamim MA, Saravanan A, Sandeep M, et al
    HPV DNA and p16(INK4a) positivity in vulvar cancer and vulvar intraepithelial neoplasia.
    Lancet Oncol. 2023;24:e235.
    Abstract

  892. CHU T, Meng Y, Wu P, Li Z, et al
    The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry.
    Lancet Oncol. 2023;24:701-708.
    Abstract

  893. MOSS EL, Teece L, Darko N
    Uterine cancer mortality and Black women: time to act.
    Lancet Oncol. 2023;24:586-588.
    Abstract

  894. APPIAH EO, Oti-Boadi E, Appiah S, Bakkari MA, et al
    Acceptance of HPV vaccination in boys among mothers from selected churches in Accra, Ghana.
    BMC Public Health. 2023;23:1053.
    Abstract

  895. ZHANG H, Xiang W, Ji ST, Xiao YP, et al
    [Clinicopathological analysis of primary gastric (gastrointestinal)-type mucoglandular lesion of endometrium].
    Zhonghua Bing Li Xue Za Zhi. 2023;52:586-591.
    Abstract

  896. EBRAHIMI N, Yousefi Z, Khosravi G, Malayeri FE, et al
    Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective.
    Front Immunol. 2023;14:1150238.
    Abstract

  897. LIU Y, Li Z, Yuan L, Liu F, et al
    Human papillomavirus genotypic characteristics of 60,685 subjects under age-expansion vaccination of the nine-valent human papillomavirus vaccine: A cross-sectional study.
    J Infect Public Health. 2023;16:989-995.
    Abstract


  898. Many Unaware of Link between HPV and Some Cancers.
    Cancer Discov. 2023;13:OF4.
    Abstract

  899. MALLAFRE-LARROSA M, Ritchie D, Papi G, Mosquera I, et al
    Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries.
    Eur J Public Health. 2023;33:502-508.
    Abstract

  900. BARR E, Noursi S, Roodzant E, Ubesie A, et al
    Public Priorities in Women's Health: Analysis of Request for Information Published to Inform "Advancing NIH Research on the Health of Women: A 2021 Conference".
    J Womens Health (Larchmt). 2023;32:625-634.
    Abstract

  901. KESKE A, Weisman PS, Xu J
    Adenosquamous carcinoma in situ of the anus: a case series.
    Virchows Arch. 2023;482:993-997.
    Abstract

  902. PARADA H JR, Pichardo MS, Gallo LC, Talavera GA, et al
    Neurocognitive test performance following cancer among middle-aged and older adults in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and the SOL-Investigation of Neurocognitive Aging Ancillary Study.
    Cancer Med. 2023;12:11860-11870.
    Abstract

  903. CLIFFORD GM, Baussano I, Heideman DAM, Tshering S, et al
    Human papillomavirus testing on self-collected samples to detect high-grade cervical lesions in rural Bhutan: The REACH-Bhutan study.
    Cancer Med. 2023;12:11828-11837.
    Abstract

  904. NUTTALL DS, Anderson WJ, Savage AJ, Denton K, et al
    Calibration of the Becton Dickinson FocalPoint GS slide profiler is essential for optimal performance: Avoiding the algorithm supersaturation cascade effect pitfall.
    Cancer Cytopathol. 2023;131:383-391.
    Abstract

  905. WANG W, Zhang N
    Oridonin inhibits Hela cell proliferation via downregulation of glutathione metabolism: a new insight from metabolomics.
    J Pharm Pharmacol. 2023;75:837-845.
    Abstract

  906. SCHURINK-VAN 'T KLOOSTER TM, Siebers AG, Hoes J, van Kemenade FJ, et al
    Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands.
    Cancer Med. 2023;12:11786-11794.
    Abstract

  907. TENG X, Kang S, Li W, Ding H, et al
    Comparison between laparoscopic and abdominal radical hysterectomy for cervical adenosquamous carcinoma at stage IA2 to IIA2: A multicenter retrospective study.
    J Obstet Gynaecol Res. 2023;49:1592-1610.
    Abstract

  908. PERSONS P, Long M, Vegunta S
    Latent Human Papillomavirus (HPV) Infection: Does HPV Last Forever in Some Women?
    J Womens Health (Larchmt). 2023;32:623-624.
    Abstract

  909. NELSON CW, Mirabello L
    Human papillomavirus genomics: Understanding carcinogenicity.
    Tumour Virus Res. 2023;15:200258.
    Abstract

  910. VELENTZIS LS, Hawkes D, Caruana M, Brotherton JM, et al
    Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening.
    Tumour Virus Res. 2023;15:200255.
    Abstract

  911. ZHANG X, Elsaid MI, DeGraffinreid C, Champion VL, et al
    Impact of the COVID-19 Pandemic on Cancer Screening Delays.
    J Clin Oncol. 2023;41:3194-3202.
    Abstract

  912. ONYEAKA HK, Muoghalu C, Deary EC, Ajayi KV, et al
    The Role of Health Information Technology in Improving Awareness of Human Papillomavirus and Human Papillomavirus Vaccine Among U.S. Adults.
    Telemed J E Health. 2023;29:886-895.
    Abstract

  913. CARTWRIGHT K, Leekity S, Sheche J, Kanda D, et al
    Health Literacy, Health Numeracy, and Cancer Screening Patterns in the Zuni Pueblo: Insights from and Limitations of "Standard" Questions.
    J Cancer Educ. 2023;38:1023-1033.
    Abstract

  914. BRITO MJ, Quintas A, Passos F, Alves AT, et al
    Lymphocyte Subsets in Cervicovaginal Lavage Specimens of HIV-Infected Women: A Surrogate Risk Marker of HPV-Associated Cervical Lesions.
    Pathobiology. 2023;90:176-186.
    Abstract

  915. THANASUWAT B, Leung SOA, Welch K, Duffey-Lind E, et al
    Human Papillomavirus (HPV) Education and Knowledge Among Medical and Dental Trainees.
    J Cancer Educ. 2023;38:971-976.
    Abstract

  916. CHAU JPC, Lo SHS, Butt L, Lee VWY, et al
    User Engagement on a Novel Educational Health Intervention Aimed at Increasing HPV Vaccine Uptake in Hong Kong: a Qualitative Study.
    J Cancer Educ. 2023;38:772-780.
    Abstract

  917. HUANG XD, Chen K, Shi L, Luo YS, et al
    Construction of refined staging classification systems integrating FIGO/T-categories and corpus uterine invasion for non-metastatic cervical cancer.
    Cancer Med. 2023 Jun 16. doi: 10.1002/cam4.6179.
    Abstract

  918. BOLANOS-SUAREZ V, Alfaro A, Espinosa AM, Medina-Martinez I, et al
    The mRNA and protein levels of the glycolytic enzymes lactate dehydrogenase A (LDHA) and phosphofructokinase platelet (PFKP) are good predictors of survival time, recurrence, and risk of death in cervical cancer patients.
    Cancer Med. 2023 Jun 16. doi: 10.1002/cam4.6123.
    Abstract

  919. SHEN NN, Lin JH, Liu PP
    [EBF1 Promotes the Sensitivity of Cervical Cancer Cells to Cisplatin via Activating FBN1 Transcription].
    Mol Biol (Mosk). 2023;57:503-504.
    Abstract

  920. ZHAO M, Gao Z, Gu X, Yang X, et al
    Predictive significance of lymphocyte level and neutrophil-to-lymphocyte ratio values during radiotherapy in cervical cancer treatment.
    Cancer Med. 2023 Jun 16. doi: 10.1002/cam4.6221.
    Abstract

  921. SHI YY, Wang AJ, Liu XL, Dai MY, et al
    Stapled peptide PROTAC induced significantly greater anti-PD-L1 effects than inhibitor in human cervical cancer cells.
    Front Immunol. 2023;14:1193222.
    Abstract

  922. ADUMALA A, Palat G, Vajjala A, Brun E, et al
    Oral Methadone versus Morphine IR for Patients with Cervical Cancer and Neuropathic Pain: A Prospective Randomised Controlled Trial.
    Indian J Palliat Care. 2023;29:200-206.
    Abstract


  923. CCDC7 Activates Interleukin-6 and Vascular Endothelial Growth Factor to Promote Proliferation via the JAK-STAT3 Pathway in Cervical Cancer Cells [Retraction].
    Onco Targets Ther. 2023;16:407-408.
    Abstract

  924. LIU L, Li L, Zu W, Jing J, et al
    PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer.
    J Cancer. 2023;14:1648-1659.
    Abstract

  925. LI L, Shen FR, Cheng Q, Sun J, et al
    SLC5A3 is important for cervical cancer cell growth.
    Int J Biol Sci. 2023;19:2787-2802.
    Abstract

  926. OTANI T, Miyake KK, Ishimori T, Kido A, et al
    Prognostic value of pretreatment FDG PET/CT in uterine cervical cancer according to two major histologic types: squamous cell carcinoma and adenocarcinoma.
    Asia Ocean J Nucl Med Biol. 2023;11:101-110.
    Abstract

  927. BHAGAVATHULA AS, Bansil S, Nishimura Y
    Google Trends in Breast and Cervical Cancer Searches From 2008 to 2021: An Infodemiology Study.
    Cureus. 2023;15:e39035.
    Abstract

  928. IIDA Y, Osaki M, Sato S, Izutsu R, et al
    AMIGO2 expression as a predictor of recurrence in cervical cancer with intermediate risk.
    Mol Clin Oncol. 2023;19:56.
    Abstract

  929. DE WAARD J, Bhattacharya A, de Boer MT, van Hemel BM, et al
    Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme.
    Clin Epigenetics. 2023;15:103.
    Abstract

  930. TORII A, Tomita N, Kuno M, Nishio M, et al
    Intensity-modulated radiation therapy with the central shielding technique for patients with uterine cervical cancerdagger.
    J Radiat Res. 2023 Jun 15:rrad039. doi: 10.1093.
    Abstract

  931. ZHU M, Zhuo Q, Liu W, Guan C, et al
    Imaging evaluation of para-aortic lymph nodes in cervical cancer.
    Acta Radiol. 2023 Jun 15:2841851231179178. doi: 10.1177/02841851231179178.
    Abstract

  932. HU M, Jiang C, Meng R, Luo Y, et al
    Effect of air pollution on the prevalence of breast and cervical cancer in China: a panel data regression analysis.
    Environ Sci Pollut Res Int. 2023 Jun 15. doi: 10.1007/s11356-023-28068.
    Abstract

  933. AMBOREE TL, Parker SL, Bulsara S, Anderson ML, et al
    Cervical cancer screening among English- and Spanish-speaking Hispanic women in an urban safety net health system, 2015-2020.
    BMC Womens Health. 2023;23:309.
    Abstract

  934. TOMITA F, Fuse H, Fujisaki T, Yasue K, et al
    [Verification of Dose Distribution in Cervical Cancer Brachytherapy Using Metal and Plastic Applicators].
    Nihon Hoshasen Gijutsu Gakkai Zasshi. 2023 Jun 14. doi: 10.6009/jjrt.2023-1375.
    Abstract

  935. APPIAH EO, Appiah S, Ani-Amponsah M, Agyekum BS, et al
    Female students' perspectives on cervical cancer screening inclusion in pre-admission university requirements in Ghana.
    PLOS Glob Public Health. 2023;3:e0001029.
    Abstract

  936. GHAFOOR S
    Editorial Comment: On the Contemporary Role of MRI and FDG PET/CT in Managing Cervical Cancer.
    AJR Am J Roentgenol. 2023 Jun 14. doi: 10.2214/AJR.23.29755.
    Abstract

  937. WU Y, Min L, Zhang P, Zhang L, et al
    ORP5 promotes migration and invasion of cervical cancer cells by inhibiting endoplasmic reticulum stress.
    Cell Stress Chaperones. 2023 Jun 14. doi: 10.1007/s12192-023-01357.
    Abstract

  938. JAGGI VK, Ansari MA, Khanna A, Gehlot S, et al
    Is postoperative radiotherapy (PORT) a viable option in high-risk early-stage cervical cancer after upfront or downstaged radical surgery? A comparative study.
    J Cancer Res Ther. 2023;19:241-252.
    Abstract

  939. EL KHOURY J, Halabi R, Hleyhel M, El Rahman Kishly W, et al
    HPV Vaccination Prevalence among Lebanese Female University Students: A Cross-Sectional Study.
    J Environ Public Health. 2023;2023:3706466.
    Abstract

  940. KAKALIASHVILI-DZAGNIDZE S, Khardzeishvili O, Tabagari S
    Diagnostic Accuracy of p16(INK4a)/Ki-67 Dual Immunostaining for Detection of High-Grade Cervical Intraepithelial Neoplasia in Women Involved in Cervical Cancer Screening in Georgia.
    Anal Cell Pathol (Amst). 2023;2023:7988323.
    Abstract

  941. ZHANG S, Chen Z, Sun J, An N, et al
    Retraction Note: circRNA hsa_circRNA_0000069 promotes the proliferation, migration and invasion of cervical cancer through miR-873-5p/TUSC3 axis.
    Cancer Cell Int. 2023;23:115.
    Abstract

  942. KRISHNA A, Sathya M, Mukesh S, Athiyamaan MS, et al
    Efficacy and safety of EGFR inhibitor gefitinib in recurrent or metastatic cervical cancer: a preliminary report.
    Med Oncol. 2023;40:203.
    Abstract

  943. WANG X, Cao C, Tan X, Liao X, et al
    SETD8, a frequently mutated gene in cervical cancer, enhances cisplatin sensitivity by impairing DNA repair.
    Cell Biosci. 2023;13:107.
    Abstract

  944. NETO BV, Tavares V, da Silva JB, Liz-Pimenta J, et al
    Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.
    Sci Rep. 2023;13:9519.
    Abstract

  945. SUBA EJ, Donnelly AD, Duong DV, Gonzalez Mena LE, et al
    WHO should adjust its global strategy for cervical cancer prevention.
    BMJ Glob Health. 2023;8:e012031.
    Abstract

  946. IBANEZ R, Roura E, Acera A, Andujar M, et al
    HPV self-sampling among cervical cancer screening users in Spain: A randomized clinical trial of on-site training to increase the acceptability.
    Prev Med. 2023 Jun 10:107571. doi: 10.1016/j.ypmed.2023.107571.
    Abstract

  947. YOU S, Zhang J, Yu L, Li Z, et al
    Construction of SLC16A1/3 Targeted Gallic Acid-Iron-Embelin Nanoparticles for Regulating Glycolysis and Redox Pathways in Cervical Cancer.
    Mol Pharm. 2023 Jun 12. doi: 10.1021/acs.molpharmaceut.3c00294.
    Abstract

  948. ADAM JA, Poel E, van Eck-Smit BLF, Mom CH, et al
    Lymphatic mapping for image-guided radiotherapy in patients with locally advanced uterine cervical cancer: a feasibility study.
    EJNMMI Res. 2023;13:58.
    Abstract

  949. WANG Y, Yuan S, Ma J, Liu H, et al
    WIF1 was downregulated in cervical cancer due to promoter methylation.
    Acta Biochim Pol. 2023 Jun 12. doi: 10.18388/abp.2020_6700.
    Abstract

  950. WANG A, Jin C, Wang Y, Yu J, et al
    FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc.
    Mol Carcinog. 2023 Jun 12. doi: 10.1002/mc.23559.
    Abstract

  951. GULER OC, Oymak E, Yazici G, Akagunduz OO, et al
    Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study.
    Oncol Res. 2023;31:299-306.
    Abstract

  952. LIU YY, Zhu WH, Li W, Hao X, et al
    Identifying the risk factors and developing a predictive model for postoperative pelvic floor dysfunction in cervical cancer patients.
    Transl Cancer Res. 2023;12:1307-1314.
    Abstract

  953. GREENLEY R, Bell S, Rigby S, Legood R, et al
    Factors influencing the participation of groups identified as underserved in cervical cancer screening in Europe: a scoping review of the literature.
    Front Public Health. 2023;11:1144674.
    Abstract

  954. DURU G, Topatan S
    A barrier to participation in cervical cancer screenings: fatalism.
    Women Health. 2023 Jun 11:1-9. doi: 10.1080/03630242.2023.2223698.
    Abstract

  955. LI F, Zhu W
    LINC00460 promotes angiogenesis by enhancing NF-kappaB-mediated VEGFA expression in cervical cancer cells.
    Biochem Biophys Res Commun. 2023;671:146-152.
    Abstract

  956. CHEN H, Xie H, Zhang Y, Wang G, et al
    Construction of a prognostic signature of RFC5 immune-related genes in patients with cervical cancer.
    Cancer Biomark. 2023 May 24. doi: 10.3233/CBM-220347.
    Abstract

  957. GOKHALE M, Yu R, Monberg M, Tekin C, et al
    Patient profiles, treatment patterns, and outcomes among persistent, recurrent, or metastatic cervical cancer patients under routine care in the United States.
    Cancer Treat Res Commun. 2023;36:100726.
    Abstract

  958. SUN X, Chen Y, Zhong Y, Chen X, et al
    Recently urodynamic and quality of life assessment in the non-menopausal women with cervical cancer after radical hysterectomy.
    Support Care Cancer. 2023;31:389.
    Abstract

  959. ZHANG R, Hong G, Liao C, Chen Z, et al
    High-risk Human Papillomavirus Infection in Putian, China: A Cross-sectional Analysis of 98085 Women.
    J Coll Physicians Surg Pak. 2023;33:642-646.
    Abstract

  960. BAYALA B, Coulibaly LL, Djigma F, Bunay J, et al
    Chemical Composition of Essential Oil of Cymbopogon schoenanthus (L.) Spreng from Burkina Faso, and Effects against Prostate and Cervical Cancer Cell Lines.
    Molecules. 2023;28:4561.
    Abstract

  961. YANG Z, Liu ZY, Ablise M, Maimaiti A, et al
    Design, Synthesis, and Anti-Cervical Cancer and Reversal of Tumor Multidrug Resistance Activity of Novel Nitrogen-Containing Heterocyclic Chalcone Derivatives.
    Molecules. 2023;28:4537.
    Abstract

  962. WANG M, Chen X, Qu Y, Ma Q, et al
    Design and Synthesis of Brefeldin A-Isothiocyanate Derivatives with Selectivity and Their Potential for Cervical Cancer Therapy.
    Molecules. 2023;28:4284.
    Abstract

  963. KNIAZEVA M, Zabegina L, Shalaev A, Smirnova O, et al
    NOVAprep-miR-Cervix: New Method for Evaluation of Cervical Dysplasia Severity Based on Analysis of Six miRNAs.
    Int J Mol Sci. 2023;24:9114.
    Abstract

  964. NYABIGAMBO A, Mayega RW, Hlongwana K, Ginindza TG, et al
    Facilitators and Barriers to HPV Self-Sampling as a Cervical Cancer Screening Option among Women Living with HIV in Rural Uganda.
    Int J Environ Res Public Health. 2023;20:6004.
    Abstract

  965. CHEN CS, Huang EY
    Comparison of Oncologic Outcomes between Radical Hysterectomy and Primary Concurrent Chemoradiotherapy in Women with Bulky IB and IIA Cervical Cancer under Risk Stratification.
    Cancers (Basel). 2023;15:3034.
    Abstract

  966. DISIS ML, Adams SF, Bajpai J, Butler MO, et al
    Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.
    J Immunother Cancer. 2023;11:e006624.
    Abstract

  967. SIDDIQUI G, Zara Rozalen A, Nava VE
    Androgen receptor amplification in mesonephric remnants.
    BMJ Case Rep. 2023;16:e251741.
    Abstract

  968. FAN Z, Wu X, Li C, Chen H, et al
    CAM-VT: A Weakly supervised cervical cancer nest image identification approach using conjugated attention mechanism and visual transformer.
    Comput Biol Med. 2023;162:107070.
    Abstract

  969. DAVIES L, Milner DA Jr, Shulman LN, Kyokunda L, et al
    Analysis of Cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities.
    JCO Glob Oncol. 2023;9:e2200203.
    Abstract

  970. LIU J, Wang C, Ma J, Wei S, et al
    Pattern of infection and genotypes of human papillomavirus in Zhengzhou City based on a four-year (2015-2018) epidemiological study.
    Women Health. 2023;63:383-391.
    Abstract

  971. SONG J, Xu F, An L, Yin Y, et al
    BTG2 suppresses the growth and metastasis of cervical squamous cell carcinoma.
    Pathol Res Pract. 2023;247:154577.
    Abstract

  972. JIA Q, Wang H, Xiao X, Sun Y, et al
    UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma.
    Pathol Res Pract. 2023;247:154574.
    Abstract

  973. MELKONIAN SC, Chen L, Jim MA, Haverkamp D, et al
    Disparities in incidence and trends of colorectal, lung, female breast, and cervical cancers among non-Hispanic American Indian and Alaska Native people, 1999-2018.
    Cancer Causes Control. 2023;34:657-670.
    Abstract

  974. ROMAN DE METTELINGE T, Desimpelaere P, Cambier D
    Cervical mobility and cervical proprioception in relation to fall risk among older adults: a prospective cohort study.
    Eur Geriatr Med. 2023;14:447-453.
    Abstract

  975. ELLIS SDP, Kenney-Herbert E, Crosby T, Mukherjee S, et al
    Cervical Oesophageal Cancer: A Call for Treatment Consensus.
    Clin Oncol (R Coll Radiol). 2023;35:478-481.
    Abstract

  976. MANZ CR, Odayar VS, Schrag D
    Cancer Screening Rates and Outcomes for Justice-Involved Individuals: A Scoping Review.
    J Correct Health Care. 2023;29:220-231.
    Abstract

  977. SEGAL HA, Rashid N
    A targeted literature review of health economic analyses of human papillomavirus vaccination from various countries.
    Int J STD AIDS. 2023;34:512-517.
    Abstract

  978. ROUSSET-JABLONSKI C, Mekki Y, Denis A, Reynaud Q, et al
    Human papillomavirus prevalence, persistence and cervical dysplasia in females with cystic fibrosis.
    J Cyst Fibros. 2023;22:505-514.
    Abstract

  979. TSAO-WU L, Chepkorir J, Han HR
    Factors associated with HPV vaccination decision-making among Korean American women.
    J Behav Med. 2023;46:509-516.
    Abstract

  980. CAEIRO V, Esteves B, Fonseca-Moutinho J
    HPV testing for cervical cancer screening: Should reflex cytology be performed after a positive test for HPV 16 and 18?
    Cancer Treat Res Commun. 2023;36:100729.
    Abstract

  981. HIRAI R, Ohta T, Igari M, Kumazaki YU, et al
    Optimal Number of Needle Applicators Inserted in Combined Intracavitary and Interstitial Brachytherapy for Cervical Cancer.
    Anticancer Res. 2023;43:3265-3271.
    Abstract

  982. DENG Y, Song Y, Du Q, Wang CC, et al
    Anti-HPV16 oncoproteins siRNA therapy for cervical cancer using a novel transdermal peptide PKU12.
    Front Oncol. 2023;13:1175958.
    Abstract

  983. QIU J, Sun S, Liu Q, Fu J, et al
    A comparison of concurrent chemoradiotherapy and radical surgery in patients with specific locally advanced cervical cancer (stage IB3, IIA2, IIICr): trial protocol for a randomized controlled study (C-CRAL trial).
    J Gynecol Oncol. 2023 Jun 20. doi: 10.3802/jgo.2023.
    Abstract

  984. CHEN L, Lu F, Wang Z, Chen H, et al
    An investigation on cervical cancer and human papillomavirus vaccine knowledge, and analysis of influencing factors for choosing domestic or imported 2vHPV vaccine among females in Shenzhen, China.
    Hum Vaccin Immunother. 2023 Jun 23:2225389. doi: 10.1080/21645515.2023.2225389.
    Abstract

  985. MATSUMURA M, Seyama Y, Ogawa R, Nemoto S, et al
    Combined thoraco-laparoscopic hepatectomy concomitant with resection of the diaphragm for solitary peritoneal seeding from cervical cancer: A case report.
    Asian J Endosc Surg. 2023 Jun 22. doi: 10.1111/ases.13219.
    Abstract

  986. MEKURIA SF, Timmermans S, Borgfeldt C, Jerkeman M, et al
    HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis.
    Syst Rev. 2023;12:103.
    Abstract

  987. RODRIGUES M, Vanoni G, Loap P, Dubot C, et al
    Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial.
    Nat Commun. 2023;14:3698.
    Abstract

  988. CHEN H, Ma R, Zhou B, Yang X, et al
    Integrated immunological analysis of single-cell and bulky tissue transcriptomes reveals the role of interactions between M0 macrophages and naive CD4(+) T cells in the immunosuppressive microenvironment of cervical cancer.
    Comput Biol Med. 2023;163:107151.
    Abstract

  989. NAYAR R
    Cervical cancer prevention in the United States-where we've been and where we're going: The American Cancer Society Primary HPV Screening Initiative.
    Cancer Cytopathol. 2023 Jun 22. doi: 10.1002/cncy.22733.
    Abstract

  990. DOWNS LS JR, Nayar R, Gerndt J, Saslow D, et al
    Implementation in action: Collaborating on the transition to primary HPV screening for cervical cancer in the United States.
    CA Cancer J Clin. 2023 Jun 22. doi: 10.3322/caac.21786.
    Abstract

  991. AKPAN E, Abinya N, Odhiambo E, Ekpo E, et al
    Determinants of an integrated cervical cancer screening services in primary healthcare: sharing lessons from Kisumu, Kenya.
    J Public Health Afr. 2023;14:1783.
    Abstract

  992. RAUF SA, Zehra SA, Shah HH
    Beyond P16/Ki67 dual-stain cytology: Exploring alternative biomarkers for diagnosing cervical cancer and its precursors.
    BJOG. 2023 Jun 22. doi: 10.1111/1471-0528.17577.
    Abstract

  993. TANG JH, Lee F, Chagomerana MB, Ghambi K, et al
    Results from Two HPV-Based Cervical Cancer Screening-Family Planning Integration Models in Malawi: A Cluster Randomized Trial.
    Cancers (Basel). 2023;15:2797.
    Abstract

  994. MABUCHI S, Sasano T, Komura N, Maeda M, et al
    Comparison of the Survival Outcomes of Minimally Invasive Surgery with Open Surgery in Patients with Uterine-Confined and Node-Negative Cervical Cancer: A Population-Based Study.
    Cancers (Basel). 2023;15:2756.
    Abstract

  995. FAN X, Wang Y, Yang N, Zhu P, et al
    Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery.
    World J Surg Oncol. 2023;21:186.
    Abstract

  996. ZHU G, Xiong Z, Chen W, Zhu Z, et al
    Identification of key biomarkers and related immune cell infiltration in cervical cancer tissue based on bioinformatics analysis.
    Sci Rep. 2023;13:10121.
    Abstract

  997. ATADAG YB, Turkmen AT, Oksuz A, Keten HS, et al
    Changes in cancer screening process in primary care during the covid-19 pandemic. A record-based descriptive study.
    Saudi Med J. 2023;44:621-624.
    Abstract

  998. KUNDROD KA, Barra M, Wilkinson A, Smith CA, et al
    An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings.
    Sci Transl Med. 2023;15:eabn4768.
    Abstract

  999. NIU G, Wang H, Ren Y, Xing X, et al
    Penpulimab and anlotinib in an elderly patient with recurrent cervical cancer: a case report and literature review.
    Immunotherapy. 2023 Jun 21. doi: 10.2217/imt-2023-0020.
    Abstract

  1000. LIU Y, Yang Z, Feng L, Xia Y, et al
    Advance in Nanomedicine for Improving Mucosal Penetration and Effective Therapy of Cervical Cancer.
    Small. 2023 Jun 20:e2303772. doi: 10.1002/smll.202303772.
    Abstract

  1001. JITVAROPAS R, Thongpoom U, Sawaswong V, Khongnomnan K, et al
    Development of a simplified and cost-effective sample preparation method for genotyping of human papillomavirus by next-generation sequencing.
    Arch Virol. 2023;168:185.
    Abstract

  1002. CINTRA GF, Derchain SFM, Bicalho DS, Filho ALDS, et al
    Cervical cancer in pregnancy.
    Rev Bras Ginecol Obstet. 2023;45:293-296.
    Abstract

  1003. LICHTENFELS M, Lorenzi NPC, Tacla M, Yokochi K, et al
    A New Brazilian Device for Cervical Cancer Screening: Acceptability and Accuracy of Self-sampling.
    Rev Bras Ginecol Obstet. 2023;45:235-241.
    Abstract

  1004. WAN Z, Zhao J, Xu L, Sun P, et al
    Global and regional estimates of cervical cancer burden associated with human immunodeficiency virus infection from 1990 to 2019.
    J Med Virol. 2023;95:e28891.
    Abstract

  1005. CARVALHO JP, Freitas D, Hanna S, Velho IA, et al
    Gemcitabine-Induced Radiation Recall Phenomenon in Cervical Cancer: A Case Report.
    Cureus. 2023;15:e39228.
    Abstract

  1006. ALABDULKADER AM, AlAsfour A, Golembiewski M, Gullett H, et al
    Disparities in cervical cancer screening among Arabic-speaking women refugees.
    Ethn Health. 2023 Jun 19:1-13. doi: 10.1080/13557858.2023.2224953.
    Abstract

  1007. BIZZARRI N, Querleu D, Dostalek L, van Lonkhuijzen LRCW, et al
    Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a sub-analysis of the SCCAN collaborative study.
    Am J Obstet Gynecol. 2023 Jun 17:S0002-9378(23)00422.
    Abstract

  1008. GHIMIRE R, Moore KL, Branco D, Rash DL, et al
    Forecasting patient-specific dosimetric benefit from daily online adaptive radiotherapy for cervical cancer.
    Biomed Phys Eng Express. 2023 Jun 19. doi: 10.1088/2057-1976.
    Abstract

  1009. ZHAO K, Hu M, Yang R, Liu J, et al
    Decreasing expression of HIF-1alpha, VEGF-A, and Ki67 with efficacy of neoadjuvant therapy in locally advanced cervical cancer.
    Medicine (Baltimore). 2023;102:e33820.
    Abstract

  1010. SONG Y, Wu Q
    RBM15 m(6) A modification-mediated OTUB2 upregulation promotes cervical cancer progression via the AKT/mTOR signaling.
    Environ Toxicol. 2023 Jun 19. doi: 10.1002/tox.23852.
    Abstract

  1011. JI L, Chen M, Yao L
    Strategies to eliminate cervical cancer in China.
    Front Oncol. 2023;13:1105468.
    Abstract

  1012. NZERIBE EA, Ododo NA, Eteike PO
    Profile of gynecological cancers in a tertiary hospital, Eastern Nigeria.
    Pan Afr Med J. 2023;44:139.
    Abstract

  1013. PENG R, Cheng X, Zhang Y, Lu X, et al
    Corrigendum to "miR-214 down-regulates MKK3 and suppresses malignant phenotypes of cervical cancer cells" [Gene 724 (2020) 144146].
    Gene. 2023;877:147538.
    Abstract

  1014. GAO Q, Fan T, Luo S, Zheng J, et al
    Lactobacillus gasseri LGV03 isolated from the cervico-vagina of HPV-cleared women modulates epithelial innate immune responses and suppresses the growth of HPV-positive human cervical cancer cells.
    Transl Oncol. 2023;35:101714.
    Abstract

  1015. GONZALEZ-RAMIREZ MI, Cardona YT, Agudelo MC, Lopez C, et al
    miRNAs signature as potential biomarkers for cervical precancerous lesions in human papillomavirus positive women.
    Sci Rep. 2023;13:9822.
    Abstract

  1016. RIANO I, Contreras-Chavez P, Pabon CM, Meza K, et al
    An Overview of Cervical Cancer Prevention and Control in Latin America and the Caribbean Countries.
    Hematol Oncol Clin North Am. 2023 Jun 15:S0889-8588(23)00067.
    Abstract

  1017. ZHENG P, Wu Y, Wang Y, Hu F, et al
    Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway.
    Cell Signal. 2023;109:110771.
    Abstract

  1018. AMPOFO AG, Boyes AW, Mackenzie LJ
    Preference For Cervical Cancer Education: A Multisite Cross-Sectional Survey of Female Senior High School Students in Ghana.
    J Cancer Educ. 2023 Jun 16. doi: 10.1007/s13187-023-02325.
    Abstract

  1019. BUKOWSKI A, Smith JS, Wheeler SB, Sanusi B, et al
    Cervical Cancer Screening Knowledge, Perceptions, and Behaviors in a Multiracial Cohort of Low-Income, Underscreened Women in North Carolina.
    J Womens Health (Larchmt). 2023 Jun 16. doi: 10.1089/jwh.2022.0412.
    Abstract

  1020. FREGA A, Gentili C, Proietti S, Lepore E, et al
    Epigallocatechin gallate, folic acid, vitamin B12, and hyaluronic acid significantly increase apoptosis and p53 expression in HeLa cells.
    Eur Rev Med Pharmacol Sci. 2023;27:5240-5245.
    Abstract

  1021. MWENDA V, Jalang'o R, Miano C, Bor JP, et al
    Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: A modelling study.
    Vaccine. 2023 Jun 7:S0264-410X(23)00546-7. doi: 10.1016/j.vaccine.2023.
    Abstract

  1022. HUANG J, Song S, Wang M, Wang H, et al
    Transforming a highly toxic agent DM1 into injectable safe nanomedicines via prodrug self-assembly for the treatment of taxane-resistant cancer.
    Nanoscale. 2023;15:10110-10124.
    Abstract

  1023. POOREBRAHIM M, Quiros-Fernandez I, Marme F, Burdach SE, et al
    A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillomavirus type 16 E7.
    Cancer Lett. 2023;566:216242.
    Abstract

  1024. YANG Z, Zhang C, Luo P, Sun F, et al
    Genetic diversity and functional implication of the long control region in human papillomavirus types 52, 58, and 16 from Central China.
    Infect Genet Evol. 2023;112:105447.
    Abstract

  1025. JONES TE, Matsko J, Elishaev E, Clark BZ, et al
    Changes over time in papanicolaou cytology test and HPV test in a large women's academic center laboratory.
    J Am Soc Cytopathol. 2023;12:307-313.
    Abstract

  1026. SARR A, Ze Ondo C, Thiam A, Badji CA, et al
    [Epidemiological, etiological and evolutionary profile of vesico-vaginal fistulas in Senegal].
    Prog Urol. 2023;33:401-406.
    Abstract

  1027. PARK S, Park D, Han S, Chung GE, et al
    LY6K depletion modulates TGF-beta and EGF signaling.
    Cancer Med. 2023;12:12593-12607.
    Abstract

  1028. FENG Y, Zhu Z, Xu J, Sun L, et al
    Molecular Evolution of Human Parainfluenza Virus Type 2 Based on Hemagglutinin-Neuraminidase Gene.
    Microbiol Spectr. 2023;11:e0453722.
    Abstract

  1029. CARROLL R, Tan KKH, Ker A, Byrne JL, et al
    Uptake, experiences and barriers to cervical screening for trans and non-binary people in Aotearoa New Zealand.
    Aust N Z J Obstet Gynaecol. 2023;63:448-453.
    Abstract

  1030. KOMESAROFF PA
    Changing times in public health: The new wave of self-collection of invasive samples.
    Aust N Z J Obstet Gynaecol. 2023;63:473-475.
    Abstract

  1031. STOLNICU S, Bartalis RJ, Mihut E, Szabo B, et al
    Cervical Pleuropulmonary Blastoma-like Tumor Associated With DICER1 and TP53 Mutations.
    Int J Gynecol Pathol. 2023;42:347-352.
    Abstract

  1032. BAGUL C, Rao GK, Veena I, Kulkarni R, et al
    Benzimidazole-linked pyrazolo[1,5-a]pyrimidine conjugates: synthesis and detail evaluation as potential anticancer agents.
    Mol Divers. 2023;27:1185-1202.
    Abstract

  1033. BENKHALED S, Diakite K, Jullian N, Poeta S, et al
    Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
    Radiat Oncol. 2023;18:105.
    Abstract

  1034. QIAN W, Chen Q, Hu C
    Whole-Lesion Apparent Diffusion Coefficient Histogram Analysis for Assessing Normal-Sized Lymph Node Metastasis in Cervical Cancer: Comparison Between Readout-Segmented and Single-Shot Echo-Planar Diffusion-Weighted Imaging.
    J Comput Assist Tomogr. 2023 Mar 9. doi: 10.1097/RCT.0000000000001463.
    Abstract

  1035. LIU H, Sun L, Lian J, Wang L, et al
    Comparison of PD-L1 expression and MMR status between primary and matched metastatic lesions in patients with cervical cancer.
    J Cancer Res Clin Oncol. 2023 Jun 28. doi: 10.1007/s00432-023-05020.
    Abstract

  1036. EL-ZEIN M, Ali R, Farah E, Botting-Provost S, et al
    Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
    Elife. 2023;12:e83764.
    Abstract

  1037. ZHINGRE A, Bedoya-Pilozo C, Gutierrez-Pallo D, Badano I, et al
    Genetic Variability in the E6/E7 Region of Human Papillomavirus 16 in Women from Ecuador.
    Viruses. 2023;15:1393.
    Abstract

  1038. NGUYEN HDT, Le TM, Lee E, Lee D, et al
    Relationship between Human Papillomavirus Status and the Cervicovaginal Microbiome in Cervical Cancer.
    Microorganisms. 2023;11:1417.
    Abstract

  1039. KANG HJ, Kwak YK, Lee SJ, Kim M, et al
    Re-Irradiation with Intensity-Modulated Radiation Therapy for the Treatment of Recurrent Cervical Cancer in the Pelvis: An Analysis of Outcomes and Toxicity.
    Medicina (Kaunas). 2023;59:1164.
    Abstract

  1040. AVESANI G, Perazzolo A, Amerighi A, Celli V, et al
    The Utility of Contrast-Enhanced Magnetic Resonance Imaging in Uterine Cervical Cancer: A Systematic Review.
    Life (Basel). 2023;13:1368.
    Abstract

  1041. KIM S, An H, Cho HW, Min KJ, et al
    Pivotal Clinical Study to Evaluate the Efficacy and Safety of Assistive Artificial Intelligence-Based Software for Cervical Cancer Diagnosis.
    J Clin Med. 2023;12:4024.
    Abstract

  1042. ALFANO A, Cafferata EGA, Gangemi M, Nicola Candia A, et al
    In Vitro and In Vivo Efficacy of a Stroma-Targeted, Tumor Microenvironment Responsive Oncolytic Adenovirus in Different Preclinical Models of Cancer.
    Int J Mol Sci. 2023;24:9992.
    Abstract

  1043. VALLE-MENDIOLA A, Gutierrez-Hoya A, Soto-Cruz I
    JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus.
    Genes (Basel). 2023;14:1141.
    Abstract

  1044. ZILIENE E, Inciura A, Ugenskiene R, Juozaityte E, et al
    Pathomorphological Manifestations and the Course of the Cervical Cancer Disease Determined by Variations in the TLR4 Gene.
    Diagnostics (Basel). 2023;13:1999.
    Abstract

  1045. PASCIUTO T, Moro F, Collarino A, Gambacorta MA, et al
    The Role of Multimodal Imaging in Pathological Response Prediction of Locally Advanced Cervical Cancer Patients Treated by Chemoradiation Therapy Followed by Radical Surgery.
    Cancers (Basel). 2023;15:3071.
    Abstract

  1046. MENGESHA MB, Chekole TT, Hidru HD
    Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis.
    BMC Womens Health. 2023;23:338.
    Abstract

  1047. ZHANG K, Ji X, Song Z, Song W, et al
    Butyrate inhibits the mitochondrial complex Iota to mediate mitochondria-dependent apoptosis of cervical cancer cells.
    BMC Complement Med Ther. 2023;23:212.
    Abstract

  1048. LI Q, Xie B, Chen X, Lu B, et al
    SNORD6 promotes cervical cancer progression by accelerating E6-mediated p53 degradation.
    Cell Death Discov. 2023;9:192.
    Abstract

  1049. YAO S, Xu J, Zhao K, Song P, et al
    Correction: Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways.
    Cell Death Dis. 2023;14:377.
    Abstract

  1050. ELEMES S, Stachteas P, Haidich AB, Mamopoulos A, et al
    The Impact of the COVID-19 Pandemic on Breast and Cervical Cancer Screening: A Systematic Review.
    In Vivo. 2023;37:1455-1476.
    Abstract

  1051. IMAI K, Chikazawa K, Kuwata T, Konno R, et al
    Volume Index Measured Using Magnetic Resonance Imaging for Diagnosing Cervical Cancer Tumors <2 cm.
    In Vivo. 2023;37:1786-1789.
    Abstract

  1052. WILLOWS K, Selk A, Auclair MH, Jim B, et al
    2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia.
    Curr Oncol. 2023;30:5738-5768.
    Abstract

  1053. MOHAMADIAN N, Nasseri S, Hosseini S, Molaie F, et al
    Dosimetric impact of bladder volume on organs at risk during external beam radiotherapy of cervical cancer.
    Radiat Prot Dosimetry. 2023 Jun 26:ncad183. doi: 10.1093.
    Abstract

  1054. SINGHAI M, Pandey V, Ashique S, Gupta GD, et al
    Design and evaluation of SLNs encapsulated curcumin-based topical formulation for the management of cervical cancer.
    Anticancer Agents Med Chem. 2023 Jun 26. doi: 10.2174/1871520623666230626145750.
    Abstract

  1055. SHIN MB, Oluoch LM, Barnabas RV, Baynes C, et al
    Implementation and scale-up of a single-visit, screen-and-treat approach with thermal ablation for sustainable cervical cancer prevention services: a protocol for a stepped-wedge cluster randomized trial in Kenya.
    Implement Sci. 2023;18:26.
    Abstract

  1056. MUTHURAMALINGAM MR, Muraleedharan VR
    Patterns in the prevalence and wealth-based inequality of cervical cancer screening in India.
    BMC Womens Health. 2023;23:337.
    Abstract

  1057. SOEJIMA Y, Fujiwara T, Fujii M, Tsushima H, et al
    Arthroscopic Treatment of Septic Arthritis of the Ankle Caused by Group B Streptococcus: A Case Report.
    Am J Case Rep. 2023;24:e939719.
    Abstract

  1058. ASHIQUE S, Hussain A, Fatima N, Altamimi MA, et al
    HPV pathogenesis, various types of vaccines, safety concern, prophylactic and therapeutic applications to control cervical cancer, and future perspective.
    Virusdisease. 2023 May 24:1-19. doi: 10.1007/s13337-023-00824.
    Abstract

  1059. REY VALZACCHI GM, Odetto D, Saadi JM, Zamora LB, et al
    Conservative treatment of cervical cancer: A single center experience over a two-decade period.
    Gynecol Oncol Rep. 2023;48:101226.
    Abstract

  1060. MCCARTHY AM, Tiro JA, Hu E, Ehsan S, et al
    Factors associated with shorter-interval cervical cancer screening for young women in three United States healthcare systems.
    Prev Med Rep. 2023;35:102279.
    Abstract

  1061. ZHANG L, Alimu G, Du Z, Yan T, et al
    Functionalized Magnetic Nanoparticles for NIR-Induced Photothermal Therapy of Potential Application in Cervical Cancer.
    ACS Omega. 2023;8:21793-21801.
    Abstract

  1062. HUANG Y, Zhang W, Yu Z, Su H, et al
    A Tumor Suppressive Role of CYLD as a Novel Potential DUB of Aurora B in Cervical Cancer.
    Clin Med Insights Oncol. 2023;17:11795549231180832.
    Abstract

  1063. MUKHERJEE AG, Ramesh Wanjari U, Valsala Gopalakrishnan A, Jayaraj R, et al
    HPV-associated cancers: insights into the mechanistic scenario and latest updates.
    Med Oncol. 2023;40:212.
    Abstract

  1064. XIE H, Wei M, Yao L, Liu Y, et al
    The Significance of Human Papillomavirus Receptors Related Genetic Variants in Cervical Cancer Screening.
    Microbiol Spectr. 2023 Jun 26:e0511722. doi: 10.1128/spectrum.05117.
    Abstract

  1065. HU H, Zhao Q, Sang Y, Xiao Y, et al
    Role and mechanism of leukemia inhibitory factor receptor in cervical cancer invasion and metastasis.
    J Int Med Res. 2023;51:3000605231182557.
    Abstract

  1066. JIANG P, Wei S, Bai Y, Qu A, et al
    The Efficacy of Volumetric Modulated Arc Therapy Combined With Chemotherapy, Brachytherapy, and Local Hyperthermia on Patients with Locally Advanced Cervical Cancer: A Retrospective Study.
    Technol Cancer Res Treat. 2023;22:15330338231185013.
    Abstract

  1067. ZHAI ZY, Li H, Li LW, Shen ZH, et al
    [Prognosis analysis of radical or modified radical hysterectomy and simple hysterectomy in patients with stage â…¡ endometrial cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2023;58:442-450.
    Abstract

  1068. TAO H, Zeng D, Chen W, Li F, et al
    Focused ultrasound: a novel therapy for improving vaginal microecology in patients with high-risk HPV infection.
    Int J Hyperthermia. 2023;40:2211276.
    Abstract

  1069. MPACHIKA-MFIPA F, Kululanga LI, Mfipa D, Kazembe A, et al
    Utilization of cervical cancer screening and its associated factors among women of child-bearing age in Mangochi district, Malawi: a facility-based cross-sectional study.
    BMC Womens Health. 2023;23:334.
    Abstract

  1070. LIU J, Li S, Cao Q, Zhang Y, et al
    Prediction of Recurrent Cervical Cancer in 2-Year Follow-Up After Treatment Based on Quantitative and Qualitative Magnetic Resonance Imaging Parameters: A Preliminary Study.
    Ann Surg Oncol. 2023 Jun 25. doi: 10.1245/s10434-023-13756.
    Abstract

  1071. LIEBERMANN E, Fontenot HB, Lim E, Matsunaga M, et al
    Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening.
    J Obstet Gynecol Neonatal Nurs. 2023 Jun 21:S0884-2175(23)00179.
    Abstract

  1072. LIU Y, Zheng Z, Han J, Lin C, et al
    Delivery of sPD1 gene by anti-CD133 antibody conjugated microbubbles combined with ultrasound for the treatment of cervical cancer in mice.
    Toxicol Appl Pharmacol. 2023 Jun 22:116605. doi: 10.1016/j.taap.2023.116605.
    Abstract

  1073. YU Y, Liu Y, Li Y, Yang X, et al
    Correction to: Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer.
    Cancer Cell Int. 2023;23:125.
    Abstract

  1074. STUEBS FA, Koch MC, Dietl AK, Schulmeyer CE, et al
    Management of Cervical Intraepithelial Neoplasia in Pregnant Women.
    Anticancer Res. 2023;43:3153-3158.
    Abstract

  1075. GUO W, Jing W
    N-Acetyl-L-Cysteine Reduces Cervical Carcinogenesis by Promoting Apoptosis.
    Drugs R D. 2023;23:165-174.
    Abstract

  1076. DELLA CORTE L, Lavitola G, Bifulco G
    How endocervicoscopy can impact obstetric outcomes in women undergoing LEEP for CIN2 + : a retrospective cohort analysis.
    Arch Gynecol Obstet. 2023;308:507-513.
    Abstract

  1077. MA Y, Xia X, Zheng W, Dai Y, et al
    HPV prevalence and genotype distribution among women in eastern China during the Covid-19 pandemic.
    Hum Vaccin Immunother. 2023;19:2212571.
    Abstract

  1078. KREIJNE JE, Goetgebuer RL, Erler NS, De Boer NK, et al
    Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2023 May 23. doi: 10.1111/apt.17555.
    Abstract

  1079. SAYINZOGA F, Tenet V, Heideman DAM, Sibomana H, et al
    Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys.
    Lancet Glob Health. 2023;11:e1096-e1104.
    Abstract

  1080. MURENZI G, Mungo C
    Impact of the human papillomavirus vaccine in low-resource settings.
    Lancet Glob Health. 2023;11:e997-e998.
    Abstract

  1081. ZHANG L, Yu K, Zhu B, Mei S, et al
    Trends in research related to vaccine and cancer prevention from 1992 to 2022: A 30-years bibliometric analysis.
    Hum Vaccin Immunother. 2023;19:2207441.
    Abstract

  1082. WANG S, Zhou X, Niu S, Chen L, et al
    Assessment of HER2 in Gastric-Type Endocervical Adenocarcinoma and its Prognostic Significance.
    Mod Pathol. 2023;36:100148.
    Abstract

  1083. SHI R, Qi W, Cai J, Zhao M, et al
    Independent risk factors for high-risk human papillomavirus infection among rural women in Shanxi Province, China: a population-based, case-control study.
    Arch Gynecol Obstet. 2023;308:551-559.
    Abstract

  1084. AHMED W, Zaib S, Ullah S, Fatima A, et al
    Role of Human Papillomavirus in Various Cancers: Epidemiology, Screening and Prevention.
    Mini Rev Med Chem. 2023;23:1079-1089.
    Abstract

  1085. YAN K, Hu C, Liu C, Chu G, et al
    LncRNA CERS6-AS1, sponging miR-6838-5p, promotes proliferation and invasion in cervical carcinoma cells by upregulating FOXP2.
    Histol Histopathol. 2023;38:823-835.
    Abstract

  1086. ZHANG J, Yang Y, Gao Y, Bai Z, et al
    Non-interference delivery of Ce6 and DOX in NIR light-responsive liposomes for synergetic cervical cancer therapy.
    Biomed Mater. 2023 Jul 5. doi: 10.1088/1748.
    Abstract

  1087. WUORI D, Skala SL, Chapel DB
    Herpes Pseudotumor Mimicking Cervical Cancer With Lymph Node Metastasis in an Immunocompetent Patient.
    Int J Gynecol Pathol. 2023 Jun 15. doi: 10.1097/PGP.0000000000000964.
    Abstract

  1088. BASAGOITIA A, Burrowes S, Solis-Soto MT, MacMillan G, et al
    Community and provider perceptions and experiences of cervical cancer screening in Rural Bolivia: a qualitative study.
    BMC Womens Health. 2023;23:359.
    Abstract

  1089. GOMES MLS, Moura NDS, Magalhaes LC, da Silva RR, et al
    Systematic literature review of primary and secondary cervical cancer prevention programs in South America.
    Rev Panam Salud Publica. 2023;47:e96.
    Abstract

  1090. THAHIRABANUIBRAHIM, Logaraj M
    The effect of the health belief model education for cervical cancer prevention, screening promotion among rural women in Chengalpattu district, Tamil Nadu (HBMECC).
    J Educ Health Promot. 2023;12:166.
    Abstract

  1091. CHENG JM, Luo WX, Tan BG, Pan J, et al
    Whole-tumor histogram analysis of apparent diffusion coefficients for predicting lymphovascular space invasion in stage IB-IIA cervical cancer.
    Front Oncol. 2023;13:1206659.
    Abstract

  1092. NEUMEYER S, Tanaka LF, Liang LA, Klug SJ, et al
    Epidemiology of cervical cancer in elderly women: Analysis of incidence, treatment, and survival using German registry data.
    Cancer Med. 2023 Jul 5. doi: 10.1002/cam4.6318.
    Abstract

  1093. SAWAYA GF, Dorismond VG
    Avoiding Low-Value Care and Patient Financial Harm in Cervical Cancer Screening.
    Cancer Prev Res (Phila). 2023;16:363-364.
    Abstract

  1094. ZHANG M, Hong X, Ma N, Wei Z, et al
    The promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer.
    J Transl Med. 2023;21:433.
    Abstract

  1095. ARI ES, Dioso RIP, Sotunsa JO
    Improving care seeking behavior toward cervical cancer screening participation among Gwafan community women, North-Central Nigeria.
    BMC Womens Health. 2023;23:356.
    Abstract

  1096. VIDRINE JI, Fennell BS, Simmons VN, Sutton SK, et al
    Enhancing long-term smoking abstinence among individuals with a history of cervical intraepithelial neoplasia or cervical cancer (Project ACCESS): protocol for a randomized clinical trial.
    BMC Public Health. 2023;23:1284.
    Abstract

  1097. ZHANG N, Jin X, Yang W, Gu C, et al
    Survival outcomes of abdominal radical hysterectomy, laparoscopic radical hysterectomy, robot-assisted radical hysterectomy and vaginal radical hysterectomy approaches for early-stage cervical cancer: a retrospective study.
    World J Surg Oncol. 2023;21:197.
    Abstract

  1098. KONG X, Xiong Y, Xue M, He J, et al
    Identification of cuproptosis-related lncRNA for predicting prognosis and immunotherapeutic response in cervical cancer.
    Sci Rep. 2023;13:10697.
    Abstract

  1099. HAN YH, Ma DY, Lee SJ, Mao YY, et al
    Bioinformatics Analysis of Novel Targets for Treating Cervical Cancer by Immunotherapy Based on Immune Escape.
    Cancer Genomics Proteomics. 2023;20:383-397.
    Abstract

  1100. ROMAN C, Andrade D, Hernandez Y, Salazar ZK, et al
    Biological, demographic, and health factors associated with HPV infection in Ecuadorian women.
    Front Public Health. 2023;11:1158270.
    Abstract

  1101. MANN M, Singh VP, Kumar L
    Cervical cancer: a tale from HPV infection to PARP inhibitors.
    Genes Dis. 2022;10:1445-1456.
    Abstract

  1102. SARIS DH, Pena D, Haggerty AF, Taunk NK, et al
    Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients.
    Gynecol Oncol Rep. 2023;47:101177.
    Abstract

  1103. PACE LE, Hagenimana M, Dusengimana JV, Balinda JP, et al
    Implementation research: including breast examinations in a cervical cancer screening programme, Rwanda.
    Bull World Health Organ. 2023;101:478-486.
    Abstract

  1104. LI Y, Wei Y, Zhang H, Bai Y, et al
    MicroRNA-154-5p suppresses cervical carcinoma growth and metastasis by silencing Cullin2 in vitro and in vivo.
    PeerJ. 2023;11:e15641.
    Abstract

  1105. SONG Y, Wang S
    Melatonin synergistically enhances docetaxel induced endoplasmic reticulum stress to promote apoptosis by suppressing NF-kappaB activation in cervical cancer.
    Med Oncol. 2023;40:219.
    Abstract

  1106. ALMASOUDI HH, Hakami MA, Alhazmi AY, Makkawi M, et al
    Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study.
    Med Oncol. 2023;40:218.
    Abstract

  1107. NAGASE Y, Kobayashi E, Kobayashi M, Kakuda M, et al
    Intracorporeal colpotomy using the Gutclamper as a novel clamping device to prevent tumor spillage during laparoscopic radical hysterectomy for cervical cancer.
    Asian J Endosc Surg. 2023;16:658-661.
    Abstract

  1108. LUO X, Liu J, Wang X, Wang Y, et al
    Circ_0005615 promotes cervical cancer cell growth and metastasis by modulating the miR-138-5p/KDM2A axis.
    J Biochem Mol Toxicol. 2023 Jul 2:e23410. doi: 10.1002/jbt.23410.
    Abstract

  1109. PAN L, Shan RY, Gao SF, Zhou Y, et al
    Application of 3.0 T multimodal MRI in FIGO staging of cervical cancer.
    Technol Health Care. 2023 Jun 29. doi: 10.3233/THC-230252.
    Abstract

  1110. TONG L, Wu L
    Unilateral ovarian recurrence 5 years after hysterectomy for microinvasive squamous cervical cancer stage IA1: a rare case report.
    BMC Womens Health. 2023;23:350.
    Abstract

  1111. SHEN S, Jin H, Zhang X, Zhang Y, et al
    LINC00426, a novel m(6)A-regulated long non-coding RNA, induces EMT in cervical cancer by binding to ZEB1.
    Cell Signal. 2023 Jun 29:110788. doi: 10.1016/j.cellsig.2023.110788.
    Abstract

  1112. POLEBOYINA PK, Naik U, Pasha A, Ravinder D, et al
    Virtual Screening, Molecular Docking, and Dynamic Simulations Revealed TGF-beta1 Potential Inhibitors to Curtail Cervical Cancer Progression.
    Appl Biochem Biotechnol. 2023 Jul 1. doi: 10.1007/s12010-023-04608.
    Abstract

  1113. WAN Q, Xu J, Zhu C, Liu X, et al
    Alkaloids from Piper longum Exhibit Anti-inflammatory Activity and Synergistic Effects with Chemotherapeutic Agents against Cervical Cancer Cells.
    J Agric Food Chem. 2023 Jul 1. doi: 10.1021/acs.jafc.3c01667.
    Abstract

  1114. SUN H, Liu Y, Yuan L, Wang N, et al
    Dosimetry study of Auto-VMAT planning and Manual-VMAT planning based on Pinnacle3 9.10 in radiotherapy for cervical cancer.
    Medicine (Baltimore). 2023;102:e34129.
    Abstract

  1115. LIU MY, Li N
    The diagnostic value of lncRNA HOTAIR for cervical carcinoma in vaginal discharge and serum.
    Medicine (Baltimore). 2023;102:e34042.
    Abstract

  1116. BORCHOWSKY K, Rush M, Mullally T, McBain L, et al
    Primary care experiences in the 'Let's test for HPV' study: a qualitative analysis.
    J Prim Health Care. 2023;15:147-154.
    Abstract

  1117. ZANON JR, Durante H, Nobrega LM, Accorsi G, et al
    Emphysematous pyelonephritis after urinary diversion by percutaneous nephrostomy in patient with advanced cervical cancer: A case report.
    SAGE Open Med Case Rep. 2023;11:2050313X231182532.
    Abstract

  1118. FU C, Wang C, Qian Q, Zhang Y, et al
    A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors.
    Gynecol Oncol Rep. 2023;48:101228.
    Abstract

  1119. SCANNING
    Retracted: Application of MRI and CT Images in Surgical Treatment of Early Cervical Cancer.
    Scanning. 2023;2023:9847106.
    Abstract

  1120. MARKERS D
    Retracted: Laparoscopic Radical Hysterectomy Combined with Neoadjuvant Chemotherapy for Cervical Cancer Patients Effectively Improves Immune Function.
    Dis Markers. 2023;2023:9781835.
    Abstract

  1121. BROSNAN B, Skarga-Bandurova I, Biloborodova T, Skarha-Bandurov I, et al
    Cervical Intraepithelial Neoplasia Grading from Prepared Digital Histology Images.
    Stud Health Technol Inform. 2023;305:402-405.
    Abstract

  1122. PETENI S, Ozoemena OC, Khawula T, Haruna AB, et al
    Electrochemical Immunosensor for Ultra-Low Detection of Human Papillomavirus Biomarker for Cervical Cancer.
    ACS Sens. 2023 Jun 29. doi: 10.1021/acssensors.3c00677.
    Abstract

  1123. DI FONTE R, Strippoli S, Garofoli M, Cormio G, et al
    Cervical cancer benefits from trabectedin combination with the beta-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids.
    Front Cell Dev Biol. 2023;11:1178316.
    Abstract

  1124. RAI R, Conrad R, Benbrook DM
    Dataset on mucin 1 and 4 proteins and SialyT and T antigens staining patterns in cervical cancer primary tumors and metastatic lymph nodes.
    Data Brief. 2023;48:109243.
    Abstract

  1125. PONTRE JC, Nathan E, Goldsmith H, McElhinney B, et al
    Does the New National Cervical Screening Programme Guideline Detect Cases of High-Grade Squamous Intraepithelial Lesions That Previously Would Have Been Missed?
    J Low Genit Tract Dis. 2023;27:230-235.
    Abstract

  1126. FAHMI MN, Kusuma F, Hellyanti T, Kekalih A, et al
    High ALDH-1 Expression Predicts Non-Complete Response of Radiotherapy in Stage III Squamous Cell Cervical Carcinoma Patients.
    Asian Pac J Cancer Prev. 2023;24:1863-1868.
    Abstract

  1127. KARTIKEYAN R, Murugan D, Ajaykamal T, Varadhan M, et al
    Mixed ligand copper(II)-diimine complexes of 2-formylpyridine-N(4)-phenylthiosemicarbazone: diimine co-ligands tune the in vitro nanomolar cytotoxicity.
    Dalton Trans. 2023;52:9148-9169.
    Abstract

  1128. SWAIN M, Budrukkar A, Rembielak A, Kron T, et al
    Challenges in the Sustainability of Brachytherapy Service in Contemporary Radiotherapy.
    Clin Oncol (R Coll Radiol). 2023;35:489-496.
    Abstract

  1129. FRANCOEUR AA, Furey KB, Ramirez J, Klomhaus AM, et al
    Recurrent High-Grade Squamous Intraepithelial Lesion After Loop Excision Procedure Versus Loop Procedure With Top Hat.
    J Low Genit Tract Dis. 2023;27:193-197.
    Abstract

  1130. BERGER D, Van Dyk S, Beaulieu L, Major T, et al
    Modern Tools for Modern Brachytherapy.
    Clin Oncol (R Coll Radiol). 2023;35:e453-e468.
    Abstract

  1131. HECKEN JM, Halagiera P, Rehman S, Tempfer CB, et al
    Virtual Reality for Anxiety Reduction in Women Undergoing Colposcopy: A Randomized Controlled Trial.
    J Low Genit Tract Dis. 2023;27:223-229.
    Abstract

  1132. COOK IC, Fuhr LI, Flores SE, Novicoff WM, et al
    Cost-Conscious Colposcopy: A Single-Institution Review of Biopsy Submission Practices and Outcomes.
    J Low Genit Tract Dis. 2023;27:198-201.
    Abstract

  1133. BOTHA MH, Van der Merwe FH, Snyman LC, Dreyer GJ, et al
    Utility of Extended HPV Genotyping as Primary Cervical Screen in an Unscreened Population With High HIV Co-Infection Rate.
    J Low Genit Tract Dis. 2023;27:212-216.
    Abstract

  1134. CAUSIN RL, Sussuchi da Silva L, Leal LF, Possati-Resende JC, et al
    The digital expression profile of BMP7, CDKN2C, HIST1H3G, and PKMYT1 genes improves high-grade cervical lesion detection in liquid-based cytology.
    Cancer Cytopathol. 2023;131:454-464.
    Abstract

  1135. IKENBERG H, Lieder S, Ahr A, Wilhelm M, et al
    Comparison of the Hologic Genius Digital Diagnostics System with the ThinPrep Imaging System-A retrospective assessment.
    Cancer Cytopathol. 2023;131:424-432.
    Abstract

  1136. HARRIS LR
    Cervical Stenosis After Conization Associated With False-Negative Human Papillomavirus-Based Post-Treatment Testing.
    J Low Genit Tract Dis. 2023;27:300-301.
    Abstract

  1137. SINGH S, Prajapati YK
    Novel Bottom-Side Polished PCF-Based Plasmonic Biosensor for Early Detection of Hazardous Cancerous Cells.
    IEEE Trans Nanobioscience. 2023;22:647-654.
    Abstract

  1138. XIAO J, Gong Y, Chen F, Chen L, et al
    Clinical Diagnostic Value of Atypical Glandular Cells in Cervical Cytology: A Single Center Experience From China.
    J Low Genit Tract Dis. 2023;27:202-206.
    Abstract

  1139. GIOVANNETTI O, Tomalty D, Greco S, Kment B, et al
    Patient and provider perspectives on LEEP/LLETZ treatment and outcomes: an interview study.
    J Sex Med. 2023;20:977-990.
    Abstract

  1140. ZARATE GDSF, Flores FLR, Burguete AI, Marina VM, et al
    Low-Dose Aspirin Has Antiproliferative and Apoptosis Effects in HPV16 Tumor Cells and Delays Tumor Development and Growth in an Experimental Model.
    Gynecol Obstet Invest. 2023;88:150-158.
    Abstract

  1141. WU G, Li C, Yin L, Wang J, et al
    Compared between support vector machine (SVM) and deep belief network (DBN) for multi-classification of Raman spectroscopy for cervical diseases.
    Photodiagnosis Photodyn Ther. 2023;42:103340.
    Abstract

  1142. LI X, Liu H, Zhang Y, Liu Y, et al
    A rare case of mesonephric adenocarcinoma in the uterine cervix.
    Asian J Surg. 2023;46:2936-2937.
    Abstract

  1143. ZHAO X, Song S, Wang Y, Mu X, et al
    Effects of photodynamic therapy in the treatment of high-grade vaginal intraepithelial lesions following hysterectomy and HPV infection.
    Photodiagnosis Photodyn Ther. 2023;42:103336.
    Abstract

  1144. GUO N, Liu H
    A rare case of minimal-deviation adenocarcinoma of the uterine cervix with ovarian metastasis.
    Asian J Surg. 2023;46:2733-2734.
    Abstract

  1145. KITAMURA SI, Yoshida H, Kobayashi-Kato M, Kikkawa N, et al
    Adenoid Basal Carcinoma with Adenoid Cystic Carcinoma Component of the Uterine Cervix: A Case Report and Literature Review.
    Int J Surg Pathol. 2023;31:819-824.
    Abstract

  1146. JIANG D, Niu Z, Tan X, He H, et al
    The mortalities of female-specific cancers in China and other countries with distinct socioeconomic statuses: A longitudinal study.
    J Adv Res. 2023;49:127-139.
    Abstract

  1147. SAUVAGET C, Selmouni F, Dangbemey DP, Kpebo DDO, et al
    Scaling-Up Cervical Cancer Screening and Treatment in Sub-Saharan Africa: Perspectives From Local Health Policymakers.
    JCO Glob Oncol. 2023;9:e2300115.
    Abstract

  1148. XIE H, Rao X, Li J, Yao L, et al
    Diagnostic accuracy of extended HPV DNA genotyping and its application for risk-based cervical cancer screening strategy.
    Clin Chem Lab Med. 2023 Jul 13. doi: 10.1515/cclm-2023-0440.
    Abstract

  1149. RAZZAK MA, Islam MN, Broti T, Kamal ES, et al
    Exploring usability problems of mHealth applications developed for cervical cancer: An empirical study.
    SAGE Open Med. 2023;11:20503121231180413.
    Abstract

  1150. ANTABE R, Luginaah NA, Kangmennaang J, Mkandawire P, et al
    Determinants of cervical cancer screening among women living with HIV in Zimbabwe.
    Health Promot Int. 2023;38:daad073.
    Abstract

  1151. GUO Y, Li T, Yang X, Qi Z, et al
    [Quantitative evaluation of radiotherapy plan in precise external beam radiotherapy process management for cervical cancer].
    Nan Fang Yi Ke Da Xue Xue Bao. 2023;43:1035-1040.
    Abstract

  1152. ZHANG F, Zhou M, Wang G, Li X, et al
    Evaluation of bladder filling effects on the dose distribution during radiotherapy for cervical cancer based on daily CT images.
    J Appl Clin Med Phys. 2023 Jul 12:e14097. doi: 10.1002/acm2.14097.
    Abstract

  1153. YU Y, Liu Y, Li Y, Yang X, et al
    Correction to: Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer.
    Cancer Cell Int. 2023;23:135.
    Abstract

  1154. ZHONG J, Su M, Jiang Y, Huang L, et al
    VEGFR2 targeted microbubble-based ultrasound molecular imaging improving the diagnostic sensitivity of microinvasive cervical cancer.
    J Nanobiotechnology. 2023;21:220.
    Abstract

  1155. HARLFINGER J, Sommer I, Gartlehner G
    [WHO Guideline for Screening and Treatment of Cervical Pre-Cancerous Lesions for Cervical Cancer Prevention (Second Edition)].
    Gesundheitswesen. 2023;85:630-634.
    Abstract

  1156. KHAN MJ
    Cervical Cancer Screening: Evolution of National Guidelines and Current Recommendations.
    Clin Obstet Gynecol. 2023 Jul 4. doi: 10.1097/GRF.0000000000000791.
    Abstract

  1157. CICERON AC, Berg CJ, Clausen M, Jeon MJ, et al
    Development of a cervical cancer prevention text-messaging program for women living with HIV.
    Health Educ Res. 2023 Jul 12:cyad024. doi: 10.1093.
    Abstract

  1158. LIU J, Li S, Cao Q, Zhang Y, et al
    ASO Author Reflections: Establishment of a Prediction Model for Recurrent Cervical Cancer During a 2-Year Follow-Up Period.
    Ann Surg Oncol. 2023 Jul 12. doi: 10.1245/s10434-023-13836.
    Abstract

  1159. GARCIA JC, Rios-Pena L, Rodriguez MCR, Maraver FM, et al
    Development and internal validation of a multivariable prediction model for the quality of life of cervical cancer survivors.
    J Obstet Gynaecol Res. 2023 Jul 12. doi: 10.1111/jog.15743.
    Abstract

  1160. BI K, Yang J, Wei X
    Alternative splicing variants involved in pyroptosis and cuproptosis contribute to phenotypic remodeling of the tumor microenvironment in cervical cancer.
    Reprod Sci. 2023 Jul 11. doi: 10.1007/s43032-023-01284.
    Abstract

  1161. OGUNSOLA OO, Olawepo JO, Ajayi O, Osayi E, et al
    AVIVA: a telehealth tool to improve cervical cancer screening in resource-constrained settings.
    BMJ Glob Health. 2023;8:e012311.
    Abstract

  1162. KARADEMIR D, Ozgur A
    The effects of STA-9090 (Ganetespib) and venetoclax (ABT-199) combination on apoptotic pathways in human cervical cancer cells.
    Med Oncol. 2023;40:234.
    Abstract

  1163. MA T, Guo J, Han J, Li L, et al
    Circ_0001589/miR-1248/HMGB1 axis enhances EMT-mediated metastasis and cisplatin resistance in cervical cancer.
    Mol Carcinog. 2023 Jul 11. doi: 10.1002/mc.23605.
    Abstract

  1164. NEGASH BA, Bayu NH, Woretaw AW
    Knowledge, attitude, and associated factor towards cervical cancer prevention among primary and secondary school female teachers in Gondar town, North West Ethiopia, 2022.
    BMC Womens Health. 2023;23:365.
    Abstract

  1165. LI J, Qi C, Liu X, Li C, et al
    Retraction Note: Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo.
    Sci Rep. 2023;13:11162.
    Abstract

  1166. CAO G, Yue J, Ruan Y, Han Y, et al
    Single-cell dissection of cervical cancer reveals key subsets of the tumor immune microenvironment.
    EMBO J. 2023 Jul 10:e110757. doi: 10.15252/embj.2022110757.
    Abstract

  1167. ZHU J, Jiang Q
    Twist1‑mediated transcriptional activation of Claudin‑4 promotes cervical cancer cell migration and invasion.
    Oncol Lett. 2023;26:335.
    Abstract

  1168. GUO Y, Wang L, Xu Z, Li M, et al
    Lymph node metastasis-related gene signature shows good performance in predicting prognosis and immune infiltration in cervical cancer.
    Front Oncol. 2023;13:1190251.
    Abstract

  1169. ROBINSON D, Hoong K, Kleijn WB, Doronin A, et al
    Polarimetric imaging for cervical pre-cancer screening aided by machine learning: ex vivo studies.
    J Biomed Opt. 2023;28:102904.
    Abstract

  1170. TAKENAKA T, Yamazaki H, Suzuki G, Masui K, et al
    Initial tumor volume as an important predictor for indication of intra-cavitary brachytherapy, intra-cavitary/interstitial brachytherapy, and multi-catheter sole interstitial brachytherapy in cervical cancer patients treated with chemoradiotherapy.
    J Contemp Brachytherapy. 2023;15:191-197.
    Abstract

  1171. YAN C, Wang X, Wen A, Luo J, et al
    Comparative analysis of dosimetric and radiobiological models of IPSA and HIPO algorithms in combined intra-cavitary/interstitial brachytherapy for cervical cancer.
    J Contemp Brachytherapy. 2023;15:212-219.
    Abstract

  1172. LUO Y, Chen Y, Jin H, Hou B, et al
    The suppression of cervical cancer ferroptosis by macrophages: The attenuation of ALOX15 in cancer cells by macrophages-derived exosomes.
    Acta Pharm Sin B. 2023;13:2645-2662.
    Abstract

  1173. GUO L, Li C, Guo J, Qiu J, et al
    CKAP2 promotes cervical cancer progression by modulating the tumor microenvironment via NF-kappaB signaling.
    Am J Cancer Res. 2023;13:2376-2391.
    Abstract

  1174. LI X, Wu J, Wu Y, Duan Z, et al
    Imbalance of Vaginal Microbiota and Immunity: Two Main Accomplices of Cervical Cancer in Chinese Women.
    Int J Womens Health. 2023;15:987-1002.
    Abstract

  1175. LING K, Dou Y, Yang N, Deng L, et al
    Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapy.
    J Control Release. 2023 Jul 7:S0168-3659(23)00431.
    Abstract

  1176. NAKAYITA RM, Benyumiza D, Nekesa C, Misuk I, et al
    Factors associated with uptake of human papilloma virus vaccine among school girls aged 9-14 years in Lira City northern Uganda: a cross-sectional study.
    BMC Womens Health. 2023;23:362.
    Abstract

  1177. YACOUTI A, Baddou R, El Mettat K, Guennouni M, et al
    Moroccan Women's Attitudes Regarding Pap Smear Test and Adherence to Cervical Cancer Screening.
    J Cancer Educ. 2023 Jul 7. doi: 10.1007/s13187-023-02317.
    Abstract

  1178. JIANG S, Nan X, Pan X, Zhang J, et al
    The effect of aminolevulinic acid hydrochloride topical powder photodynamic therapy versus nocardia rubra cell wall skeleton and observers group in the treatment of cervical low-grade squamous intraepithelial lesions with human papillomavirus infectio
    Medicine (Baltimore). 2023;102:e34302.
    Abstract

  1179. METHODS IN MEDICINE CAM
    Retracted: The Effect of Pilates Exercise Nursing Combined with Communication Standard-Reaching Theory Nursing and Pelvic Floor Muscle Training on Bladder Function and Family Function of Patients after Cervical Cancer Surgery.
    Comput Math Methods Med. 2023;2023:9786109.
    Abstract

  1180. METHODS IN MEDICINE CAM
    Retracted: Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
    Comput Math Methods Med. 2023;2023:9869683.
    Abstract

  1181. PATEL N, Bavikar R, Buch A, Kulkarni M, et al
    A Comparison of Conventional Pap Smear and Liquid-Based Cytology for Cervical Cancer Screening.
    Gynecol Minim Invasive Ther. 2023;12:77-82.
    Abstract

  1182. NAZARI E, Hasanzadeh M, Rezvani R, Rejali M, et al
    Association of dietary intake and cervical cancer: a prevention strategy.
    Infect Agent Cancer. 2023;18:42.
    Abstract

  1183. MILESHKIN LR, Narayan K, Gaffney DK, Barnes EH, et al
    Adjuvant chemotherapy for locally advanced cervical cancer - Authors' reply.
    Lancet Oncol. 2023;24:e290.
    Abstract

  1184. SARI SY, Akdag NNS, Gultekin M, Yildiz F, et al
    Adjuvant chemotherapy for locally advanced cervical cancer.
    Lancet Oncol. 2023;24:e289.
    Abstract

  1185. EZECHI O, Akinsolu F, Salako A, Abodunrin O, et al
    High-risk human papillomavirus infection among Nigerian women: A systematic review and meta-analysis.
    J Int Med Res. 2023;51:3000605231182884.
    Abstract

  1186. KAMBHAMPATI A, Meghani K, Ndlovu N, Monare B, et al
    A Multi-Institutional Study of Barriers to Cervical Cancer Care in Sub-Saharan Africa.
    Adv Radiat Oncol. 2023;8:101257.
    Abstract

  1187. HARJANA NPA, Nita S, Sebayang M, Mukuan OS, et al
    Factors Associated With Utilization of Cervical Cancer Screening Program Among Women Living With HIV in Indonesia.
    Asia Pac J Public Health. 2023 Jul 5:10105395231185982.
    Abstract

  1188. YE X, Zou J, Chen J, Luo S, et al
    An adhesion-based method for rapid and low-cost isolation of circulating tumor cells.
    Clin Chim Acta. 2023;547:117421.
    Abstract

  1189. LAGO V, Guijarro-Campillo AR, Vidal BS, Padilla-Iserte P, et al
    An Easy Learning Approach to a Complex Surgical Technique: A Step-by-Step Site-Relapse Lateral Extended Endopelvic Resection (LEER).
    Ann Surg Oncol. 2023;30:4991-4993.
    Abstract

  1190. BERASALUCE GOMEZ A, Martin-Calvo N, Boria F, Manzour N, et al
    SUCCOR Nodes: May Sentinel Node Biopsy Determine the Need for Adjuvant Treatment?
    Ann Surg Oncol. 2023;30:4975-4985.
    Abstract

  1191. QUERLEU D, Bizzarri N, Ianieri MM, Scambia G, et al
    ASO Visual Abstract: Radical Vaginal Hysterectomy, Type B An Educational Video, Cadaver Model.
    Ann Surg Oncol. 2023;30:4990.
    Abstract

  1192. STAR J, Bandi P, Nargis N, Islami F, et al
    Updated Review of Major Cancer Risk Factors and Screening Test use in the United States, with a Focus on Changes During the COVID-19 Pandemic.
    Cancer Epidemiol Biomarkers Prev. 2023;32:879-888.
    Abstract

  1193. THIPPANA M, Dwivedi A, Das A, Palanisamy M, et al
    Identification of key molecular players and associated pathways in cervical squamous cell carcinoma progression through network analysis.
    Proteins. 2023;91:1173-1187.
    Abstract

  1194. MORRIS VK, Jazaeri A, Westin SN, Pettaway C, et al
    Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers.
    Oncologist. 2023;28:618-623.
    Abstract

  1195. QUERLEU D, Bizzarri N, Ianieri MM, Scambia G, et al
    Radical Vaginal Hysterectomy, Type B: An Educational Video, Cadaver Model.
    Ann Surg Oncol. 2023;30:4988-4989.
    Abstract

  1196. BEFANO B, Campos NG, Egemen D, Herrero R, et al
    Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial.
    J Natl Cancer Inst. 2023;115:788-795.
    Abstract

  1197. LI S, Liu J, Guo R, Nickel MD, et al
    T(1) mapping and extracellular volume fraction measurement to evaluate the poor-prognosis factors in patients with cervical squamous cell carcinoma.
    NMR Biomed. 2023;36:e4918.
    Abstract

  1198. SONG Y, Shou X, Sheng B, Mei J, et al
    Cell Membranes from Tumor-Tropic MSCs Screened by a Microfluidic Chip for Drug Nanoparticles Encapsulation and Cancer Targeted Therapy.
    Adv Healthc Mater. 2023;12:e2202904.
    Abstract

  1199. FLORES LEGARRETA A, Salvo G, Gonzales NR, Chisholm G, et al
    RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study.
    J Gynecol Oncol. 2023;34:e50.
    Abstract

  1200. HUANG HC, Chang PC, Li SF, Wang CY, et al
    The Significant Predictors for Breast, Cervical, Colorectal, or Oral Cancer Screening Intention and Behavior in Taiwan.
    Cancer Nurs. 2023;46:E261-E267.
    Abstract

  1201. ZHAO F, Fang T, Liu H, Wang S, et al
    Long non-coding RNA MALAT1 promotes cell proliferation, migration and invasion in cervical cancer by targeting miR-625-5p and AKT2.
    Panminerva Med. 2023;65:266-267.
    Abstract

  1202. KITA M, Butsuhara Y, Hisamatsu Y, Yokoe T, et al
    Pneumovaginoscopy-assisted radical hysterectomy for early-stage cervical cancer: a novel bidirectional approach for tumor spillage prevention and R0 resection.
    J Gynecol Oncol. 2023 Jul 6. doi: 10.3802/jgo.2023.
    Abstract

  1203. ZHOU X, Liang D, Li Q, Zhao L, et al
    The sealing effect of magnetic-sealing uterine manipulator in isolated uterus from patients with early-stage cervical cancer: a pre-clinical study.
    J Gynecol Oncol. 2023 Jul 7. doi: 10.3802/jgo.2023.
    Abstract

  1204. NICOLAI L, Yigit R, Bleeker MCG, Bart J, et al
    The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter.
    J Gynecol Oncol. 2023 Jul 7. doi: 10.3802/jgo.2023.
    Abstract

  1205. METHODS IN MEDICINE CAM
    Retracted: Identification and Validation of Invasion-Related Molecular Subtypes and Prognostic Features for Cervical Cancer.
    Comput Math Methods Med. 2023;2023:9853237.
    Abstract

  1206. DHAKAL K, Wang P, Mboineki JF, Getu MA, et al
    The distinct experience of supportive care needs among cervical cancer patients: A qualitative study.
    Tumori. 2023;109:394-405.
    Abstract


  1207. Long Noncoding RNA ST7-AS1 Upregulates TRPM7 Expression by Sponging microRNA-543 to Promote Cervical Cancer Progression [Retraction].
    Onco Targets Ther. 2023;16:581-582.
    Abstract

  1208. CHOU PC, Chen HC, Yeh CL, Hsu LC, et al
    [Improving the Pap Smear Screening Rate for Cervical Cancer in a Health Management Center: A Quality Improvement Program].
    Hu Li Za Zhi. 2023;70:77-86.
    Abstract

  1209. JIANG W, Ouyang X, Li C, Long Y, et al
    Targeting PI3Kalpha increases the efficacy of anti-PD-1 antibody in cervical cancer.
    Immunology. 2023 Jul 19. doi: 10.1111/imm.13682.
    Abstract

  1210. GU J, Ding B
    Cross-talk of pyroptosis-based subtypes, the development of a risk classifier and immune responses in cervical cancer.
    J Gene Med. 2023 Jul 19:e3566. doi: 10.1002/jgm.3566.
    Abstract

  1211. YAN ZY, Di XH, Qiu Y, Ying YY, et al
    Cervical carcinogenesis risk association of HPV33 E6 and E7 genetic variations in Taizhou, Southeast China.
    Virol J. 2023;20:156.
    Abstract

  1212. SHI J, Rui X, Han C, Wang C, et al
    circRNF13, a novel N(6)-methyladenosine-modified circular RNA, enhances radioresistance in cervical cancer by increasing CXCL1 mRNA stability.
    Cell Death Discov. 2023;9:253.
    Abstract

  1213. WEI X, Sun K, Li S, Lin C, et al
    PSME3 induces radioresistance and enhances aerobic glycolysis in cervical cancer by regulating PARP1.
    Tissue Cell. 2023;83:102151.
    Abstract

  1214. KONG X, Xiong Y
    A novel necroptosis-related long non-coding RNA signature predicts prognosis and immune response in cervical cancer patients.
    J Cancer Res Clin Oncol. 2023 Jul 19. doi: 10.1007/s00432-023-05158.
    Abstract

  1215. HIDAYATULLAH A, Putra WE, Sustiprijatno S, Rifa'i M, et al
    Concatenation of molecular docking and dynamics simulation of human papillomavirus type 16 E7 oncoprotein targeted ligands: In quest of cervical cancer's treatment.
    An Acad Bras Cienc. 2023;95.
    Abstract

  1216. THIANGPHAK E, Leetanaporn K, Buhachat R
    Pretreatment total lymphocyte count as a prognostic factor of survival in patients with recurrent cervical cancer after definitive radiation-based therapy: a retrospective study.
    Obstet Gynecol Sci. 2023 Jul 19. doi: 10.5468/ogs.23119.
    Abstract

  1217. GONG X, Chi H, Xia Z, Yang G, et al
    Advances in HPV-associated tumor management: Therapeutic strategies and emerging insights.
    J Med Virol. 2023;95:e28950.
    Abstract

  1218. TIAN R, Li H, Ren S, Li S, et al
    circRNA THBS1 silencing inhibits the malignant biological behavior of cervical cancer cells via the regulation of miR-543/HMGB2 axis.
    Open Med (Wars). 2023;18:20230709.
    Abstract

  1219. ZHENG Z, Hu K, Hou X, Yu L, et al
    Radiotherapy for postoperative vaginal recurrences of cervical squamous cell carcinoma: analysis of dosing and prognosis.
    J Obstet Gynaecol. 2023;43:2213328.
    Abstract

  1220. ISHIMOTO T, Yagi A, Nakajima K, Okamoto N, et al
    A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation.
    Hum Vaccin Immunother. 2023;19:2229222.
    Abstract

  1221. GILMAN SD, Gravitt PE, Paz-Soldan VA, Group PPS, et al
    Implementation of new technologies designed to improve cervical cancer screening and completion of care in low-resource settings: A case study from the Proyecto Precancer.
    Res Sq. 2023 Jul 7:rs.3.rs-3093534. doi: 10.21203/rs.3.rs-3093534.
    Abstract

  1222. BASSAL R, Shalev V, Eisenberg VH, Stein-Reisner O, et al
    The Association Between Depression and Invasive and In-situ Cervical Tumors: A Large Population Based Cohort Study.
    Isr Med Assoc J. 2023;25:490-494.
    Abstract

  1223. GYONGYOSI E, Laszlo B, Szalmas A, Konya J, et al
    Transcriptional activity of the long control region in human papillomavirus type 33 intratype variants.
    Virol J. 2023;20:152.
    Abstract

  1224. FENG X, Shan R, Hu X
    The linkage of NF-kappaB signaling pathway-associated long non-coding RNAs with tumor microenvironment and prognosis in cervical cancer.
    BMC Med Genomics. 2023;16:169.
    Abstract

  1225. ZEWDIE A, Kasahun AW, Habtie A, Gashaw A, et al
    Human papillomavirus vaccine acceptance among adolescent girls in Ethiopia: a systematic review and meta-analysis.
    BMC Public Health. 2023;23:1369.
    Abstract

  1226. LAKHMAN Y, Aherne EA, Jayaprakasam VS, Nougaret S, et al
    Staging of Cervical Cancer: A Practical Approach Using MRI and FDG PET.
    AJR Am J Roentgenol. 2023 Jun 7. doi: 10.2214/AJR.23.29003.
    Abstract

  1227. LEATH CA 3RD, Nysenbaum J, Ting J, Zhang YJ, et al
    Assessing Geographic Variation in Rates of Cervical Cancer and Recurrent or Metastatic Cervical Cancer Among Medicaid Enrollees.
    Am J Clin Oncol. 2023 Jul 17. doi: 10.1097/COC.0000000000001026.
    Abstract

  1228. SIVARANJINI K, Oak A, Cheulkar S, Maheshwari A, et al
    Role of education and income on disparities of time-to-treatment initiation and its impact on cervical cancer survival.
    Indian J Public Health. 2023;67:235-239.
    Abstract

  1229. GAO Y, Liu H, Wan J, Chang F, et al
    Construction and Assessment of a Prognostic Risk Model for Cervical Cancer Based on Lactate Metabolism-Related lncRNAs.
    Int J Gen Med. 2023;16:2943-2960.
    Abstract

  1230. FAN C, Ma Q, Wu X, Dai X, et al
    Detection of DNA Methylation in Gene Loci ASTN1, DLX1, ITGA4, RXFP3, SOX17, and ZNF671 for Diagnosis of Cervical Cancer.
    Cancer Manag Res. 2023;15:635-644.
    Abstract

  1231. JIANG S, Zheng J, Cui Z, Li Y, et al
    FBXO5 acts as a novel prognostic biomarker for patients with cervical cancer.
    Front Cell Dev Biol. 2023;11:1200197.
    Abstract

  1232. WANG T, Zhang H, Liu Y, Zhao C, et al
    Updates in Cervical Cancer Screening Guidelines, The Bethesda System for Reporting Cervical Cytology, and Clinical Management Recommendations.
    J Clin Transl Pathol. 2023;3:75-83.
    Abstract

  1233. SANTANA D, Gamboa OA, Saenz J, Esguerra JA, et al
    Morbidity of adjuvant treatment in early cervical cancer: a retrospective cohort study in a Latin American center.
    Rep Pract Oncol Radiother. 2023;28:189-197.
    Abstract

  1234. LEE J, Ismail-Pratt I, Machalek DA, Kumarasamy S, et al
    The recovery strategies to support cervical cancer elimination in lower-and middle-income countries (LMICs) following COVID-19 disruptions.
    Prev Med Rep. 2023;35:102291.
    Abstract

  1235. ALSUBAI S, Alqahtani A, Sha M, Almadhor A, et al
    Privacy Preserved Cervical Cancer Detection Using Convolutional Neural Networks Applied to Pap Smear Images.
    Comput Math Methods Med. 2023;2023:9676206.
    Abstract

  1236. ZHAO K, Han D, Tang L, Jin H, et al
    CD39 Expression in Peripheral T Cells is Associated with Clinicopathological Characteristics in Patients with Cervical Cancer.
    Iran J Immunol. 2023;20.
    Abstract

  1237. CANDYSE LEMBA TSIMBA P, Magloire Anicet Boumba L, Pere H, Christy Nganga P, et al
    Human papillomavirus genotype distribution by cytological status and associated risk factors in the general population of Congolese women living in urban and rural areas: Implications for cervical cancer prevention.
    Infect Dis Now. 2023 Jul 14:104762. doi: 10.1016/j.idnow.2023.104762.
    Abstract

  1238. STUEBS FA, Beckmann MW, Fehm T, Dannecker C, et al
    Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG).
    J Cancer Res Clin Oncol. 2023 Jul 15. doi: 10.1007/s00432-023-05132.
    Abstract

  1239. STRELOW B, Francis M, Gertner G, Olson R, et al
    Saturday Pap Smear Clinic: addressing barriers to cervical cancer screening.
    BMJ Open Qual. 2023;12:e002252.
    Abstract

  1240. LOPEZ-AMPUERO C, Hansen N, Larraondo MA, Taipe-Quico R, et al
    Squamocolumnar junction visibility among cervical cancer screening population in Peru might influence upper age for screening programs.
    Prev Med. 2023 Jul 12:107596. doi: 10.1016/j.ypmed.2023.107596.
    Abstract

  1241. LI G, Moniod L, Chenafi S, Lamsisi M, et al
    Detection of HPV in urine for cervical cancer screening : feasibilty of an assay system.
    J Gynecol Obstet Hum Reprod. 2023 Jul 12:102631.
    Abstract

  1242. XIANG X, Kang J, Jiang J, Zhang Y, et al
    A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing.
    Front Immunol. 2023;14:1198391.
    Abstract

  1243. KUIPERS S, Godart J, Corbeau A, Sharfo AW, et al
    The impact of bone marrow sparing on organs at risk dose for cervical cancer: a Pareto front analysis.
    Front Oncol. 2023;13:1138433.
    Abstract

  1244. SHARAFUTDINOVA KI, Shlyapina VS, Baeva AI, Timurshin AA, et al
    [Diabetes mellitus and the female reproductive system tumors].
    Probl Endokrinol (Mosk). 2023;69:103-110.
    Abstract

  1245. SIRICO A, Simonelli S, Pignatiello S, Fulgione C, et al
    BDNF and NGF Expression in Preneoplastic Cervical Disease According to HIV Status.
    Int J Mol Sci. 2023;24:10729.
    Abstract

  1246. PALAFOX-MARISCAL LA, Ortiz-Lazareno PC, Jave-Suarez LF, Aguilar-Lemarroy A, et al
    Pentoxifylline Inhibits TNF-alpha/TGF-beta1-Induced Epithelial-Mesenchymal Transition via Suppressing the NF-kappaB Pathway and SERPINE1 Expression in CaSki Cells.
    Int J Mol Sci. 2023;24:10592.
    Abstract

  1247. OKONOGI N, Murata K, Yamada S, Habu Y, et al
    A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results.
    Int J Mol Sci. 2023;24:10565.
    Abstract

  1248. KOSE B, Laar RV, Beekhuizen HV, Kemenade FV, et al
    Quantitative Proteomic Analysis of MCM3 in ThinPrep Samples of Patients with Cervical Preinvasive Cancer.
    Int J Mol Sci. 2023;24:10473.
    Abstract

  1249. MKUU RS, Hall JM, Galochkina Z, Cho HD, et al
    Does the Intersectionality of Race/Ethnicity and Type 2 Diabetes Increase the Odds of a Cervical Cancer Diagnosis? A Nested Case-Control Study of a Florida Statewide Multisite EHR Database.
    Healthcare (Basel). 2023;11:1863.
    Abstract

  1250. CHEON W, Han M, Jeong S, Oh ES, et al
    Feature Importance Analysis of a Deep Learning Model for Predicting Late Bladder Toxicity Occurrence in Uterine Cervical Cancer Patients.
    Cancers (Basel). 2023;15:3463.
    Abstract

  1251. IVERS R, Levett T, Wynn K
    Cervical Screening Reminders for Aboriginal and Torres Strait Islander Women in Primary Care-Randomised Controlled Trial of Letter vs. Phone/SMS Reminders.
    Int J Environ Res Public Health. 2023;20:6257.
    Abstract

  1252. DING R, Su Z, Chen M, Chen L, et al
    Prognostic models for predicting overall and cancer-specific survival of patients with initially diagnosed metastatic cervical squamous cell carcinoma: A study based on SEER database.
    Medicine (Baltimore). 2023;102:e34313.
    Abstract

  1253. SCARTH JA, Wasson CW, Patterson MR, Evans D, et al
    Exploitation of ATP-sensitive potassium ion (K(ATP)) channels by HPV promotes cervical cancer cell proliferation by contributing to MAPK/AP-1 signalling.
    Oncogene. 2023 Jul 13. doi: 10.1038/s41388-023-02772.
    Abstract

  1254. LI S, Shi L, Wang Y, Zhang L, et al
    FBXO22 inhibits proliferation and metastasis of cervical cancer cells by mediating ubiquitination-dependent degradation of GAK.
    Exp Cell Res. 2023;430:113719.
    Abstract

  1255. BIAN L, Wang N, Tuersong K, Kaidierdan A, et al
    Oxygen vacancy engineering of TiO(2) nanosheets for enhanced photothermal therapy against cervical cancer in the second near-infrared window.
    Colloids Surf B Biointerfaces. 2023;229:113427.
    Abstract

  1256. CESAR JA, Souto AM, Lelis CF, Pinheiro LP, et al
    Pap smears in the extreme South of Brazil: low coverage and exposure of the most vulnerable pregnant women.
    Rev Bras Epidemiol. 2023;26:e230032.
    Abstract

  1257. MCGEE-AVILA JK, Richmond J, Henry KA, Stroup AM, et al
    Disparities in geospatial patterns of cancer care within urban counties and structural inequities in access to oncology care.
    Health Serv Res. 2023;58 Suppl 2.
    Abstract

  1258. BAI A, Xue P, Li Q, Jiang Y, et al
    Diagnostic value of high-risk HPV other than type 16/18 in high-grade cervical neoplasia among cytology-negative women: A multicenter retrospective study.
    Cancer Med. 2023;12:14794-14805.
    Abstract

  1259. NAKAGAWA M, Nakajima M, Inoue N, Takise S, et al
    Segmental cervical esophagectomy with free jejunal flap reconstruction for cervical esophageal cancer in patients with previous history of gastric surgery: a report of two cases.
    Clin J Gastroenterol. 2023;16:515-520.
    Abstract

  1260. YE Y, Fu A, Cai J, Ma Z, et al
    Primary malignant melanoma of the cervix: A comprehensive analysis of case reports in the Chinese population.
    Cancer Med. 2023;12:14052-14061.
    Abstract

  1261. DA SILVA NCH, Sonon P, Medeiros FS, da Silva MC, et al
    Contribution of HLA-G and FOXP3 genes and proteins in the severity of cervical intraepithelial neoplasia during HPV infection.
    Hum Immunol. 2023;84:408-417.
    Abstract

  1262. DIENDERE J, Kiemtore S, Coulibaly A, Tougri G, et al
    Low attendance in cervical cancer screening, geographical disparities and sociodemographic determinants of screening uptake among adult women in Burkina Faso : results from the first nationwide population-based survey.
    Rev Epidemiol Sante Publique. 2023;71:101845.
    Abstract

  1263. YEN HK, Cheng SY, Chiu KN, Huang CC, et al
    Adding a nonpainful end to reduce pain recollection of Pap smear screening: a randomized controlled trial.
    Pain. 2023 Apr 12. doi: 10.1097/j.pain.0000000000002897.
    Abstract

  1264. BLAUVELT A, Lebwohl M, Langley RG, Rowland K, et al
    Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials.
    J Am Acad Dermatol. 2023;89:274-282.
    Abstract

  1265. NESSER W, Ayodele O
    Human Papilloma Virus Knowledge Among University Students, Staff, and Faculty in the State of Indiana During 2016, 2019, and 2022.
    J Community Health. 2023;48:718-723.
    Abstract

  1266. GRIGOLO AV, Wendt GW, Lucio LC
    Factors Associated with HPV Knowledge Among Professionals in the City of Francisco Beltrao, Brazil.
    J Community Health. 2023;48:652-658.
    Abstract

  1267. FEDELE F, Parazzini F, Vercellini P, Bergamini V, et al
    Reconstructive surgery for congenital atresia of the uterine cervix: a systematic review.
    Arch Gynecol Obstet. 2023;308:685-700.
    Abstract

  1268. ZHAO F, Jastorff A, Hong Y, Hu S, et al
    Safety of AS04-HPV-16/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: A 10-year follow-up study.
    Asia Pac J Clin Oncol. 2023;19:458-467.
    Abstract

  1269. TONG T, Fan Q, Shi S, Li Y, et al
    Gastric-type mucinous adenocarcinoma of the cervix in a woman with Peutz-Jeghers syndrome: a case report.
    Acta Chir Belg. 2023;123:448-453.
    Abstract

  1270. RAHMAN MA, Hasan MM, Hossain A, Alam KM, et al
    Analysis of E-cadherin (CDH1) Gene Polymorphism and Its Association with Cervical Cancer Risk in Bangladeshi Women.
    Asian Pac J Cancer Prev. 2023;24:2361-2368.
    Abstract

  1271. HON HJ, Chong PP, Choo HL, Khine PP, et al
    A Comprehensive Review of Cervical Cancer Screening Devices: The Pros and the Cons.
    Asian Pac J Cancer Prev. 2023;24:2207-2215.
    Abstract

  1272. ZHANG M, Sit JWH, Wang T, Chan CWH, et al
    Exploring the sources of cervical cancer screening self-efficacy among rural females: A qualitative study.
    Health Expect. 2023 Jul 28. doi: 10.1111/hex.13840.
    Abstract

  1273. DEVOTTA K, Vahabi M, Prakash V, Lofters AK, et al
    Implementation of a Cervical Cancer Screening Intervention for Under- or Never-Screened Women in Ontario, Canada: Understanding the Acceptability of HPV Self-Sampling.
    Curr Oncol. 2023;30:6786-6804.
    Abstract

  1274. HWANG J, Moon H, Kim H, Kim KY, et al
    Identification of a Novel ERK5 (MAPK7) Inhibitor, MHJ-627, and Verification of Its Potent Anticancer Efficacy in Cervical Cancer HeLa Cells.
    Curr Issues Mol Biol. 2023;45:6154-6169.
    Abstract

  1275. VENKATAS J, Singh M
    Curcumin-reduced gold nanoparticles facilitate IL-12 delivery to a cervical cancer in vitro cell model.
    Nanomedicine (Lond). 2023 Jul 28. doi: 10.2217/nnm-2023-0076.
    Abstract

  1276. BIFULCO M
    Nobel laureate Harald zur Hausen passed. He was the first to discover the HPV-cervical cancer link.
    J Med Virol. 2023;95:e28982.
    Abstract

  1277. WOLF J, Xu Y
    Immune checkpoint inhibitor therapy in advanced cervical cancer: Deepened response with prolonged treatment and repeat response to re-initiation of therapy.
    Gynecol Oncol Rep. 2023;48:101244.
    Abstract

  1278. SIMELANE SM, Munyakazi JB, Dlamini PG, Egbelowo OF, et al
    Projections of human papillomavirus vaccination and its impact on cervical cancer using the Caputo fractional derivative.
    Math Biosci Eng. 2023;20:11605-11626.
    Abstract

  1279. BOWDEN SJ, Doulgeraki T, Bouras E, Markozannes G, et al
    Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies.
    BMC Med. 2023;21:274.
    Abstract

  1280. MESFIN AH, Gufue ZH, Alemayehu MA, Kedida BD, et al
    Usage of cervical cancer screening services among HIV-positive women in Southern Ethiopia: a multicentre cross-sectional study.
    BMJ Open. 2023;13:e068253.
    Abstract

  1281. SEIFERT F, Eisenblatter R, Beckmann J, Schurmann P, et al
    Association of two genomic variants with HPV type-specific risk of cervical cancer.
    Tumour Virus Res. 2023 Jul 25:200269. doi: 10.1016/j.tvr.2023.200269.
    Abstract

  1282. BUSTAMANTE G, Liebermann E, McNair K, Fontenot HB, et al
    Women's perceptions and preferences for cervical cancer screening in light of updated guidelines.
    J Am Assoc Nurse Pract. 2023 Jul 27. doi: 10.1097/JXX.0000000000000923.
    Abstract

  1283. XUE XL, Zhao S, Xu MC, Li Y, et al
    Circular RNA_0000326 accelerates breast cancer development via modulation of the miR-9-3p/YAP1 axis.
    Neoplasma. 2023;70:430-442.
    Abstract

  1284. WANG YN, Zhong ML, Liang MR, Yang JT, et al
    The therapeutic value of adjuvant chemotherapy after concurrent chemoradiotherapy for locally advanced cervical cancer.
    Gynecol Obstet Invest. 2023 Jul 27. doi: 10.1159/000533122.
    Abstract

  1285. GUO S, Jiang H, Deng Y, Dong Y, et al
    Reduced 2,4-dienoyl-CoA reductase 1 is served as an unfavorable biomarker and is related to immune infiltration in cervical cancer.
    J Obstet Gynaecol Res. 2023 Jul 27. doi: 10.1111/jog.15751.
    Abstract

  1286. RAIS F, Boudam K, Menard C, Beauchemin MC, et al
    Role of 18F-choline and 18F-fluorodeoxyglucose positron emission tomography in combination with magnetic resonance imaging in brachytherapy planning for locally advanced cervical cancer: A pilot study.
    Phys Imaging Radiat Oncol. 2023;27:100467.
    Abstract

  1287. ITTIAMORNLERT P, Jareemit N, Phianpiset R, Kuljarusnont S, et al
    High-risk human papillomavirus genotyping in women with atypical squamous cells of undetermined significance.
    Sci Rep. 2023;13:12134.
    Abstract

  1288. ZHANG J, Xiang JD, Jia C, Du LF, et al
    Contrast-Enhanced Ultrasonography for Transabdominal and Transrectal Ultrasound in Staging Cervical Cancer: A Reliability Study.
    Ultrasound Med Biol. 2023 Jul 24:S0301-5629(23)00212.
    Abstract

  1289. TUNG TH, Chen HW, Chou HH, Tsai JL, et al
    Does a one-session sexual health education program improve sexual confidence in patients with cervical cancer? A transtheoretical model-based clinical study.
    Arch Gynecol Obstet. 2023 Jul 26. doi: 10.1007/s00404-023-07141.
    Abstract

  1290. GHOSE A, Agarwal A, Sirohi B, Nag S, et al
    Translating the COVID-19 experience in widening the HPV vaccination campaign for cervical cancer in India.
    Gynecol Oncol Rep. 2023;48:101247.
    Abstract

  1291. JIN G, Li K, Niu S, Fan X, et al
    Efficacy and safety of intensity Modulated Radiation therapy combined with Concurrent Chemoradiotherapy in the treatment of Recurrent Cervical Cancer.
    Pak J Med Sci. 2023;39:1062-1067.
    Abstract

  1292. ZHANG W, Chen M, Xiang Q, Sun S, et al
    Boosting the abscopal effect with chemoradiotherapy/immunotherapy combination in metastatic cervical cancer: a case report.
    Immunotherapy. 2023 Jul 25. doi: 10.2217/imt-2022-0044.
    Abstract

  1293. SHIGETA S, Shimada M, Tsuji K, Watanabe Z, et al
    Surgically treated cervical cancer in a high-risk group in the era of the 2018 FIGO staging schema: a nationwide study.
    Sci Rep. 2023;13:12020.
    Abstract

  1294. BERMUDEZ PC, Arrivillaga M, Torres Poveda K, Castrillon Libreros DM, et al
    Barriers to adherence to cytology exam: a case study in low-income Colombian women.
    BMC Health Serv Res. 2023;23:796.
    Abstract

  1295. CHAN YM, Ismail MZH, Khaw WF
    Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey.
    BMC Womens Health. 2023;23:389.
    Abstract

  1296. BATMAN S, Varon ML, San Miguel-Majors SL, Benitez Majano S, et al
    Elimination of cervical cancer in Latin America (Project ECHO-ELA): lessons from phase one of implementation.
    Rev Panam Salud Publica. 2023;47:e113.
    Abstract

  1297. ZENG WH, Liang Y, Zhou JQ, Lin HH, et al
    Comparison of the efficacy and safety of total laparoscopic hysterectomy without and with uterine manipulator combined with pelvic lymphadenectomy for early cervical cancer.
    J Obstet Gynaecol Res. 2023 Jul 24. doi: 10.1111/jog.15749.
    Abstract

  1298. FISCHER AM, Hague T, Hoskin PJ
    CBCT-based deformable dose accumulation of external beam radiotherapy in cervical cancer.
    Acta Oncol. 2023 Jul 24:1-9. doi: 10.1080/0284186X.2023.2238543.
    Abstract

  1299. MAN I, Georges D, Sankaranarayanan R, Basu P, et al
    Building resilient cervical cancer prevention through gender-neutral HPV vaccination.
    Elife. 2023;12:e85735.
    Abstract

  1300. ZHANG J, Li Y, Ren Y, Li J, et al
    miR-214-5p increases the radiosensitivity of cervical cancer by targeting ROCK1 expression.
    Adv Clin Exp Med. 2023 Jul 24. doi: 10.17219/acem/166673.
    Abstract

  1301. FANG X, Hu P, Gao Y, Chen C, et al
    Transferrin receptor modulated by microRNA-497-5p suppresses cervical cancer cell malignant phenotypes.
    Adv Clin Exp Med. 2023 Jul 24. doi: 10.17219/acem/168342.
    Abstract


  1302. Retraction: INPP1 up-regulation by miR-27a contributes to the growth, migration and invasion of human cervical cancer.
    J Cell Mol Med. 2023 Jul 24. doi: 10.1111/jcmm.17859.
    Abstract


  1303. HPV and Cervical Cancer.
    J Midwifery Womens Health. 2023 Jul 23. doi: 10.1111/jmwh.13552.
    Abstract

  1304. LONG Y, Ren Y, Wei Q, Mobet Y, et al
    NAT10-mediated RNA acetylation enhances HNRNPUL1 mRNA stability to contribute cervical cancer progression.
    Int J Med Sci. 2023;20:1079-1090.
    Abstract

  1305. MO X, Wang N, He Z, Kang W, et al
    The sub-molecular characterization identification for cervical cancer.
    Heliyon. 2023;9:e16873.
    Abstract

  1306. AMIR SM, Idris IB, Said ZM, Yusoff HM, et al
    A Comparison of the National Cervical Cancer Policies in Six Developing Countries with the World Health Organization Recommendations: A Narrative Review.
    Iran J Public Health. 2023;52:1108-1120.
    Abstract

  1307. KOMODA J, Hori T, Sato K, Kusajima K, et al
    Hypomagnesemia because of nedaplatin for cervical cancer: A case report.
    J Gen Fam Med. 2023;24:257-260.
    Abstract

  1308. BAREK MA, Basher MA, Aziz MA, Hossen MS, et al
    Assessment of the association of CYP1A1 gene polymorphisms with the susceptibility of cervical cancer: A case-control study and meta-analysis.
    Heliyon. 2023;9:e17712.
    Abstract

  1309. LIANG X, He H, Li Y, Chen S, et al
    An optimized robotic surgical technique for cervical cancer: investigating whether the use of the pulling robotic arm has better surgical outcomes.
    Front Oncol. 2023;13:1159081.
    Abstract

  1310. ABDELMONSEF AHMED HA, Ibrahim Yassin SY, Mohamed Ahmed MS, Yousof Ali HZ, et al
    Application Of Health Belief Model About Cervical Cancer Screening Among Female Officer Employees In Kafr-El Sheikh University, Egypt.
    J Pak Med Assoc. 2023;73.
    Abstract

  1311. LI P, Liu ZK, Zhao HY, Liu XY, et al
    [A risk prediction model of cervical cancer developed based on nested case-control design].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2023;44:1139-1145.
    Abstract

  1312. LADBURY C, Harkenrider M, Taunk N, Fisher C, et al
    A practical guide to hybrid interstitial/intracavitary brachytherapy for locally-advanced cervical cancer.
    Brachytherapy. 2023 Jul 20:S1538-4721(23)01595.
    Abstract

  1313. HUO FC, Zhu ZM, Du WQ, Pan YJ, et al
    HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.
    Pharmacol Res. 2023 Jul 20:106863. doi: 10.1016/j.phrs.2023.106863.
    Abstract

  1314. BAUMANN M, von Knebel Doeberitz M
    Harald zur Hausen, virologist who linked viruses to cancer (1936-2023).
    Nature. 2023;619:693.
    Abstract

  1315. XIE N, Lin J, Liu L, Deng S, et al
    Nomograms constructed for predicting diagnosis and prognosis in cervical cancer patients with second primary malignancies: a SEER database analysis.
    J Cancer Res Clin Oncol. 2023 Jul 21. doi: 10.1007/s00432-023-05192.
    Abstract

  1316. BROMLEY-DULFANO RA, Rossin-Slater M, Bundorf MK
    Association Between Cervical Cancer Screening Guidelines and Preterm Delivery Among Females Aged 18 to 24 Years.
    JAMA Health Forum. 2023;4:e231974.
    Abstract

  1317. ZANG L, Chen Q, Lin A, Chen J, et al
    A prognostic model using FIGO 2018 staging and MRI-derived tumor volume to predict long-term outcomes in patients with uterine cervical squamous cell carcinoma who received definitive radiotherapy.
    World J Surg Oncol. 2023;21:210.
    Abstract

  1318. CHEN F, Di W, Hu YJ, Li CZ, et al
    [Evaluation of the efficacy and safety of Nocardia rubra cell wall skeleton immunotherapy for cervical high-risk HPV persistent infection].
    Zhonghua Fu Chan Ke Za Zhi. 2023;58:536-545.
    Abstract

  1319. WU MX, He XM, You ZX
    [Analysis of natural regression and influencing factors of HSIL in the cervix of childbearing age patients].
    Zhonghua Fu Chan Ke Za Zhi. 2023;58:516-525.
    Abstract

  1320. MISTRY S, Thakkar M, Singh AK, Patel D, et al
    Synthesis, in vitro cytotoxic activity and molecular docking study of androstene and estrone derivatives.
    Steroids. 2023;197:109259.
    Abstract

  1321. YAPINDI L, Bowley T, Kurtaneck N, Bergeson RL, et al
    Activation of p53-regulated pro-survival signals and hypoxia-independent mitochondrial targeting of TIGAR by human papillomavirus E6 oncoproteins.
    Virology. 2023;585:1-20.
    Abstract

  1322. KHAMISY-FARAH R, Endrawis M, Odeh M, Tuma R, et al
    Knowledge of Human Papillomavirus (HPV), Attitudes, and Practices Towards Anti-HPV Vaccination Among Israeli Nurses.
    J Cancer Educ. 2023;38:1391-1396.
    Abstract

  1323. LA FRINERE-SANDOVAL QNNB, Cubbin C, DiNitto DM
    Racial and ethnic disparities in cervical and breast cancer screenings by nativity and length of U.S. residence.
    Ethn Health. 2023;28:895-911.
    Abstract

  1324. LYU Y, Song L, Mao R, Liu C, et al
    hnRNP K induces HPV16 oncogene expression and promotes cervical cancerization.
    J Cancer Res Clin Oncol. 2023;149:6225-6237.
    Abstract

  1325. HEALTHCARE ENGINEERING JO
    Retracted: Analysis of Clinicopathological Factors Associated with Radiation-Induced Cystitis in Patients with Cervical Cancer.
    J Healthc Eng. 2023;2023:9816261.
    Abstract

  1326. OLLIVIER L, Moreau Bachelard C, Renaud E, Dhamelincourt E, et al
    The abscopal effect of immune-radiation therapy in recurrent and metastatic cervical cancer: a narrative review.
    Front Immunol. 2023;14:1201675.
    Abstract

  1327. HIRANUMA K, Asami Y, Kato MK, Murakami N, et al
    Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis.
    Cancer Med. 2023 Aug 3. doi: 10.1002/cam4.6415.
    Abstract

  1328. DHAKAL K, Wang P, Mboineki JF, Getu MA, et al
    Assessment of supportive care needs among cervical cancer patients under treatment in Nepal: a cross-sectional study.
    BMC Womens Health. 2023;23:407.
    Abstract

  1329. LEE SJ, Kim M, Kwak YK, Kang HJ, et al
    The impact of boost radiation therapy after hysterectomy on cervical cancer patients with close or positive resection margins.
    Clin Transl Oncol. 2023 Aug 4. doi: 10.1007/s12094-023-03283.
    Abstract

  1330. HILLYAR CR, Kanabar SS, Pufal KR, Saw Hee JL, et al
    A systematic review and meta-analysis of miRNAs for the detection of cervical cancer.
    Epigenomics. 2023 Aug 3. doi: 10.2217/epi-2023-0183.
    Abstract

  1331. PENG Y, Yan H, Mei W, Zhang P, et al
    Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?
    Curr Treat Options Oncol. 2023 Aug 3. doi: 10.1007/s11864-023-01128.
    Abstract

  1332. ILIC I, Babic G, Dimitrijevic A, Sipetic Grujicic S, et al
    Psychological Distress in Women With Abnormal Pap Smear Results Attending Cervical Cancer Screening.
    J Low Genit Tract Dis. 2023 Aug 3. doi: 10.1097/LGT.0000000000000761.
    Abstract

  1333. JIANG HH, Li XF, Wang JL
    [Relationship between chronic radiation enteritis of cervical cancer and gut microbiota].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2023;55:619-624.
    Abstract

  1334. KURNIADI A, Setiawan D, Kireina J, Suardi D, et al
    Clinical and Management Dilemmas Concerning Early-Stage Cervical Cancer in Pregnancy - A Case Report.
    Int J Womens Health. 2023;15:1213-1218.
    Abstract

  1335. KATAOKA Y, Fujita T, Fukunaga K, Hanaoka J, et al
    A case of primary lung cancer requiring differentiation from metastatic cervical cancer.
    Respirol Case Rep. 2023;11:e01196.
    Abstract

  1336. NIYAZI M, Han L, Husaiyin S, Aishanjiang A, et al
    Analysis of somatic mutations and key driving factors of cervical cancer progression.
    Open Med (Wars). 2023;18:20230759.
    Abstract

  1337. LI X, Liu H, Zhou X, Zhou Y, et al
    PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer.
    Clin Epigenetics. 2023;15:123.
    Abstract

  1338. SALTA S, Lobo J, Magalhaes B, Henrique R, et al
    DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis.
    Clin Epigenetics. 2023;15:125.
    Abstract

  1339. ANGULO D, Cortes MF, Mura I, Akhavan-Tabatabaei R, et al
    Fine-grained mathematical modeling for cost-effectiveness evaluation of public health policies for cervical cancer, with application to a Colombian case study.
    BMC Public Health. 2023;23:1470.
    Abstract

  1340. HUGUET N, Ezekiel-Herrera D, Gunn R, Pierce A, et al
    Uptake of a Cervical Cancer Clinical Decision Support Tool: A Mixed-Methods Study.
    Appl Clin Inform. 2023;14:594-599.
    Abstract

  1341. BERTAGNIN C, Messa L, Pavan M, Celegato M, et al
    A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells.
    Cancer Lett. 2023 Jul 31:216331. doi: 10.1016/j.canlet.2023.216331.
    Abstract

  1342. XIAO T, Wang C, Yang M, Yang J, et al
    Use of Virus Genotypes in Machine Learning Diagnostic Prediction Models for Cervical Cancer in Women With High-Risk Human Papillomavirus Infection.
    JAMA Netw Open. 2023;6:e2326890.
    Abstract

  1343. HABILA MA, Sagay E, Obeng-Kusi M, Ali MJ, et al
    Utilization of opportunistic cervical cancer screening in Nigeria.
    Cancer Causes Control. 2023 Aug 2. doi: 10.1007/s10552-023-01764.
    Abstract

  1344. ELLINGSON MK, Sheikha H, Nyhan K, Oliveira CR, et al
    Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review.
    Hum Vaccin Immunother. 2023;19:2239085.
    Abstract

  1345. ADEKUNLE TB, Arreola A, Sembian S, Castro R, et al
    Feasibility and anticipated acceptability of community health worker-facilitated HPV self-sampling for cervical cancer screening around Lake County, Indiana.
    J Clin Transl Sci. 2023;7:e157.
    Abstract

  1346. LIU S, Zhou Y, Wang C, Shen J, et al
    Prediction of lymph node status in patients with early-stage cervical cancer based on radiomic features of magnetic resonance imaging (MRI) images.
    BMC Med Imaging. 2023;23:101.
    Abstract

  1347. LIU L, Liu J, Lyu Q, Huang J, et al
    Disulfidptosis-associated LncRNAs index predicts prognosis and chemotherapy drugs sensitivity in cervical cancer.
    Sci Rep. 2023;13:12470.
    Abstract

  1348. WANG Y, Ma B, Li W, Li P, et al
    The efficacy of pre-operative conization in patients undergoing surgical treatment for early-stage cervical cancer: A meta-analysis.
    Eur J Surg Oncol. 2023 Jul 27:106995. doi: 10.1016/j.ejso.2023.106995.
    Abstract

  1349. LONG ME, Lee YS, Vegunta S
    Cervical cancer screening in menopause: when is it safe to exit?
    Menopause. 2023 Jul 25. doi: 10.1097/GME.0000000000002222.
    Abstract

  1350. WEN H, Xu Q, Sheng X, Li H, et al
    Prevalence and Landscape of Pathogenic or Likely Pathogenic Germline Variants and Their Association With Somatic Phenotype in Unselected Chinese Patients With Gynecologic Cancers.
    JAMA Netw Open. 2023;6:e2326437.
    Abstract

  1351. WANG Y, Yuan S, Ma J, Liu H, et al
    Substance P is overexpressed in cervical squamous cell carcinoma and promoted proliferation and invasion of cervical cancer cells in vitro.
    Eur J Histochem. 2023;67.
    Abstract

  1352. LUO X, Liu J, Wang X, Yuan J, et al
    Circ-DTL sponges miR-758-3p to accelerate cervical cancer malignant progression by regulating DCUN1D1 expression.
    J Biochem Mol Toxicol. 2023 Jul 31:e23462. doi: 10.1002/jbt.23462.
    Abstract

  1353. LI M, Zeng J, Chang Y, Lv L, et al
    CCT3 as a Diagnostic and Prognostic Biomarker in Cervical Cancer.
    Crit Rev Eukaryot Gene Expr. 2023;33:17-28.
    Abstract

  1354. RAJ S, Kattepur AK, Shylasree TS, Mishra GA, et al
    Novel educational training of para medical professionals in cervical cancer screening.
    Gynecol Oncol Rep. 2023;48:101241.
    Abstract

  1355. TAN X, Wang X, Liao X, Wang X, et al
    Downregulation of VPS13C promotes cisplatin resistance in cervical cancer by upregulating GSTP1.
    iScience. 2023;26:107315.
    Abstract

  1356. ALDARMAHI A, Alzahrani H, Alqutub S, Alzahrani F, et al
    Exploring the attitudes and practices of female doctors towards cervical cancer screening in primary health care centers.
    J Med Life. 2023;16:773-781.
    Abstract

  1357. MURAMOTO Y, Murakami N, Karino T, Sugimoto S, et al
    MucoUp(R) as a spacer in brachytherapy for uterine cervical cancer: A first-in-human experience.
    Clin Transl Radiat Oncol. 2023;42:100659.
    Abstract

  1358. LI J, Feng X, Zhu C, Jiang Y, et al
    Intact glycopeptides identified by LC-MS/MS as biomarkers for response to chemotherapy of locally advanced cervical cancer.
    Front Oncol. 2023;13:1149599.
    Abstract

  1359. SHARMA J, Yennapu M, Priyanka Y
    Screening Guidelines and Programs for Cervical Cancer Control in Countries of Different Economic Groups: A Narrative Review.
    Cureus. 2023;15:e41098.
    Abstract

  1360. LEPE M
    Disparities in cervical cancer screening in the United States.
    Cancer Cytopathol. 2023 Jul 31. doi: 10.1002/cncy.22752.
    Abstract

  1361. WANG T, Luan L, Deng J, Liu N, et al
    Prevalence and human papillomavirus (HPV) genotype distribution in Suzhou, China.
    Hum Vaccin Immunother. 2023;19:2241309.
    Abstract

  1362. GAO F, Wang C, Bai B, Ji J, et al
    ELK4 Promotes Cell Cycle Progression and Stem Cell-like Characteristics in HPV-associated Cervical Cancer by Regulating the FBXO22/PTEN Axis.
    Balkan Med J. 2023 Jul 31. doi: 10.4274/balkanmedj.galenos.2023.2023.
    Abstract

  1363. SENIOR K
    Africa needs to boost HPV vaccine uptake to stem rise in cervical cancer.
    Lancet Oncol. 2023 Jul 27:S1470-2045(23)00380.
    Abstract

  1364. LIU Y, Chen C, Xie X, Lv X, et al
    For cervical cancer diagnosis: Tissue Raman spectroscopy and multi-level feature fusion with SENet attention mechanism.
    Spectrochim Acta A Mol Biomol Spectrosc. 2023;303:123147.
    Abstract

  1365. KIM J, Jung JH, Jo H, Kim MH, et al
    Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis.
    Scand J Gastroenterol. 2023 Jul 30:1-10. doi: 10.1080/00365521.2023.2238101.
    Abstract

  1366. MALEVOLTI MC, Maci C, Lugo A, Possenti I, et al
    Second-hand smoke exposure and cervical cancer: a systematic review and meta-analysis.
    J Cancer Res Clin Oncol. 2023 Jul 30. doi: 10.1007/s00432-023-04841.
    Abstract

  1367. BAI W, Cui F, Wang Z, Gu X, et al
    Receptor-interacting protein kinase 1 (RIPK1) regulates cervical cancer cells via NF-kappaB-TNF-alpha pathway: An in vitro study.
    Transl Oncol. 2023;36:101748.
    Abstract

  1368. YE X, Dong H, Wang Y, Chen Z, et al
    [Preparation and identification of rabbit anti-cyclin dependent kinase 6 (CDK6) antibodies].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2023;39:742-747.
    Abstract

  1369. WILLIAMSON AL
    Recent Developments in Human Papillomavirus (HPV) Vaccinology.
    Viruses. 2023;15:1440.
    Abstract

  1370. REZQ KA, Algamdi M, Alanazi R, Alanazi S, et al
    Knowledge, Perception, and Acceptance of HPV Vaccination and Screening for Cervical Cancer among Saudi Females: A Cross-Sectional Study.
    Vaccines (Basel). 2023;11:1188.
    Abstract

  1371. AL BAROOT A, Elsayed KA, Khan FA, Haladu SA, et al
    Anticancer Activity of Au/CNT Nanocomposite Fabricated by Nanosecond Pulsed Laser Ablation Method on Colon and Cervical Cancer.
    Micromachines (Basel). 2023;14:1455.
    Abstract

  1372. HONNAVAR P, Mansoor E, Tulloch C, Udayan U, et al
    Cervical Cancer and Human Papillomavirus Awareness among Women in Antigua and Barbuda.
    Medicina (Kaunas). 2023;59:1230.
    Abstract

  1373. DICU-ANDREESCU IG, Marincas AM, Ungureanu VG, Ionescu SO, et al
    Current Therapeutic Approaches in Cervical Cancer Based on the Stage of the Disease: Is There Room for Improvement?
    Medicina (Kaunas). 2023;59:1229.
    Abstract

  1374. PISKUR I, Topolovec Z, Bakula M, Zagorac I, et al
    Expression of Vascular Endothelial Growth Factor-A (VEGF-A) in Adenocarcinoma and Squamous Cell Cervical Cancer and Its Impact on Disease Progression: Single Institution Experience.
    Medicina (Kaunas). 2023;59:1189.
    Abstract

  1375. HEO SY, Lee Y, Kim TH, Heo SJ, et al
    Anti-Cancer Effect of Chlorophyllin-Assisted Photodynamic Therapy to Induce Apoptosis through Oxidative Stress on Human Cervical Cancer.
    Int J Mol Sci. 2023;24:11565.
    Abstract

  1376. GWAVU Z, Murray D, Okafor UB
    Perception of Women's Knowledge of and Attitudes towards Cervical Cancer and Papanicolaou Smear Screenings: A Qualitative Study in South Africa.
    Healthcare (Basel). 2023;11:2089.
    Abstract

  1377. ZHOU J, Xu L, Zhou H, Wang J, et al
    Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Genes (Basel). 2023;14:1381.
    Abstract

  1378. DE FIGUEIREDO FV, Santos GRBD, Vidal FCB, da Silva MACN, et al
    Impact of HPV-16 Lineages Infection in Response to Radio-Chemotherapy in Cervical Cancer.
    Biomedicines. 2023;11:2069.
    Abstract

  1379. SAUSEN DG, Shechter O, Gallo ES, Dahari H, et al
    Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications.
    Cancers (Basel). 2023;15:3692.
    Abstract

  1380. KALAFATI E, Drakopoulou E, Anagnou NP, Pappa KI, et al
    Developing Oncolytic Viruses for the Treatment of Cervical Cancer.
    Cells. 2023;12:1838.
    Abstract

  1381. KUMAR V, Bauer C, Stewart JH 4th
    TIME Is Ticking for Cervical Cancer.
    Biology (Basel). 2023;12:941.
    Abstract

  1382. SHAMSUTDINOVA A, Turdaliyeva B, Tanabayeva S, Omarova A, et al
    Screening for Breast, Cervical and Prostate Cancers in Kazakhstan: Key Factors and Psychological Aspects.
    Asian Pac J Cancer Prev. 2023;24:2515-2522.
    Abstract

  1383. PATEL SS, Singh N, Jamwal A, Sahu C, et al
    Comparison of Human Papillomavirus Genotype Detection in Paired Urine and Self-Collected Cervical Swabs: A Pilot Study.
    Asian Pac J Cancer Prev. 2023;24:2427-2430.
    Abstract

  1384. BOSE M, Sunder Singh S, Ganesharaja S, Chiwate AS, et al
    Development and Evaluation of p16 based Double Antibody Sandwich ELISA for Detection of Cervical Precancer and Cancer.
    Asian Pac J Cancer Prev. 2023;24:2337-2346.
    Abstract

  1385. SEO YA, Kim YA
    Factors associated with Pap test screening among South Korean women aged 20 to 39 years.
    Medicine (Baltimore). 2023;102:e34539.
    Abstract

  1386. KOTOWSKI K, Malyszczak P, Towarek M, Jagasyk A, et al
    An unusual coincidence of giant cervical leiomyoma and incidental ovarian granulosa cell tumor: A case report.
    Medicine (Baltimore). 2023;102:e34387.
    Abstract

  1387. HAWARD B, Tatar O, Zhu P, Griffin-Mathieu G, et al
    Are Canadian Women Prepared for the Transition to Primary HPV Testing in Cervical Screening? A National Survey of Knowledge, Attitudes, and Beliefs.
    Curr Oncol. 2023;30:7055-7072.
    Abstract

  1388. ZHOU K, Yuzhakov O, Behloul N, Wang D, et al
    HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions.
    Front Immunol. 2023;14:1213285.
    Abstract

  1389. GUIMARAES RIBEIRO A, Ferlay J, Pineros M, Dias de Oliveira Latorre MDR, et al
    Geographic variations in cancer incidence and mortality in the State of Sao Paulo, Brazil 2001-17.
    Cancer Epidemiol. 2023;85:102403.
    Abstract

  1390. TABATABAI MK, Lophaven S, Lauenborg J, Holmager T, et al
    Socioeconomic, lifestyle and biological determinants of cervical screening coverage: Lolland-Falster Health Study, Denmark.
    Eur J Public Health. 2023;33:568-573.
    Abstract

  1391. OH SH, Lee KB, Shin JW, Lee SH, et al
    Risk factors for recurrence of cervical intraepithelial neoplasia after loop electrosurgical excisional procedure in patients with positive margins.
    J Obstet Gynaecol Res. 2023;49:2102-2108.
    Abstract

  1392. EGAWA N
    Papillomaviruses and cancer: commonalities and differences in HPV carcinogenesis at different sites of the body.
    Int J Clin Oncol. 2023;28:956-964.
    Abstract

  1393. QIN L
    Study on the preoperative value of serum SCC-Ag in predicting the stromal invasion of cervical squamous cell carcinoma.
    J Cancer Res Clin Oncol. 2023;149:9167-9171.
    Abstract

  1394. LONG L, Liu M, Deng X, Cao M, et al
    3D multifrequency magnetic resonance elastography in distinguishing endometrial and cervical adenocarcinoma.
    Magn Reson Imaging. 2023;102:62-68.
    Abstract

  1395. PEDERSEN K, Kristiansen IS, Sy S, Kim JJ, et al
    Designing Guidelines for Those Who Do Not Follow Them: The Impact of Adherence Assumptions on Optimal Screening Guidelines.
    Value Health. 2023;26:1217-1224.
    Abstract

  1396. HUANG P, Zhang PF, Li Q
    Causal relationship between cannabis use and cancer: a genetically informed perspective.
    J Cancer Res Clin Oncol. 2023;149:8631-8638.
    Abstract

  1397. LAI B, Luo T, Zhou J, Yang H, et al
    Cervical mixed adenocarcinoma-neuroendocrine carcinoma: A case report with liquid-based cytology.
    Asian J Surg. 2023;46:3351-3352.
    Abstract

  1398. MARCHADIER A, Bezannier L, Barre-Pierrel S, Manceau A, et al
    Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing.
    J Med Screen. 2023;30:113-119.
    Abstract

  1399. HU L, Mwanahamuntu MH, Sahasrabuddhe VV, Barrett C, et al
    Validation of Automated Visual Evaluation (AVE) on Smartphone Images for Cervical Cancer Screening in a Prospective Study in Zambia.
    medRxiv. 2023 Jul 23:2023.07.19.23292888. doi: 10.1101/2023.07.19.23292888.
    Abstract

  1400. ZHAO YC, Wang TJ, Qu GH, She LZ, et al
    TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior in vivo and in vitro.
    Am J Cancer Res. 2023;13:3123-3139.
    Abstract

  1401. DOU Z, Zhang X, Su W, Zhang T, et al
    Indisulam exerts anticancer effects via modulation of transcription, translation and alternative splicing on human cervical cancer cells.
    Am J Cancer Res. 2023;13:2922-2937.
    Abstract

  1402. LI C, Cang W, Gu Y, Chen L, et al
    The anti-PD-1 era of cervical cancer: achievement, opportunity, and challenge.
    Front Immunol. 2023;14:1195476.
    Abstract

  1403. SHIMBO T, Yoshida K, Nakata M, Kobata K, et al
    KORTUC, a novel hydrogen peroxide‑based radiosensitizer for the enhancement of brachytherapy in patients with unresectable recurrent uterine cervical cancer.
    Oncol Lett. 2023;26:378.
    Abstract

  1404. LIU Q, Jiang N, Hao Y, Hao C, et al
    Identification of lymph node metastasis in pre-operation cervical cancer patients by weakly supervised deep learning from histopathological whole-slide biopsy images.
    Cancer Med. 2023 Aug 10. doi: 10.1002/cam4.6437.
    Abstract

  1405. LINARES I, Berenguer Frances MA, Canas R, Najjari D, et al
    Brachytherapy for targeting the immune system in cervical cancer patients.
    BMC Immunol. 2023;24:23.
    Abstract

  1406. ZHU P, Xiong J, Yuan D, Li X, et al
    ZNF671 methylation test in cervical scrapings for cervical intraepithelial neoplasia grade 3 and cervical cancer detection.
    Cell Rep Med. 2023 Aug 3:101143. doi: 10.1016/j.xcrm.2023.101143.
    Abstract

  1407. ZHAO Z, Zhang J, Ren Y, Dong L, et al
    Discovery of 2,4-diphenyl-substituted thiazole derivatives as PRMT1 inhibitors and investigation of their anti-cervical cancer effects.
    Bioorg Med Chem. 2023;92:117436.
    Abstract

  1408. SAMBYAL D, Sarwar A
    Recent developments in cervical cancer diagnosis using deep learning on whole slide images: An Overview of models, techniques, challenges and future directions.
    Micron. 2023;173:103520.
    Abstract

  1409. OPUNI RK, Adei D, Mensah AA, Adamtey R, et al
    Health needs of migrant female head porters in Ghana: evidence from the Greater Accra and Greater Kumasi Metropolitan areas.
    Int J Equity Health. 2023;22:151.
    Abstract

  1410. GUILLAUME D, Moise R, Chepkorir J, Alexander K, et al
    Sociodemographics and health-literacy as predictors of cervical cancer screening practices among Haitian women: A secondary data analysis of 2016-17 DHS surveys.
    PLOS Glob Public Health. 2023;3:e0002221.
    Abstract

  1411. WANBERG LJ, Kim A, Vogel RI, Sadak KT, et al
    Usability and Satisfaction Testing of Game-Based Learning Avatar-Navigated Mobile (GLAm), an App for Cervical Cancer Screening: Mixed Methods Study.
    JMIR Form Res. 2023;7:e45541.
    Abstract

  1412. PERKINS RB, Wentzensen N, Guido RS, Schiffman M, et al
    Cervical Cancer Screening: A Review.
    JAMA. 2023;330:547-558.
    Abstract


  1413. Histone Demethylase KDM3A Promotes Cervical Cancer Malignancy Through the ETS1/KIF14/Hedgehog Axis [Retraction].
    Onco Targets Ther. 2023;16:655-656.
    Abstract


  1414. Long Intergenic Non-Coding RNA LINC00885 Promotes Tumorigenesis of Cervical Cancer by Upregulating MACC1 Expression Through Serving as a Competitive Endogenous RNA for microRNA-432-5p [Retraction].
    Cancer Manag Res. 2023;15:789-790.
    Abstract

  1415. ZREIK J, Takagi MA, Akhter MF, Ahmad AA, et al
    Sociodemographic Disparities in the Diagnosis and Prognosis of Patients With Cervical Cancer: An Analysis of the Surveillance, Epidemiology, and End Results Program.
    Cureus. 2023;15:e41477.
    Abstract

  1416. WANG X, Ji Y, Qi J, Zhou S, et al
    Mitochondrial carrier 1 (MTCH1) governs ferroptosis by triggering the FoxO1-GPX4 axis-mediated retrograde signaling in cervical cancer cells.
    Cell Death Dis. 2023;14:508.
    Abstract

  1417. MOHAN A, Krishnamoorthy S, Sabanayagam R, Schwenk G, et al
    Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer.
    Eur J Pharmacol. 2023 Aug 5:175961. doi: 10.1016/j.ejphar.2023.175961.
    Abstract

  1418. GAO M, Hu S, Zhao X, You T, et al
    Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling study.
    Lancet Reg Health West Pac. 2023;36:100768.
    Abstract

  1419. AWAZU Y, Fukuda T, Noda T, Uchikura E, et al
    CLPTM1L expression predicts recurrence of patients with intermediate‑ and high‑risk stage IB‑IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy.
    Oncol Lett. 2023;26:353.
    Abstract

  1420. HE Y, Wang M, Yi S, Lu Y, et al
    Diffusion-weighted imaging in the assessment of cervical cancer: comparison of reduced field-of-view diffusion-weighted imaging and conventional techniques.
    Acta Radiol. 2023 Aug 6:2841851231183870. doi: 10.1177/02841851231183870.
    Abstract

  1421. SABANAYAGAM R, Krishnamoorthy S, Gnanagurusamy J, Muruganatham B, et al
    EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells.
    Med Oncol. 2023;40:261.
    Abstract

  1422. ZNAOR A, Ryzhov A, Losada ML, Carvalho A, et al
    Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: a population-based survey.
    J Cancer Policy. 2023 Aug 4:100436. doi: 10.1016/j.jcpo.2023.100436.
    Abstract

  1423. AZIZIKIA H, Didar H, Teymourzadeh A, Nakhostin-Ansari A, et al
    Uterine and Cervical Cancer in Iran: An epidemiologic analysis of the Iranian National Population-Based Cancer Registry.
    Arch Iran Med. 2023;26:1-7.
    Abstract

  1424. BEDNARSKA-CZERWINSKA A, Morawiec E, Zmarzly N, Szapski M, et al
    Dynamics of Microbiome Changes in the Endometrium and Uterine Cervix during Embryo Implantation: A Comparative Analysis.
    Med Sci Monit. 2023;29:e941289.
    Abstract

  1425. LI X, Xiang F, Zhao Y, Li Q, et al
    Detection of cervical high-grade squamous intraepithelial lesions and assessing diagnostic performance of colposcopy among women with oncogenic HPV.
    BMC Womens Health. 2023;23:411.
    Abstract

  1426. FENG W, Zhang D, Zhang R
    Correction: Circ‑ABCB10 knockdown inhibits the malignant progression of cervical cancer through microRNA‑128‑3p/ZEB1 axis.
    Biol Proced Online. 2023;25:23.
    Abstract

  1427. LEE MS, Elliott NS, Bethel VD, Balise RR, et al
    Identifying Neighborhoods with Cervical Cancer Disparities for Targeted Community Outreach and Engagement by an NCI-Designated Cancer Center: A Geospatial Approach.
    Cancer Epidemiol Biomarkers Prev. 2023 Aug 4:EPI-23-0132.
    Abstract

  1428. ZHANG J, Chu G, Zheng L, Liu J, et al
    Circular RNA circ_0000119 promotes cervical cancer cell growth and migration via miR-433-3p/PAK2 axis.
    J Appl Genet. 2023 Aug 4. doi: 10.1007/s13353-023-00772.
    Abstract

  1429. LI J, Wang X, Li Z, Li M, et al
    SULF1 Activates the VEGFR2/PI3K/AKT Pathway to Promote the Development of Cervical Cancer.
    Curr Cancer Drug Targets. 2023 Aug 4. doi: 10.2174/1568009623666230804161607.
    Abstract

  1430. ERIKSEN DO, Pape M, Petersen LK, Larsen CS, et al
    [Not Available].
    Ugeskr Laeger. 2023;185:V01230005.
    Abstract

  1431. FENG C, Gu L, Wei Y, Niu J, et al
    Analysis of outcomes following loop electrosurgical excision and clinical features of patients with cervical high-grade squamous intraepithelial lesions with abnormal preoperative endocervical curettage.
    World J Surg Oncol. 2023;21:237.
    Abstract

  1432. EINECKE D
    [Not Available].
    MMW Fortschr Med. 2023;165:14-15.
    Abstract

  1433. BIZZARRI N, Pavone M, Loverro M, Querleu D, et al
    Ovarian preservation in gynecologic oncology: current indications and techniques.
    Curr Opin Oncol. 2023;35:401-411.
    Abstract


  1434. Simple Hysterectomy Safe for Some Cervical Cancers.
    Cancer Discov. 2023;13:OF1.
    Abstract

  1435. TAN JHJ, Jones A, Steele A, Vicario E, et al
    Diagnostic outcomes after colposcopy at a tertiary clinic for women aged 50-74 referred after detection of oncogenic human papillomavirus at primary screening.
    Aust N Z J Obstet Gynaecol. 2023;63:564-570.
    Abstract

  1436. GILLES C, Konopnicki D, Rozenberg S
    The recent natural history of human papillomavirus cervical infection in women living with HIV: A scoping review of meta-analyses and systematic reviews and the construction of a hypothetical model.
    HIV Med. 2023 Apr 16. doi: 10.1111/hiv.13490.
    Abstract

  1437. DUPREZ D, Trauernicht C, Simonds H, Williams O, et al
    Self-configuring nnU-Net for automatic delineation of the organs at risk and target in high-dose rate cervical brachytherapy, a low/middle-income country's experience.
    J Appl Clin Med Phys. 2023;24:e13988.
    Abstract

  1438. CHEN Z, Xiao Z, Tian W, Li Z, et al
    Two Enhances the Cisplatin Sensitivity of Cervical Cancer Cells via Suppression of c-MET Expression.
    Iran J Public Health. 2023;52:1476-1486.
    Abstract

  1439. WU X, Yu H, Bai Y, Hou Y, et al
    A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IB3 and IIA2): study protocol of the LAUNCH 3 trial.
    Trials. 2023;24:542.
    Abstract

  1440. WOKS NIE, Anwi MM, Kefiye TB, Sama DJ, et al
    Disparities in cervical cancer screening programs in Cameroon: a scoping review of facilitators and barriers to implementation and uptake of screening.
    Int J Equity Health. 2023;22:156.
    Abstract

  1441. ZHANG B, Wang S, Yang X, Chen M, et al
    Knowledge, willingness, uptake and barriers of cervical cancer screening services among Chinese adult females: a national cross-sectional survey based on a large e-commerce platform.
    BMC Womens Health. 2023;23:435.
    Abstract

  1442. SPEER L
    Limited Benefit for Routine Cervical Cancer Screening With Cotesting vs. HPV Testing Alone.
    Am Fam Physician. 2023;108:204-205.
    Abstract

  1443. GJERDE PB, Tollanes MC, Trope A, Eide ML, et al
    [Not Available].
    Tidsskr Nor Laegeforen. 2023;143.
    Abstract

  1444. SCHULMEYER CE, Koch MC, Dietl AK, Stuebs FA, et al
    Standardized Procedures for Patients with Dysplasia and Other Diseases of the Cervix, Vulva, and Vagina at a Certified Dysplasia Unit Prior to the Introduction of the Organized Cervical Cancer Screening Program.
    Geburtshilfe Frauenheilkd. 2023;83:1031-1042.
    Abstract

  1445. FINZER P, Kuppers V, Griesser H
    Dysbiotic Co-Factors in Cervical Cancer. How the Microbiome Influences the Development of Cervical Intraepithelial Neoplasia (CIN).
    Geburtshilfe Frauenheilkd. 2023;83:1017-1021.
    Abstract

  1446. NAKASHIMA T, Matsumoto K, Yoshitake T, Wakiyama H, et al
    Transvaginal approach combined intracavitary and interstitial brachytherapy assisted by transrectal ultrasound: results from 30 patients with locally advanced cervical cancer.
    Jpn J Radiol. 2023 Aug 17. doi: 10.1007/s11604-023-01481.
    Abstract

  1447. CHEN W, Xia X, Xie X, Wei Y, et al
    Nomogram for prognosis of elderly patients with cervical cancer who receive combined radiotherapy.
    Sci Rep. 2023;13:13299.
    Abstract

  1448. HU S, Xu H, Xie C, Meng Y, et al
    Inhibition of human cervical cancer development through p53-dependent pathways induced by the specified triple helical beta-glucan.
    Int J Biol Macromol. 2023 Aug 14:126222. doi: 10.1016/j.ijbiomac.2023.126222.
    Abstract

  1449. KUNDROD KA, Jeronimo J, Vetter B, Maza M, et al
    Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing.
    PLOS Glob Public Health. 2023;3:e0001982.
    Abstract

  1450. ELEBIYO OT
    Knowledge, attitude, and uptake of Human Papilloma Virus (HPV) vaccine among parents of adolescents attending outpatient clinic at the University of Benin Teaching Hospital, Nigeria.
    Afr J Reprod Health. 2023;27:108-117.
    Abstract

  1451. WARDHANA A, Dahliana A, Angkawidjaja KM
    Cervical cancer screening in former sex workers in ex-localization area.
    Afr J Reprod Health. 2023;27:45-48.
    Abstract

  1452. AKPAN MI, Ndep AO, Ekpenyong BN, Akpan IA, et al
    Cervical cancer screening services targeting adult women in Cross River State, Nigeria.
    Afr J Reprod Health. 2023;27:34-42.
    Abstract

  1453. ESWARAN S, Padavu M, Kumar D, Kabekkodu SP, et al
    Systematic Analysis of the Therapy Resistance Genes and Their Prognostic Relevance in Cervical Cancer.
    Curr Pharm Des. 2023 Aug 16. doi: 10.2174/1381612829666230816100623.
    Abstract

  1454. TAGUCHI A, Kato K, Hara K, Furusawa A, et al
    Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate-risk group.
    Cancer Med. 2023 Aug 16. doi: 10.1002/cam4.6460.
    Abstract

  1455. GONG P, Shi B, Cong X, Yang L, et al
    Multiple infections containing the top five prevalent HPV genotypes and their impact on cervical lesions in Changzhou, China.
    Hum Vaccin Immunother. 2023;19:2245723.
    Abstract

  1456. LI AJ, Wang JQ, Liu HL, Lin MB, et al
    [Classification system of radical surgery for rectal cancer based on membrane anatomy].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2023;26:625-632.
    Abstract

  1457. TUERXUN G, Abudurexiti G, Abulizi G
    Prevalence, persistence, clearance and risk factors for HPV infection in rural Uyghur women in China.
    BMC Womens Health. 2023;23:433.
    Abstract

  1458. ORJI AF, Gimm G, Desai A, Parekh T, et al
    The Association of Cervical Cancer Screening with Disability Type among U.S. Women (25-64 years).
    Am J Prev Med. 2023 Aug 13:S0749-3797(23)00323.
    Abstract

  1459. GOODMAN A
    Age cutoffs for cervical cancer screening: good medicine or ageism?
    Menopause. 2023 Aug 15. doi: 10.1097/GME.0000000000002240.
    Abstract

  1460. IRINO S, Ose H, Takata N, Kamoshida S, et al
    Barriers to undergoing cervical cancer screening among health sciences university students in Japan: A cross-sectional study.
    Nurs Health Sci. 2023 Aug 15. doi: 10.1111/nhs.13043.
    Abstract

  1461. SHAO H, Li X, Wu P, Chen Z, et al
    A Cellular Senescence-Related Signature Predicts Cervical Cancer Patient Outcome and Immunotherapy Sensitivity.
    Reprod Sci. 2023 Aug 14. doi: 10.1007/s43032-023-01305.
    Abstract

  1462. NAMOOS A, Sheppard V, Abdelkarim M, Abosamak N, et al
    Exploring Factors Influencing Cervical Cancer Prevention Behaviors: Unveiling Perspectives of Conservative Muslim American Women in Virginia.
    J Relig Health. 2023 Aug 14. doi: 10.1007/s10943-023-01886.
    Abstract

  1463. SONG C, Lee JJ, Lee SH, Park JY, et al
    Application of preoperative fluorodeoxyglucose-PET/CT parameters for predicting prognosis of high-grade neuroendocrine cervical cancer.
    Nucl Med Commun. 2023 Aug 14. doi: 10.1097/MNM.0000000000001741.
    Abstract

  1464. NA J, Li Y, Wang J, Wang X, et al
    The correlation between multiple HPV infections and the occurrence, development, and prognosis of cervical cancer.
    Front Microbiol. 2023;14:1220522.
    Abstract

  1465. TUCKER TC, Durbin EB, Huang B, Pictor K, et al
    Using the Incidence of Cervical Cancer Precursors to Assess the Impact of HPV Vaccination Efforts in Kentucky.
    J Registry Manag. 2023;50:34-35.
    Abstract

  1466. GARI A, Ghazzawi MA, Ghazzawi SA, Alharthi SM, et al
    Knowledge about cervical cancer risk factors and human papilloma virus vaccine among Saudi women of childbearing age: A community-based cross-sectional study from Saudi Arabia.
    Vaccine X. 2023;15:100361.
    Abstract

  1467. ONG SK, Abe SK, Thilagaratnam S, Haruyama R, et al
    Towards elimination of cervical cancer - human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries.
    Lancet Reg Health West Pac. 2023;39:100860.
    Abstract

  1468. GUSTAFSON EA, Santa Rosario JC, Rios-Bedoya C, de Socarraz M, et al
    High risk HPV testing for cervical cancer screening in a Puerto Rican population.
    Gynecol Oncol Rep. 2023;48:101236.
    Abstract

  1469. SHEWA GARI F, Fenta Biru T, Endale Gurmu S
    Application of the Joint Frailty Copula Model for Analyzing Time to Relapse and Time to Death of Women with Cervical Cancer.
    Int J Womens Health. 2023;15:1295-1304.
    Abstract

  1470. ALSHAMLAN NA, AlOmar RS, AlAbdulKader AM, AlGhamdi FA, et al
    Beliefs and Utilization of Cervical Cancer Screening by Female Health Care Workers in Saudi Arabia Using the Health Belief Model: A Nationwide Study.
    Int J Womens Health. 2023;15:1245-1259.
    Abstract

  1471. GHOLAMALIZADEH M, Ardekanizadeh NH, Aghakhaninejad Z, Mohammadi S, et al
    The effects of dietary supplements in patients with cervical cancer: a comprehensive systematic review.
    Eur J Obstet Gynecol Reprod Biol X. 2023;19:100217.
    Abstract

  1472. AUMA J, Ndawula A, Ackers-Johnson J, Horder C, et al
    Task-shifting for point-of-care cervical cancer prevention in low- and middle-income countries: a case study from Uganda.
    Front Public Health. 2023;11:1105559.
    Abstract

  1473. FUSS CG, Msami K, Kahesa C, Mwaiselage J, et al
    The impact of in-house pathology services on downstaging cervical cancer in Tanzania over an 18-year period.
    Cancer Causes Control. 2023 Aug 14. doi: 10.1007/s10552-023-01768.
    Abstract

  1474. SMALL C, Prior P, Nasief H, Zeitlin R, et al
    A general framework to develop a radiomic fingerprint for progression-free survival in cervical cancer.
    Brachytherapy. 2023 Aug 11:S1538-4721(23)00080.
    Abstract

  1475. MOLIKA P, Bissanum R, Surachat K, Pattanapanyasat K, et al
    Exploration of extracellular vesicle long non-coding RNAs in serum of patients with cervical cancer.
    Oncology. 2023 Aug 12. doi: 10.1159/000533145.
    Abstract

  1476. LI Y, Jiang YJ, Nie KH, Li J, et al
    Rational design of genotyping nanodevice for HPV subtype distinction.
    Anal Chim Acta. 2023;1276:341651.
    Abstract

  1477. TYAGI A, Karapurkar JK, Colaco JC, Sarodaya N, et al
    USP19 Negatively Regulates p53 and Promotes Cervical Cancer Progression.
    Mol Biotechnol. 2023 Aug 12. doi: 10.1007/s12033-023-00814.
    Abstract

  1478. AMEMIYA T, Shibata K, Yamaguchi T
    Metabolic Oscillations and Glycolytic Phenotypes of Cancer Cells.
    Int J Mol Sci. 2023;24:11914.
    Abstract

  1479. HAMDI M, Senan EM, Awaji B, Olayah F, et al
    Analysis of WSI Images by Hybrid Systems with Fusion Features for Early Diagnosis of Cervical Cancer.
    Diagnostics (Basel). 2023;13:2538.
    Abstract

  1480. MOKOALA KMG, Lawal IO, Maserumule LC, Bida M, et al
    Correlation between [(68)Ga]Ga-FAPI-46 PET Imaging and HIF-1alpha Immunohistochemical Analysis in Cervical Cancer: Proof-of-Concept.
    Cancers (Basel). 2023;15:3953.
    Abstract

  1481. WOLSWINKEL JT, Eikelder MLGT, Verhoef CG, Zusterzeel PLM, et al
    High- or Intermediate-Risk Histologic Features in Patients with Clinical Early-Stage Cervical Cancer Planned for Fertility-Sparing Surgery: A Systematic Review.
    Cancers (Basel). 2023;15:3920.
    Abstract

  1482. FARHADI A, Abuei H, Okhovat MA, Geramizadeh B, et al
    Type distribution of human papillomaviruses in ThinPrep cytology samples and HPV16/18 E6 gene variations in FFPE cervical cancer specimens in Fars province, Iran.
    Cancer Cell Int. 2023;23:166.
    Abstract

  1483. ZHANG J, Li X, Zhou Y, Lin M, et al
    FNBP1 Facilitates Cervical Cancer Cell Survival by the Constitutive Activation of FAK/PI3K/AKT/mTOR Signaling.
    Cells. 2023;12:1964.
    Abstract

  1484. LI Y, Patterson MR, Morgan EL, Wasson CW, et al
    CREB1 activation promotes human papillomavirus oncogene expression and cervical cancer cell transformation.
    J Med Virol. 2023;95:e29025.
    Abstract

  1485. NARVAEZ L, Viviano M, Dickson C, Jeannot E, et al
    The acceptability of HPV vaginal self-sampling for cervical cancer screening in Latin America: A systematic review.
    Public Health Pract (Oxf). 2023;6:100417.
    Abstract

  1486. RAHAMAN A, Anantharaju A, Jeyachandran K, Manideep R, et al
    Optical imaging for early detection of cervical cancer: state of the art and perspectives.
    J Biomed Opt. 2023;28:080902.
    Abstract

  1487. CHEN G, Huang K, Sun J, Yang L, et al
    Cervical neuroendocrine carcinoma in the third trimester: a rare case report and literature review.
    BMC Pregnancy Childbirth. 2023;23:571.
    Abstract

  1488. JIA W, Zhao Y, Yuan P
    Circ-HMGCS1, an Indicator of Survival and Prognosis in Cervical Cancer Patients.
    Clin Lab. 2023;69.
    Abstract

  1489. MEZIN L, Rousseau A, Sellier Y, Teixeira L, et al
    ["A vaccine that nonetheless remains apart": Papillomavirus and vaccination in France].
    Sante Publique. 2023;35:127-137.
    Abstract

  1490. CARVALHO HA, Mauro GP
    History of radiotherapy in the treatment of uterine cervix cancer: an overview.
    Rev Assoc Med Bras (1992). 2023;69.
    Abstract

  1491. NOGUEIRA-RODRIGUES A, Rosa DD, Suzuki DA, Paulino E, et al
    Breast and gynecologic cancers as a Brazilian health priority.
    Rev Assoc Med Bras (1992). 2023;69.
    Abstract

  1492. FU H, Fu Z, Mao M, Si L, et al
    Prevalence and prognostic role of PD-L1 in patients with gynecological cancers: A systematic review and meta-analysis.
    Crit Rev Oncol Hematol. 2023;189:104084.
    Abstract

  1493. KHAMJAN NA, Beigh S, Algaissi A, Megha K, et al
    Natural and synthetic drugs and formulations for intravaginal HPV clearance.
    J Infect Public Health. 2023;16:1471-1480.
    Abstract

  1494. PAL D, Samadder S, Dutta P, Roychowdhury A, et al
    Differential association of hedgehog pathway in development of cervical carcinoma and its chemo-tolerance.
    Pathol Res Pract. 2023;248:154696.
    Abstract

  1495. YANG Y, Zuo S, Li W, Di M, et al
    TRIM21 promotes tumor progression and cancer stemness in cervical squamous cell carcinoma.
    Pathol Res Pract. 2023;248:154710.
    Abstract

  1496. MIRZAVAND BOROUJENI N, Richard JP, Sterling D, Wilke C, et al
    A linear optimization model for high dose rate brachytherapy using a novel distance metric.
    Phys Med Biol. 2023;68.
    Abstract

  1497. HAGHIGHI ZMS, Tabatabaei T, Rafigh M, Karampour R, et al
    Human papillomavirus maybe is a critical player in the regulation of chemoresistance related factors (P53, Rb, TWIST, Bcl-2, Bcl-XL, c-IAP2, cytochrome C, and caspase 3) in breast cancer.
    Pathol Res Pract. 2023;248:154653.
    Abstract

  1498. GOU T, Liu P, Yao X, Zhang L, et al
    Clinical Characteristics of Human Papillomavirus Infection in the Male Genital Tract.
    Altern Ther Health Med. 2023;29:425-429.
    Abstract

  1499. ZHANG J, Xie Y, Liu X, Gan L, et al
    Carbon ions trigger DNA damage response to overcome radioresistance by regulating beta-catenin signaling in quiescent HeLa cells.
    J Cell Physiol. 2023;238:1836-1849.
    Abstract

  1500. OSEI EA
    Innovations in healthcare delivery: Human papilloma virus self sampling diagnostics and participatory innovations for CCS.
    Cancer Med. 2023;12:15544-15551.
    Abstract

  1501. MWAMBA M, Lombe DC, Msadabwe S, Bond V, et al
    A Narrative Synthesis of Literature on the Barriers to Timely Diagnosis and Treatment of Cancer in Sub-Saharan Africa.
    Clin Oncol (R Coll Radiol). 2023;35:e537-e548.
    Abstract

  1502. HABARA K, Nishikori A, Kiyama J, Nakashima M, et al
    A case of coexistent poorly differentiated adenosquamous carcinoma (glassy cell carcinoma), usual-type adenocarcinoma, and squamous cell carcinoma in situ of the cervix.
    Med Mol Morphol. 2023;56:217-224.
    Abstract

  1503. SATO M, Inoue A, Takasawa A, Takasawa K, et al
    Elevated expression of endocan in the development of cervical squamous neoplasia of the uterus.
    Med Mol Morphol. 2023;56:187-193.
    Abstract

  1504. RAJENDRAN S, McGivern U, Gonzalez D, McCluggage WG, et al
    Cervical Gastric-type Adenosquamous Carcinoma: Case Report of a Rare Neoplasm Associated With a BRCA1 Pathogenic Variant.
    Int J Gynecol Pathol. 2023;42:529-534.
    Abstract

  1505. MALAGON T, Trottier H, El-Zein M, Villa LL, et al
    Human Papillomavirus Intermittence and Risk Factors Associated With First Detections and Redetections in the Ludwig-McGill Cohort Study of Adult Women.
    J Infect Dis. 2023;228:402-411.
    Abstract

  1506. AND BIOMECHANICS AB
    Retracted: Role of Phosphatidylinositol 3-Kinase and Its Catalytic Unit PIK3CA in Cervical Cancer: A Mini-Review.
    Appl Bionics Biomech. 2023;2023:9894241.
    Abstract

  1507. AND BIOMECHANICS AB
    Retracted: Construction of Nursing Practice Model in Case Management of Concurrent Chemotherapy and Radiochemotherapy Treatment in Cervical Cancer.
    Appl Bionics Biomech. 2023;2023:9826491.
    Abstract

  1508. GUTHRIE L, Mkandawire J, Stevenson E, Bonya S, et al
    Lessons in Cultural Adaptations: Translation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Cervical Cancer Module From English to Chichewa in Malawi.
    J Surg Res. 2023;292:150-157.
    Abstract

  1509. WANG L, Wang Y, Wang C, Yang K, et al
    CISD2 transcriptional activated by transcription factor E2F7 promotes the malignant progression of cervical cancer.
    J Mol Histol. 2023 Aug 24. doi: 10.1007/s10735-023-10145.
    Abstract

  1510. SUDHAKARAN S, Bhatla N, Mathur SR, Mahey R, et al
    Evaluation of cervical cancer screening during pregnancy in India: Human papillomavirus testing can change the paradigm.
    Natl Med J India. 2023;36:17-21.
    Abstract

  1511. VINOKUROV MA, Mironov KO, Domonova EA, Romanyuk TN, et al
    The genetic variant rs55986091 HLA-DQB1 is associated with a protective effect against cervical cancer.
    Front Oncol. 2023;13:1207935.
    Abstract

  1512. DING X, Zhang Y, Wang J, Huang A, et al
    The association of adverse reactions and depression in cervical cancer patients treated with radiotherapy and/or chemotherapy: moderated mediation models.
    Front Psychol. 2023;14:1207265.
    Abstract

  1513. DHAKAL K, Chen C, Wang P, Mboineki JF, et al
    The supportive care needs survey short form 34 (SCNS-SF34): translation and cultural adaptation into the Nepali language among patients with cervical cancer in Nepal.
    Health Qual Life Outcomes. 2023;21:98.
    Abstract

  1514. MUSA J, Kocherginsky M, Magaji FA, Maryam AJ, et al
    Epidemiology and Survival outcomes of HIV-associated cervical cancer in Nigeria.
    medRxiv. 2023 Aug 13:2023.08.08.23293820. doi: 10.1101/2023.08.08.23293820.
    Abstract

  1515. KUMAR N, Kalyani KP, Sharma A, Sivakoti S, et al
    "Uncommon location for a common disease, simulating cervical cancer: A rare case report".
    Infect Disord Drug Targets. 2023 Aug 22. doi: 10.2174/1871526523666230822155148.
    Abstract

  1516. DO NASCIMENTO MEDEIROS JA, Sarmento ACA, Bernardes-Oliveira E, de Oliveira R, et al
    Evaluation of Exosomal miRNA as Potential Biomarkers in Cervical Cancer.
    Epigenomes. 2023;7:16.
    Abstract

  1517. GHOSH S, Fantes J, Leschly K, Mazul J, et al
    Electronic data review, client reminders, and expanded clinic hours for improving cervical cancer screening rates after COVID-19 pandemic shutdowns: a multi-component quality improvement program.
    Elife. 2023;12:e85724.
    Abstract

  1518. GUVEN CM, Ozgur A
    BIIB021, an orally available and small-molecule inhibitor of HSP90, activates intrinsic apoptotic pathway in human cervical adenocarcinoma cell line (HeLa).
    Eur Rev Med Pharmacol Sci. 2023;27:7299-7308.
    Abstract

  1519. SHENG N, He C, Jin X, Meng Q, et al
    A comprehensive study of oxidative stress-related effects on the prognosis and drug therapy of cervical cancer.
    J Gene Med. 2023 Aug 22:e3581. doi: 10.1002/jgm.3581.
    Abstract

  1520. SU CH, Hsu PS, Lin CS
    Impact of the COVID-19 pandemic on population-based cancer screening, a nationwide retrospective study in Taiwan.
    BMC Health Serv Res. 2023;23:878.
    Abstract

  1521. WU L, Tan Y, Zhang H, Guo P, et al
    A Laser Free Self-luminous Nanosystem for Photodynamic Therapy of Cervical Cancer Cells.
    Photodiagnosis Photodyn Ther. 2023 Aug 19:103756.
    Abstract

  1522. COLLARINO A, Florit A, Bizzarri N, Lanni V, et al
    Radioguided surgery with beta decay: A feasibility study in cervical cancer.
    Phys Med. 2023;113:102658.
    Abstract

  1523. CHAIWIANG N, Poyomtip T
    Toll-Like Receptor Polymorphisms and the Risk of Cancer: Meta-analysis Study.
    Methods Mol Biol. 2023;2700:179-185.
    Abstract

  1524. OLUWADAMILOLA MIRIAM K, Rosemary IA, Adebimpe IW, Olusola AM, et al
    Formulation and evaluation of paclitaxel-loaded boronated chitosan/alginate nanoparticles as a mucoadhesive system for localized cervical cancer drug delivery.
    J Drug Deliv Sci Technol. 2023;87:104810.
    Abstract

  1525. HOU J, Zeng M, Liu C, Xie B, et al
    Cervical HPV infection in Yueyang, China: a cross-sectional study of 125,604 women from 2019 to 2022.
    Front Public Health. 2023;11:1210253.
    Abstract

  1526. ZHANG Y, Tian F, Zhao J
    MiR-520d-3p suppresses the proliferation and epithelial-mesenchymal transition of cervical cancer cells by targeting ZFP36L2.
    Heliyon. 2023;9:e18789.
    Abstract

  1527. GUO L, Su Y, Liu X, Xie W, et al
    Serum cell division cycle 42 reflects the treatment response and survival in patients with advanced cervical cancer who receive immune checkpoint inhibitor treatment.
    Oncol Lett. 2023;26:414.
    Abstract

  1528. MAO Y, Jiang X, Guo P, Ouyang Y, et al
    ZXDC enhances cervical cancer metastasis through IGF2BP3-mediated activation of RhoA/ROCK signaling.
    iScience. 2023;26:107447.
    Abstract

  1529. GHOSH A, Ghosh A, Sinha A, Mathai S, et al
    Identification of HPV16 positive cervical cancer subsets characterized by divergent immune and oncogenic phenotypes with potential implications for immunotherapy.
    Tumour Biol. 2023;45:55-69.
    Abstract

  1530. ALGHAMDI S, Baeissa HM, Azhar Kamal M, Rafeeq MM, et al
    Unveiling the multitargeted potency of Sodium Danshensu against cervical cancer: a multitargeted docking-based, structural fingerprinting and molecular dynamics simulation study.
    J Biomol Struct Dyn. 2023 Aug 20:1-13. doi: 10.1080/07391102.2023.2248260.
    Abstract

  1531. LIN E, Sleboda P, Rimel BJ, Chen JT, et al
    Sexual orientation and gender identity inequities in cervical cancer screening by race and ethnicity.
    Cancer Causes Control. 2023 Aug 21. doi: 10.1007/s10552-023-01771.
    Abstract

  1532. ZHENG F, Wang K
    The impact of social media on guideline-concordant cervical cancer-screening: insights from a national survey.
    Public Health. 2023;223:50-56.
    Abstract

  1533. TRUJILLO-CIRILO L, Weiss-Steider B, Vargas-Angeles CA, Corona-Ortega MT, et al
    Immune microenvironment of cervical cancer and the role of IL-2 in tumor promotion.
    Cytokine. 2023;170:156334.
    Abstract

  1534. LE-TRUNG N, Duong TM, Dang TTP, Kamei K, et al
    Potent anti-cancer activity of Sphaerocoryne affinis fruit against cervical cancer HeLa cells via inhibition of cell proliferation and induction of apoptosis.
    BMC Complement Med Ther. 2023;23:290.
    Abstract

  1535. XIN S, Jianbo Y, Chen J
    Analysis of treatment strategies for patients with advanced cervical cancer and obstructive renal failure after failure of ureteral catheterization.
    Asian J Surg. 2023 Aug 17:S1015-9584(23)01228.
    Abstract

  1536. CAMARA H, Nosi S, Munnull G, Badman SG, et al
    "This is really something: same place, same day result, same day treatment" women's experiences of testing positive for HPV and receiving same-day treatment in Papua New Guinea: an interpretative phenomenological analysis.
    BMC Womens Health. 2023;23:438.
    Abstract

  1537. GIUFFRE G, Iacobellis M
    Re: '2020 list of human papillomavirus assays suitable for primary cervical cancer screening' by arbyn et al.
    Clin Microbiol Infect. 2023 Aug 16:S1198-743X(23)00390.
    Abstract

  1538. KIBRET YM, Tigeneh W, Jemal A, Kantelhardt EJ, et al
    Implementation of Brachytherapy for Patients With Cervical Cancer in Ethiopia: A 3-Year Practice Report.
    JCO Glob Oncol. 2023;9:e2200407.
    Abstract

  1539. COBUSSEN A, Petric P, Wulff CN, Buus S, et al
    Clinical outcomes using a 3D printed tandem-needle-template and the EMBRACE-II planning aims for image guided adaptive brachytherapy in locally advanced cervical cancer.
    Acta Oncol. 2023 Aug 18:1-9. doi: 10.1080/0284186X.2023.2246642.
    Abstract

  1540. LI D, Huang Y, Wei M, Chen B, et al
    Overexpression of SOCS2 Inhibits EMT and M2 Macrophage Polarization in Cervical Cancer via IL-6/JAK2/STAT3 Pathway.
    Comb Chem High Throughput Screen. 2023.
    Abstract

  1541. NING Y, Liu Y, Zeng D, Zhou Y, et al
    Patterns of lymph node metastasis in level IIB and contralateral level VI for papillary thyroid carcinoma with pN1b and safety of low collar extended incision for neck dissection in level II.
    World J Surg Oncol. 2023;21:249.
    Abstract

  1542. FLOYD-ELLIS V, Taylor A
    Dermatomyositis: a debilitating paraneoplastic phenomenon following a diagnosis of localised squamous cell carcinoma of the cervix.
    BMJ Case Rep. 2023;16:e253640.
    Abstract

  1543. BRUNI L, Albero G, Rowley J, Alemany L, et al
    Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
    Lancet Glob Health. 2023;11:e1345-e1362.
    Abstract

  1544. APPIAH LC, Moravek M, Hoefgen H, Rotz S, et al
    Reproductive late effects after hematopoietic stem cell transplant in pediatric, adolescent, and young adult cancer survivors.
    Pediatr Blood Cancer. 2023;70 Suppl 5:e30551.
    Abstract

  1545. POLJAK M, Cuschieri K, Alemany L, Vorsters A, et al
    Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory.
    J Clin Microbiol. 2023;61:e0140322.
    Abstract

  1546. PARVEEN S, Kumar S, Pal S, Yadav NP, et al
    Enhanced therapeutic efficacy of Piperlongumine for cancer treatment using nano-liposomes mediated delivery.
    Int J Pharm. 2023;643:123212.
    Abstract

  1547. KEALEY MR, Urakami J, Henderson K, Chignell M, et al
    In what ways does user experience design improve printed educational materials?
    Appl Ergon. 2023;113:104081.
    Abstract

  1548. HOEFGEN HR, Benoit J, Chan S, Jayasinghe Y, et al
    Female reproductive health in pediatric, adolescent, and young adult cancer survivors.
    Pediatr Blood Cancer. 2023;70 Suppl 5:e29170.
    Abstract

  1549. LATSUZBAIA A, Vanden Broeck D, Van Keer S, Weyers S, et al
    Comparison of the Clinical Accuracy of Xpert HPV Assay on Vaginal Self-Samples and Cervical Clinician-Taken Samples within the VALHUDES Framework.
    J Mol Diagn. 2023;25:702-708.
    Abstract

  1550. HWANG JH, Kim BW
    The incidence of perioperative lymphatic complications after radical hysterectomy and pelvic lymphadenectomy between robotic and laparoscopic approach : a systemic review and meta-analysis.
    Int J Surg. 2023;109:2478-2485.
    Abstract

  1551. XUE P, Xu HM, Tang HP, Weng HY, et al
    Improving the Accuracy and Efficiency of Abnormal Cervical Squamous Cell Detection With Cytologist-in-the-Loop Artificial Intelligence.
    Mod Pathol. 2023;36:100186.
    Abstract

  1552. ALIE MS, Negesse Y, Ayenew M
    Determinants of Cervical Cancer Screening Among Women Aged 30-49 Years Old in Four African Countries: A Cross-Sectional Secondary Data Analysis.
    Cancer Control. 2023;30:10732748231195681.
    Abstract

  1553. KENTER GG, Greggi S, Vergote I, Katsaros D, et al
    Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994.
    J Clin Oncol. 2023 Sep 1:JCO2202852. doi: 10.1200/JCO.22.02852.
    Abstract

  1554. YUAN Y, Liu X, Yin C, Shi L, et al
    Cognitive behavioral stress management is an effective intervention to relieve anxiety and depression, improve the quality of life in patients with cervical cancer.
    Ir J Med Sci. 2023 Sep 1. doi: 10.1007/s11845-023-03501.
    Abstract

  1555. GHAI I, Wagner GJ, Matovu JKB, Juncker M, et al
    Increased Knowledge Mediates the Effect of Game Changers for Cervical Cancer Prevention on Diffusion of Cervical Cancer Screening Advocacy Among Social Network Members in a Pilot Trial.
    Int J Behav Med. 2023 Sep 1. doi: 10.1007/s12529-023-10217.
    Abstract

  1556. FUZZELL L, Brownstein NC, Fontenot HB, Lake PW, et al
    Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment.
    Elife. 2023;12:e85682.
    Abstract

  1557. AI C, Zhang L, Ding W, Zhong S, et al
    A nomogram-based optimized Radscore for preoperative prediction of lymph node metastasis in patients with cervical cancer after neoadjuvant chemotherapy.
    Front Oncol. 2023;13:1117339.
    Abstract

  1558. MOU J, Zheng W, Wei D, Li D, et al
    CD200-CD200R affects cisplatin and paclitaxel sensitivity by regulating cathepsin K-mediated p65 NF-kappaB signaling in cervical cancer.
    Heliyon. 2023;9:e19220.
    Abstract

  1559. LEE SW, Kim A, Lee SJ, Kim SH, et al
    Intensity-Modulated Radiation Therapy (IMRT) for Uterine Cervical Cancer to Reduce Toxicity and Enhance Efficacy - an Option or a Must?: A Narrative Review.
    Cancer Res Treat. 2023 Aug 30. doi: 10.4143/crt.2023.
    Abstract

  1560. WAGNER GJ, Matovu JKB, Juncker M, Namisango E, et al
    Correlates of cervical cancer prevention advocacy and cervical cancer screening in Uganda: Cross-sectional evaluation of a conceptual model.
    Medicine (Baltimore). 2023;102:e34888.
    Abstract

  1561. ZHANG N, Pang C, Li Z, Xu F, et al
    Serum CXCL8 and CXCR2 as diagnostic biomarkers for noninvasive screening of cervical cancer.
    Medicine (Baltimore). 2023;102:e34977.
    Abstract

  1562. LABAN M, Chen X, Guo B
    Unmasking the Hypoxia Landscape in Cervical Cancer: S100A2 and Its Implication for Immunotherapy Resistance.
    Reprod Sci. 2023 Aug 31. doi: 10.1007/s43032-023-01336.
    Abstract

  1563. DOVER L, Dulaney C
    Spine Stereotactic Radiosurgery, Prostate Radiation Frequency, Adjuvant Chemotherapy for Cervical Cancer, Bacteria and Radiation Dermatitis, and Breast Conservation Therapy for Multifocal Disease.
    Pract Radiat Oncol. 2023;13:379-383.
    Abstract

  1564. ROMANOVA M, Zidlik V, Javurkova V, Konde A, et al
    L1CAM Is Not a Predictive Factor in Early-stage Squamous-cell Cervical Cancer.
    In Vivo. 2023;37:2334-2339.
    Abstract

  1565. CENCI M, Rossi F, Pisani T
    Detection of 14 High-risk Human Papillomavirus (HPV) Genotypes Within the Italian Cervical Cancer Screening.
    In Vivo. 2023;37:2161-2165.
    Abstract

  1566. OSEI EA, Ali Bakkari M, Boateng SA, Acquah A, et al
    Perceptions and attitudes toward partners support for cervical cancer screening among married men in Ghana.
    Public Health. 2023;223:139-144.
    Abstract

  1567. VERGOTE I, Van Nieuwenhuysen E, O'Cearbhaill RE, Westermann A, et al
    Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.
    J Clin Oncol. 2023 Aug 31:JCO2300720. doi: 10.1200/JCO.23.00720.
    Abstract

  1568. WANG H, Luo S, Wu X, Ruan Y, et al
    Exploration of glycosyltransferases mutation status in cervical cancer reveals PARP14 as a potential prognostic marker.
    Glycoconj J. 2023 Aug 31. doi: 10.1007/s10719-023-10134.
    Abstract

  1569. BOISEN M, Guido R
    Emerging Treatment Options for Cervical Dysplasia and Early Cervical Cancer.
    Clin Obstet Gynecol. 2023;66:500-515.
    Abstract

  1570. GUIDO R, Perkins RB
    Management of Abnormal Cervical Cancer Screening Test: A Risk-based Approach.
    Clin Obstet Gynecol. 2023;66:478-499.
    Abstract

  1571. CLARKE MA
    HPV Testing and its Role in Cervical Cancer Screening.
    Clin Obstet Gynecol. 2023;66:448-469.
    Abstract

  1572. GUIDO R
    Foreword: Contemporary Recommendations for Cervical Cancer and Anal Cancer Screening and Prevention.
    Clin Obstet Gynecol. 2023;66:431-432.
    Abstract


  1573. Contributors: Contemporary Recommendations for Cervical Cancer and Anal Cancer Screening and Prevention.
    Clin Obstet Gynecol. 2023;66:vi.
    Abstract

  1574. MCMULLAN JC, Rainey L, Morgan D, Johnston L, et al
    The effect of COVID-19 on the cervical screening programme within a Northern Irish Health and Social care trust.
    Ulster Med J. 2023;92:84-88.
    Abstract

  1575. YANG J, Wan S, Zhao M, Cai H, et al
    Multi-omics Analysis Identifies Hypoxia Subtypes and S100A2 as an Immunosuppressive Factor in Cervical Cancer.
    Reprod Sci. 2023 Aug 30. doi: 10.1007/s43032-023-01304.
    Abstract

  1576. KODAMA K, Tateishi C, Oda T, Cui L, et al
    Development of novel tracers for sentinel node identification in cervical cancer.
    Cancer Sci. 2023 Aug 30. doi: 10.1111/cas.15927.
    Abstract

  1577. YIN S, Cui H, Qin S, Yu S, et al
    Manipulating TGF-beta signaling to optimize immunotherapy for cervical cancer.
    Biomed Pharmacother. 2023;166:115355.
    Abstract

  1578. RICHARDSON MT, Attwood K, Smith G, Liang SY, et al
    Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey.
    Cancer Control. 2023;30:10732748231182795.
    Abstract

  1579. LI Y, Wang C, Ma A, Rani AQ, et al
    Identification of HPV oncogene and host cell differentiation associated cellular heterogeneity in cervical cancer via single-cell transcriptomic analysis.
    bioRxiv. 2023 Aug 14:2023.08.10.552878. doi: 10.1101/2023.08.10.552878.
    Abstract

  1580. DESSIE TM, Kassaw AT, Alen GD
    Determinants of precancerous cervical lesion among HIV infected women on ART in Woldia comprehensive specialized hospital NorthEast Ethiopia.
    BMC Womens Health. 2023;23:458.
    Abstract

  1581. OUANHNON L, Bugat MR, Druel V, Grosclaude P, et al
    Link between the referring physician and breast and cervical cancers screening: a cross-sectional study in France.
    BMC Prim Care. 2023;24:167.
    Abstract

  1582. DING Y, Fu T, Zhou W, Zhang X, et al
    Myasthenia gravis after the third dose of human papillomavirus 9-valent vaccine: A case report.
    Hum Vaccin Immunother. 2023;19:2252252.
    Abstract

  1583. MCCORMICK LJ, Gutreuter S, Adeoye O, Alger SX, et al
    Cervical cancer screening positivity among women living with HIV in CDC-PEPFAR programs 2018-2022.
    J Acquir Immune Defic Syndr. 2023 Aug 23. doi: 10.1097/QAI.0000000000003286.
    Abstract

  1584. ZOU R, Gu R, Tu X, Chen J, et al
    Effects of metalloprotease ADAMTS12 on cervical cancer cell phenotype and its potential mechanism.
    Discov Oncol. 2023;14:162.
    Abstract

  1585. GOES EF, Guimaraes JMN, Almeida MDCC, Gabrielli L, et al
    The intersection of race/ethnicity and socioeconomic status: inequalities in breast and cervical cancer mortality in 20,665,005 adult women from the 100 Million Brazilian Cohort.
    Ethn Health. 2023 Aug 29:1-16. doi: 10.1080/13557858.2023.2245183.
    Abstract

  1586. ARECHKIK A, Lahlou L, Kharbach A, Baba MA, et al
    Awareness, Knowledge and Attitude Regarding Cervical Cancer among Women Living with HIV in the Souss-Massa Region, Southern Morocco: A Cross-Sectional Study.
    Asian Pac J Cancer Prev. 2023;24:2875-2884.
    Abstract

  1587. DHANI FK, Daryanto B, Seputra KP
    Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
    Asian Pac J Cancer Prev. 2023;24:2641-2646.
    Abstract

  1588. SANGRAJRANG S, Pitakkarnkul S, Muwonge R, Ploysawang P, et al
    Agreement between Self- and Physician?Sampling for Detection of High?Risk Human Papillomavirus Infections in Women Attending Cervical Screening at National Cancer Institute, Thailand.
    Asian Pac J Cancer Prev. 2023;24:2615-2619.
    Abstract

  1589. WANG J, Wu Y, Zhang W, Chen Y, et al
    Elective nodal irradiation versus involved-field irradiation for stage II-IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes.
    Radiat Oncol. 2023;18:142.
    Abstract

  1590. BARBERA F, Frassine F, Volpi G, Ghedi B, et al
    Locally advanced cervical cancer: how the improvement in techniques in external beam radiotherapy and brachytherapy impacts on survival outcomes and long-term toxicities.
    Radiol Med. 2023 Aug 28. doi: 10.1007/s11547-023-01705.
    Abstract

  1591. WU S, Liu L, Xu H, Zhu Q, et al
    The involvement of MALAT1-ALKBH5 signaling axis into proliferation and metastasis of human papillomavirus-positive cervical cancer.
    Cancer Biol Ther. 2023;24:2249174.
    Abstract

  1592. HASAN MUJAHID M, Upadhyay TK, Upadhye V, Sharangi AB, et al
    Phytocompound identification of aqueous Zingiber officinale rhizome (ZOME) extract reveals antiproliferative and reactive oxygen species mediated apoptotic induction within cervical cancer cells: an in vitro and in silico approach.
    J Biomol Struct Dyn. 2023 Aug 28:1-28. doi: 10.1080/07391102.2023.2247089.
    Abstract

  1593. LI Y, Wang C, Ma A, Rani AQ, et al
    Identification of HPV oncogene and host cell differentiation associated cellular heterogeneity in cervical cancer via single-cell transcriptomic analysis.
    J Med Virol. 2023;95:e29060.
    Abstract

  1594. DING N, Qi W, Wu Z, Zhang Y, et al
    Development of Enzymatic Recombinase Amplification Assays for the Rapid Visual Detection of HPV16/18.
    J Microbiol Biotechnol. 2023;33:1091-1100.
    Abstract

  1595. MOTSA MPS, Estinfort W, Phiri YVA, Simelane MS, et al
    Body mass index and cervical cancer screening among women aged 15-69 years in Eswatini: evidence from a population-based survey.
    BMC Public Health. 2023;23:1638.
    Abstract

  1596. PREM K, Choi YH, Benard E, Burger EA, et al
    Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis.
    BMC Med. 2023;21:313.
    Abstract

  1597. WANG F, Wang X, Shi Y, Li L, et al
    Development of a risk nomogram predicting urinary tract infection in patients with indwelling urinary catheter after radical surgery for cervical cancer.
    Prog Urol. 2023 Aug 25:S1166-7087(23)00169-0. doi: 10.1016/j.purol.2023.
    Abstract

  1598. ARBYN M, Cuschieri K, Poljak M, Bonde J, et al
    Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?
    Clin Microbiol Infect. 2023 Aug 25:S1198-743X(23)00403.
    Abstract

  1599. GUPTA MK, Kushwah AS, Singh R, Srivastava K, et al
    Genetic and epigenetic alterations in MGMT gene and correlation with concomitant chemoradiotherapy (CRT) in cervical cancer.
    J Cancer Res Clin Oncol. 2023 Aug 27. doi: 10.1007/s00432-023-05305.
    Abstract

  1600. OGUNSOLA OO, Ajayi OA, Ojo TO, Osayi E, et al
    Cervical cancer screening and treatment for PLWHIV: experiences from an innovative program in Nigeria.
    Reprod Health. 2023;20:125.
    Abstract

  1601. SOWA I, Moldoch J, Paduch R, Strzemski M, et al
    Polyphenolic Composition of Carlina acaulis L. Extract and Cytotoxic Potential against Colorectal Adenocarcinoma and Cervical Cancer Cells.
    Molecules. 2023;28:6148.
    Abstract

  1602. SINGH D, Desai N, Shah V, Datta B, et al
    In Silico Identification of Potential Quadruplex Forming Sequences in LncRNAs of Cervical Cancer.
    Int J Mol Sci. 2023;24:12658.
    Abstract

  1603. RAYNER M, Welp A, Stoler MH, Cantrell LA, et al
    Cervical Cancer Screening Recommendations: Now and for the Future.
    Healthcare (Basel). 2023;11:2273.
    Abstract

  1604. RUNGKAMOLTIP P, Roytrakul S, Navakanitworakul R
    MALDI-TOF MS Analysis of Serum Peptidome Patterns in Cervical Cancer.
    Biomedicines. 2023;11:2327.
    Abstract

  1605. LIZCANO-MENESES S, Hernandez-Pando R, Garcia-Aguirre I, Bonilla-Delgado J, et al
    Combined Inhibition of Indolamine-2,3-Dioxygenase 1 and C-X-C Chemokine Receptor Type 2 Exerts Antitumor Effects in a Preclinical Model of Cervical Cancer.
    Biomedicines. 2023;11:2280.
    Abstract

  1606. LIU P, Liu Z, Luo Q, Fu Q, et al
    A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer.
    Sci Rep. 2023;13:13898.
    Abstract

  1607. POURROOSTAEI ARDAKANI P, Abkhiz S, Sheykhi K, Adhami Mojarad K, et al
    Molecular Investigation of the Association Among Common Interleukin-6 Polymorphism and Human Papillomavirus Genotypes with Cervical Cancer Among Iranian Women.
    Monoclon Antib Immunodiagn Immunother. 2023;42:125-131.
    Abstract

  1608. SUN W, Chen X, Fu S, Huang X, et al
    Feasibility of Sentinel Lymph Node Mapping With Carbon Nanoparticles in Cervical Cancer: A Retrospective Study.
    Cancer Control. 2023;30:10732748231195716.
    Abstract

  1609. FERIOLI M, Benini A, Malizia C, Forlani L, et al
    Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study).
    J Pers Med. 2023;13:1229.
    Abstract

  1610. BECERRA-BOLANOS A, Jimenez-Gil M, Federico M, Dominguez-Diaz Y, et al
    Pain in High-Dose-Rate Brachytherapy for Cervical Cancer: A Retrospective Cohort Study.
    J Pers Med. 2023;13:1187.
    Abstract

  1611. BARTL T, Grimm C, Mader RM, Zielinski C, et al
    Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer.
    J Pers Med. 2023;13:1186.
    Abstract

  1612. NYABIGAMBO A, Mayega RW, Ginindza TG
    Effectiveness of Clinic-Based Patient-Led Human Papillomavirus DNA Self-Sampling among HIV-Infected Women in Uganda.
    Int J Environ Res Public Health. 2023;20:6613.
    Abstract

  1613. SMAYDA LC, Day GM, Redwood DG, Beans JA, et al
    Cancer Screening Prevalence among Participants in the Southcentral Alaska Education and Research towards Health (EARTH) Study at Baseline and Follow-Up.
    Int J Environ Res Public Health. 2023;20:6596.
    Abstract

  1614. RAVEINTHIRANATHAN N, Simkin J, Donken R, Ogilvie G, et al
    Age-Specific Trends of Invasive Cervical Cancer Incidence in British Columbia, Canada, 1971-2017.
    Curr Oncol. 2023;30:7692-7705.
    Abstract

  1615. ELIT L, Tum EM, Ngalla C, Fungchwi GM, et al
    Perceptions of Cancer in Parents of Adolescent Daughters in Northwest Cameroon.
    Curr Oncol. 2023;30:7167-7177.
    Abstract

  1616. WANG M, Jin Y, Zheng ZJ
    The association of cervical cancer screening and quality of care: A systematic analysis of the Global Burden of Disease Study 2019.
    J Glob Health. 2023;13:04090.
    Abstract

  1617. MERTENS RC, Sykes PH, Innes CR, Simcock BJ, et al
    Endometrial cancer diagnoses prompted by routine cervical cytology: a retrospective case study.
    N Z Med J. 2023;136:56-65.
    Abstract

  1618. MORI S, Ishii Y, Takeuchi T, Kukimoto I, et al
    Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1.
    J Virol. 2023;97:e0081523.
    Abstract

  1619. CHEN B, Zhao L, Yang R, Xu T, et al
    Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis.
    Arch Biochem Biophys. 2023;745:109716.
    Abstract

  1620. DAVID A, Julia M, David H, Serge M, et al
    Epidemiological profile of cancer at the laboratory of anatomy and pathological cytology of mungbere in the Democratic Republic of Congo.
    J Cancer Policy. 2023;37:100434.
    Abstract

  1621. KHAN A, Han S, Ilyas N, Lee YM, et al
    CervixFormer: A Multi-scale swin transformer-Based cervical pap-Smear WSI classification framework.
    Comput Methods Programs Biomed. 2023;240:107718.
    Abstract

  1622. MISHRA R, Pandey A, Mishra H, Singh S, et al
    Survival outcome and prognostic factors post inadvertent hysterectomy in carcinoma cervix treated with salvage chemo-radiation.
    J Cancer Res Clin Oncol. 2023;149:12355-12364.
    Abstract

  1623. WINTERS AN, Berry AK, Dewenter TA, Chowdhury NU, et al
    MicroRNA expression associated with low-grade cervical intraepithelial neoplasia outcomes.
    J Cancer Res Clin Oncol. 2023;149:11969-11978.
    Abstract

  1624. RIBEIRO AG, Ferlay J, Vaccarella S, Latorre MDRDO, et al
    Cancer inequalities in incidence and mortality in the State of Sao Paulo, Brazil 2001-17.
    Cancer Med. 2023;12:16615-16625.
    Abstract

  1625. GOPALANI SV, Dasari SR, Adam EE, Thompson TD, et al
    Variation in hysterectomy prevalence and trends among U.S. States and Territories-Behavioral Risk Factor Surveillance System, 2012-2020.
    Cancer Causes Control. 2023;34:829-835.
    Abstract

  1626. MISHRA SI, Adsul P, Leekity S, Rodman J, et al
    A culturally informed model to enhance breast, cervical, and colorectal cancer screenings: perspectives of American Indian adults and healthcare providers in rural New Mexico.
    Cancer Causes Control. 2023;34:855-871.
    Abstract

  1627. ZENG Z, Wang W, Liu X, Wang G, et al
    Optimal cisplatin cycles in locally advanced cervical carcinoma patients treated with concurrent chemoradiotherapy.
    Clin Transl Oncol. 2023;25:2892-2900.
    Abstract

  1628. COX E
    Performing HeLa: theatrical bodies and living remains.
    Med Humanit. 2023;49:447-456.
    Abstract

  1629. SHIGA T, Taguchi A, Mori M, Yamaguchi S, et al
    Risk stratification of invasive cervical cancer diagnosed after cervical conization.
    Jpn J Clin Oncol. 2023 Sep 7:hyad121. doi: 10.1093.
    Abstract

  1630. WEN Y, Liang H, Zhang H
    Clinical utility of HPV typing and quantification combined with PAX1/ZNF582 methylation detection in accurate cervical cancer screening.
    Cytojournal. 2023;20:26.
    Abstract

  1631. GU L, Feng C, Li M, Hong Z, et al
    Exosomal NOX1 promotes tumor-associated macrophage M2 polarization-mediated cancer progression by stimulating ROS production in cervical cancer: a preliminary study.
    Eur J Med Res. 2023;28:323.
    Abstract

  1632. BEDUK ESEN CS, Gedik ME, Canpinar H, Yedekci FY, et al
    Radiosensitising Effects of Metformin Added to Concomitant Chemoradiotherapy with Cisplatin in Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2023 Sep 3:S0936-6555(23)00296.
    Abstract

  1633. DA SILVA IF, da Silva IF, Saraceni V, Koifman RJ, et al
    Delays in treatment initiation and conclusion in women with stage IA to IIIB cervical cancer: A survival study in a hospital-based cohort from a developing country.
    Cancer Epidemiol. 2023;86:102450.
    Abstract

  1634. BACORRO W, Baldivia K, Mariano J, Dancel E, et al
    Patient Decision Aid for Chemotherapy or Exclusion in Cisplatin-Intolerant Patients With Locally Advanced Cervical Cancer: Development, Alpha Testing, and Peer Validation.
    JCO Glob Oncol. 2023;9:e2300096.
    Abstract

  1635. DIO CD, Azenkoud I, Trezza A, Lentini E, et al
    Early-stage cervical cancer treatment - what's new?
    Prz Menopauzalny. 2023;22:87-92.
    Abstract

  1636. MORSE R, Brown J, Lopez EJR, Prieto BA, et al
    Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention in Iquitos, Peru: a mixed methods study.
    Res Sq. 2023 Aug 23:rs.3.rs-3210614. doi: 10.21203/rs.3.rs-3210614.
    Abstract

  1637. SHAHNAZ S, Fricovsky E, Anwar R, Arain MI, et al
    Cervical Cancer Awareness and Attitude Towards Cervical Cancer Screening and Human Papillomavirus Vaccines Among Urban Women of Karachi, Pakistan.
    Cureus. 2023;15:e42970.
    Abstract

  1638. KONG L, Wang L, Wang Z, Xiao X, et al
    Cytological DNA methylation for cervical cancer screening: a validation set.
    Front Oncol. 2023;13:1181982.
    Abstract

  1639. SUN YH, Chen LJ, Wang CH, Lee CY, et al
    Impact of LINC00673 genetic variants on uterine cervical cancer clinicopathologic characteristics.
    J Cancer. 2023;14:2529-2537.
    Abstract

  1640. CHEN YQ
    [Dysplastic ichthyosis uteri-like changes of the entire endometrium associated with a high-grade squamous intraepithelial lesion of the uterine cervix: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2023;52:943-945.
    Abstract

  1641. DONG S, Zhang Y, Wang Y
    Role of extracellular vesicle in human papillomavirus-associated cervical cancer.
    J Cancer Res Clin Oncol. 2023 Sep 5. doi: 10.1007/s00432-023-05374.
    Abstract

  1642. FENG Q, Cui N, Li S, Cao J, et al
    Upregulation of SOX9 promotes the self-renewal and tumorigenicity of cervical cancer through activating the Wnt/beta-catenin signaling pathway.
    FASEB J. 2023;37:e23174.
    Abstract

  1643. MARTELL K, McIntyre JB, Abedin T, Kornaga EN, et al
    Prevalence and Prognostic Significance of PIK3CA Mutation and CNV Status and Phosphorylated AKT Expression in Patients With Cervical Cancer Treated With Primary Surgery.
    Int J Gynecol Pathol. 2023 Aug 25. doi: 10.1097/PGP.0000000000000978.
    Abstract

  1644. PHAN NTH, Tran QT, Nguyen NPT, Nguyen HT, et al
    Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education Symposium.
    J Gynecol Oncol. 2023;34:e88.
    Abstract

  1645. SCHOLL S, Roufai DB, Cherif LL, Kamal M, et al
    RAIDS atlas of significant genetic and protein biomarkers in cervical cancer.
    J Gynecol Oncol. 2023;34:e74.
    Abstract

  1646. DE MUZIO F, Fusco R, Simonetti I, Grassi F, et al
    Functional assessment in endometrial and cervical cancer: diffusion and perfusion, two captivating tools for radiologists.
    Eur Rev Med Pharmacol Sci. 2023;27:7793-7810.
    Abstract

  1647. HIDESHIMA M, Hashiguchi M, Honda A, Umezaki Y, et al
    Are HPV-negative lesions concerned for the introduction of primary HPV testing for cervical cancer screening in Japan?
    J Obstet Gynaecol Res. 2023 Sep 4. doi: 10.1111/jog.15784.
    Abstract

  1648. GONG Z, Ge L, Ye S, Xu Y, et al
    Hsa_circ_0000069 Accelerates Cervical Cancer Progression by Sponging miR-1270 to Facilitate CPEB4 Expression.
    Biochem Genet. 2023 Sep 4. doi: 10.1007/s10528-023-10494.
    Abstract

  1649. FENG S, Zhao J, Yang T, Li L, et al
    TMPRSS11D/ALR-mediated ER stress regulates the function of myeloid-derived suppressor cells in the cervical cancer microenvironment.
    Int Immunopharmacol. 2023;124.
    Abstract

  1650. ZHANG Y, Li X, Zhang J, Mao L, et al
    USF1 regulated circPRDM4 modulates tumorigenesis and immune escape in chemoresistant cervical cancer.
    J Cell Mol Med. 2023 Sep 4. doi: 10.1111/jcmm.17945.
    Abstract

  1651. FUZZELL L, Lake P, Brownstein NC, Fontenot HB, et al
    Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study.
    Elife. 2023;12:e86358.
    Abstract

  1652. LIU H, Xie T, Liu Y
    Ginsenoside Rg3 inhibits the malignant progression of cervical cancer cell by regulating AKT2 expression.
    Heliyon. 2023;9:e19045.
    Abstract

  1653. TIAN W, Sun S, Wu B, Yu C, et al
    Development and validation of a deep learning algorithm for pattern-based classification system of cervical cancer from pathological sections.
    Heliyon. 2023;9:e19229.
    Abstract

  1654. TENKIR L, Mamuye A, Jemebere W, Yeheyis T, et al
    The magnitude of precancerous cervical lesions and its associated factors among women screened for cervical cancer at a referral center in southern Ethiopia, 2021: a cross-sectional study.
    Front Glob Womens Health. 2023;4:1187916.
    Abstract

  1655. HUANG J, Zeng X, Chen H, Luo D, et al
    Clinical analysis of decision implementation by a multidisciplinary team in cervical cancer cases in Ganzhou, China.
    Front Oncol. 2023;13:1160626.
    Abstract

  1656. ITANYI IU, Viglione C, Rositch AF, Olawepo JO, et al
    Rapid implementation mapping to identify implementation determinants and strategies for cervical cancer control in Nigeria.
    Front Public Health. 2023;11:1228434.
    Abstract

  1657. SHRESTHA IB, Bhusal S, Rajbanshi M, Mali P, et al
    Awareness of Cervical Cancer, Risk Perception, and Practice of Pap Smear Test among Young Adult Women of Dhulikhel Municipality, Nepal.
    J Cancer Epidemiol. 2023;2023:6859054.
    Abstract

  1658. RODRIGUEZ I, Rossi NM, Keskus A, Xie Y, et al
    Insights into the Mechanisms and Structure of Breakage-Fusion-Bridge Cycles in Cervical Cancer using Long-Read Sequencing.
    medRxiv. 2023 Aug 22:2023.08.21.23294276. doi: 10.1101/2023.08.21.23294276.
    Abstract

  1659. PALMER M, Katanoda K, Saito E, Acuti Martellucci C, et al
    Corrigendum to "Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis" [Vaccine 40(41) (2022) 5971-5996].
    Vaccine. 2023 Sep 1:S0264-410X(23)00787-9. doi: 10.1016/j.vaccine.2023.
    Abstract

  1660. WANG D, Wu S, He J, Sun L, et al
    FAT4 overexpression promotes antitumor immunity by regulating the beta-catenin/STT3/PD-L1 axis in cervical cancer.
    J Exp Clin Cancer Res. 2023;42:222.
    Abstract

  1661. LAWSON O, Ameyan L, Tukur Z, Dunu S, et al
    Cervical cancer screening outcomes in public health facilities in three states in Nigeria.
    BMC Public Health. 2023;23:1688.
    Abstract

  1662. BUDAK B, Kalin SN, Yapca OE
    Antiproliferative, antimigratory, and apoptotic effects of diffractaic and vulpinic acids as thioredoxin reductase 1 inhibitors on cervical cancer.
    Naunyn Schmiedebergs Arch Pharmacol. 2023 Sep 1. doi: 10.1007/s00210-023-02698.
    Abstract

  1663. XU H, Tian G, Wu C, Sun X, et al
    Meta-analysis of the efficacy and safety of Xihuang Pills/capsules in adjuvant treatment of uterine cervical neoplasms.
    Medicine (Baltimore). 2023;102:e34846.
    Abstract

  1664. HEINIG M, Schafer W, Langner I, Zeeb H, et al
    German mammography screening program: adherence, characteristics of (non-)participants and utilization of non-screening mammography-a longitudinal analysis.
    BMC Public Health. 2023;23:1678.
    Abstract

  1665. ENOMOTO T, Okamoto A, Kim JH, Lai CH, et al
    East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective.
    J Gynecol Oncol. 2023;34:e86.
    Abstract

  1666. ZHANG W, Che Q, Tan H, Qi X, et al
    A novel antimycin analogue antimycin A2c, derived from marine Streptomyces sp., suppresses HeLa cells via disrupting mitochondrial function and depleting HPV oncoproteins E6/E7.
    Life Sci. 2023;330:121998.
    Abstract

  1667. THAKUR K, Janjua D, Aggarwal N, Chhokar A, et al
    Physical interaction between STAT3 and AP1 in cervical carcinogenesis: Implications in HPV transcription control.
    Biochim Biophys Acta Mol Basis Dis. 2023;1869:166817.
    Abstract

  1668. ZHANG L, Ma J, Zhou D, Zhou J, et al
    Single-Nucleus Transcriptome Profiling of Locally Advanced Cervical Squamous Cell Cancer Identifies Neural-Like Progenitor Program Associated with the Efficacy of Radiotherapy.
    Adv Sci (Weinh). 2023;10:e2300348.
    Abstract

  1669. WANG L, Liu X, Zhang J, Li H, et al
    Comparison of ALA-PDT and CO(2) laser treatment of low-grade vaginal intraepithelial neoplasia with high-risk HPV infection: A non-randomized controlled pilot study.
    Photodiagnosis Photodyn Ther. 2023;43:103695.
    Abstract

  1670. MUKHERJEE A, Ye Y, Wiener HW, Kuniholm MH, et al
    Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Precancer.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1190-1197.
    Abstract

  1671. RECHT HS, Shampain KL, Flory MN, Nougaret S, et al
    Gynecologic oncology tumor board: the central role of the radiologist.
    Abdom Radiol (NY). 2023;48:3265-3279.
    Abstract

  1672. ZHUANG Y, Yang H
    The significance of nonsurgical therapies for cervical infection of high-risk human papilloma virus: A systematic review and meta-analysis.
    J Obstet Gynaecol Res. 2023;49:2213-2231.
    Abstract

  1673. KOBORI T, Ito Y, Doukuni R, Urashima Y, et al
    Radixin modulates the plasma membrane localization of CD47 in human uterine cervical adenocarcinoma cells.
    J Reprod Immunol. 2023;158:103982.
    Abstract

  1674. TANAKA M, Yamanoi K, Taki M, Kitamura S, et al
    High-grade vaginal intraepithelial neoplasia after hysterectomy for high-grade cervical intraepithelial neoplasia: Is hysterectomy a "definitive" treatment compared to conization?
    J Obstet Gynaecol Res. 2023;49:2361-2369.
    Abstract

  1675. QUINTAL C, Antunes M
    Picturing Prevalence and Inequalities in Cancer Screening Attendance to Population-Based Programs in Portugal.
    Acta Med Port. 2023;36:577-587.
    Abstract

  1676. PENG S, Zhang X, Wu Y
    Potential applications of DNA methylation testing technology in female tumors and screening methods.
    Biochim Biophys Acta Rev Cancer. 2023;1878:188941.
    Abstract

  1677. HISAMATSU Y, Kita M, Yokoe T, Butsuhara Y, et al
    A pilot study of repeated 5-aminolevulinic acid photodynamic therapy for cervical intraepithelial neoplasia by a newly developed intravaginal irradiation system.
    Photodiagnosis Photodyn Ther. 2023;43:103655.
    Abstract

  1678. FRANCO EL
    Homage to Georgios Papanikolaou: A pilgrimage to his birthplace.
    Cancer Cytopathol. 2023;131:546-547.
    Abstract

  1679. WELBY S, Feng Y, Tang H, Ye C, et al
    A feasibility assessment of real-world data capabilities for monitoring vaccine safety and effectiveness in China: Human papillomavirus vaccination in the Yinzhou district as a use case.
    Pharmacoepidemiol Drug Saf. 2023;32:1131-1141.
    Abstract

  1680. YANG EJ, Lee AJ, So KA, Lee SJ, et al
    Laparoscopic radical hysterectomy without uterine manipulator or vaginal tube use.
    J Gynecol Oncol. 2023;34:e63.
    Abstract

  1681. WU Y, Ying H, Wang J
    Myxoid leiomyosarcoma of the uterine cervix: A case report.
    Asian J Surg. 2023;46:3835-3836.
    Abstract

  1682. LIN X, Yoshikawa N, Liu W, Matsukawa T, et al
    DDIT4 Facilitates Lymph Node Metastasis via the Activation of NF-kappaB Pathway and Epithelial-Mesenchymal Transition.
    Reprod Sci. 2023;30:2829-2841.
    Abstract

  1683. ZHANG M, Xin L, Cheng B, Yan B, et al
    Clinical Value Analysis of Serum TK1, SCC-Ag, and MUC-1 in the Diagnosis and Prognosis Evaluation of Cervical Cancer.
    Altern Ther Health Med. 2023 Sep 15:AT9130.
    Abstract

  1684. LAWTON B, MacDonald EJ, Storey F, Stanton JA, et al
    A Model for Empowering Rural Solutions for Cervical Cancer Prevention (He Tapu Te Whare Tangata): Protocol for a Cluster Randomized Crossover Trial.
    JMIR Res Protoc. 2023;12:e51643.
    Abstract

  1685. SINGH G, Sharma SK, Dorata A, Singh SK, et al
    miR-17 ~ 92 suppresses proliferation and invasion of cervical cancer cells by inhibiting cell cycle regulator Cdt2.
    Discov Oncol. 2023;14:172.
    Abstract

  1686. HAN Y, Wang X, Li X, Chen J, et al
    Analysis of clinicopathological features and prognosis of double primary cervical cancer and ovarian cancer based on SEER database.
    J Cancer Res Clin Oncol. 2023 Sep 14. doi: 10.1007/s00432-023-05373.
    Abstract

  1687. IOVA CF, Badau D, Daina MD, Suteu CL, et al
    Evaluation of the Knowledge and Attitude of Adolescents Regarding the HPV Infection, HPV Vaccination and Cervical Cancer in a Region from the Northwest of Romania.
    Patient Prefer Adherence. 2023;17:2249-2262.
    Abstract

  1688. CHU M, Ji H, Li K, Liu H, et al
    Investigating the potential mechanism of quercetin against cervical cancer.
    Discov Oncol. 2023;14:170.
    Abstract

  1689. WAGNER GJ, Matovu JKB, Juncker M, Namisango E, et al
    Effects of a peer advocacy intervention on cervical cancer screening among social network members: results of a randomized controlled trial in Uganda.
    J Behav Med. 2023 Sep 13. doi: 10.1007/s10865-023-00418.
    Abstract

  1690. DHILLON SK, Chung PYJ, Padalko E, Praet M, et al
    Intra- and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay.
    J Med Virol. 2023;95:e29093.
    Abstract

  1691. WANG M, Liu K, Zhou Z, Geng H, et al
    miR-638 suppresses cervical cancer progression by inhibiting NCAPG2 under the treatment of Tetrandrine.
    Histol Histopathol. 2023 Aug 4:18657. doi: 10.14670.
    Abstract

  1692. HAN C, Huang W, Ye M, Zou R, et al
    HPV prevalence and genotype distribution in 2,306 patients with cervical squamous cell carcinoma in central and eastern China.
    Front Public Health. 2023;11:1225652.
    Abstract

  1693. HUANG Z, Jing H, Lv J, Chen Y, et al
    Investigating Doxorubicin's mechanism of action in cervical cancer: a convergence of transcriptomic and metabolomic perspectives.
    Front Genet. 2023;14:1234263.
    Abstract

  1694. SU X, Liu P, Zhao H, Sun L, et al
    Impact of HR-HPV infection on oncological outcomes in early cervical cancer.
    Front Oncol. 2023;13:1264114.
    Abstract

  1695. KULTALAHTI H, Heinavaara S, Sarkeala T, Pankakoski M, et al
    Effect of Test History at Ages 50-64 on Later Cervical Cancer Risk: A Population-based Case-control Study.
    Cancer Res Commun. 2023;3:1823-1829.
    Abstract

  1696. MIR BA, Ahmad A, Farooq N, Priya MV, et al
    Increased expression of HPV-E7 oncoprotein correlates with a reduced level of pRb proteins via high viral load in cervical cancer.
    Sci Rep. 2023;13:15075.
    Abstract

  1697. LIU C, Ran X, Wang Z, Zhang K, et al
    Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study.
    Chin Clin Oncol. 2023;12:38.
    Abstract

  1698. MOHAMMADI ESFANJANI S, Aghebati Maleki L, Nami S, Ebrahimi M, et al
    Induction of TLR5, IRAK1, and NF-kappaB expression by Trichomonas vaginalis in cervical cancer cell (HeLa) and normal human vaginal epithelial cell (HVECs) lines.
    J Infect Dev Ctries. 2023;17:1160-1167.
    Abstract

  1699. MURUGESAN B, Subramanian A, Bakthavachalam S, Rajendran K, et al
    Molecular insights of anticancer potential of usnic acid towards cervical cancer target proteins: An in silico validation for novel anti-cancer compound from lichens.
    J Biomol Struct Dyn. 2023 Sep 11:1-19. doi: 10.1080/07391102.2023.2252076.
    Abstract

  1700. MAKONI M
    Africa reaffirms commitments to eliminate cervical cancer.
    Lancet Oncol. 2023 Sep 8:S1470-2045(23)00450.
    Abstract

  1701. MOZES N, Feith HJ
    [Comparative study of factors influencing cytological screening for cervical cancer attendance in Hungary among Roma and non-Roma population, in relation to Slovak and Romanian results].
    Orv Hetil. 2023;164:1416-1425.
    Abstract

  1702. PU T, Jin Y, Tang C, Fu J, et al
    An innovative predictive model for cervical cancer constructed around a gene profile associated with cholesterol metabolism.
    Environ Toxicol. 2023 Sep 11. doi: 10.1002/tox.23969.
    Abstract

  1703. GAO F, Yin J, Wang Y, Li H, et al
    miR-182 promotes cervical cancer progression via activating the Wnt/beta-catenin axis.
    Am J Cancer Res. 2023;13:3591-3598.
    Abstract

  1704. ZHANG H, Wang X, Ma Y, Zhang Q, et al
    Review of possible mechanisms of radiotherapy resistance in cervical cancer.
    Front Oncol. 2023;13:1164985.
    Abstract

  1705. HUANG S, Qi Y, Chen S, He B, et al
    Effect of heat-clearing and dampness-eliminating Chinese medicine for high-risk cervical cancer papillomavirus infection: a systematic review and meta-analysis of randomized controlled trials.
    Front Med (Lausanne). 2023;10:1022030.
    Abstract

  1706. AKHLAQ A, Ashraf M, Omer MO, Altaf I, et al
    Carvacrol-Fabricated Chitosan Nanoparticle Synergistic Potential with Topoisomerase Inhibitors on Breast and Cervical Cancer Cells.
    ACS Omega. 2023;8:31826-31838.
    Abstract

  1707. DAI B
    A Comparison of Colour Doppler Ultrasound and 2D Ultrasound as Promising Prediction Methods for the Treatment effect of Patients with Advanced Cervical Cancer.
    Curr Med Imaging. 2023 Sep 8. doi: 10.2174/1573405620666230908111722.
    Abstract

  1708. ZUGHAIBI TA, Jabir NR, Khan AU, Khan MS, et al
    Screening of Cu(4) O(3) NPs efficacy and its anticancer potential against cervical cancer.
    Cell Biochem Funct. 2023 Sep 10. doi: 10.1002/cbf.3850.
    Abstract

  1709. LEUNG SMK, Wu J, Chan KKL, Jit M, et al
    Maximising the cost-effectiveness of human papillomavirus testing for cervical screening in the context of routine HPV vaccination in Hong Kong: abridged secondary publication.
    Hong Kong Med J. 2023;29 Suppl 4:11-15.
    Abstract

  1710. SCHIVARDI G, Casarin J, Habermann EB, Bews KA, et al
    Practice patterns and complications of hysterectomy for invasive cervical cancer after the LACC trial.
    Am J Obstet Gynecol. 2023 Sep 8:S0002-9378(23)00608.
    Abstract

  1711. LATUL YP, Ince C, van Trommel NE, van den Brandhof-van den Berg A, et al
    Handheld vital microscopy for the identification of microcirculatory alterations in cervical intraepithelial neoplasia and cervical cancer.
    Microvasc Res. 2023 Sep 8:104608. doi: 10.1016/j.mvr.2023.104608.
    Abstract

  1712. LIU L, Wu M, Huang A, Gao C, et al
    Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
    J Transl Med. 2023;21:611.
    Abstract

  1713. HAN S, Liu X, Ju S, Mu W, et al
    New mechanisms and biomarkers of lymph node metastasis in cervical cancer: reflections from plasma proteomics.
    Clin Proteomics. 2023;20:35.
    Abstract

  1714. JAAPAR FN, Parmin NA, Halim NHA, Hashim U, et al
    Micro-interdigitated electrodes genosensor based on Au-deposited nanoparticles for early detection of cervical cancer.
    Int J Biol Macromol. 2023;253.
    Abstract

  1715. ONUKI M, Takahashi F, Iwata T, Nakazawa H, et al
    Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study.
    Cancer Sci. 2023 Sep 8. doi: 10.1111/cas.15943.
    Abstract

  1716. YANG Y, Liao Y, Qing Y, Li H, et al
    Electrochemical DNA Biosensors with Dual-Signal Amplification Strategy for Highly Sensitive HPV 16 Detection.
    Sensors (Basel). 2023;23:7380.
    Abstract

  1717. KREGIELEWSKI K, Fraczek W, Grodzik M
    Graphene Oxide Enhanced Cisplatin Cytotoxic Effect in Glioblastoma and Cervical Cancer.
    Molecules. 2023;28:6253.
    Abstract

  1718. KARAMTI H, Alharthi R, Anizi AA, Alhebshi RM, et al
    Improving Prediction of Cervical Cancer Using KNN Imputed SMOTE Features and Multi-Model Ensemble Learning Approach.
    Cancers (Basel). 2023;15:4412.
    Abstract

  1719. MICHAAN N, Leshno M, Fire G, Safra T, et al
    Cost-Utility Analysis of Open Radical Hysterectomy Compared to Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer.
    Cancers (Basel). 2023;15:4325.
    Abstract

  1720. CAKIR MO, Bilge U, Naughton D, Ashrafi GH, et al
    Ficus carica Latex Modulates Immunity-Linked Gene Expression in Human Papillomavirus Positive Cervical Cancer Cell Lines: Evidence from RNA Seq Transcriptome Analysis.
    Int J Mol Sci. 2023;24:13646.
    Abstract

  1721. OKODO M, Okayama K, Sasagawa T, Teruya K, et al
    Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses.
    Int J Mol Sci. 2023;24:13151.
    Abstract

  1722. BRUNO V, Chiofalo B, Logoteta A, Brandolino G, et al
    Urological Complications in Radical Surgery for Cervical Cancer: A Comparative Meta-Analysis before and after LACC Trial.
    J Clin Med. 2023;12:5677.
    Abstract

  1723. SIMION L, Rotaru V, Cirimbei C, Gales L, et al
    Inequities in Screening and HPV Vaccination Programs and Their Impact on Cervical Cancer Statistics in Romania.
    Diagnostics (Basel). 2023;13:2776.
    Abstract

  1724. ALSALATIE M, Alquran H, Mustafa WA, Zyout A, et al
    A New Weighted Deep Learning Feature Using Particle Swarm and Ant Lion Optimization for Cervical Cancer Diagnosis on Pap Smear Images.
    Diagnostics (Basel). 2023;13:2762.
    Abstract

  1725. LI C, Chen L, Pan G, Zhang W, et al
    Deciphering complex breakage-fusion-bridge genome rearrangements with Ambigram.
    Nat Commun. 2023;14:5528.
    Abstract

  1726. RAFFA S, Lanfranchi F, Satragno C, Giannelli F, et al
    The prognostic value of FIGO staging defined by combining MRI and [(18)F]FDG PET/CT in patients with locally advanced cervical cancer.
    Curr Probl Cancer. 2023 Sep 5:101007. doi: 10.1016/j.currproblcancer.2023.101007
    Abstract

  1727. MARTINS LFL, Moreira MAM, Pinto RA, Reis NBD, et al
    Human Papillomavirus 16 Lineage D is Associated with High Risk of Cervical Cancer in the Brazilian Northeast Region.
    Rev Bras Ginecol Obstet. 2023;45:e474-e479.
    Abstract

  1728. GE BB, Liu Y, Jin JH, Wu JT, et al
    Effect of bladder filling status on positioning errors in post-hysterectomy cervical cancer radiotherapy.
    Ann Med. 2023;55:2249936.
    Abstract

  1729. ZHANG Y, Xu L, Li L
    The feasibility of using the compound kushen injection to treat cervical cancer based on network pharmacology and transcriptomics.
    Medicine (Baltimore). 2023;102:e35135.
    Abstract

  1730. VAN TRAPPEN P
    Robotic para-aortic sentinel lymph node mapping in endometrial, cervical, and ovarian cancer.
    Best Pract Res Clin Obstet Gynaecol. 2023;90:102402.
    Abstract

  1731. HUIYUN J, Jie D, Huan W, Yuebo Y, et al
    Prevalence and characteristics of cervical human papillomavirus genotypes and cervical lesions among 58630 women from Guangzhou, China.
    J Infect Public Health. 2023;16:1531-1536.
    Abstract

  1732. WANG L, Chen G, Zhou C, Wu C, et al
    Expression and Significance of MTA2 and CPNE1 in Cervical Squamous Cell Carcinoma.
    Appl Immunohistochem Mol Morphol. 2023;31:569-573.
    Abstract

  1733. BARTIN R, Delangle R, Mergui JL, Azais H, et al
    Impact of cervical excisional dimensions on endocervical margins status in adenocarcinoma in situ of the uterine cervix: A multicenter study from the FRANCOGYN group.
    J Gynecol Obstet Hum Reprod. 2023;52:102622.
    Abstract

  1734. YUAN L, Dong X, Chen M, Yao L, et al
    A Vascular Centered Surgical Approach to Radical Hysterectomy: Laparoscopic Anatomy of Pelvic Vascular System Revisited.
    J Minim Invasive Gynecol. 2023;30:692.
    Abstract

  1735. KISELEVA M, Lescot T, Selivanova SV, Fortin MA, et al
    Gold-Enhanced Brachytherapy by a Nanoparticle-Releasing Hydrogel and 3D-Printed Subcutaneous Radioactive Implant Approach.
    Adv Healthc Mater. 2023;12:e2300305.
    Abstract

  1736. GROVER S, MacDuffie E, Nsingo M, Lei X, et al
    Benchmarking of the Cervical Cancer Care Cascade and Survival Outcomes After Radiation Treatment in a Low- and Middle-Income Country Setting.
    JCO Glob Oncol. 2023;9:e2200397.
    Abstract

  1737. MREMA AS, Ngoma M, Josiah C, Lugina E, et al
    HIV and Early Treatment Outcomes Among Women With Cervical Cancer Treated With Concurrent Chemoradiation in Tanzania.
    JCO Glob Oncol. 2023;9:e2200441.
    Abstract

  1738. AMECK K, Kutha B, Jessica P, Rosemary M, et al
    Towards cervical cancer elimination in Zambia: Stakeholder views on lessons learned, progress to date, and future needs and priorities.
    Afr J Reprod Health. 2023;27:28-38.
    Abstract

  1739. LI J, Wan C, Li X, Quan C, et al
    Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer.
    J Transl Med. 2023;21:647.
    Abstract

  1740. HAN EJ, Choi EY, Jeon SJ, Lee SW, et al
    Piperlongumine induces apoptosis and autophagy via the PI3K/Akt/mTOR pathway in KB human cervical cancer cells.
    Food Chem Toxicol. 2023 Sep 19:114051. doi: 10.1016/j.fct.2023.114051.
    Abstract

  1741. SASSENOU J, Ringa V, Zins M, Ozguler A, et al
    Combined influence of immigration status and income on cervical cancer screening uptake.
    Prev Med Rep. 2023;36:102363.
    Abstract

  1742. YANG S, Zhang Z, Shen L
    Prognostic significance of C-reactive protein in patients with cervical cancer: a meta-analysis.
    Front Oncol. 2023;13:1232409.
    Abstract

  1743. KURMYSHKINA OV, Dobrynin PV, Kovchur PI, Volkova TO, et al
    Sequencing-based transcriptome analysis reveals diversification of immune response- and angiogenesis-related expression patterns of early-stage cervical carcinoma as compared with high-grade CIN.
    Front Immunol. 2023;14:1215607.
    Abstract

  1744. ZHONG J, Huang L, Su M, Wu M, et al
    Ultrasound Microvessel Visualization in Cervical Cancer: Association Between Novel Ultrasound Techniques and Histologic Microvessel Densities.
    Ultrasound Med Biol. 2023 Sep 18:S0301-5629(23)00278.
    Abstract

  1745. JODRY D, Obedin-Maliver J, Flowers L, Jay N, et al
    Understanding Sexual and Gender Minority Populations and Organ-Based Screening Recommendations for Human Papillomavirus-Related Cancers.
    J Low Genit Tract Dis. 2023;27:307-321.
    Abstract


  1746. miR-4429 Regulates the Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Cervical Cancer by Targeting FOXM1 [Retraction].
    Cancer Manag Res. 2023;15:1009-1010.
    Abstract


  1747. MiR-29a Function as Tumor Suppressor in Cervical Cancer by Targeting SIRT1 and Predict Patient Prognosis [Retraction].
    Onco Targets Ther. 2023;16:749-750.
    Abstract

  1748. OOKO F, Mothiba T, Van Bogaert P, Wens J, et al
    Access to palliative care in patients with advanced cancer of the uterine cervix in the low- and middle-income countries: a systematic review.
    BMC Palliat Care. 2023;22:140.
    Abstract

  1749. SUN L, Patel S, Fiorina C, Glass A, et al
    A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe.
    Eur J Health Econ. 2023 Sep 20. doi: 10.1007/s10198-023-01627.
    Abstract

  1750. MUYA S, Ndumbalo J, Kutika Nyagabona S, Yusuf S, et al
    Feasibility and Clinical Acceptability of Automation-Assisted 3D Conformal Radiotherapy Planning for Patients With Cervical Cancer in a Resource-Constrained Setting.
    JCO Glob Oncol. 2023;9:e2300050.
    Abstract

  1751. JIANG X, Zhang S, Fu Y, Yu H, et al
    Assembling High-Quality Lymph Node Clinical Target Volumes for Cervical Cancer Radiotherapy Using a Deep Learning-Based Approach.
    Curr Med Imaging. 2023 Sep 15. doi: 10.2174/1573405620666230915125606.
    Abstract

  1752. SONG XC, Zhang H, Zhong S, Tan XJ, et al
    [Value of postoperative radiotherapy and analysis of prognostic factors in early-stage neuroendocrine carcinoma of cervix].
    Zhonghua Fu Chan Ke Za Zhi. 2023;58:680-690.
    Abstract

  1753. RAJABI A, Dastmalchi N, Shokri N, Tayefeh-Gholami S, et al
    Expression Level of lncRNA CYTOR in Iranian Cervical Cancer Patients.
    Rep Biochem Mol Biol. 2023;12:120-126.
    Abstract

  1754. ASARE M, Lanning BA, Montealegre JR, Akowuah E, et al
    Determinants of Low-Income Women's Participation in Self-Collected Samples for Cervical Cancer Detection: Application of the Theory of Planned Behavior.
    Community Health Equity Res Policy. 2023;44:65-76.
    Abstract

  1755. ZHANG YH, Martin S, Liu H, Todor D, et al
    Utilizing a novel hybrid brachytherapy technique FINITO (Freehand Interstitial Needles in addition to Tandem and Ovoid) for locally advanced cervical cancer.
    Brachytherapy. 2023 Sep 16:S1538-4721(23)00082.
    Abstract

  1756. LANDE PS, Adhao VS, Ambhore JP, Gaikwad KP, et al
    Anticancer action of naturally occurring emodin for the controlling of cervical cancer.
    Explor Target Antitumor Ther. 2023;4:690-698.
    Abstract

  1757. SUN Z, Xiang D, Jiang J, Luo S, et al
    Cervical cancer heart metastasis presents as a giant mass.
    Eur Heart J Case Rep. 2023;7:ytad445.
    Abstract

  1758. SATO M, Tamauchi S, Yoshida K, Yoshihara M, et al
    Unclear tumor border in magnetic resonance imaging as a prognostic factor of squamous cell cervical cancer.
    Sci Rep. 2023;13:15392.
    Abstract

  1759. YANG JY, Li Y, Shi J, Wan SM, et al
    CNIH4 governs cervical cancer progression through reducing ferroptosis.
    Chem Biol Interact. 2023 Sep 14:110712. doi: 10.1016/j.cbi.2023.110712.
    Abstract

  1760. WU M, Ye M
    Transcription factor Dp-1 knockdown downregulates thymidine kinase 1 expression to protect against proliferation and epithelial-mesenchymal transition in cervical cancer.
    Funct Integr Genomics. 2023;23:301.
    Abstract

  1761. ERKIN O
    How did adult women's fear of COVID-19 affect their attitudes toward cervical cancer screening? An example of Turkey.
    Afr J Reprod Health. 2023;27:77-87.
    Abstract

  1762. CHEN H, Ren S, Wan H, Wei W, et al
    DUSP1 regulates the JAK2/STAT3 signaling pathway through targeting miR-21 in cervical cancer cells.
    Cell Mol Biol (Noisy-le-grand). 2023;69:40-44.
    Abstract

  1763. ZHAO X, Li S, Wen J, Li Y, et al
    The expression and clinical value of LRP11, FUBP1 and TET1 in cervical cancer.
    Cell Mol Biol (Noisy-le-grand). 2023;69:80-84.
    Abstract


  1764. A vaccine against the cervical-cancer virus shows its prowess.
    Nature. 2023;621:447.
    Abstract

  1765. HE L, Li P, Zhang H
    Clinical significance of MATN1-AS1 as ceRNA of Mir-200b in tissues and serum of patients with cervical cancer.
    Sci Rep. 2023;13:15336.
    Abstract

  1766. HU Y, Jin Y, Wang D, Luo Y, et al
    Observation of hemostatic effectiveness and safety of ultrasound-CT guided 3D intracavitary and interstitial brachytherapy in the treatment of larger cervical cancer with bleeding: A retrospective study.
    Medicine (Baltimore). 2023;102:e34904.
    Abstract

  1767. BERTOLAZZI MA, Genta MLND, Carvalho F, Baracat EC, et al
    Successful Pre-Treatment Ovarian Fresh Tissue Transplantation in a Cervical Cancer Patient Undergoing Radiation Therapy: A Case Report.
    Cureus. 2023;15:e43472.
    Abstract

  1768. FALCARO M, Sasieni P, Castanon A
    audit_cc: A Stata command for the analysis of matched case-control audits of cervical cancer screening.
    Inform Med Unlocked. 2023;38:101182.
    Abstract

  1769. MINCHEW LA, Cesario SK, Richmond MM, Mbango CM, et al
    Examining the Burden of Self-Blame Attribution Among Women With Cervical Cancer.
    J Holist Nurs. 2023 Sep 14:8980101231194218. doi: 10.1177/08980101231194218.
    Abstract

  1770. GRACIA M, Rodriguez E, Diestro MD, Spagnolo E, et al
    Impact of the Covid-19 pandemic on the management of gynecologic cancer: a Spanish survey. Observational, multicenter study.
    BMC Womens Health. 2023;23:488.
    Abstract

  1771. SHUKLA S, Vishwakarma C, Sah AN, Ahirwar S, et al
    Smartphone-based fluorescence spectroscopic device for cervical precancer diagnosis: a random forest classification of in vitro data.
    Appl Opt. 2023;62:6826-6834.
    Abstract

  1772. MIRAHMAD A, Hafez Ghoran S, Alipour P, Taktaz F, et al
    Oliveria decumbens Vent. (Apiaceae): Biological screening and chemical compositions.
    J Ethnopharmacol. 2024;318.
    Abstract

  1773. CHU B, Dong J, Chen Y, Ru X, et al
    Triage Value of Cervical Exfoliated Cell DNA Ploidy Analysis in Cervical High-Risk Human Papillomavirus-Positive Women.
    J Low Genit Tract Dis. 2023;27:331-336.
    Abstract

  1774. LETAFATI A, Sakhavarz T, Khosravinia MM, Ardekani OS, et al
    Exploring the correlation between progression of human papillomavirus infection towards carcinogenesis and nutrition.
    Microb Pathog. 2023;183:106302.
    Abstract

  1775. CHI Y, Shi L, Lu S, Cui H, et al
    Inhibitory effect of Lonicera japonica-derived exosomal miR2911 on human papilloma virus.
    J Ethnopharmacol. 2024;318.
    Abstract

  1776. FUJITA Y, Fukuda Y, Sanuki F, Irei I, et al
    Protease-Activated Receptor 1 (PAR1) Expression Contributes to HPV-Associated Oropharyngeal Cancer Prognosis.
    Head Neck Pathol. 2023;17:658-672.
    Abstract

  1777. ING BI, Scott ME, Lentz SE
    Opportunities Missed: Cervix Cancer Screening Failures in Women Aged 65 and Older.
    J Low Genit Tract Dis. 2023;27:337-342.
    Abstract

  1778. ISNARD C, Chanal J, Bergeron C, Aynaud O, et al
    High-grade cervical squamous intraepithelial lesions in female partners of men with high-grade penile squamous intraepithelial lesions: a monocentric retrospective study.
    Br J Dermatol. 2023;189:485-486.
    Abstract

  1779. ECE GT, Pira D, Bodur GL
    Prevalence and distribution of high-risk Human Papillomavirus in Western Turkiye between 2019 and 2022.
    Acta Microbiol Immunol Hung. 2023;70:252-257.
    Abstract

  1780. KULKARNI A, Covens A, Durand N, Ghorab Z, et al
    Role of HPV in the Prediction of Persistence/Recurrence After Treatment for Cervical Precancer.
    J Obstet Gynaecol Can. 2023;45:102171.
    Abstract

  1781. FERNANDES FP, Cambui RAG, Soares JLDS, Reis ECD, et al
    Cervical carcinoma induces NLRP3 inflammasome activation and IL-1ss release in human peripheral blood monocytes affecting patients' overall survival.
    Clin Transl Oncol. 2023;25:3277-3286.
    Abstract

  1782. LI C, Hua K
    Single-cell transcriptomics provides insights into the origin and immune microenvironment of cervical precancerous lesions.
    Cancer Commun (Lond). 2023;43:1055-1058.
    Abstract

  1783. KEIM-MALPASS J, Vavolizza RD, Cohn WF, Kennedy EM, et al
    Cancer Screening and Treatment Delays During the COVID-19 Pandemic and the Role of Health Literacy in Care Re-engagement: Findings from an NCI-Designated Comprehensive Cancer Center sample.
    J Cancer Educ. 2023;38:1405-1412.
    Abstract

  1784. XIAO X, Yan L, Yang X, Zhou Z, et al
    Optical Coherence Tomography Can Reduce Colposcopic Referral Rates in Patients With High-Risk Human Papillomavirus.
    J Low Genit Tract Dis. 2023;27:324-330.
    Abstract

  1785. TAMMARO A, Kulakowska KA, Adebanjo GAR, Parisella FR, et al
    Oral and genital mucosa lesions in patients with COVID-19: a multicentric case series.
    Int J Dermatol. 2023;62:e554-e556.
    Abstract

  1786. LI Q, Wang X, Liu J, Wu L, et al
    POT1 involved in telomeric DNA damage repair and genomic stability of cervical cancer cells in response to radiation.
    Mutat Res Genet Toxicol Environ Mutagen. 2023;891:503670.
    Abstract

  1787. YUE S, Wang Q, Zhang J, Hu Q, et al
    Understanding cervical cancer at single-cell resolution.
    Cancer Lett. 2023 Sep 26:216408. doi: 10.1016/j.canlet.2023.216408.
    Abstract

  1788. BREVIK TB, da Matta Calegari LR, Metcalfe IM, Laake P, et al
    Training health care providers to administer VIA as a screening test for cervical cancer: a systematic review of essential training components.
    BMC Med Educ. 2023;23:712.
    Abstract

  1789. WAGNER GJ, Matovu JK, Juncker M, Namisango E, et al
    Knowledge Mediates the Effects of Game Changers for Cervical Cancer Prevention (GC-CCP) Intervention on Increased VIA Screening Advocacy in Uganda.
    Cancer Prev Res (Phila). 2023 Sep 28. doi: 10.1158/1940-6207.CAPR-23-0262.
    Abstract

  1790. NAIR V, Dau H, Vidler M, AboMoslim M, et al
    Understanding the cervical cancer self-collection preferences of women living in urban and rural Rwanda.
    PLOS Glob Public Health. 2023;3:e0002135.
    Abstract

  1791. YANG W, An L, Li Y, Qian S, et al
    A cellular senescence-related genes model allows for prognosis and treatment stratification of cervical cancer: a bioinformatics analysis and external verification.
    Aging (Albany NY). 2023;15.
    Abstract

  1792. YE Y, Zhang G, Li Z, Chen B, et al
    Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.
    Cancer Med. 2023 Sep 28. doi: 10.1002/cam4.6586.
    Abstract

  1793. RAMIREZ AT, Valls J, Baena A, Rojas FD, et al
    Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study.
    Lancet Reg Health Am. 2023;26:100593.
    Abstract

  1794. CI LQ, Huang ZG, Lv FM, Wang J, et al
    Correction: Ci et al. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics 2019, 11, 15.
    Pharmaceutics. 2023;15:2188.
    Abstract

  1795. ASHENAFI T, Stroetmann CY, Getachew S, Addissie A, et al
    Characteristics of Women Seeking Cervical Cancer Cytology Screening in a Private Health Facility.
    Medicina (Kaunas). 2023;59:1624.
    Abstract

  1796. BIANCHI T, Grassi T, Bazzurini L, Di Martino G, et al
    Radical Hysterectomy in Early-Stage Cervical Cancer: Abandoning the One-Fits-All Concept.
    J Pers Med. 2023;13:1292.
    Abstract

  1797. WATKINS DE, Craig DJ, Vellani SD, Hegazi A, et al
    Advances in Targeted Therapy for the Treatment of Cervical Cancer.
    J Clin Med. 2023;12:5992.
    Abstract

  1798. CHUA B, Lim LM, Ng JSY, Ma Y, et al
    Correction: Chua et al. Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore. Cancers 2023, 15, 1812.
    Cancers (Basel). 2023;15:4658.
    Abstract

  1799. CHEUNG ES, Law FC, Fung NT, Soong IS, et al
    Simultaneous Integrated Boost for Dose Escalation in Node-Positive Cervical Cancer: 5-Year Experience in a Single Institution.
    Cancers (Basel). 2023;15:4647.
    Abstract

  1800. DENNY L, Saidu R, Boa R, Mbatani N, et al
    Point-of-care testing with Xpert HPV for single-visit, screen-and-treat for cervical cancer prevention: a demonstration study in South Africa.
    Sci Rep. 2023;13:16182.
    Abstract

  1801. EGEMEN D, Perkins RB, Cheung LC, Befano B, et al
    AI-based image analysis in clinical testing: lessons from cervical cancer screening.
    J Natl Cancer Inst. 2023 Sep 27:djad202. doi: 10.1093.
    Abstract

  1802. HOBENU KA, Naab F
    A qualitative exploration of the spiritual wellbeing of women with advanced cervical cancer in Ghana.
    Int J Palliat Nurs. 2023;29:434-444.
    Abstract

  1803. SHU Q, He X, Chen X, Liu M, et al
    Head-to-Head Comparison of 18F-FDG and 68Ga-FAPI-04 PET/CT for Radiological Evaluation of Cervical Cancer.
    Clin Nucl Med. 2023 Sep 19. doi: 10.1097/RLU.0000000000004833.
    Abstract

  1804. LI J, Chen S, Wu J, Liu X, et al
    Pathogenomics model for personalized medicine in cervical cancer: Cross-talk of gene expressions and pathological images related to oxidative stress.
    Environ Toxicol. 2023 Sep 26. doi: 10.1002/tox.23974.
    Abstract

  1805. YADAV N, Singh M, Mishra SP, Ansari S, et al
    Development of an Anthropomorphic Heterogeneous Female Pelvic Phantom and Its Comparison with a Homogeneous Phantom in Advance Radiation Therapy: Dosimetry Analysis.
    Med Sci (Basel). 2023;11:59.
    Abstract

  1806. KHAN S, Sheikh T, Castro G, Barengo NC, et al
    Effect Modification of Race on the Associated Tumor Size at Diagnosis and 10-Year Cancer Survival Rates in Women with Cervical Squamous Cell Carcinoma in the United States.
    Int J Environ Res Public Health. 2023;20:6742.
    Abstract

  1807. ALMOMEN A, Badran M, Alhowyan AA, Alkholief M, et al
    Imiquimod-Loaded Chitosan-Decorated Di-Block and Tri-Block Polymeric Nanoparticles Loaded In Situ Gel for the Management of Cervical Cancer.
    Gels. 2023;9:713.
    Abstract

  1808. TANG B, Dou S
    Knockdown of PAF1 reduces cervical cancer cell proliferation, migration and invasion via retarding FLOT2-mediated MEK/ERK1/2 pathway.
    Cell Adh Migr. 2023;17:1-10.
    Abstract

  1809. MULCAHY SYMMONS S, Leavy P, Heavey L, Mason Mohan C, et al
    How is equity captured for colorectal, breast and cervical cancer incidence and screening in the Republic of Ireland: A review.
    Prev Med Rep. 2023;36:102405.
    Abstract

  1810. WANG L, Yi S, Teng Y, Li W, et al
    Role of the tumor microenvironment in the lymphatic metastasis of cervical cancer (Review).
    Exp Ther Med. 2023;26:486.
    Abstract

  1811. LI J, Wang Y, Huo L, Huang X, et al
    Definitive irradiation as a first treatment strategy for primary and metastatic sites of newly diagnosed IVB cervical cancer that presented with synchronous oligometastases.
    Radiat Oncol. 2023;18:159.
    Abstract

  1812. LIU L, Deng X, Guo S, Yang S, et al
    Successful neoadjuvant chemotherapy plus sintilimab for locally advanced cervical cancer: case series and review of the literature.
    Diagn Pathol. 2023;18:107.
    Abstract

  1813. ALIFU N, Ma R, Zhu L, Du Z, et al
    Retraction: A novel TMTP1-modified theranostic nanoplatform for targeted in vivo NIR-II fluorescence imaging-guided chemotherapy for cervical cancer.
    J Mater Chem B. 2023 Sep 26. doi: 10.1039/d3tb90178.
    Abstract

  1814. WANG M, Li Z
    Prediction of prognosis and immune landscape in cervical cancer based on heat shock protein-related genes.
    Int J Hyperthermia. 2023;40:2259140.
    Abstract

  1815. MCGINNIS JM, Pond GR, Reade CJ, Schnarr KL, et al
    Evaluating equity of access and predictors of minimally invasive hysterectomy for endometrial and cervical cancer from 2000 to 2017 in Ontario, Canada: A population-based cohort study.
    J Surg Oncol. 2023 Sep 26. doi: 10.1002/jso.27461.
    Abstract

  1816. KUTZ JM, Rausche P, Rasamoelina T, Ratefiarisoa S, et al
    Female genital schistosomiasis, human papilloma virus infection, and cervical cancer in rural Madagascar: a cross sectional study.
    Infect Dis Poverty. 2023;12:89.
    Abstract

  1817. BECERRA-CANALES B, Campos M, Atuncar-Deza S, Caceres-Yparraguirre H, et al
    Prevalence and factors associated with cervical cancer preventive screening in a Peruvian region.
    Medwave. 2023;23.
    Abstract

  1818. TABRIZI-NEZHADI P, MotieGhader H, Maleki M, Sahin S, et al
    Application of Protein-Protein Interaction Network Analysis in Order to Identify Cervical Cancer miRNA and mRNA Biomarkers.
    ScientificWorldJournal. 2023;2023:6626279.
    Abstract

  1819. ZRAIDI M, Ibriz M
    Human papillomavirus vaccination in view of the National Cancer Control Plan 2020-2029 in Morocco.
    Pan Afr Med J. 2023;45:115.
    Abstract

  1820. ZRAIDI M, Ibriz M
    [Epidemiological and clinical profile of cervical cancer in Morocco: cases in the Gharb region].
    Pan Afr Med J. 2023;45:114.
    Abstract

  1821. LIU X, Wang CX, Feng Q, Zhang T, et al
    lncRNA TINCR promotes the development of cervical cancer via the miRNA?7/mTOR axis in vitro.
    Exp Ther Med. 2023;26:487.
    Abstract

  1822. LI X, Zhang X, Li A, Xie P, et al
    Editorial: The role of maintenance therapy (immunotherapy, targeted therapy, etc) in cancer control and biologic behavior of recurrent/metastatic cervical cancer.
    Front Immunol. 2023;14:1281775.
    Abstract

  1823. BACORRO W, Olonan BN, Co HC, Fineza-Dela Cruz AM, et al
    Challenges and opportunities in the implementation of advanced brachytherapy programs for cervical cancer in the Philippines.
    Asia Pac J Clin Oncol. 2023 Sep 24. doi: 10.1111/ajco.14012.
    Abstract

  1824. PHAN NTH, Tran QT, Nguyen NPT, Nguyen HT, et al
    Erratum: Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education Symposium.
    J Gynecol Oncol. 2023 Sep 18. doi: 10.3802/jgo.2023.
    Abstract

  1825. ABAH AU, Omokhapue A, Adewole A, Usifoh N, et al
    Environmental and psychosocial predictors of cervical cancer screening among women in Gwagwalada Area Council, Abuja, North Central, Nigeria.
    Afr J Reprod Health. 2023;27:32-42.
    Abstract

  1826. JOLLY PE, Junkins A, Aung M
    Sociodemographic characteristics, attitudes, and knowledge associated with previous screening for cervical cancer among women in western Jamaica.
    Infect Agent Cancer. 2023;18:53.
    Abstract

  1827. QU N, Meng Y, Zhai J, Griffin N, et al
    Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b(+) NCR1(+) NKs of tumor microenvironment.
    Int Immunopharmacol. 2023;124.
    Abstract

  1828. SHENG B, Wang W, Xia D, Qu X, et al
    Panobinostat (LBH589) combined with AM1241 induces cervical cancer cell apoptosis through autophagy pathway.
    BMC Pharmacol Toxicol. 2023;24:45.
    Abstract

  1829. KASSYMBEKOVA F, Zhetpisbayeva I, Tcoy E, Dyussenov R, et al
    Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: a mixed-methods study protocol.
    BMJ Open. 2023;13:e074097.
    Abstract

  1830. ZHAO XL, Hu SY, Hu JW, Wang HH, et al
    Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward.
    Infect Dis Poverty. 2023;12:86.
    Abstract

  1831. JI J, Zhang W, Dong Y, Lin R, et al
    Automated cervical cell segmentation using deep ensemble learning.
    BMC Med Imaging. 2023;23:137.
    Abstract

  1832. SCHIMUNEK L, Schopp K, Wagner M, Brucker SY, et al
    Hyperspectral imaging as a new diagnostic tool for cervical intraepithelial neoplasia.
    Arch Gynecol Obstet. 2023;308:1525-1530.
    Abstract

  1833. BIEHL R, Efre A
    Improving human papilloma virus vaccination rates among adolescents.
    J Am Assoc Nurse Pract. 2023;35:642-645.
    Abstract

  1834. MINAMITANI M, Mukai T, Tatemichi M, Katano A, et al
    [A report of five cancer screening rates and the related measures for cancer control in the workplace, surveyed by the Corporate Action to Promote Cancer Control].
    Sangyo Eiseigaku Zasshi. 2023;65:231-247.
    Abstract

  1835. CHEN X, Aljrees T, Umer M, Saidani O, et al
    Cervical cancer detection using K nearest neighbor imputer and stacked ensemble learningmodel.
    Digit Health. 2023;9:20552076231203802.
    Abstract

  1836. METHODS IN MEDICINE CAM
    Retracted: Effect of Comprehensive Care Based on Appropriate Chinese Medicine Techniques on Urinary Retention and Bladder Function Recovery after Total Hysterectomy in Patients with Cervical Cancer.
    Comput Math Methods Med. 2023;2023:9761425.
    Abstract

  1837. SAWADA M, Shiraishi Y, Toyama H, Tanaka T, et al
    Dosimetric comparison of rectal dose-reductive techniques in intra-cavitary brachytherapy for cervical cancer: A retrospective analysis.
    J Contemp Brachytherapy. 2023;15:269-274.
    Abstract

  1838. ELMALI A, Biltekin F, Sari SY, Gultekin M, et al
    Inter-observer variation of target volume delineation for CT-guided cervical cancer brachytherapy.
    J Contemp Brachytherapy. 2023;15:253-260.
    Abstract

  1839. GROSSMANN LM, Napierala H, Herrmann WJ
    Differences in breast and cervical cancer screening between West and East Germany: a secondary analysis of a german nationwide health survey.
    BMC Public Health. 2023;23:1931.
    Abstract

  1840. FLEMING GF
    Flashback Foreword: Concurrent Chemotherapy/Radiotherapy for Cervical Cancer.
    J Clin Oncol. 2023;41:4603-4604.
    Abstract

  1841. WANG X, Shuai G, Xu J, Liu M, et al
    HPV16 E7 oncoprotein test as a triage strategy for HPV16-positive women in cervical cancer screening: long-term follow-up outcome.
    Front Oncol. 2023;13:1221962.
    Abstract

  1842. WANG Y, Chen Y, Wang M, Qin Z, et al
    Oncological and reproductive outcomes of conization combined with pelvic node evaluation in patients with early-stage cervical cancer: a systematic review and meta-analysis.
    Front Oncol. 2023;13:1251453.
    Abstract

  1843. MAURO GP, de Aquino Calheiros V, Vonsowski MS, Avelar T, et al
    Curative treatment for stage IIIC2 cervical cancer: what to expect?
    Rep Pract Oncol Radiother. 2023;28:332-339.
    Abstract

  1844. QU X, Wang Y, Jiang Q, Ren T, et al
    Interactions of Indoleamine 2,3-dioxygenase-expressing LAMP3(+) dendritic cells with CD4(+) regulatory T cells and CD8(+) exhausted T cells: synergistically remodeling of the immunosuppressive microenvironment in cervical cancer and therapeutic implic
    Cancer Commun (Lond). 2023 Oct 4. doi: 10.1002/cac2.12486.
    Abstract

  1845. SIVARS L, Holzhauser S, Ramqvist T, Tham E, et al
    Prevalence of human papillomavirus (HPV) types 16 and 18 in cervical cancer in Stockholm, Sweden during 2019-2023 compared to 2003-2008.
    Acta Oncol. 2023 Oct 4:1-4. doi: 10.1080/0284186X.2023.2264485.
    Abstract

  1846. XU L, Tan Y, Xiang P, Luo Y, et al
    Diet-Related Risk Factors for Cervical Cancer: Data from National Health and Nutrition Examination Survey 1999-2018.
    Nutr Cancer. 2023 Oct 4:1-8. doi: 10.1080/01635581.2023.2261649.
    Abstract

  1847. AGOSTINELLI V, Musacchio L, Camarda F, Salutari V, et al
    Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data.
    Cancer Manag Res. 2023;15:1063-1072.
    Abstract

  1848. MORSE RM, Brown J, Gage JC, Prieto BA, et al
    "Easy women get it": Pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program.
    Res Sq. 2023 Sep 11:rs.3.rs-3256535. doi: 10.21203/rs.3.rs-3256535.
    Abstract

  1849. JALLAH JK, Anjankar A, Nankong FA
    Public Health Approach in the Elimination and Control of Cervical Cancer: A Review.
    Cureus. 2023;15:e44543.
    Abstract

  1850. KEDIA M, Khatun S, Phukon U, Shankar B, et al
    Trinuclear rhenium(I)-based metallocages as anticancer agents towards human cervical cancer cells.
    Dalton Trans. 2023 Oct 4. doi: 10.1039/d3dt02535.
    Abstract

  1851. DE HOND YJM, van Haaren PMA, Verrijssen AE, Tijssen RHN, et al
    Inter-observer variability in library plan selection on iterative CBCT and synthetic CT images of cervical cancer patients.
    J Appl Clin Med Phys. 2023 Oct 3:e14170. doi: 10.1002/acm2.14170.
    Abstract

  1852. SINGH N, Rajput S, Jaiswar SP
    Correlation of menstrual hygiene management with cervical intraepithelial neoplasia and cervical cancer.
    J Cancer Res Ther. 2023;19:1148-1152.
    Abstract

  1853. DIAKITE I, Kyle J, Situ S, Bai P, et al
    Public health impact of 2-, 4-, and 9-valent HPV vaccination in females on cervical and noncervical diseases in men and women under different coverage scenarios in China: A simulation study.
    Hum Vaccin Immunother. 2023;19:2258569.
    Abstract

  1854. CIBI A, Rose RJ
    Classification of stages in cervical cancer MRI by customized CNN and transfer learning.
    Cogn Neurodyn. 2023;17:1261-1269.
    Abstract

  1855. MUTHAMILSELVAN S, Palaniappan A
    CESCProg: a compact prognostic model and nomogram for cervical cancer based on miRNA biomarkers.
    PeerJ. 2023;11:e15912.
    Abstract

  1856. FITCH KC, Nguyen CGT, Vasquez Guzman CE, Holmes RS, et al
    Persistent cervical cancer disparities among American Indian/Alaska Native women: a systematic scoping review exploring the state of the science in this population.
    Cancer Causes Control. 2023 Oct 3. doi: 10.1007/s10552-023-01799.
    Abstract

  1857. AKASH S, Bayil I, Hossain MS, Islam MR, et al
    Novel computational and drug design strategies for inhibition of human papillomavirus-associated cervical cancer and DNA polymerase theta receptor by Apigenin derivatives.
    Sci Rep. 2023;13:16565.
    Abstract

  1858. LIU X, Liu Z, Liu Y, Wang N, et al
    ATG9A modulated by miR-195-5p can boost the malignant progression of cervical cancer cells.
    Epigenetics. 2023;18:2257538.
    Abstract

  1859. KABUKYE JK, Namugga J, Mpamani CJ, Katumba A, et al
    Implementing Smartphone-Based Telemedicine for Cervical Cancer Screening in Uganda: Qualitative Study of Stakeholders' Perceptions.
    J Med Internet Res. 2023;25:e45132.
    Abstract

  1860. ORJI AF, Roess AA
    Assessing Disparities in Cervical Cancer Screening with Pap Test by Disability Types.
    J Cancer Educ. 2023 Oct 2. doi: 10.1007/s13187-023-02373.
    Abstract

  1861. AMENGUAL VILA J, Torrent Colomer A, Sampol Bas C, Quintero Duarte A, et al
    A hybrid approach: a safe option for surgical treatment of early-stage cervical cancer.
    Eur Rev Med Pharmacol Sci. 2023;27:8905-8914.
    Abstract

  1862. AVCI F, Kulhan M, Guler AH, Ates MC, et al
    Lymph node size detected by magnetic resonance imaging for prediction of lymph node involvement in locally advanced cervical cancer.
    Eur Rev Med Pharmacol Sci. 2023;27:8889-8894.
    Abstract

  1863. ZHAO YC, Wang TJ, She LZ, Cui J, et al
    S100A10 Overexpression Correlates with Adverse Prognosis, Tumor Microenvironment, and Aggressive Behavior In Vitro and In Vivo of Cervical Cancer.
    J Cancer. 2023;14:2931-2945.
    Abstract

  1864. HERSHKOVITZ G, Ochshorn Y, Michaan N, Fiszer E, et al
    Knowledge is power? Cervical cancer prevention in female OB/GYNs compared to other female physicians.
    Front Public Health. 2023;11:1269393.
    Abstract

  1865. DABAN-LOPEZ P, Fernandez-Martinez NF, Petrova D, Rodriguez-Barranco M, et al
    Epidemiology of human papillomavirus-associated anogenital cancers in Granada: a three-decade population-based study.
    Front Public Health. 2023;11:1205170.
    Abstract

  1866. LUBEYA MK, Chibwesha CJ, Mwanahamuntu M, Mukosha M, et al
    "When you get the HPV vaccine, it will prevent cervical cancer; it will act as a shield": adolescent girls' knowledge and perceptions regarding the human papillomavirus vaccine in Zambia.
    Front Health Serv. 2023;3:1208458.
    Abstract

  1867. KERR L, Bourne A, Hill AO, McNair R, et al
    Cervical screening among LGBTQ people: how affirming services may aid in achieving cervical cancer elimination targets.
    Women Health. 2023 Oct 1:1-11. doi: 10.1080/03630242.2023.2263594.
    Abstract

  1868. LIU C, Zhou L, Chen J, Yang Z, et al
    Galectin-7 promotes cisplatin efficacy by facilitating apoptosis and G3BP1 degradation in cervical cancer.
    Biochem Pharmacol. 2023 Sep 29:115834. doi: 10.1016/j.bcp.2023.115834.
    Abstract

  1869. PAUL A, Sarker S, Banik BC, Paul A, et al
    Detection of Oncogenic Human Papillomavirus (HPV-16 and HPV-18) from Bacterial Vaginosis Positive Patient Attending at Tertiary Care Hospital in Mymensingh.
    Mymensingh Med J. 2023;32:959-967.
    Abstract

  1870. WUBU A, Balta B, Cherie A, Bizuwork K, et al
    Perception about human papillomavirus vaccination among middle adolescent school girls in Addis Ababa, Ethiopia 2023: qualitative study.
    BMC Womens Health. 2023;23:520.
    Abstract

  1871. BENARD E, Drolet M, Laprise JF, Gingras G, et al
    Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis.
    Lancet Public Health. 2023;8:e788-e799.
    Abstract

  1872. HARPER DM, O'Dwyer MC
    One less dose of HPV vaccine to prevent cancer.
    Lancet Public Health. 2023;8:e748-e749.
    Abstract

  1873. KASSA R, Irene Y, Woldetsadik E, Kidane E, et al
    Survival of women with cervical cancer in East Africa: a systematic review and meta-analysis.
    J Obstet Gynaecol. 2023;43:2253308.
    Abstract

  1874. MARTINEZ-ESQUIVIAS F, Guzman-Flores JM, Chavez-Diaz IF, Iniguez-Munoz LE, et al
    Pharmacological network study on the effect of 6-gingerol on cervical cancer using computerized databases.
    J Biomol Struct Dyn. 2023 Sep 29:1-12. doi: 10.1080/07391102.2023.2264943.
    Abstract

  1875. CARICATO P, Trivellato S, Pellegrini R, Montanari G, et al
    Updating approach for lexicographic optimization-based planning to improve cervical cancer plan quality.
    Discov Oncol. 2023;14:180.
    Abstract

  1876. SHAO R, Qiao X, Cao L, Man J, et al
    Multimodal imaging and photothermal/chemodynamic therapy of cervical cancer using GSH-responsive MoS(2)@MnO(2) theranostic nanoparticles.
    Discov Nano. 2023;18:122.
    Abstract

  1877. HERWEIJER E, Wang J, Hu K, Valdimarsdottir UA, et al
    Overall and Cervical Cancer Survival in Patients With and Without Mental Disorders.
    JAMA Netw Open. 2023;6:e2336213.
    Abstract

  1878. ZHANG D, Zhang S, He Z, Chen Y, et al
    Cytosine-phosphate-guanine oligodeoxynucleotides alleviate radiation-induced kidney injury in cervical cancer by inhibiting DNA damage and oxidative stress through blockade of PARP1/XRCC1 axis.
    J Transl Med. 2023;21:679.
    Abstract

  1879. MENG H, Guo X, Zhang D
    Multimodal magnetic resonance imaging in the diagnosis of cervical cancer and its correlation with the differentiation process of cervical cancer.
    BMC Med Imaging. 2023;23:144.
    Abstract

  1880. DIAO W, Zhu C, Guo Q, Cao Y, et al
    [Retracted] Tripartite motif?containing 14 regulates cell proliferation and apoptosis in cervical cancer via the Akt signaling pathway.
    Mol Med Rep. 2023;28:213.
    Abstract

  1881. MARTINELLI M, Giubbi C, Di Meo ML, Perdoni F, et al
    Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy.
    Viruses. 2023;15:1889.
    Abstract

  1882. TAMPAKOUDIS G, Anastasiou OE
    Burden of HPV-Related Hospitalization in Germany from 2000 to 2021.
    Viruses. 2023;15:1857.
    Abstract

  1883. CHEN Y, Wu D
    Cervical ulcer caused by group B streptococcus with bacterial vaginosis: a case report.
    BMC Womens Health. 2023;23:516.
    Abstract

  1884. LI T, Yang Z, Zhang C, Wang S, et al
    Genetic variation of E6 and E7 genes of human papillomavirus type 16 from central China.
    Virol J. 2023;20:217.
    Abstract

  1885. JAFARI B, Gholizadeh E, Jafari B, Zhoulideh M, et al
    Highly sensitive label-free biosensor: graphene/CaF(2) multilayer for gas, cancer, virus, and diabetes detection with enhanced quality factor and figure of merit.
    Sci Rep. 2023;13:16184.
    Abstract

  1886. XIAO X, Cao Y, Bi K, Wang W, et al
    The Triaging Effect of the Human Papillomavirus 16/18 E7 Oncoprotein Assay in HPV 16/18-Positive Patients for High-Grade Cervical Intraepithelial Neoplasia Screening: A Cross-Sectional Study.
    J Womens Health (Larchmt). 2023;32:1136-1141.
    Abstract

  1887. KOIKE R, Yunokawa M, Omatsu K, Kurihara N, et al
    Retrospective study of the efficacy and safety of docetaxel/carboplatin combination therapy as postoperative adjuvant chemotherapy for nonsquamous cell carcinoma of the cervix.
    Int J Clin Oncol. 2023;28:1421-1430.
    Abstract

  1888. BEAVERSON S, Cyrus JW, Huffstetler AN
    Concordance of Primary Human Papillomavirus Testing Among Clinicians and Patients: A Systematic Review.
    J Womens Health (Larchmt). 2023;32:1062-1072.
    Abstract

  1889. BERRY WCE, Capbarat EV, Walker TV, Rosenberg SF, et al
    Associations between gynecologic clinician type and routine female sexual dysfunction screening.
    J Sex Med. 2023;20:1235-1240.
    Abstract

  1890. TOURNAIRE M, Gondry J, Mauny L, Devouche E, et al
    Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening.
    J Gynecol Obstet Hum Reprod. 2023;52:102630.
    Abstract

  1891. TOROUS VF
    Cervicovaginal Papanicolaou tests in transgender men: Cytomorphologic alterations, interpretation considerations, and clinical implications.
    Cancer Cytopathol. 2023;131:626-636.
    Abstract

  1892. NAKAJIMA Y, Iwasaki E, Kayashima A, Machida Y, et al
    Successful radiotherapy for recurrent obstructive pancreatitis secondary to pancreatic metastasis from cervical squamous-cell carcinoma.
    Clin J Gastroenterol. 2023;16:755-760.
    Abstract

  1893. HU J, Tang L, Wang C, Zhang D, et al
    A rare case of cervical mesonephric adenocarcinoma with right femur metastasis.
    Asian J Surg. 2023;46:4639-4640.
    Abstract

  1894. GERIS JM, Amirian ES, Marquez-Do DA, Guillaud M, et al
    Polymorphisms in the Nonhomologous End-joining DNA Repair Pathway are Associated with HPV Integration in Cervical Dysplasia.
    Cancer Prev Res (Phila). 2023;16:461-469.
    Abstract

  1895. HU J, Xiao Y, Liu Y, Zhang D, et al
    A rare case of primary isolated myeloid sarcoma arising at the uterine cervix.
    Asian J Surg. 2023;46:4533-4535.
    Abstract

  1896. CHEN G, Zheng Z, Sun H, You J, et al
    Dedifferentiated Schwann cells promote perineural invasion mediated by the PACAP paracrine signalling in cervical cancer.
    J Cell Mol Med. 2023 Oct 13. doi: 10.1111/jcmm.17897.
    Abstract

  1897. AND ALTERNATIVE MEDICINE EC
    Retracted: The Influence of Family-Oriented Enabling Psychological Nursing on Posttraumatic Stress and Fear of Recurrence in Patients with Cervical Cancer.
    Evid Based Complement Alternat Med. 2023;2023:9806573.
    Abstract

  1898. YOSHIKAWA N, Itoh Y, Matsukawa T, Kawamura M, et al
    Local hyperthermia with built-in endoscopy for radioresistant cervical cancer: a case series.
    Nagoya J Med Sci. 2023;85:639-647.
    Abstract

  1899. HEALTHCARE ENGINEERING JO
    Retracted: Effects of Continuous Catheterization on Reducing Postoperative Urinary Tract Infection in Cervical Cancer Patients with Double J Stent Placement.
    J Healthc Eng. 2023;2023:9797565.
    Abstract

  1900. DU JQ, Zhang F, Wang CQ, Zhu JF, et al
    Effects of peripheral blood neutrophil/lymphocyte ratio levels and their changes on the prognosis of patients with early cervical cancer.
    Front Oncol. 2023;13:1139809.
    Abstract

  1901. JIA X, Zhou J, Fu Y, Ma C, et al
    Establishment of prediction models to predict survival among patients with cervical cancer based on socioeconomic factors: a retrospective cohort study based on the SEER Database.
    BMJ Open. 2023;13:e072556.
    Abstract

  1902. WANG Y, Zhao J, Wu J, Liu J, et al
    Genome-wide perturbations of A-to-I RNA editing dysregulated circular RNAs promoting the development of cervical cancer.
    Comput Biol Med. 2023;166:107546.
    Abstract

  1903. BATMAN S, Rangeiro R, Monteiro E, Changule D, et al
    Expanding Cervical Cancer Screening in Mozambique: Challenges Associated With Diagnosing and Treating Cervical Cancer.
    JCO Glob Oncol. 2023;9:e2300139.
    Abstract

  1904. JELIC M, Mandic A, Maricic S, Bozin B, et al
    PREDICTIVE POWER OF OXIDATIVE STRESS BIOMARKERS IN RECURRENCE AND SURVIVAL IN ADVANCED CERVICAL CANCER.
    Exp Oncol. 2023;45:231-241.
    Abstract

  1905. MARTELLO G, Gori S, Frayle H, Franceschi S, et al
    Acceptability of deferring the start of cervical cancer screening to age 30 for women vaccinated against human papillomavirus.
    Prev Med Rep. 2023;36:102438.
    Abstract

  1906. LI J, Zhou H, Lu X, Wang Y, et al
    Preoperative prediction of cervical cancer survival using a high-resolution MRI-based radiomics nomogram.
    BMC Med Imaging. 2023;23:153.
    Abstract

  1907. SANTANA EO, Silva LDS, Silva LAAD, Lemos JLA, et al
    Effect of guided imagery relaxation on anxiety in cervical cancer: randomized clinical trial.
    Rev Bras Enferm. 2023;76:e20210874.
    Abstract

  1908. MA Y, Yang QQ, Gu DM, Yuan X, et al
    Canadine inhibits epithelial mesenchymal transformation of HPV-negative cervical cancer.
    Tissue Barriers. 2023 Oct 11:2256641. doi: 10.1080/21688370.2023.2256641.
    Abstract

  1909. CHEN X, Hao Y, Liu Y, Zhong S, et al
    NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer.
    Adv Sci (Weinh). 2023 Oct 11:e2302705. doi: 10.1002/advs.202302705.
    Abstract

  1910. HUANG Q, Li S, Chen X, He C, et al
    Association between serum lactate dehydrogenase and lymph node metastasis in cervical cancer.
    Oncol Lett. 2023;26:482.
    Abstract

  1911. YANG H, Sun Y, Jia X, Cai Y, et al
    TBX3 promotes the epithelial mesenchymal transition of cervical cancer by upregulating ID1.
    Am J Cancer Res. 2023;13:4115-4124.
    Abstract

  1912. HAN L, Chen Y, Zheng A, Tan X, et al
    Minimally invasive versus abdominal radical trachelectomy for early-stage cervical cancer: a systematic review and meta-analysis.
    Am J Cancer Res. 2023;13:4466-4477.
    Abstract

  1913. YADAV A, Yadav S, Alam MA
    Immunotherapies landscape and associated inhibitors for the treatment of cervical cancer.
    Med Oncol. 2023;40:328.
    Abstract

  1914. YI J, Li X, Zhang R, Kong L, et al
    The impact of the COVID-19 pandemic on the prevalence and genotype distribution of HPV infection in Beijing, China.
    J Med Virol. 2023;95:e29155.
    Abstract

  1915. LIU H, Rao Y, Sun C, Wang Y, et al
    [Changes of brain network in patients with insomnia following radiotherapy for cervical cancer and their correlation with IT-TMS treatment efficacy: a graph-theory analysis].
    Nan Fang Yi Ke Da Xue Xue Bao. 2023;43:1629-1635.
    Abstract

  1916. OLIUSHINA EM, Zavalishina LE, Andreeva YY, Kuznetsova OA, et al
    [Predictive markers of immunotherapy in cervical cancer].
    Arkh Patol. 2023;85:5-12.
    Abstract

  1917. DENG S, Welby S, Liu Z, Yang Y, et al
    MOnitoring human papillomavirus Vaccine effect on Infection and cErvical diseases (MOVIE): Protocol for a cohort study using electronic health records from Yinzhou, China.
    Hum Vaccin Immunother. 2023;19:2257989.
    Abstract

  1918. SARWAR KA, Hussain S, Syed AS, Khan K, et al
    Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer.
    Brachytherapy. 2023 Oct 7:S1538-4721(23)01631.
    Abstract

  1919. AYANTO SY, Belachew Lema T, Wordofa MA
    Women's and health professionals' perceptions, beliefs and barriers to cervical cancer screening uptake in Southern Ethiopia: a qualitative study.
    Sex Reprod Health Matters. 2023;31:2258477.
    Abstract

  1920. CHEN R, Fang T, Liu N, Shi X, et al
    Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway.
    Naunyn Schmiedebergs Arch Pharmacol. 2023 Oct 9. doi: 10.1007/s00210-023-02757.
    Abstract

  1921. IMAGING CMM
    Retracted: Investigation of the Clinical Application Value of HR-HPV DNA Combined with Liquid Based Cytology in Colposcopy of Cervical Cancer.
    Contrast Media Mol Imaging. 2023;2023:9891864.
    Abstract

  1922. LE BIHAN-BENJAMIN C, Audiger C, Khati I, de Bels F, et al
    Cervical cancer screening pathways in France in 2015-2021, a nationwide study based on medico-administrative data.
    Prev Med Rep. 2023;36:102429.
    Abstract

  1923. WEI HF, Zhang RF, Zhao YC, Tong XS, et al
    SERPINB7 as a prognostic biomarker in cervical cancer: Association with immune infiltration and facilitation of the malignant phenotype.
    Heliyon. 2023;9:e20184.
    Abstract

  1924. PATEL D, Tayade S, Tidke VP, Toshniwal S, et al
    Radiotherapy Versus Chemotherapy in Locally Advanced Cervical Cancer.
    Cureus. 2023;15:e44726.
    Abstract

  1925. ALSHARIF F, Ibrahim F, Alotaibi M, Khalaf M, et al
    The Relationship Between Knowledge and Practice of Postreproductive Women Toward Prevention and Screening of Breast and Cervical Cancer in Saudi Arabia.
    Cureus. 2023;15:e44858.
    Abstract

  1926. HENES M, Mann E, Hirchenhain C, Bauer E, et al
    Registry Study of the Working Group on Cervical Pathology and Colposcopy (AGCPC) on the Diagnostic Algorithm for the New Cervical Cancer Screening - Initial Data.
    Geburtshilfe Frauenheilkd. 2023;83:1250-1262.
    Abstract

  1927. FEHM T, Beckmann MW, Mahner S, Denschlag D, et al
    Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Surgical Therapy for Patients with Stage IA2-IIB1 Cervical Cancer.
    Geburtshilfe Frauenheilkd. 2023;83:1199-1204.
    Abstract

  1928. LV X, Jia Y, Li J, Deng S, et al
    The construction of a prognostic model of cervical cancer based on four immune-related LncRNAs and an exploration of the correlations between the model and oxidative stress.
    Front Pharmacol. 2023;14:1234181.
    Abstract

  1929. ZHU X, Song X, Chen Q, Peng Y, et al
    The prognostic, immunological and single-cell features of m6A molecules in cervical cancer.
    Cell Mol Biol (Noisy-le-grand). 2023;69:89-99.
    Abstract

  1930. WANG X, Xu J, Hua F, Wang Y, et al
    MiR-214-3p suppresses cervical cancer cell metastasis by downregulating THBS2.
    Cell Mol Biol (Noisy-le-grand). 2023;69:195-200.
    Abstract

  1931. GHOSH S, Saha R, Sarkar S, Biswas A, et al
    Rhodamine hydrazide-linked naphthalimide derivative: Selective naked eye detection of Cu(2+), S(2-) and understanding the therapeutic potential of the copper complex as an anti-cervical cancer agent.
    Spectrochim Acta A Mol Biomol Spectrosc. 2023;305:123428.
    Abstract

  1932. DOZIE UW, Ezeala OV, David CI, Dozie KCN, et al
    Factors associated with health seeking delay in the screening of cervical cancer among women in Imo state, south Eastern Nigeria.
    Cancer Treat Res Commun. 2023;37:100765.
    Abstract

  1933. LUO Q, Zeng X, Luo H, Pan L, et al
    Epidemiologic characteristics of high-risk HPV and the correlation between multiple infections and cervical lesions.
    BMC Infect Dis. 2023;23:667.
    Abstract

  1934. MODABBER N, Mahboub SS, Khoshravesh S, Karimpour F, et al
    Evaluation of Long Non-coding RNA (LncRNA) in the Pathogenesis of Chemotherapy Resistance in Cervical Cancer: Diagnostic and Prognostic Approach.
    Mol Biotechnol. 2023 Oct 7. doi: 10.1007/s12033-023-00909.
    Abstract

  1935. PAK K, Yoon HJ
    Impact of 18F-FDG PET on the Management in Patients With Recurrent Gynecologic cancer: A Meta-analysis.
    Clin Nucl Med. 2023 Sep 19. doi: 10.1097/RLU.0000000000004839.
    Abstract

  1936. YOSHINO Y, Yanai S, Sawada M, Sakate S, et al
    Extraovarian Dysgerminoma Involving the Uterine Cervix: A Rare Case Report With Literature Review.
    Int J Gynecol Pathol. 2023;42:544-549.
    Abstract

  1937. ELBANNA M, Pynda Y, Kalinchuk O, Rosa A, et al
    Radiotherapy resources in Latin America and the Caribbean: a review of current and projected needs based on International Atomic Energy Agency data.
    Lancet Oncol. 2023;24:e376-e384.
    Abstract

  1938. HA Y, Lee K, Park B, Suh M, et al
    Parental intention to vaccinate daughters with the human papillomavirus vaccine in Korea: a nationwide cross-sectional survey.
    Epidemiol Health. 2023;45:e2023076.
    Abstract

  1939. MONSRUD AL, Avadhani V, Mosunjac MB, Flowers L, et al
    Programmed Death Ligand-1 (PD-L1) Expression in Cervical Squamous Cell Carcinoma: Does it Correlate With Outcomes?
    Int J Gynecol Pathol. 2023;42:535-543.
    Abstract

  1940. BOGANI G, Sopracordevole F, Ciavattini A, Vizza E, et al
    Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia.
    Eur J Cancer Prev. 2023;32:525-532.
    Abstract

  1941. ZHANG H, Zhang R, Su Y, Zheng J, et al
    Anti-cervical cancer mechanism of bioactive compounds from Alangium platanifolium based on the 'compound-target-disease' network.
    Heliyon. 2023;9:e20747.
    Abstract

  1942. HEALTHCARE ENGINEERING JO
    Retracted: Functional New Transcription Factors (TFs) Associated with Cervical Cancer.
    J Healthc Eng. 2023;2023:9835459.
    Abstract

  1943. HEALTHCARE ENGINEERING JO
    Retracted: A Research Study to Measure the Efficacy of Terminating Cervical Cancer via Customized Optimum Pathway.
    J Healthc Eng. 2023;2023:9840958.
    Abstract

  1944. KANAO H, Kanno M, Fusegi A, Aoki Y, et al
    Transperineal endoscopic approach with GelPOINT V-path in laparoscopic pelvic exenteration for postirradiated recurrent cervical cancer.
    Gynecol Oncol Rep. 2023;50:101291.
    Abstract

  1945. BAI Y, Wang W, Cheng Y, Yang Y, et al
    Research progress on the GRP78 gene in the diagnosis, treatment and immunity of cervical cancer.
    Eur J Med Res. 2023;28:447.
    Abstract

  1946. LI F, Mei F, Yin S, Du Y, et al
    Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor.
    J Gynecol Oncol. 2023 Sep 26. doi: 10.3802/jgo.2024.
    Abstract

  1947. HWANG JH, Kim B
    Comparison of survival outcomes between robotic and laparoscopic radical hysterectomies for early-stage cervical cancer: a systemic review and meta-analysis.
    J Gynecol Oncol. 2023 Sep 25. doi: 10.3802/jgo.2024.
    Abstract

  1948. SUN S, Wang Y, Liu Y, Leng Z, et al
    Telomerase reverse transcriptase gene polymorphisms and cervical cancer susceptibility in high-risk human papillomavirus-infected women.
    J Obstet Gynaecol Res. 2023 Oct 19. doi: 10.1111/jog.15815.
    Abstract

  1949. DAMGACIOGLU H, Burus T, Sonawane K, Hill E, et al
    County-Level Trends in Cervical Cancer Incidence, Stage at Diagnosis, and Mortality in Kentucky.
    JAMA Netw Open. 2023;6:e2338333.
    Abstract

  1950. BONLOKKE S, Steiniche T, Sorensen BS, Nyvang GB, et al
    Circulating cell-free HPV DNA is a strong marker for disease severity in cervical cancer.
    Mol Oncol. 2023 Oct 19. doi: 10.1002/1878-0261.13538.
    Abstract

  1951. DAI Y, Zhang Y, Ke X, Liu Y, et al
    Cutaneous metastasis from cervical cancer to the scalp and trunk: a case report and review of the literature.
    J Med Case Rep. 2023;17:435.
    Abstract

  1952. LI Z, Chen S, Mahjabeen I, Shafique R, et al
    Nurses and doctors 's awareness and knowledge towards treatment and care of cervical cancer patients: a cross-sectional study.
    BMC Nurs. 2023;22:389.
    Abstract

  1953. CHEN X, Shi W, Wang C, Zhu H, et al
    Personalized prognostic prediction tool for high-grade neuroendocrine cervical cancer: a SEER database analysis and single-center validation.
    J Cancer Res Clin Oncol. 2023 Oct 18. doi: 10.1007/s00432-023-05414.
    Abstract

  1954. HUANG J, Tan Z, Wu W, Wu X, et al
    Effect of robotic versus laparoscopic surgery on postoperative wound infection in patients with cervical cancer: A meta-analysis.
    Int Wound J. 2023 Oct 18. doi: 10.1111/iwj.14437.
    Abstract

  1955. SHI YY, Dong DR, Fan G, Dai MY, et al
    A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.
    Front Immunol. 2023;14:1237964.
    Abstract

  1956. AMINI-FARSANI Z, Hashemi Sheikhshabani S, Shaygan N, Asgharzade S, et al
    The impact of oleuropein on miRNAs regulating cell death signaling pathway in human cervical cancer cells.
    Biotechnol Appl Biochem. 2023 Oct 17. doi: 10.1002/bab.2521.
    Abstract

  1957. YANG X, Sun F, Gao Y, Li M, et al
    Histone acetyltransferase CSRP2BP promotes the epithelial-mesenchymal transition and metastasis of cervical cancer cells by activating N-cadherin.
    J Exp Clin Cancer Res. 2023;42:268.
    Abstract

  1958. ASARE M, Obiri-Yeboah D, Enyan NIE, Nuer-Allornuvor G, et al
    An intervention to increase cervical cancer screening among women living with HIV: A mixed methods study.
    Patient Educ Couns. 2023;118:107993.
    Abstract

  1959. HUANG J, Wei W, Kang F, Tan S, et al
    ANXA3, associated with YAP1 regulation, participates in the proliferation and chemoresistance of cervical cancer cells.
    Genes Genomics. 2023 Oct 16. doi: 10.1007/s13258-023-01461.
    Abstract

  1960. KULHAN M, Bilgi A, Avci F, Ucar MG, et al
    Is HPV-negative cervical carcinoma a different type of cervical cancer?
    Eur Rev Med Pharmacol Sci. 2023;27:9205-9212.
    Abstract

  1961. VIMPERE L, Sami J, Jeannot E
    Cervical cancer screening programs for female sex workers: a scoping review.
    Front Public Health. 2023;11:1226779.
    Abstract

  1962. WAGNER-LARSEN KS, Hodneland E, Fasmer KE, Lura N, et al
    MRI-based radiomic signatures for pretreatment prognostication in cervical cancer.
    Cancer Med. 2023 Oct 16. doi: 10.1002/cam4.6526.
    Abstract

  1963. SHARMA CP, Vyas A, Pandey P, Gupta S, et al
    A new class of teraryl-based AIEgen for highly selective imaging of intracellular lipid droplets and its detection in advanced-stage human cervical cancer tissues.
    J Mater Chem B. 2023 Oct 16. doi: 10.1039/d3tb01764.
    Abstract

  1964. LV Z, Wang YY, Wang YW, He JJ, et al
    A meta-analysis of treatment for early-stage cervical cancer: open versus minimally invasive radical trachelectomy.
    BMC Pregnancy Childbirth. 2023;23:727.
    Abstract

  1965. CHIAPPA V, Bogani G, Interlenghi M, Vittori Antisari G, et al
    Using Radiomics and Machine Learning Applied to MRI to Predict Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer.
    Diagnostics (Basel). 2023;13:3139.
    Abstract

  1966. LEE YM, Lee B, Cho NH, Park JH, et al
    Beyond the Microscope: A Technological Overture for Cervical Cancer Detection.
    Diagnostics (Basel). 2023;13:3079.
    Abstract

  1967. WASHINGTON B, Cheek D, Fabian D, Kudrimoti M, et al
    Effects of Interfraction Dose Variations of Target and Organs at Risk on Clinical Outcomes in High Dose Rate Brachytherapy for Cervical Cancer.
    Cancers (Basel). 2023;15:4862.
    Abstract

  1968. PACHE B, Tantari M, Guani B, Mathevet P, et al
    Predictors of Non-Sentinel Lymph Node Metastasis in Patients with Positive Sentinel Lymph Node in Early-Stage Cervical Cancer: A SENTICOL GROUP Study.
    Cancers (Basel). 2023;15:4737.
    Abstract

  1969. ALSHAMI I, Alattas RO, Waad A A, Anwar A S, et al
    Role of T cells in cervical cancer.
    Bioinformation. 2023;19:556-561.
    Abstract

  1970. LU Q, Lao X, Gan J, Du P, et al
    Impact of NLRP3 gene polymorphisms (rs10754558 and rs10733113) on HPV infection and cervical cancer in southern Chinese population.
    Infect Agent Cancer. 2023;18:64.
    Abstract

  1971. ZHAO M, Zhang X, Huan Q, Dong M, et al
    Metabolism-associated molecular classification of cervical cancer.
    BMC Womens Health. 2023;23:555.
    Abstract

  1972. XU J, Xue B, Gong M, Ling L, et al
    circ_0000337 Promotes the Progression of Cervical Cancer by miR-155-5p/RAB3B Axis.
    Biochem Genet. 2023 Oct 26. doi: 10.1007/s10528-023-10534.
    Abstract

  1973. MAROGA N, Mokoena T, Ledibane N, Musekiwa A, et al
    Profile of human papillomavirus genotypes in breast and oesophageal cancer patients in Pretoria, South Africa.
    S Afr Med J. 2023;113:49-54.
    Abstract

  1974. KHAN A
    Role of human papillomavirus (HPV) in cancers.
    S Afr Med J. 2023;113:10.
    Abstract


  1975. LncRNA SNHG7 Functions as an Oncogene in Cervical Cancer by Sponging miR-485-5p to Modulate JUND Expression [Retraction].
    Onco Targets Ther. 2023;16:847-848.
    Abstract

  1976. FUNDERUD M, Hoem IS, Guleng MAD, Eidem M, et al
    Script-based automatic radiotherapy planning for cervical cancer.
    Acta Oncol. 2023 Oct 25:1-10. doi: 10.1080/0284186X.2023.2267171.
    Abstract

  1977. ASHIQUE S, Faruk A, Ahmad FJ, Khan T, et al
    It Is All about Probiotics to Control Cervical Cancer.
    Probiotics Antimicrob Proteins. 2023 Oct 25. doi: 10.1007/s12602-023-10183.
    Abstract

  1978. SASIVIMOLRATTANA T, Chaiwongkot A, Bhattarakosol P
    HPV16E1 downregulation altered the cell characteristics involved in cervical cancer development.
    Sci Rep. 2023;13:18217.
    Abstract

  1979. SAHSUVAR S, Guner R, Gok O, Can O, et al
    Development and pharmaceutical investigation of novel cervical cancer-targeting and redox-responsive melittin conjugates.
    Sci Rep. 2023;13:18225.
    Abstract

  1980. IBRAHIM KHALIL A, Zhang L, Muwonge R, Sauvaget C, et al
    Efficacy and safety of therapeutic HPV vaccines to treat CIN 2/CIN 3 lesions: a systematic review and meta-analysis of phase II/III clinical trials.
    BMJ Open. 2023;13:e069616.
    Abstract

  1981. SILVA GAE, Damacena GN, Ribeiro CM, Alcantara LLM, et al
    Papanicolaou test in Brazil: analysis of the National Health Survey of 2013 and 2019.
    Rev Saude Publica. 2023;57:55.
    Abstract

  1982. ASWATHY R, Sumathi S
    Defining new biomarkers for overcoming therapeutical resistance in cervical cancer using lncRNA.
    Mol Biol Rep. 2023 Oct 25. doi: 10.1007/s11033-023-08864.
    Abstract

  1983. SUN X, Ye G, Li J, Shou H, et al
    Parkin regulates IGF2BP3 through ubiquitination in the tumourigenesis of cervical cancer.
    Clin Transl Med. 2023;13:e1457.
    Abstract

  1984. LI J, Huang L, Wu H, Li J, et al
    Re-irradiation for recurrent cervical cancer: A single institutional experience.
    Clin Transl Radiat Oncol. 2023;43:100690.
    Abstract

  1985. WANG X, Xu J, Zhang H, Qu P, et al
    The effect of albumin and hemoglobin levels on the prognosis of early-stage cervical cancer: a prospective, single-center-based cohort study.
    BMC Womens Health. 2023;23:553.
    Abstract

  1986. TIAN J, Wang N, Wang C, Wu DP, et al
    [Hsa_circ_0000392 affects the radiation sensitivity of cervical cancer by targeting the miR-145-5p/CRKL/MAPK pathway].
    Zhonghua Zhong Liu Za Zhi. 2023;45:879-891.
    Abstract

  1987. BRANDFORD AA, Williams EN, Han G, Weston C, et al
    Adverse Childhood Experiences and Preventive Cervical Cancer Screening Behavior.
    Oncol Nurs Forum. 2023;50:679-691.
    Abstract

  1988. CRAFTON SM, Venkat PS, Salani R
    A review of the state of cervical cancer: updates from prevention to recurrent disease.
    Curr Opin Obstet Gynecol. 2023 Oct 12. doi: 10.1097/GCO.0000000000000918.
    Abstract

  1989. DESPOT A, Fures R, Despot AM, Mikus M, et al
    Reactive oxygen species within the vaginal space: An additional promoter of cervical intraepithelial neoplasia and uterine cervical cancer development?
    Open Med (Wars). 2023;18:20230826.
    Abstract

  1990. GASHU C, Aguade AE
    Predictors of cervical tumour size for outpatients with cervical cancer at the University of Gondar referral hospital: a retrospective study design.
    Eur J Med Res. 2023;28:453.
    Abstract

  1991. DING S, Wang H, Liao Y, Chen R, et al
    HPV16 E7 protein antagonizes TNF-alpha-induced apoptosis of cervical cancer cells via Daxx/JNK pathway.
    Microb Pathog. 2023;185:106423.
    Abstract

  1992. GIUDICE E, Mirza MR, Lorusso D
    Advances in the Management of Recurrent Cervical Cancer: State of the Art and Future Perspectives.
    Curr Oncol Rep. 2023 Oct 23. doi: 10.1007/s11912-023-01463.
    Abstract

  1993. SCHITCU VH, Marica NA, Borz MB
    3D Laparoscopic Ureterolysis for Retroperitoneal Fibrosis Secondary to Radical Hysterectomy and Radiation Treatment for Cervical Cancer: Results from the Oncological Institute, Cluj Napoca.
    Arch Esp Urol. 2023;76:519-524.
    Abstract

  1994. WANG M, Liu J, Liao X, Yi Y, et al
    The SGK3-Catalase antioxidant signaling axis drives cervical cancer growth and therapy resistance.
    Redox Biol. 2023;67:102931.
    Abstract

  1995. IKOMA T, Kato T, Okada K, Takama N, et al
    Right ventricular metastasis of cervical cancer visualized on transthoracic echocardiography: the importance of the "modified off-axis right ventricular apical 4-chamber view".
    J Med Ultrason (2001). 2023 Oct 21. doi: 10.1007/s10396-023-01372.
    Abstract

  1996. SWANSON AA, Pantanowitz L
    The evolution of cervical cancer screening.
    J Am Soc Cytopathol. 2023 Sep 25:S2213-2945(23)00229.
    Abstract

  1997. ALSHEHRI MA, Asiri SA, Alzahrani A, Alazragi RS, et al
    Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: a multitargeted docking-based MM\GBSA and MD simulation study.
    Med Oncol. 2023;40:337.
    Abstract

  1998. CORRADO G, Anchora LP, Bruni S, Sperduti I, et al
    Patterns of recurrence in FIGO stage IB1-IB2 cervical cancer: Comparison between minimally invasive and abdominal radical hysterectomy.
    Eur J Surg Oncol. 2023;49:107047.
    Abstract

  1999. WANG Y, Sun Y, Gan K, Yuan J, et al
    Bone marrow sparing oriented multi-model image registration in cervical cancer radiotherapy.
    Comput Biol Med. 2023;166:107581.
    Abstract

  2000. REYNDERS C, Lerho T, Goebel EA, Crum CP, et al
    Prevalence and genotype distribution of human papillomavirus in cervical adenocarcinoma (usual type and variants): A systematic review and meta-analysis.
    J Med Virol. 2023;95:e29190.
    Abstract

  2001. WANG MY, Cun YN
    [Current status of clinical trials of HPV therapeutic vaccines].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2023;57:1647-1654.
    Abstract

  2002. LE A, Rohweder C, Wheeler SB, Lafata JE, et al
    Self-Collection for Primary HPV Testing: Perspectives on Implementation From Federally Qualified Health Centers.
    Prev Chronic Dis. 2023;20:E93.
    Abstract

  2003. BARTHOLOMEW K, Aye PS, Griffiths V, Schaapveld T, et al
    Retrospective survey of colposcopy experience for wahine Maori across two time periods (2016 and 2021) in Waitemata and Auckland districts, New Zealand.
    N Z Med J. 2023;136:10-26.
    Abstract

  2004. HOCHMANN J, Millan M, Hernandez P, Lafon-Hughes L, et al
    Contributions of viral oncogenes of HPV-18 and hypoxia to oxidative stress and genetic damage in human keratinocytes.
    Sci Rep. 2023;13:17734.
    Abstract

  2005. BAENA A, Paolino M, Villarreal-Garza C, Torres G, et al
    Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening.
    Cancer Epidemiol. 2023;86 Suppl 1:102446.
    Abstract

  2006. XIE S, Huang R, Zhan Y, Cai Q, et al
    Efficacy of fosaprepitant combined with tropisetron plus dexamethasone in preventing nausea and emesis during fractionated radiotherapy with weekly cisplatin chemotherapy: interim analysis of a randomized, prospective, clinical trial using competing r
    Support Care Cancer. 2023;31:640.
    Abstract

  2007. CHEN LM, Cong Q, Wu D, Chen Y, et al
    A prospective multicentre controlled study of Gaoweikang (Chinese multiherb extract-based tincture) used in high-risk HPV infections.
    Eur Rev Med Pharmacol Sci. 2023;27:8985-8992.
    Abstract

  2008. LIU X, Wallace N
    HPV and HPV-associated cancer.
    J Med Virol. 2023;95:e29177.
    Abstract

  2009. COSMAS NT, Nimzing L, Egah DZ, Famooto OA, et al
    Dataset for vaginal human papillomavirus infection among adolescent and early adult girls in Jos, Nigeria.
    BMC Res Notes. 2023;16:272.
    Abstract

  2010. ZHOU YX, Wang L, Wang TT, Qu XL, et al
    Analysis of HPV prevalence among individuals with reproductive tract infections in a Chinese population.
    Medicine (Baltimore). 2023;102:e34989.
    Abstract

  2011. CHECCHI M, Mesher D, Panwar K, Anderson A, et al
    The impact of over ten years of HPV vaccination in England: Surveillance of type-specific HPV in young sexually active females.
    Vaccine. 2023 Oct 9:S0264-410X(23)01162-3. doi: 10.1016/j.vaccine.2023.
    Abstract

  2012. YAN C, Ma Y, Li J, Chen X, et al
    Identification of key immune cell-related genes involved in tumorigenesis and prognosis of cervical squamous cell carcinoma.
    Hum Vaccin Immunother. 2023;19:2254239.
    Abstract

  2013. FRICK C, Rumgay H, Vignat J, Ginsburg O, et al
    Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study.
    Lancet Glob Health. 2023;11:e1700-e1712.
    Abstract

  2014. MONTI E, Matozzo CMM, Cetera GE, DI Loreto E, et al
    Correlation Between Colposcopic Patterns and Histological Grade of Vaginal Intraepithelial Neoplasia: A Retrospective Cohort Study.
    Anticancer Res. 2023;43:4637-4642.
    Abstract

  2015. XIN Z, Yan W, Feng Y, Yunzhi L, et al
    An MRI-based machine learning radiomics can predict short-term response to neoadjuvant chemotherapy in patients with cervical squamous cell carcinoma: A multicenter study.
    Cancer Med. 2023;12:19383-19393.
    Abstract

  2016. MOSQUERA I, Barajas CB, Zhang L, Lucas E, et al
    Assessment of organization of cervical and breast cancer screening programmes in the Latin American and the Caribbean states: The CanScreen5 framework.
    Cancer Med. 2023;12:19935-19948.
    Abstract

  2017. BARTEMES KR, Gochanour BR, Routman DM, Ma DJ, et al
    Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease.
    Oral Oncol. 2023;146:106568.
    Abstract

  2018. REUSCHENBACH M, Doorbar J, Del Pino M, Joura EA, et al
    Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer.
    Vaccine. 2023 Sep 11:S0264-410X(23)00990-8. doi: 10.1016/j.vaccine.2023.
    Abstract

  2019. DUTTA P, Pal D, Roy A, Mandal RK, et al
    Role of MLH1 and MSH2 deficiency in the development of tumorigenesis and chemo-tolerance of cervical Carcinoma: Clinical implications.
    Gene. 2023;888:147746.
    Abstract

  2020. HOPFENSPERGER KM, Adams QE, Kim Y, Wu X, et al
    The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
    Med Phys. 2023;50:6469-6478.
    Abstract

  2021. MAO Z, Deng A, Jin X, Li M, et al
    A microfluidic-chip-based system with loop-mediated isothermal amplification for rapid and parallel detection of Trichomonas vaginalis and human papillomavirus.
    Analyst. 2023;148:4820-4828.
    Abstract

  2022. YU L, Gao Z, Li Z, Liu P, et al
    Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
    J Cancer Res Clin Oncol. 2023;149:14673-14689.
    Abstract

  2023. WANG N, Li X, Liu X, Bian M, et al
    Clinical Efficacy and Safety of AdV-tk Gene Therapy for Patients with Cervical Squamous Intraepithelial Lesion: A Prospective Study.
    Hum Gene Ther. 2023;34.
    Abstract

  2024. YETIK I, Tanoglu FB, Pasin O, Cetin C, et al
    Knowledge levels and community guidance of doctors working in family health centers on HPV screening and HPV vaccination.
    J Obstet Gynaecol Res. 2023;49:2519-2527.
    Abstract

  2025. LI X, Ling Y, Hu L, Zhang L, et al
    Detection of HPV DNA, E6/E7 mRNA, and p16INK4a in lung cancer: A systematic review and meta-analysis.
    J Infect Dis. 2023 Jul 28:jiad295. doi: 10.1093.
    Abstract

  2026. JARADI B, Das T, Koo KM
    Design and Analytical Evaluation of a Rapid Plasma Screening Assay for Circulating Human Papillomavirus DNA via Thermostable Enzyme Chemistries.
    Anal Chem. 2023;95:11172-11180.
    Abstract

  2027. NOFAL A, Nofal H, Alwirshiffani E, ElGhareeb MI, et al
    Treatment response and tolerability of intralesional quadrivalent versus bivalent human papillomavirus vaccine for recalcitrant warts: A randomized controlled trial.
    J Am Acad Dermatol. 2023;89:1051-1052.
    Abstract

  2028. RAIS M, Ouyahia A, Mohammedi D, Sadouki N, et al
    First study of genital HPV infection among women living with HIV recruited from May to September 2018 in Eastern Algeria.
    Int J STD AIDS. 2023 Jun 28:9564624231179274. doi: 10.1177/09564624231179274.
    Abstract

  2029. SANO Y, Yoshida K, Hibi E, Sekiya A, et al
    A rare case of signet ring cell carcinoma with diffuse cutaneous systemic sclerosis: A case report.
    J Obstet Gynaecol Res. 2023;49:2549-2552.
    Abstract

  2030. KISHIGAMI Y, Nakamura M, Nakao M, Okamoto H, et al
    Three-dimensional assessment of interfractional cervical and uterine motions using daily magnetic resonance images to determine margins and timing of replanning.
    J Appl Clin Med Phys. 2023;24:e14073.
    Abstract

  2031. LOFTERS A, Prakash V, Devotta K, Vahabi M, et al
    The potential benefits of "community champions" in the healthcare system.
    Healthc Manage Forum. 2023;36:382-387.
    Abstract

  2032. SMITH J, Dodd RH, Gainey KM, Naganathan V, et al
    Factors Influencing Primary Care Practitioners' Cancer Screening Recommendations for Older Adults: a Systematic Review.
    J Gen Intern Med. 2023;38:2998-3020.
    Abstract

  2033. CHEN F, Hsu Lin L, Hindi I, Sun W, et al
    HPV Cotesting of Unsatisfactory Papanicolaou Tests: Implications for Follow-up Intervals.
    Am J Clin Pathol. 2023;160:137-143.
    Abstract

  2034. GOSBELL E, Panambalana A, Stephenson A, Vici C, et al
    Awareness and attitudes towards the revised National Cervical Screening Program amongst women in rural New South Wales: a cross-sectional study.
    Aust J Prim Health. 2023;29:471-479.
    Abstract

  2035. MINALT N, Caldwell A, Yedlicka GM, Joseph S, et al
    Association of Intrauterine Device Use and Endometrial, Cervical, and Ovarian Cancer: an Expert Review.
    Am J Obstet Gynecol. 2023 Mar 29:S0002-9378(23)00224.
    Abstract

  2036. SHIGEISHI H
    Association between human papillomavirus and oral cancer: a literature review.
    Int J Clin Oncol. 2023;28:982-989.
    Abstract

  2037. VATTAI A, Kremer N, Meister S, Beyer S, et al
    Increase of the T-reg-recruiting chemokine CCL22 expression in a progressive course of cervical dysplasia.
    J Cancer Res Clin Oncol. 2023;149:6613-6623.
    Abstract

  2038. FELICELLI C, Strickland A, Wei JJ
    Primary HPV-Associated Enteric-Type Adenocarcinoma of Vagina: A Case Report.
    Int J Surg Pathol. 2023;31:1393-1397.
    Abstract

  2039. WATANABE-GALLOWAY S, Ratnapradipa K, Subramanian R, Ramos A, et al
    Mobile Health (mHealth) Interventions to Increase Cancer Screening Rates in Hispanic/Latinx Populations: A Scoping Review.
    Health Promot Pract. 2023;24:1215-1229.
    Abstract

  2040. KANEKO N, Nishino Y, Ito Y, Nakaya T, et al
    Association of Socioeconomic Status Assessed by Areal Deprivation With Cancer Incidence and Detection by Screening in Miyagi, Japan Between 2005 and 2010.
    J Epidemiol. 2023;33:521-530.
    Abstract

  2041. KIM JY, Hong J, Yoon J, Park J, et al
    Regularity of cervical cancer screening in Korea: analysis using national public data for 12 years.
    J Gynecol Oncol. 2023 Oct 16. doi: 10.3802/jgo.2024.
    Abstract

  2042. MONTHATIP K, Boonnag C, Muangmool T, Charoenkwan K, et al
    A machine learning-based prediction model of pelvic lymph node metastasis in women with early-stage cervical cancer.
    J Gynecol Oncol. 2023 Oct 18. doi: 10.3802/jgo.2024.
    Abstract

  2043. LIANG T, Lu T, Jia W, Li R, et al
    Knockdown of lncRNA MALAT1 induces pyroptosis by regulating the miR?124/SIRT1 axis in cervical cancer cells.
    Int J Oncol. 2023;63:138.
    Abstract

  2044. AHMED F, Yang YJ, Samantasinghar A, Kim YW, et al
    Network-based drug repurposing for HPV-associated cervical cancer.
    Comput Struct Biotechnol J. 2023;21:5186-5200.
    Abstract

  2045. MING C, Bai X, Zhao L, Yu D, et al
    RPL24 as a potential prognostic biomarker for cervical cancer treated by Cisplatin and concurrent chemoradiotherapy.
    Front Oncol. 2023;13:1131803.
    Abstract

  2046. ZENG M, Zhang X, He L, Liu X, et al
    Human papillomavirus infections among women with cervical lesions and cervical cancer in Yueyang, China: a cross-sectional study of 3674 women from 2019 to 2022.
    Virol J. 2023;20:254.
    Abstract

  2047. WOLF B, Weydandt L, Dornhofer N, Hiller GGR, et al
    Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype.
    Sci Rep. 2023;13:18946.
    Abstract

  2048. WEN F, Li C, Liang B, You J, et al
    Efficacy of high-dose-rate brachytherapy with different radiation source activities among cervical cancer patients and risk factors for long-term outcomes: A 6-year retrospective study.
    Brachytherapy. 2023 Oct 31:S1538-4721(23)01650.
    Abstract

  2049. KOMBE AJK, Zoa-Assoumou S, Bounda GA, Nsole-Biteghe FA, et al
    Advances in Etiopathological Role and Control of HPV in Cervical Cancer Oncogenesis.
    Front Biosci (Landmark Ed). 2023;28:245.
    Abstract

  2050. ELZEINY N, Sayed Shafei AE, Wagih S, Saad M, et al
    Phytochemicals in cervical cancer: an epigenetic overview.
    Epigenomics. 2023 Nov 2. doi: 10.2217/epi-2023-0181.
    Abstract

  2051. MIAN DB, Koffi SV, Nsahlai CJ, Adjoby R, et al
    Knowledge, Attitudes and Behaviors of Clients Regarding Cervical Cancer Screening at Gynecology Consultations of the University Hospital of Cocody.
    J Obstet Gynaecol India. 2023;73.
    Abstract

  2052. LE CT, Nguyen AQ, Thi Pham HD, Tran LT, et al
    Recurrent early-stage squamous cell carcinoma cervical cancer presenting with isolated ovary metastasis: a rare case report.
    Ann Med Surg (Lond). 2023;85:5662-5665.
    Abstract

  2053. KUMARI S
    Screening for Cervical Cancer in Pregnancy.
    Oncol Rev. 2023;17:11429.
    Abstract

  2054. ATENCHONG N, Olayinka O, Sesan OT, Akinyinka O, et al
    Reproductive health challenges among women in internally displaced camps in Benue State: A protocol for a community-based health education interventional study.
    Afr J Reprod Health. 2023;27:133-144.
    Abstract

  2055. MUSA J, Kocherginsky M, Magaji FA, Maryam AJ, et al
    Epidemiology and survival outcomes of HIV-associated cervical cancer in Nigeria.
    Infect Agent Cancer. 2023;18:68.
    Abstract

  2056. ISAJI Y, Tsuyoshi H, Tsujikawa T, Orisaka M, et al
    Prognostic value of (18)F-FDG PET in uterine cervical cancer patients with stage IIICr allocated by imaging.
    Sci Rep. 2023;13:18864.
    Abstract

  2057. SONG Y, Zou J, Choi KS, Lei B, et al
    Cell classification with worse-case boosting for intelligent cervical cancer screening.
    Med Image Anal. 2023;91:103014.
    Abstract

  2058. MONK BJ, Colombo N, Tewari KS, Dubot C, et al
    First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826.
    J Clin Oncol. 2023 Nov 1:JCO2300914. doi: 10.1200/JCO.23.00914.
    Abstract

  2059. YOO SS, Katsarakes P, Gashi J, Kim E, et al
    Non-thermal Acoustic Enhancement of Chemotherapeutic Effects of Cisplatin on Xenografted Cervical Cancer in Mice.
    Anticancer Res. 2023;43:4793-4800.
    Abstract

  2060. LI Y, Shen F, Tan Q, Chen Y, et al
    Research Progress of Immuno-Inhibitory Receptors in Gynecological Cervical Cancer.
    Technol Cancer Res Treat. 2023;22:15330338231208846.
    Abstract

  2061. CHENG H, Long J, Su J, Chu J, et al
    Mechanism of Paris polyphylla saponin II inducing autophagic to inhibit angiogenesis of cervical cancer.
    Naunyn Schmiedebergs Arch Pharmacol. 2023.
    Abstract

  2062. AYTAC I, Guven Aytac B, Postaci A
    Inadvertent hypothermia in patients undergoing brachytherapy under monitored anesthesia care: A prospective observational cohort study.
    Medicine (Baltimore). 2023;102:e35735.
    Abstract

  2063. TAN J, Gong R, Zhang Q, Zheng Y, et al
    Meta-analysis of clinical efficacy of electroacupuncture versus conventional treatment for postoperative urinary retention in cervical cancer.
    Medicine (Baltimore). 2023;102:e35580.
    Abstract

  2064. WU Y, Mou J, Liu Y, Zheng W, et al
    Association of LncRNA PCBP1-AS1 with cancer occurrence and development: A review.
    Medicine (Baltimore). 2023;102:e35631.
    Abstract

  2065. SIKANDER M, Malik S, Apraku J, Kumari S, et al
    Synthesis and Antitumor Activity of Brominated-Ormeloxifene (Br-ORM) against Cervical Cancer.
    ACS Omega. 2023;8:38839-38848.
    Abstract

  2066. HASANKHANI MB, Jahani Y, Bazrafshan A, Yazdizadeh A, et al
    Factors Affecting Survival of Patients with Cervical Cancer.
    Iran J Public Health. 2023;52:2216-2224.
    Abstract

  2067. WU D, Liu P, Song D, Wang H, et al
    Implementing the free HPV vaccination for adolescent girls aged below 14 in Shenzhen, Guangdong Province of China: experience, challenges, and lessons.
    Infect Dis Poverty. 2023;12:98.
    Abstract

  2068. BERGQVIST L, Heinonen A, Carcopino X, Redman C, et al
    Added value of electrical impedance spectroscopy in adjunction of colposcopy: a prospective cohort study.
    BMJ Open. 2023;13:e074921.
    Abstract

  2069. ZHANG J, Tian Y
    Construction of prognostic risk markers for cervical cancer combined with anoikis-related genes and their clinical significance.
    Reprod Fertil Dev. 2023 Oct 30. doi: 10.1071/RD23050.
    Abstract

  2070. WINATA IGS, Yusrika MU, Paramitha PP
    Midwives as the Primary Care Providers: Knowledge, Attitude, Practice, and Skill of Early Detection of Cervical Cancer Using Visual Inspection with Acetic Acid.
    Asian Pac J Cancer Prev. 2023;24:3549-3553.
    Abstract

  2071. WINATA IGS, Paramitha PP, Yusrika MU
    Correlation between Knowledge, Attitude, and Partner Support Towards Visual Inspection with Acetic Acid Test among Women in Denpasar City, Indonesia.
    Asian Pac J Cancer Prev. 2023;24:3543-3547.
    Abstract

  2072. BOSE S, Basu P, Mandal R, Chakrabarti J, et al
    A Study of the Impact and Restitutive Efforts of Cervical Cancer Screening during the COVID-19 Pandemic in a Regionsl Cancer Centre in Eastern India.
    Asian Pac J Cancer Prev. 2023;24:3495-3500.
    Abstract

  2073. GUPTA IJ, Ghosh A, Yadav J, Tuteja JS, et al
    External Beam Radiotherapy Interdigitated with High Dose Rate(HDR) Intracavitary Brachytherapy versus External Beam Radiotherapy followed by Sequential HDR Intracavitary Brachytherapy for Locally Advanced Carcinoma Cervix-Randomized Control Study.
    Asian Pac J Cancer Prev. 2023;24:3441-3445.
    Abstract

  2074. THIPSANTHIAH K, Kamsa-Ard S, Musika W, Teemuangsai W, et al
    Factors Affecting Non-Histologically Proven Invasive Cancer of the Uterine Cervix that Had an Abnormal Pap Smear: Results of the CCS Program.
    Asian Pac J Cancer Prev. 2023;24:3429-3436.
    Abstract

  2075. RASI F, Zarredar H, Amini M, Onsori H, et al
    Suppression of E6 Oncogene Induces Apoptosis in CaSki Cervical Cancer Cells.
    Asian Pac J Cancer Prev. 2023;24:3389-3395.
    Abstract

  2076. HAILU G, Wirtu D, Tesfaye T, Getachew M, et al
    Human papillomavirus vaccine uptake and associated factors among adolescent girls in high schools of Nekemte city, Western Ethiopia, 2020.
    BMC Womens Health. 2023;23:560.
    Abstract

  2077. KOGURE G, Tanaka K, Matsui T, Onuki M, et al
    Intra-Patient Genomic Variations of Human Papillomavirus Type 31 in Cervical Cancer and Precancer.
    Viruses. 2023;15:2104.
    Abstract

  2078. LIN Y, Lin WY, Lin TW, Tseng YJ, et al
    Trend of HPV Molecular Epidemiology in the Post-Vaccine Era: A 10-Year Study.
    Viruses. 2023;15:2015.
    Abstract

  2079. HAN X, Gao Z, Cheng Y, Wu S, et al
    A Therapeutic DNA Vaccine Targeting HPV16 E7 in Combination with Anti-PD-1/PD-L1 Enhanced Tumor Regression and Cytotoxic Immune Responses.
    Int J Mol Sci. 2023;24:15469.
    Abstract

  2080. SHAKUR A, Lee JYJ, Freeman S
    An Update on the Role of MRI in Treatment Stratification of Patients with Cervical Cancer.
    Cancers (Basel). 2023;15:5105.
    Abstract

  2081. MAZUREC K, Trzeszcz M, Mazurec M, Streb J, et al
    Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology.
    Cancers (Basel). 2023;15:5095.
    Abstract

  2082. MEDICI F, Ferioli M, Forlani L, Laghi V, et al
    Decoding the Complexity of Systemic Inflammation Predictors in Locally Advanced Cervical Cancer, with Hemoglobin as the Hidden Key (the ESTHER Study).
    Cancers (Basel). 2023;15:5056.
    Abstract

  2083. BLACKMAN A, Creasman W
    A Case for the Conservative Management of Stage IA Cervical Cancer.
    Cancers (Basel). 2023;15:5051.
    Abstract

  2084. EASWARAN V, Shorog EM, Alshahrani AA, Mohammad AAS, et al
    Knowledge, Attitudes, and Practices Related to Cervical Cancer Prevention and Screening among Female Pharmacy Students at a Public University in a Southern Region of Saudi Arabia.
    Healthcare (Basel). 2023;11:2798.
    Abstract

  2085. VOIDAZAN S, Budianu AM, Francisc RF, Kovacs Z, et al
    Assessing the Level of Knowledge and Experience Regarding Cervical Cancer Prevention and Screening among Roma Women in Romania.
    Medicina (Kaunas). 2023;59:1885.
    Abstract

  2086. ONG WL, Lunca S, Morarasu S, Musina AM, et al
    Evaluation of Changes in Circulating Cell-Free DNA as an Early Predictor of Response to Chemoradiation in Rectal Cancer-A Pilot Study.
    Medicina (Kaunas). 2023;59:1742.
    Abstract

  2087. ANGHEL B, Serboiu C, Marinescu A, Taciuc IA, et al
    Recent Advances and Adaptive Strategies in Image Guidance for Cervical Cancer Radiotherapy.
    Medicina (Kaunas). 2023;59:1735.
    Abstract

  2088. FERNANDEZ-AVILA L, Castro-Amaya AM, Molina-Pineda A, Hernandez-Gutierrez R, et al
    The Value of CXCL1, CXCL2, CXCL3, and CXCL8 as Potential Prognosis Markers in Cervical Cancer: Evidence of E6/E7 from HPV16 and 18 in Chemokines Regulation.
    Biomedicines. 2023;11:2655.
    Abstract

  2089. SCAGLIONE G, Arciuolo D, Travaglino A, Santoro A, et al
    Prognostic Value of Mandard's Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer.
    Diagnostics (Basel). 2023;13:3228.
    Abstract

  2090. YU Z, Zhihui Q, Linrui L, Long L, et al
    Machine Learning-Based Models for Assessing Postoperative Risk Factors in Patients with Cervical Cancer.
    Acad Radiol. 2023 Oct 25:S1076-6332(23)00510-X. doi: 10.1016/j.acra.2023.
    Abstract

  2091. VOELKER RA
    Cervical Cancer Screening.
    JAMA. 2023 Oct 27. doi: 10.1001/jama.2023.21987.
    Abstract


  2092. Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.
    Asia Pac J Clin Oncol. 2023 Oct 27. doi: 10.1111/ajco.13997.
    Abstract

  2093. ALONSO-ESPIAS M, Gorostidi M, Gracia M, Garcia-Pineda V, et al
    Role of Adjuvant Radiotherapy in Patients with Cervical Cancer Undergoing Radical Hysterectomy.
    J Pers Med. 2023;13:1486.
    Abstract

  2094. MBULAWA ZZA, Mahlangu LL, Makhabane E, Mavivane S, et al
    Poor Cervical Cancer Knowledge and Awareness among Women and Men in the Eastern Cape Province Rural Community.
    Int J Environ Res Public Health. 2023;20:6916.
    Abstract

  2095. DOVNIK A, Repse Fokter A
    The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening.
    Curr Issues Mol Biol. 2023;45:8476-8491.
    Abstract

  2096. SABATINO SA, Thompson TD, White MC, Villarroel MA, et al
    Up-to-Date Breast, Cervical, and Colorectal Cancer Screening Test Use in the United States, 2021.
    Prev Chronic Dis. 2023;20:E94.
    Abstract

  2097. SUPHATTANAPORN O, Saraluck A, Mononai J, Lekskul N, et al
    Prevalence of precancerous gynecological lesions and gynecological cancer in patients undergoing vaginal hysterectomy for pelvic organ prolapse.
    Ann Med. 2023;55:2273428.
    Abstract

  2098. ZENG H, Dai Q, Jiang D
    A single-institutional retrospective analysis of factors related to vaginal intraepithelial neoplasia.
    BMC Womens Health. 2023;23:548.
    Abstract

  2099. VELENTZIS LS, Smith MA, Killen J, Brotherton JML, et al
    A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination.
    Elife. 2023;12:e85720.
    Abstract

  2100. PERKINS RB, Humiston S, Oliver K
    Evidence supporting the initiation of HPV vaccination starting at age 9: Collection overview.
    Hum Vaccin Immunother. 2023;19:2269026.
    Abstract

  2101. LUPIA T, Fornari V, Gaviraghi A, De Rosa FG, et al
    Cerebral cystic echinococcosis reactivation during therapy for squamous tumor of the cervix: possible interactions?
    J Infect Dev Ctries. 2023;17:1348-1350.
    Abstract

  2102. STOEKLE HC, Sekkate S, Ayoubi JM, Bennouna J, et al
    Vaccination against HPV: Easier said than done?
    Hum Vaccin Immunother. 2023;19:2266935.
    Abstract

  2103. HASHIMOTO K, Kumagai T, Nomura K, Miyagawa Y, et al
    Validation of an on-chip p16(ink4a)/Ki-67 dual immunostaining cervical cytology system using microfluidic device technology.
    Sci Rep. 2023;13:17052.
    Abstract

  2104. HE Y
    A personal tribute to Dr. Harald zur Hausen: A distinguished scientist and caring mentor.
    J Med Virol. 2023;95:e29162.
    Abstract

  2105. UNVER T, Celik-Uzuner S, Erenler AS
    Comparative evaluation of cytotoxic and anti-metastatic function of microbial chondroitin sulfate and animal-originated commercial chondroitin sulfate in cancer cells.
    Cell Mol Biol (Noisy-le-grand). 2023;69:8-14.
    Abstract

  2106. ZOU Z, Zhang L
    The one-dose schedule opens the door to rapid scale-up of HPV vaccination.
    BMC Med. 2023;21:387.
    Abstract

  2107. BAVOR C, Brotherton JM, Smith MA, Prang KH, et al
    The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study.
    BMC Health Serv Res. 2023;23:1073.
    Abstract

  2108. GAO X, Xu N, Li Z, Shen L, et al
    Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
    Lancet Oncol. 2023;24:1134-1146.
    Abstract

  2109. TASSEMBEDO S, Winter CH, Traore IT, Ouattara A, et al
    Cervical pre-cancer screening by visual inspection of the cervix after application of acetic acid in rural Burkina Faso: evaluation of women's knowledge, screening practice habits, acceptability and prevalence of risk factors and lesions in Bousse hea
    Pan Afr Med J. 2023;45:135.
    Abstract

  2110. WANG X, Lu X, Chen J, Yi H, et al
    Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis.
    BMC Surg. 2023;23:299.
    Abstract

  2111. SHAFIQUE R, Mahjabeen I, Bibi K, Kalsoom F, et al
    miRNA-767 and its binding site polymorphism in the mTOR gene act as potential biomarkers for female reproductive cancers.
    Future Oncol. 2023;19:1929-1943.
    Abstract

  2112. SONG X, Na R, Peng N, Cao W, et al
    Exploring the role of macrophages in the progression from atypical hyperplasia to endometrial carcinoma through single-cell transcriptomics and bulk transcriptomics analysis.
    Front Endocrinol (Lausanne). 2023;14:1198944.
    Abstract

  2113. AZZI PA, Bastos Russomano F, de Andrade CV, de Camargo MJ, et al
    Frequency of post-treatment disease after excisional procedure in stage IA1 squamous cervical carcinoma - a case series.
    Women Health. 2023;63:747-755.
    Abstract

  2114. CUI J, Xiao J, Hou Y, Wu X, et al
    Unsupervised Domain Adaptive Dose Prediction via Cross-Attention Transformer and Target-Specific Knowledge Preservation.
    Int J Neural Syst. 2023;33:2350057.
    Abstract

  2115. LEE VWY, Yip WWL, Tang SYK, Leung MPH, et al
    Efficacy and feasibility of 3D printed redesigned Venezia applicator for treating advanced cervix and recurrent endometrial cancer.
    Phys Med. 2023;114:103150.
    Abstract

  2116. NIYOTEKA S, Seban RD, Rouhi R, Scarsbrook A, et al
    A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers.
    Eur J Nucl Med Mol Imaging. 2023;50:4010-4023.
    Abstract

  2117. JOU J, Kato S, Miyashita H, Thangathurai K, et al
    Cancer-Immunity Marker RNA Expression Levels across Gynecologic Cancers: Implications for Immunotherapy.
    Mol Cancer Ther. 2023;22:1352-1362.
    Abstract

  2118. KITAZAWA S, Chiyoda T, Nakamura K, Sakai K, et al
    Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.
    Int J Clin Oncol. 2023;28:1554-1562.
    Abstract

  2119. NG JKM, Cheung BHC, Lee DHY, Li JJX, et al
    Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear.
    Cancer Med. 2023;12:17581-17591.
    Abstract

  2120. ARROYO MUHR LS, Dillner J
    Biosimilar second-generation human papillomavirus vaccines.
    Lancet Infect Dis. 2023;23:1215-1216.
    Abstract

  2121. WANG T, Su K, Wang L, Shi Y, et al
    Pan-cancer analysis of the oncogenic effects of G-protein-coupled receptor kinase-interacting protein-1 and validation on liver hepatocellular carcinoma.
    Adv Clin Exp Med. 2023;32:1139-1147.
    Abstract

  2122. HAARSAGER J, Legerton P, DeBats C, Austin G, et al
    Perceptions and implications for cervical screening and self-collection: A qualitative exploration of never and under-screened Queensland women.
    Health Promot J Austr. 2023;34:943-952.
    Abstract

  2123. PARIDA P, Lewis S, Sharan K, Kamal MV, et al
    Increased Gene Expression of C1orf74 Is Associated with Poor Prognosis in Cervical Cancer.
    Cells. 2023;12:2530.
    Abstract

  2124. DU N, Li D, Zhao W, Liu Y, et al
    Stratifin (SFN) Regulates Cervical Cancer Cell Proliferation, Apoptosis, and Cytoskeletal Remodeling and Metastasis Progression Through LIMK2/Cofilin Signaling.
    Mol Biotechnol. 2023 Nov 9. doi: 10.1007/s12033-023-00946.
    Abstract

  2125. YANG H, Ma X, Song B, Wang D, et al
    Golgi Phosphoprotein 3 Promotes Cervical Cancer Progression via Wnt/beta-catenin Mediated Epithelial-Mesenchymal Transition.
    Ann Clin Lab Sci. 2023;53:738-748.
    Abstract

  2126. MCCLELLAN SP, Unger-Saldana K, Espinosa-Tamez P, Suazo-Zepeda E, et al
    The Cervical Cancer Treatment Gap in Mexico Under Seguro Popular, 2006-2016.
    Health Syst Reform. 2023;9:2272371.
    Abstract

  2127. ZHANG Y, Chen X, Chen H, Zhang Y, et al
    ZC3H13 Enhances the Malignancy of Cervical Cancer by Regulating m6A Modification of CKAP2.
    Crit Rev Immunol. 2023;43:1-13.
    Abstract

  2128. SANTOS JMO, Tavares V, Gil da Costa RM, Medeiros R, et al
    MiR-150 and miR-155 expression predicts survival of cervical cancer patients: a translational approach to novel prognostic biomarkers.
    Biomarkers. 2023 Nov 9:1-20. doi: 10.1080/1354750X.2023.2269320.
    Abstract

  2129. WEN J, Huang C, Guo N, Wang W, et al
    Eyelid Metastasis from Cervical Cancer: A Case Report.
    Case Rep Oncol. 2023;16:1311-1317.
    Abstract

  2130. A D, Li J, Zhang D, Xiao B, et al
    Status of common sexually transmitted infection in population referred for colposcopy and correlation with human papillomavirus infection.
    BMC Womens Health. 2023;23:579.
    Abstract

  2131. WU RR, Zhou YM, Xie XY, Chen JY, et al
    Delta radiomics analysis for prediction of intermediary- and high-risk factors for patients with locally advanced cervical cancer receiving neoadjuvant therapy.
    Sci Rep. 2023;13:19409.
    Abstract

  2132. NAZARI AM, Zare-Kaseb A, Arbabi Z, Gholampour MH, et al
    The effect of Benson relaxation technique on cancer patients: a systematic review.
    Support Care Cancer. 2023;31:681.
    Abstract

  2133. WANG L, Wang C, He Y, Jin M, et al
    Identification of a prognostic model based on immune and hypoxia-related gene expressions in cervical cancer.
    J Obstet Gynaecol. 2023;43:2277242.
    Abstract

  2134. ZHOU J, Lei N, Tian W, Guo R, et al
    Hypoxic tumor cell-derived small extracellular vesicle miR-152-3p promotes cervical cancer radioresistance through KLF15 protein.
    Radiat Oncol. 2023;18:183.
    Abstract

  2135. MAEDA M, Mabuchi S, Sakata M, Deguchi S, et al
    Significance of tumor size and number of positive nodes in patients with FIGO 2018 stage IIIC1 cervical cancer.
    Jpn J Clin Oncol. 2023 Nov 1:hyad141. doi: 10.1093.
    Abstract

  2136. HE J, Xiang L, Zhu T, Wang H, et al
    Maackiain suppresses the development of cervical cancer via AMPK priming autophagy.
    J Pharm Pharmacol. 2023 Nov 2:rgad100. doi: 10.1093.
    Abstract

  2137. NUJHAT S, Leese HS, Di Lorenzo M, Bowen R, et al
    Advances in screening and diagnostic lab-on-chip tools for gynaecological cancers - a review.
    Artif Cells Nanomed Biotechnol. 2023;51:618-629.
    Abstract

  2138. TAMAUCHI S, Iyoshi S, Yoshihara M, Yoshida K, et al
    An update of oncologic and obstetric outcomes of radical trachelectomy for early-stage cervical cancer: The need for further minimally invasive treatment.
    J Obstet Gynaecol Res. 2023 Nov 6. doi: 10.1111/jog.15824.
    Abstract

  2139. LI J
    High-risk HPV-associated ovarian squamous cell carcinoma: A case report and literature review.
    Medicine (Baltimore). 2023;102:e35907.
    Abstract

  2140. WUTHRICH-GROSSENBACHER U, Midzi N, Mutsaka-Makuvaza MJ, Mutsinze A, et al
    Religious and traditional beliefs and practices as predictors of mental and physical health outcomes and the role of religious affiliation in health outcomes and risk taking.
    BMC Public Health. 2023;23:2170.
    Abstract

  2141. MOGI K, Koya Y, Yoshihara M, Sugiyama M, et al
    9-oxo-ODAs suppresses the proliferation of human cervical cancer cells through the inhibition of CDKs and HPV oncoproteins.
    Sci Rep. 2023;13:19208.
    Abstract

  2142. PATRA S, Ghosal S, Shand H, Mondal R, et al
    Function of gamma delta (gammadelta) T cell in cancer with special emphasis on cervical cancer.
    Hum Immunol. 2023 Nov 4:110724. doi: 10.1016/j.humimm.2023.110724.
    Abstract


  2143. Correction: Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five subSaharan African countries.
    BMJ Open. 2023;13:e065074corr1.
    Abstract

  2144. WAKWOYA EB, Sadi CG, Sendo EG
    Precancerous cervical lesion screening acceptance among women in Eastern Ethiopia.
    BMJ Open. 2023;13:e073721.
    Abstract

  2145. M DE CARVALHO T, Man I, Georges D, Saraswati LR, et al
    Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India.
    BMJ Glob Health. 2023;8:e012580.
    Abstract

  2146. YADAV R, Das PP, Sharma S, Sengupta S, et al
    Recent advancement of nanomedicine-based targeted delivery for cervical cancer treatment.
    Med Oncol. 2023;40:347.
    Abstract

  2147. MA Z, Cai Y, Tian C
    ZWINT promotes the proliferation, migration, and invasion of cervical cancer cells by regulating the p53/p21 signaling pathway.
    Chin J Physiol. 2023;66:372-378.
    Abstract

  2148. DAI J, Zhang S, Shi Y, Xu J, et al
    rs217727 of lncRNA H19 is Associated with Cervical Cancer Risk in the Chinese Han Population.
    Pharmgenomics Pers Med. 2023;16:933-948.
    Abstract

  2149. ZHETPISBAYEVA I, Kassymbekova F, Sarmuldayeva S, Semenova Y, et al
    Cervical Cancer Prevention in Rural Areas.
    Ann Glob Health. 2023;89:75.
    Abstract

  2150. DANAN ER, Than C, Chawla N, Hoggatt KJ, et al
    Abnormal cervical cancer screening results among US Veteran and non-Veteran participants in the National Health Interview Survey (NHIS).
    Prev Med Rep. 2023;36:102472.
    Abstract

  2151. LIU KH, Yang W, Tian HP
    Relationships between intravoxel incoherent motion parameters and expressions of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) in patients with cervical cancer.
    Clin Radiol. 2023 Oct 29:S0009-9260(23)00458-0. doi: 10.1016/j.crad.2023.
    Abstract

  2152. ADEPOJU P
    Nigeria targets almost 8 million girls with HPV vaccine.
    Lancet. 2023;402:1612.
    Abstract

  2153. PAN C, Lin J, Dai X, Jiao L, et al
    An m1A/m6A/m5C-associated long non-coding RNA signature: Prognostic and immunotherapeutic insights into cervical cancer.
    J Gene Med. 2023 Nov 3:e3618. doi: 10.1002/jgm.3618.
    Abstract

  2154. YEN A, Zhong X, Lin MH, Nwachukwu C, et al
    Optimizing Online Adaptation Timing in the Treatment of Locally Advanced Cervical Cancer.
    Pract Radiat Oncol. 2023 Nov 1:S1879-8500(23)00283.
    Abstract

  2155. JIN J, Fan Z, Long Y, Li Y, et al
    Matrine induces ferroptosis in cervical cancer through activation of piezo1 channel.
    Phytomedicine. 2023;122:155165.
    Abstract

  2156. CHRISTENSEN AJ, Mwayi J, Mbabazi J, Juncker M, et al
    Fighting cervical cancer in Africa: a cross-sectional study on prevalence and risk factors for precancerous lesions in rural Uganda.
    Public Health. 2023;225:87-95.
    Abstract

  2157. ENDALAMAW A, Alganeh H, Azage M, Atnafu A, et al
    Improving cervical cancer continuum of care towards elimination in Ethiopia: a scoping review.
    Cancer Causes Control. 2023 Nov 4. doi: 10.1007/s10552-023-01813.
    Abstract

  2158. MENG M, Guo Y, Chen Y, Li X, et al
    Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways.
    Cell Oncol (Dordr). 2023 Nov 4. doi: 10.1007/s13402-023-00891.
    Abstract

  2159. DENG YR, Chen XJ, Xu CQ, Wu QZ, et al
    A preoperative nomogram predicting risk of lymph node metastasis for early-stage cervical cancer.
    BMC Womens Health. 2023;23:568.
    Abstract

  2160. PELIZZOLA M, Tanderup K, Chopra S, Jurgenliemk-Schulz IM, et al
    Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients: a cluster analysis.
    Acta Oncol. 2023;62:1479-1487.
    Abstract

  2161. TOPKARA S, Sucu S, Cakir AT, Harma M, et al
    Investigation of human papilloma virus frequency in pregnant women.
    J Obstet Gynaecol Res. 2023;49:2728-2733.
    Abstract

  2162. YOSHINO K, Kurita T, Takahashi F, Nagase S, et al
    Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2020 and Annual Treatment Report for 2015.
    J Obstet Gynaecol Res. 2023;49:2584-2592.
    Abstract

  2163. ANDRING LM, Corrigan KL, Rooney M, Bailard N, et al
    Patient Reported Outcomes for Women Undergoing Definitive Chemoradiation for Gynecologic Cancer: A Prospective Clinical Trial.
    Pract Radiat Oncol. 2023;13:e538-e546.
    Abstract

  2164. CHAO A, Wu RC, Lin CY, Chang TC, et al
    Small cell neuroendocrine carcinoma of the cervix: From molecular basis to therapeutic advances.
    Biomed J. 2023;46:100633.
    Abstract

  2165. CHEN CC, Lai CH, Chang CL, Cheng WF, et al
    Managing the transition in cervical screening methods for Taiwan: Policy recommendations and perspectives.
    J Formos Med Assoc. 2023;122:1213-1218.
    Abstract

  2166. CONNELLY CF, Collins N, Cimic A, Baskota SU, et al
    Significance of concurrent HPV testing with unsatisfactory Papanicolaou test for prediction of follow-up HPV, Papanicolaou test, and biopsy results.
    Am J Clin Pathol. 2023;160:444-449.
    Abstract

  2167. VISIOLI CB, Iossa A, Gorini G, Mantellini P, et al
    The 5-year risk of recurrence of grade 2/3 cervical intraepithelial neoplasia after treatment in a population screening programme by human papillomavirus status: A cohort study in central Italy.
    J Med Screen. 2023;30:191-200.
    Abstract

  2168. YANG S, Yang X, Li C
    Integrated analysis of EREG expression, a gene associated with cervical cancer prognosis.
    Am J Cancer Res. 2023;13:4644-4660.
    Abstract

  2169. SIVASUBRAMANIAN N, Beeman M, Bharatbhai Patel U, Payalben V, et al
    Knowledge on cervical cancer among Indian women in the state of Gujarat.
    Bioinformation. 2023;19:999-1002.
    Abstract

  2170. LI Y, Wang W, Tian J, Zhou Y, et al
    Clinical Significance of Soluble LAG-3 (sLAG-3) in Patients With Cervical Cancer Determined via Enzyme-Linked Immunosorbent Assay With Monoclonal Antibodies.
    Technol Cancer Res Treat. 2023;22:15330338231202650.
    Abstract

  2171. MAHASE E
    NHS England says it will eliminate cervical cancer by 2040.
    BMJ. 2023;383:p2693.
    Abstract

  2172. AWUA AK
    Ration health resources to save more statistical lives from cervical cancer death in Africa: Why are we allowing them to die?
    Dev World Bioeth. 2023 Nov 15. doi: 10.1111/dewb.12434.
    Abstract

  2173. TESFAYE D, Weldegebreal F, Ayele F, Dheresa M, et al
    Cervical cancer screening uptake and associated factors among Women Living with Human Immunodeficiency Virus in public hospitals, eastern Ethiopia.
    Front Oncol. 2023;13:1249151.
    Abstract

  2174. RUTILI DE LIMA C, Khan SG, Shah SH, Ferri L, et al
    Mask region-based CNNs for cervical cancer progression diagnosis on pap smear examinations.
    Heliyon. 2023;9:e21388.
    Abstract

  2175. DINICU AI, Dioun S, Goldberg M, Crookes DM, et al
    Region of origin and cervical cancer stage in multiethnic Hispanic/Latinx patients living in the United States.
    Cancer Med. 2023 Nov 15. doi: 10.1002/cam4.6697.
    Abstract

  2176. JAILANI AS, Balqis-Ali NZ, Tang KF, Fun WH, et al
    Prevalence and sociodemographic predictors of high-risk vaginal human papillomavirus infection: findings from a public cervical cancer screening registry.
    BMC Public Health. 2023;23:2243.
    Abstract

  2177. SABANAYAGAM R, Krishnamoorthy S, Anbuselvam M, Muruganantham B, et al
    A comparative analysis of phyto-components on EGFR binding, viability, and migration in HPV positive ME180 and HPV negative C33A cervical cancer cells.
    Med Oncol. 2023;40:357.
    Abstract

  2178. LEE NK, Tiro JA, Odunsi K
    Disparities in Gynecologic Cancers.
    Cancer J. 2023;29:343-353.
    Abstract

  2179. TAN SL, Selvachandran G, Ding W, Paramesran R, et al
    Cervical Cancer Classification From Pap Smear Images Using Deep Convolutional Neural Network Models.
    Interdiscip Sci. 2023 Nov 14. doi: 10.1007/s12539-023-00589.
    Abstract

  2180. PORTER VL, O'Neill K, MacLennan S, Corbett RD, et al
    Genomic structures and regulation patterns at HPV integration sites in cervical cancer.
    bioRxiv. 2023 Nov 5:2023.11.04.564800. doi: 10.1101/2023.11.04.564800.
    Abstract

  2181. WANG J, Li M, Zhao L, Zhou B, et al
    Whole genome sequencing in high-grade cervical intraepithelial neoplasia patients from different ethnic groups in China.
    Medicine (Baltimore). 2023;102:e35953.
    Abstract

  2182. JO J, Kim JY, Yun JJ, Lee YJ, et al
    beta-Cyclodextrin Nanophotosensitizers for Redox-Sensitive Delivery of Chlorin e6.
    Molecules. 2023;28:7398.
    Abstract

  2183. MEREU L, Pecorino B, Ferrara M, Tomaselli V, et al
    Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: Retrospective Single-Center Study.
    Cancers (Basel). 2023;15:5207.
    Abstract

  2184. KALANTAR R, Curcean S, Winfield JM, Lin G, et al
    Deep Learning Framework with Multi-Head Dilated Encoders for Enhanced Segmentation of Cervical Cancer on Multiparametric Magnetic Resonance Imaging.
    Diagnostics (Basel). 2023;13:3381.
    Abstract

  2185. YU J, Yuan S, Song J, Yu S, et al
    USP39 interacts with SIRT7 to promote cervical squamous cell carcinoma by modulating autophagy and oxidative stress via FOXM1.
    J Transl Med. 2023;21:807.
    Abstract

  2186. KABUE M, Gauvreau CL, Daceney N, Bertram MM, et al
    Understanding integrated HPV testing and treatment of pre-cancerous cervical cancer in Burkina Faso, Cote d'Ivoire, Guatemala and Philippines: study protocol.
    Reprod Health. 2023;20:167.
    Abstract

  2187. FENG T, Cheng B, Sun W, Yang Y, et al
    Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions.
    BMC Womens Health. 2023;23:599.
    Abstract

  2188. SOKALE IO, Thrift AP, Montealegre J, Adekanmbi V, et al
    Geographic Variation in Late-Stage Cervical Cancer Diagnosis.
    JAMA Netw Open. 2023;6:e2343152.
    Abstract

  2189. SEBITLOANE HM, Forestier M, Ginindza TG, Dhlomo W, et al
    Cervical Cancer Screening and Treatment algorithms using Human Papillomavirus testing - lessons learnt from a South African pilot randomized controlled trial.
    Cancer Epidemiol Biomarkers Prev. 2023.
    Abstract

  2190. ALI AH, Marhoon SE, Taman M
    Emergency Presentation of Invasive Cervical Cancer in Late Pregnancy: A Case Report and Literature Review.
    Cureus. 2023;15:e46900.
    Abstract

  2191. WANG C, Cheng Y, Song Y, Lei J, et al
    Dosimetric parameters and safety analysis of 3D-printing non-coplanar template-assisted interstitial brachytherapy for non-centrally recurrent cervical cancer.
    Front Oncol. 2023;13:1174470.
    Abstract

  2192. WANG S, Liu X, Wu Y, Jiang C, et al
    Habitat-based radiomics enhances the ability to predict lymphovascular space invasion in cervical cancer: a multi-center study.
    Front Oncol. 2023;13:1252074.
    Abstract

  2193. HAOJUE WANG, Xianyi Lu, Ling Fang, Qifeng Shi, et al
    Identification and characterization of differentially expressed genes in cervical cancer: insights from transcriptomic analysis.
    Cell Mol Biol (Noisy-le-grand). 2023;69:276-281.
    Abstract

  2194. YANG Q, Fu J, Wang M, Fang Y, et al
    MiR-1299 is regulated by KCNQ1OT1 and inhibits cervical cancer progression.
    Cell Mol Biol (Noisy-le-grand). 2023;69:166-173.
    Abstract

  2195. SCHUURMAN TN, Schaafsma M, To KH, Verhoef VMJ, et al
    Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study.
    Lancet Oncol. 2023 Nov 9:S1470-2045(23)00467.
    Abstract

  2196. MAO Z, Wang B, Zhang T, Cui B, et al
    The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications.
    Cell Death Dis. 2023;14:734.
    Abstract

  2197. PHAN TA, Sarower F, Duan J, Tian JP, et al
    Stochastic dynamics of human papillomavirus delineates cervical cancer progression.
    J Math Biol. 2023;87:85.
    Abstract

  2198. SIEGLER K, Plaikner A, Hertel H, Hasenbein K, et al
    Oncologic and fertility outcomes after simple trachelectomy in women with early cervical cancer.
    J Minim Invasive Gynecol. 2023 Nov 9:S1553-4650(23)00960.
    Abstract

  2199. WEN B, Luo L, Zeng Z, Luo X, et al
    MYL9 promotes squamous cervical cancer migration and invasion by enhancing aerobic glycolysis.
    J Int Med Res. 2023;51:3000605231208582.
    Abstract

  2200. ELBARAZI I, Alam Z, Abdullahi AS, Al Alawi S, et al
    Knowledge, Attitudes and Practices of Women in the UAE Towards Breast and Cervical Cancer Prevention: A Cross-Sectional Study.
    Cancer Control. 2023;30:10732748231211459.
    Abstract

  2201. ZHANG Y, Zhang W, Du H, Qu X, et al
    A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results.
    BMC Infect Dis. 2023;23:783.
    Abstract

  2202. SCHILLER JT, Kreimer AR
    An HPV vaccine from India: broadening possibilities for cervical cancer control.
    Lancet Oncol. 2023 Nov 7:S1470-2045(23)00535.
    Abstract

  2203. MARCELINA VM, Widyastiti NS, Bramantyo DF, Kristiawan EC, et al
    PREDICTIVE VALUE OF PLATELET COUNT AND PLATELET INDICES IN CERVICAL CANCER PATIENTS WITH EXTERNAL RADIATION THERAPY.
    Wiad Lek. 2023;76:2269-2276.
    Abstract

  2204. LIN Y, Yang Q
    Mechanism of gemcitabine combined with lobaplatin in interventional treatment of locally advanced cervical cancer.
    Anticancer Drugs. 2023 Nov 13. doi: 10.1097/CAD.0000000000001551.
    Abstract

  2205. SPENCER JC, Burger EA, Campos NG, Regan MC, et al
    Adapting a model of cervical carcinogenesis to self-identified Black women to evaluate racial disparities in the United States.
    J Natl Cancer Inst Monogr. 2023;2023:188-195.
    Abstract

  2206. RAN XM, Xiao H, Tang YX, Jin X, et al
    The effect of cuproptosis-relevant genes on the immune infiltration and metabolism of gynecological oncology by multiply analysis and experiments validation.
    Sci Rep. 2023;13:19474.
    Abstract

  2207. PIMENOFF VN, Gray P, Louvanto K, Eriksson T, et al
    Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts.
    Cell Host Microbe. 2023;31:1921-1929.
    Abstract

  2208. ANDERSON JR, Yogeshkumar S, Lu E, Yenokyan G, et al
    The CryoPop study: Screening for high-grade cervical dysplasia in Karnataka, India.
    BJOG. 2023;130 Suppl 3:158-167.
    Abstract

  2209. LIN S, Sun Y, Cao C, Zhu Z, et al
    Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma.
    EBioMedicine. 2023;97:104846.
    Abstract

  2210. COLBERT LE, El Alam MB, Wang R, Karpinets T, et al
    Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring.
    Cancer Cell. 2023;41:1945-1962.
    Abstract

  2211. VARON M, Salcedo MP, Fellman B, Troisi C, et al
    A Comprehensive Program to Improve Treatment of Precancerous Cervical Lesions in the Rio Grande Valley of Texas.
    J Public Health Manag Pract. 2024;30:89-98.
    Abstract

  2212. LIN HY, Fu Q, Tseng TS, Zhu X, et al
    Impact of Dietary Quality on Genital Oncogenic HPV Infection in Women.
    J Infect Dis. 2023 May 10:jiad146. doi: 10.1093.
    Abstract

  2213. JONG FC, Kotzur M, Amiri R, Ling J, et al
    Using a participatory approach to encourage uptake of breast, colorectal, and cervical cancer screening for Scottish Muslim women: a pilot qualitative study.
    Lancet. 2023;402 Suppl 1:S12.
    Abstract

  2214. WASHINGTON A, Smith L, Anderson G, Randall J, et al
    A Systematic Review of the Effectiveness of Health Education Programs for Cervical Cancer Prevention in Rural Communities: Implications for Promoting Health Equity.
    J Cancer Educ. 2023 Nov 24. doi: 10.1007/s13187-023-02385.
    Abstract

  2215. CHEN JL, Huang CY, Shih IL, Liou YM, et al
    Prognostic nutritional index and neutrophil-lymphocyte ratio predict toxicities and prognosis in patients with cervical cancer treated with curative radiochemotherapy.
    J Formos Med Assoc. 2023 Nov 22:S0929-6646(23)00440.
    Abstract

  2216. ZONG Y, Chang Y, Huang K, Liu J, et al
    The role of BATF2 deficiency in immune microenvironment rearrangement in cervical cancer - New biomarker benefiting from combination of radiotherapy and immunotherapy.
    Int Immunopharmacol. 2023;126:111199.
    Abstract

  2217. LI W, Zhang X, Gao T, Liu L, et al
    Jagged1 contained in MSC-derived small extracellular vesicles promotes squamous differentiation of cervical cancer by activating NOTCH pathway.
    J Cancer Res Clin Oncol. 2023 Nov 23. doi: 10.1007/s00432-023-05495.
    Abstract

  2218. LIU L, Lin J, Deng S, Yu H, et al
    A novel nomogram and risk stratification for early metastasis in cervical cancer after radical radiotherapy.
    Cancer Med. 2023 Nov 23. doi: 10.1002/cam4.6745.
    Abstract

  2219. GUNES AC, Ozgul N, Turkyilmaz M, Kara F, et al
    Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program.
    Cancer Med. 2023 Nov 23. doi: 10.1002/cam4.6740.
    Abstract

  2220. KNUDSEN AB, Trentham-Dietz A, Kim JJ, Mandelblatt JS, et al
    Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening.
    JAMA Netw Open. 2023;6:e2344698.
    Abstract

  2221. JIANG L, Xie T, Xia Y, Li F, et al
    ZIP14 Affects the Proliferation, Apoptosis, and Migration of Cervical Cancer Cells by Regulating the P38 MAPK Pathway.
    Curr Cancer Drug Targets. 2023 Nov 21. doi: 10.2174/0115680096250711231024063841
    Abstract

  2222. CHANG MM, Ma A, Novak EN, Barra M, et al
    A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care.
    Sci Rep. 2023;13:20397.
    Abstract

  2223. SAVROVA A, Jaal J, Nomm O, Innos K, et al
    Factors associated with advanced-stage diagnosis of cervical cancer in Estonia: a population-based study.
    Public Health. 2023;225:369-375.
    Abstract

  2224. ALARCON-BARRIOS S, Luvian-Morales J, Castro-Eguiluz D, Delgadillo-Gonzalez M, et al
    Chemoradiotherapy treatment with gemcitabine improves renal function in locally advanced cervical cancer patients with renal dysfunction.
    Curr Probl Cancer. 2023;48:101041.
    Abstract

  2225. HAO S, Meng Q, Sun H, Yang X, et al
    Human papillomavirus type 16 E6 promotes cervical cancer proliferation by upregulating transketolase enzymatic activity through the activation of protein kinase B.
    Mol Carcinog. 2023 Nov 21. doi: 10.1002/mc.23656.
    Abstract

  2226. XUE J, Yan X, Ding Q, Li N, et al
    Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours.
    Ann Med. 2023;55:2282181.
    Abstract

  2227. LOFTERS AK, Wu F, Frymire E, Kiran T, et al
    Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    JAMA Netw Open. 2023;6:e2343796.
    Abstract

  2228. ISLAM S, Shahzad SA, Hassan Bin Asad MH, Mannan A, et al
    Novel amodiaquine analogues to treat cervical cancer and microbial infection in the future.
    Future Med Chem. 2023 Nov 20. doi: 10.4155/fmc-2023-0245.
    Abstract

  2229. RUSSO L, Pasciuto T, Lupinelli M, Urbano A, et al
    The value of MRI in quantification of parametrial invasion and association with prognosis in locally advanced cervical cancer: the "PLACE" study.
    Eur Radiol. 2023 Nov 20. doi: 10.1007/s00330-023-10443.
    Abstract

  2230. BOGANI G, Sopracordevole F, Ciavattini A, Ghelardi A, et al
    HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination.
    Tumori. 2023 Nov 17:3008916231208344. doi: 10.1177/03008916231208344.
    Abstract

  2231. KRISHNAMOORTHY S, Muruganantham B, Yu JR, Park WY, et al
    Exploring the utility of FTS as a bonafide binding partner for EGFR: A potential drug target for cervical cancer.
    Comput Biol Med. 2023;167:107592.
    Abstract

  2232. NAERT E, Decruyenaere A, Bultijnck R, De Jaeghere EA, et al
    Vaginal morbidity, sexual functioning, and health-related quality of life in cervical cancer survivors: a cross-sectional multicenter study (VAMOS).
    Support Care Cancer. 2023;31:703.
    Abstract

  2233. CHEN Z, Xu Z, Wang Q, Wang L, et al
    Exosome-delivered circRNA circSYT15 contributes to cisplatin resistance in cervical cancer cells through the miR-503-5p/RSF1 axis.
    Cell Cycle. 2023 Nov 16:1-18. doi: 10.1080/15384101.2023.2281768.
    Abstract

  2234. LIU Y, Wang S, Liu J, Su M, et al
    Characteristics of vaginal microbiota in various cervical intraepithelial neoplasia: a cross-sectional study.
    J Transl Med. 2023;21:816.
    Abstract

  2235. YANG L, Lei Y, Huang Z, Geng M, et al
    An interactive nuclei segmentation framework with Voronoi diagrams and weighted convex difference for cervical cancer pathology images.
    Phys Med Biol. 2023 Nov 16. doi: 10.1088/1361-6560.
    Abstract

  2236. HAN K, Zou J, Zhao Z, Baskurt Z, et al
    Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer.
    J Clin Oncol. 2023 Nov 16:JCO2300954. doi: 10.1200/JCO.23.00954.
    Abstract

  2237. SILVA TV, Borovac-Pinheiro A, Pacagnella RC
    Estimates of avoided costs attributed to a short cervix screening program to prevent preterm birth from the perspective of the Unified Health System (SUS).
    Rev Saude Publica. 2023;57:87.
    Abstract

  2238. GRAZIA GA, Bastos DR, Villa LL
    CD40/CD40L expression and its prognostic value in cervical cancer.
    Braz J Med Biol Res. 2023;56:e13047.
    Abstract

  2239. FOWLER JR, Maani EV, Dunton CJ, Gasalberti DP, et al
    Association of urinary arsenic, polycyclic aromatic hydrocarbons, and metals with cancers among the female population in the US.
    Toxicol Appl Pharmacol. 2023;480:116746.
    Abstract

  2240. GUO Y, Hua S, Wang B, Wang B, et al
    In situ grown magnetic COF@MOF with a phosphoserine anchor for in-depth N-glycopeptide analysis in serum.
    Analyst. 2023;148:5864-5872.
    Abstract

  2241. NAGAO A, Okamoto H, Nakayama H, Chiba T, et al
    Assessment of intrafractional motion of the cervix-uterus by MR-guided radiotherapy systemdagger.
    J Radiat Res. 2023;64:967-972.
    Abstract

  2242. CARDONA-MENDOZA A, Fonseca-Benitez A, Buitrago DM, Coy-Barrera E, et al
    Down-regulation of human papillomavirus E6 oncogene and antiproliferative effect of Schisandra chinensis and Pueraria lobata natural extracts on Hela cell line.
    J Ethnopharmacol. 2024;319.
    Abstract

  2243. VON BLANCKENBURG P, Kohler C, Petzel A, Julicher A, et al
    Quality of breaking bad news to patients diagnosed with neoplasia of the uterine cervix.
    J Cancer Res Clin Oncol. 2023;149:17215-17222.
    Abstract

  2244. CHEN L, Chen Y, Shi H, Cai R, et al
    Enhancing prognostic accuracy: a SEER-based analysis for overall and cancer-specific survival prediction in cervical adenocarcinoma patients.
    J Cancer Res Clin Oncol. 2023;149:17027-17037.
    Abstract

  2245. GROVER S, Lichter KE, Likhacheva A, Jang JW, et al
    The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries.
    Brachytherapy. 2023;22:716-727.
    Abstract

  2246. GAUTAM H, Mehta S, Nayar N, Kumar N, et al
    Prevalence of human papilloma virus and Chlamydia trachomatis in endometrial and cervical carcinoma: a comparative study in North Indian women.
    Syst Biol Reprod Med. 2023;69:399-409.
    Abstract

  2247. TANG X, Zhang H, Wang T, Jiang W, et al
    Single and Multiple High-Risk Human Papillomavirus Infections in Histopathologically Confirmed Cervical Squamous Lesions: Incidences, Distribution, and Associated Detection Rates for Precancerous and Cancerous Lesions.
    Lab Invest. 2023;103:100234.
    Abstract

  2248. SAPRA T, Romm KF, Le D, Berg CJ, et al
    Gaps in Adhering to Pap Testing Recommendations and Related Barriers in a Sample of Young Adults in the US.
    J Cancer Educ. 2023;38:1845-1852.
    Abstract

  2249. DU H, Qu X, Wang G, Guo C, et al
    Application an internet facilitation in a community-based cervical cancer screening project.
    BMC Womens Health. 2023;23:641.
    Abstract

  2250. MONK BJ, Toita T, Wu X, Vazquez Limon JC, et al
    Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial.
    Lancet Oncol. 2023;24:1334-1348.
    Abstract

  2251. MILESHKIN LR
    The challenge of improving outcomes in locally advanced cervical cancer.
    Lancet Oncol. 2023;24:1289-1291.
    Abstract

  2252. NIU Z, Yan B
    Prognostic and clinicopathological effect of the prognostic nutritional index (PNI) in patients with cervical cancer: a meta-analysis.
    Ann Med. 2023;55:2288705.
    Abstract

  2253. YANG S, Ding Y, Li H, Wu S, et al
    Impact of peritoneal vaginoplasty combined with radical hysterectomy on the quality of sexual life for patients with early-stage cervical cancer: trial protocol for a multi-center superiority randomized controlled trial.
    J Gynecol Oncol. 2023 Nov 27. doi: 10.3802/jgo.2024.
    Abstract

  2254. AFSAH YR, Kaneko N
    Barriers to cervical cancer screening faced by immigrant Muslim women: a systematic scoping review.
    BMC Public Health. 2023;23:2375.
    Abstract

  2255. CASTANEDA KM, Sidorenkov G, Mourits MJE, van der Vegt B, et al
    Impact of health-related behavioral factors on participation in a cervical cancer screening program: the lifelines population-based cohort.
    BMC Public Health. 2023;23:2376.
    Abstract

  2256. HABILA MA, Obeng-Kusi M, Ali MJ, Magaji FA, et al
    The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria.
    BMC Womens Health. 2023;23:640.
    Abstract

  2257. KUNNUMMAL M, Raveendran PS, Basu B, Rani SV, et al
    HPV16 E6/E7-mediated regulation of PiwiL1 expression induces tumorigenesis in cervical cancer cells.
    Cell Oncol (Dordr). 2023 Dec 1. doi: 10.1007/s13402-023-00904.
    Abstract

  2258. CHIOU PZ
    HPV Primary and Co-testing: An Ethical Analysis Exploring the Role of Cytology in Cervical Cancer Screening and Management.
    J Allied Health. 2023;52:301-304.
    Abstract

  2259. DZOBO M, Dzinamarira T, Murewanhema G, Chishapira T, et al
    Co-creation of human papillomavirus self-sampling delivery strategies for cervical cancer screening in rural Zimbabwe: nominal group technique.
    Front Public Health. 2023;11:1275311.
    Abstract

  2260. BEGLIARZADE S, Sufianov A, Ilyasova T, Shumadalova A, et al
    Circular RNA in cervical cancer: Fundamental mechanism and clinical potential.
    Noncoding RNA Res. 2023;9:116-124.
    Abstract

  2261. LYU Y, Chen X, Liu H, Xi Y, et al
    Comparison of the diagnostic value of [(68) Ga]Ga-FAPI-04 PET/MR and [(18)F]FDG PET/CT in patients with T stage
    Eur J Nucl Med Mol Imaging. 2023 Nov 30. doi: 10.1007/s00259-023-06539.
    Abstract

  2262. SHVYGIN A, Manning-Geist BL, Sonoda Y
    Fertility-sparing and minimally invasive surgery for early-stage cervical cancer.
    J Surg Oncol. 2023 Nov 30. doi: 10.1002/jso.27540.
    Abstract

  2263. WEI X, Huang Q, Huang J, Yu L, et al
    Erastin induces ferroptosis in cervical cancer cells via Nrf2/HO-1 signaling pathway.
    Int J Immunopathol Pharmacol. 2023;37:3946320231219348.
    Abstract

  2264. JUNG YK, Park SB, Park HJ, Lee ES, et al
    Recurred Uterine Cervical Cancer Initially Manifesting as Hemorrhagic Cyst: A Case Report Recurred Uterine Cervical Cancer Initially Manifesting.
    Curr Med Imaging. 2023 Nov 29. doi: 10.2174/0115734056271308231120052123.
    Abstract

  2265. VAN DER SLUIS TC, van Haften FJ, van Duikeren S, Pardieck IN, et al
    Delayed vaccine-induced CD8(+) T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication.
    J Immunother Cancer. 2023;11:e007158.
    Abstract

  2266. LYCKE KD, Kahlert J, Petersen LK, Damgaard RK, et al
    Untreated cervical intraepithelial neoplasia grade 2 and subsequent risk of cervical cancer: population based cohort study.
    BMJ. 2023;383:e075925.
    Abstract

  2267. POSSATI-RESENDE JC, Fritsch TZ, Souza KCB
    Risk Profile of High-grade Cervical Lesions and Cervical Cancer Considering the Combination of Cytology, HPV Genotype, and Age among Women Undergoing Colposcopy.
    Rev Bras Ginecol Obstet. 2023;45:e689-e698.
    Abstract

  2268. XU T, Jiang J, Xiang X, Jahanshahi H, et al
    Conduction and validation of a novel prognostic signature in cervical cancer based on the necroptosis characteristic genes via integrating of multiomics data.
    Comput Biol Med. 2023;168:107656.
    Abstract

  2269. ZHAO YC, Wang TJ, Cui J, She LZ, et al
    The role of SLC39A4 in the prognosis, immune microenvironment, and contribution to malignant behavior in vivo and in vitro of cervical cancer.
    Transl Oncol. 2023;40:101839.
    Abstract

  2270. KROMIDAS E, Geier A, Weghofer A, Liu HY, et al
    Immunocompetent PDMS-free Organ-on-Chip Model of Cervical Cancer Integrating Patient-Specific Cervical Fibroblasts and Neutrophils.
    Adv Healthc Mater. 2023 Nov 29:e2302714. doi: 10.1002/adhm.202302714.
    Abstract

  2271. LI S, Li X, Zhang S, Feng Y, et al
    Corrigendum: Association between GSDMB gene polymorphism and cervical cancer in the Northeast Chinese Han population.
    Front Genet. 2023;14:1298000.
    Abstract

  2272. WU Z, Lin Q, Sheng L, Chen W, et al
    A novel immune-related risk-scoring system associated with the prognosis and response of cervical cancer patients treated with radiation therapy.
    Front Mol Biosci. 2023;10:1297774.
    Abstract

  2273. TIAN P, Deng J, Ma C, Miershali A, et al
    CBX7 is involved in the progression of cervical cancer through the ITGbeta3/TGFbeta1/AKT pathway.
    Oncol Lett. 2023;27:14.
    Abstract

  2274. GUO D, Huang Y, Wang K, Yang C, et al
    Preparation and Characterization Evaluation of Poly(L-Glutamic Acid)-g-Methoxy Poly(Ethylene Glycol)/Combretastatin A4/BLZ945 Nanoparticles for Cervical Cancer Therapy.
    Int J Nanomedicine. 2023;18:6901-6914.
    Abstract

  2275. GUO H, Feng S, Li Z, Yin Y, et al
    Prognostic Value of Body Composition and Systemic Inflammatory Markers in Patients with Locally Advanced Cervical Cancer Following Chemoradiotherapy.
    J Inflamm Res. 2023;16:5145-5156.
    Abstract

  2276. HUANG H, Pan Y, Huang J, Zhang C, et al
    Patient-derived organoids as personalized avatars and a potential immunotherapy model in cervical cancer.
    iScience. 2023;26:108198.
    Abstract

  2277. LIU B, Wu Y, Sun L, Guo C, et al
    Dosimetry and plan parameters study of three-dimensional-printed template-based intra-cavitary/interstitial interpolation technology using computed tomography-guided high-dose-rate brachytherapy in locally advanced cervical cancer.
    J Contemp Brachytherapy. 2023;15:325-333.
    Abstract

  2278. JAYARATHNA S, Hoang M, Badkul R, Hoover A, et al
    Dosimetric impact of applicator displacement on three-dimensional image-guided high-dose-rate brachytherapy treatments for cervical cancer.
    J Contemp Brachytherapy. 2023;15:334-343.
    Abstract

  2279. UMEMMUO MU, Eleje GU, Oluwasola TA, Ezeanochie M, et al
    Improving Treatment Outcome for Cervical Cancer Using 2-Point Assessment of Quality of Life Among Nigerian Women: A Protocol for a Multi-Center Study.
    Clin Med Insights Oncol. 2023;17:11795549231212339.
    Abstract

  2280. GUANI B, Chacon E, Fanfani F, Bizzarri N, et al
    Editorial: Lymph node assessment in cervical cancer.
    Front Oncol. 2023;13:1324654.
    Abstract

  2281. TANG X, Zhou S, Zhang X, Hua K, et al
    Comparison of the survival outcomes of laparoscopic, abdominal and gasless laparoscopic radical hysterectomy for early-stage cervical cancer: trial protocol of a multicenter randomized controlled trial (LAGCC trial).
    Front Oncol. 2023;13:1287697.
    Abstract

  2282. BOATMAN D, Kennedy-Rea S, Cottrell L, Hazard-Jenkins H, et al
    Cancer Screening Behaviors and Associations with Childhood Trauma, Resiliency, and Patient-Provider Relationships: Findings from an Exploratory Study of Appalachian Cervical Cancer Survivors.
    J Appalach Health. 2023;5:22-37.
    Abstract

  2283. EBADI SHARAFABAD B, Abdoli A, Panahi M, Abdolmohammadi Khiav L, et al
    Anti-tumor Effects of Cisplatin Synergist in Combined Treatment with Clostridium novyi-NT Spores Against Hypoxic Microenvironments in a Mouse Model of Cervical Cancer Caused by TC-1 Cell Line.
    Adv Pharm Bull. 2023;13:817-826.
    Abstract

  2284. WIJERATNE Y, Hapuachchige C
    Surgical Outcomes in Early-Stage Cervical Cancer Following Radical Hysterectomy in a Resource-Limited Setting: The Experience of the National Cancer Institute (Apeksha Hospital, Maharagama), Sri Lanka.
    Cureus. 2023;15:e47744.
    Abstract

  2285. BATMAN SH, Varon ML, Daheri M, Ogburn T, et al
    Addressing cervical cancer disparities in Texas: Expansion of a community-based prevention initiative for medically underserved populations.
    Prev Med Rep. 2023;36:102486.
    Abstract

  2286. LI Z, He H, Ren X, Chen Y, et al
    APOBEC3A suppresses cervical cancer via apoptosis.
    J Cancer. 2023;14:3429-3443.
    Abstract

  2287. LI M, Wang D, Huang J, Luan S, et al
    Sexual Behaviors and Intimate Relationships of Sexual Partners of Young Patients with Early-Stage Cervical Cancer: A Qualitative Study.
    Int J Gen Med. 2023;16:5377-5387.
    Abstract

  2288. DAMTIE S, Legese B, Berhan A, Kiros T, et al
    Knowledge, attitude, and practice of cervical cancer screening and its associated risk factors among family planning service users at Debre Tabor town health facilities, North Central Ethiopia: A cross-sectional study.
    SAGE Open Med. 2023;11:20503121231208654.
    Abstract

  2289. WIJAYANTI KE, Schutze H, Mac Phail C, Ivers R, et al
    Exploring Parents' Decisions Regarding HPV Vaccination for Their Daughters in Jakarta, Indonesia: A Qualitative Study.
    Asian Pac J Cancer Prev. 2023;24:3993-3998.
    Abstract

  2290. DEVI S, Joshi S
    The Effect of Multimodal Interventions Regarding Early Cervical Cancer Diagnosis on the Women's Knowledge, Attitude and Participation in Cervical Screening Program.
    Asian Pac J Cancer Prev. 2023;24:3949-3956.
    Abstract

  2291. ARI A, Uysal E, Ozer H, Kilincer A, et al
    Metastatic breast cancer in the uterine cervix.
    Br J Hosp Med (Lond). 2023;84:1.
    Abstract

  2292. MARINO JM, Nunes LMP, Ali YCMM, Tonhi LDC, et al
    Educational interventions for cervical cancer prevention: a scoping review.
    Rev Bras Enferm. 2023;76:e20230018.
    Abstract

  2293. ZHENG Y, Liu J, Beeraka NM, Manogaran P, et al
    Inflammation and Stem Cell Stochasticity of HPV-induced Cervical Cancer: Epigenetics Based Biomarkers through Microbiome and Metabolome for Personalized Medicine: A Systematic Review.
    Curr Med Chem. 2023 Nov 24. doi: 10.2174/0109298673257429231108072717.
    Abstract

  2294. ZHU X, Ye L, Fu Y, You B, et al
    Radical hysterectomy with preoperative conization in early-stage cervical cancer: a systematic review and pairwise and network meta-analysis.
    J Minim Invasive Gynecol. 2023 Nov 26:S1553-4650(23)00975.
    Abstract

  2295. ELVATUN S, Knoors D, Nygard M, Uuskula A, et al
    Cross-population evaluation of cervical cancer risk prediction algorithms.
    Int J Med Inform. 2023;181:105297.
    Abstract

  2296. LIU L, Gu K, Hua D
    HDAC1 suppresses radiotherapy sensitivity in cervical cancer via regulating HIF-1alpha/VEGF signaling pathway.
    Cell Mol Biol (Noisy-le-grand). 2023;69:132-140.
    Abstract

  2297. WINER RL, Lin J, Anderson ML, Tiro JA, et al
    Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial.
    JAMA. 2023;330:1971-1981.
    Abstract

  2298. FA XY, Yang YJ, Niu CC, Yu YJ, et al
    Development and validation of a nomogram to predict overall survival for cervical adenocarcinoma: A population-based study.
    Medicine (Baltimore). 2023;102:e36226.
    Abstract

  2299. CHEN H, Zhong Q, Liu Y, Li J, et al
    A prospective single-arm study on the relationship between dose-volume parameters of pelvic functional bone marrow and acute hematological toxicities during intensity-modulated radiotherapy with or without concurrent chemotherapy for uterine cervical/
    Radiat Oncol. 2023;18:193.
    Abstract

  2300. EASTMENT MC, Wanje G, Richardson BA, Mwaringa E, et al
    Results of a cluster randomized trial testing the Systems Analysis and Improvement Approach to increase cervical cancer screening in family planning clinics in Mombasa County, Kenya.
    Implement Sci. 2023;18:66.
    Abstract

  2301. LACIKA JL, Wabinga H, Kagaayi J, Opito R, et al
    Diagnostic and pre-treatment intervals among patients with cervical cancer attending care at the Uganda Cancer Institute: a cross-sectional study.
    BMC Womens Health. 2023;23:633.
    Abstract

  2302. VERBERCKMOES B, De Vos T, Maelegheer K, Ali-Risasi C, et al
    Evaluation of the applicability of internal controls on self-collected samples for high-risk human papillomavirus is needed.
    BMC Womens Health. 2023;23:635.
    Abstract

  2303. STANIETZKY N, Bednarski B, Shafer A, Taggart MW, et al
    Rectal Adenocarcinoma Presenting as a Cervical Mass: A Case Report.
    Am J Case Rep. 2023;24:e941884.
    Abstract

  2304. ZHOU J, Lei N, Qin B, Chen M, et al
    Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation.
    Cancer Biol Ther. 2023;24:2287128.
    Abstract

  2305. WENDEL SO, Snow JA, Gu L, Banerjee NS, et al
    The potential of PCNA inhibition as a therapeutic strategy in cervical cancer.
    J Med Virol. 2023;95:e29244.
    Abstract

  2306. MOLINA MA, Melchers WJG
    Methodological and analytical challenges in microbiome-HPV association studies.
    J Med Virol. 2023;95:e29260.
    Abstract

  2307. BORELLA F, Gallio N, Mangherini L, Cassoni P, et al
    Recent advances in treating female genital human papillomavirus related neoplasms with topical imiquimod.
    J Med Virol. 2023;95:e29238.
    Abstract

  2308. TRZESZCZ M, Mazurec M, Jach R, Mazurec K, et al
    p16/Ki67 dual stain triage versus cytology in primary human papillomavirus-based cervical cancer screening with limited genotyping.
    J Med Virol. 2023;95:e29271.
    Abstract

  2309. STROBEL TD, Weber M, Heber N, Holzer A, et al
    Revisiting the role of endogenous STAT3 in HPV-positive cervical cancer cells.
    J Med Virol. 2023;95:e29230.
    Abstract

  2310. HUANG X, Huo L, Xiao B, Ouyang Y, et al
    Activating STING/TBK1 suppresses tumor growth via degrading HPV16/18 E7 oncoproteins in cervical cancer.
    Cell Death Differ. 2023 Nov 25. doi: 10.1038/s41418-023-01242.
    Abstract

  2311. VERMA ML, Sharma P, Singh U, Sachan R, et al
    Comparison of acceptability & efficacy of thermal ablation (thermocoagulation) & cryotherapy in VIA positive cervical lesions: A pilot study.
    Indian J Med Res. 2023;158:423-431.
    Abstract

  2312. GORGONE M, Squeri A, Cuffari S, Fauci V, et al
    Rates of Primary and Secondary Prevention of Cervical Cancer: A Study in a Province in the South of Italy.
    Vaccines (Basel). 2023;11:1688.
    Abstract

  2313. MAEHAMA T, Shimada S, Sakamoto J, Shibata T, et al
    Chemical Peeling Therapy Using Phenol for the Cervico-Vaginal Intraepithelial Neoplasia.
    Viruses. 2023;15:2219.
    Abstract

  2314. ABDELHAFEZ OH, Abdel-Rahman IM, Alaaeldin E, Refaat H, et al
    Pro-Apoptotic Activity of Epi-Obtusane against Cervical Cancer: Nano Formulation, In Silico Molecular Docking, and Pharmacological Network Analysis.
    Pharmaceuticals (Basel). 2023;16:1578.
    Abstract

  2315. LIU X, Yang R, Xiong T, Yang X, et al
    CBCT-to-CT Synthesis for Cervical Cancer Adaptive Radiotherapy via U-Net-Based Model Hierarchically Trained with Hybrid Dataset.
    Cancers (Basel). 2023;15:5479.
    Abstract

  2316. SORBYE SW, Falang BM, Botha MH, Snyman LC, et al
    Enhancing Cervical Cancer Prevention in South African Women: Primary HPV mRNA Screening with Different Genotype Combinations.
    Cancers (Basel). 2023;15:5453.
    Abstract

  2317. LIU J, Tang L, Chu W, Wei L, et al
    Cellular Retinoic Acid Binding Protein 2 (CRABP2), Up-regulated by HPV E6/E7, Leads to Aberrant Activation of the Integrin beta1/FAK/ERK Signaling Pathway and Aggravates the Malignant Phenotypes of Cervical Cancer.
    Biochem Genet. 2023 Nov 24. doi: 10.1007/s10528-023-10568.
    Abstract

  2318. XUE Y, Zheng X, Wu G, Wang J, et al
    Rapid diagnosis of cervical cancer based on serum FTIR spectroscopy and support vector machines.
    Lasers Med Sci. 2023;38:276.
    Abstract

  2319. DINCER N, Ugurluer G, Mustafayev TZ, Serkizyan A, et al
    Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer.
    Brachytherapy. 2023 Nov 23:S1538-4721(23)01644.
    Abstract

  2320. MCCARTNEY M
    Calls for cervical screening should treat women like adults.
    BMJ. 2023;383:2772.
    Abstract

  2321. MABUCHI S, Komura N, Sasano T, Sakata M, et al
    Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer.
    Curr Oncol. 2023;30:9428-9436.
    Abstract

  2322. PALUMBO M, Della Corte L, Ronsini C, Guerra S, et al
    Surgical Treatment for Early Cervical Cancer in the HPV Era: State of the Art.
    Healthcare (Basel). 2023;11:2942.
    Abstract

  2323. LI S, Huang M, Zhu Y, Zeng H, et al
    Temporal trends in incidence and mortality of cervical cancer in China from 1990 to 2019 and predictions for 2034.
    Eur J Cancer Prev. 2023 Nov 6. doi: 10.1097/CEJ.0000000000000849.
    Abstract

  2324. COWLING A, Nevens L, Contogiorgi N, Bradley N, et al
    Developing and piloting an intervention to reduce colposcopy non-attendance and corresponding inequalities: a mixed-methods study.
    Lancet. 2023;402 Suppl 1:S35.
    Abstract

  2325. LIN R, Jin H, Fu X
    Comparative efficacy of human papillomavirus vaccines: systematic review and network meta-analysis.
    Expert Rev Vaccines. 2023;22:1168-1178.
    Abstract

  2326. TIEN CT, Ding DC
    Adenomyoma recurrence 7 years after laparoscopic supracervical hysterectomy: A case report and literature review.
    Medicine (Baltimore). 2023;102:e36089.
    Abstract

  2327. WANG P, Yang B, Huang H, Liang P, et al
    HIV gp120/Tat protein-induced epithelial-mesenchymal transition promotes the progression of cervical lesions.
    AIDS Res Ther. 2023;20:82.
    Abstract

  2328. PALMER C, Tobe K, Negishi Y, You X, et al
    Health impact and cost effectiveness of implementing gender-neutral HPV vaccination in Japan.
    J Med Econ. 2023;26:1546-1554.
    Abstract

  2329. MVUNDURA M, Slavkovsky R, Debellut F, Naddumba T, et al
    Cost and operational context for national human papillomavirus (HPV) vaccine delivery in six low- and middle-income countries.
    Vaccine. 2023 Nov 8:S0264-410X(23)01306-3. doi: 10.1016/j.vaccine.2023.
    Abstract

  2330. QIN F, Pang H, Ma J, Xu H, et al
    The value of multiparametric MRI combined with clinical prognostic parameters in predicting the 5-year survival of stage IIIC1 cervical squamous cell carcinoma.
    Eur J Radiol. 2023;169:111181.
    Abstract

  2331. FOWLER JR, Maani EV, Dunton CJ, Gasalberti DP, et al
    Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol.
    J Mol Diagn. 2023;25:957-966.
    Abstract

  2332. ZHENG X, Hu N, Liu J, Zhao K, et al
    Cervicovaginal microbiota disorder combined with the change of cytosine phosphate guanine motif- toll like receptor 9 axis was associated with cervical cancerization.
    J Cancer Res Clin Oncol. 2023;149:17371-17381.
    Abstract

  2333. DO AMARAL CC, Castro PT, Frota R, de Freitas Lima LAC, et al
    Vaginal leiomyoma: Advantages of clinical sonovaginography and ultrasound dynamic evaluation of uterine cervix-related lesions.
    J Clin Ultrasound. 2023;51:1509-1511.
    Abstract

  2334. NAKAGAWA S, Yagi A, Ueda Y, Ikeda S, et al
    Intentions for catch-up HPV vaccination in Japan: an internet survey.
    Int J Clin Oncol. 2023;28:1667-1679.
    Abstract

  2335. LEUNG SOA, Villa A, Duffey-Lind E, Welch K, et al
    An Interactive Educational Tool to Improve Human Papillomavirus Vaccine Knowledge and Recommendation Among Nurses.
    J Cancer Educ. 2023;38:1880-1886.
    Abstract

  2336. LYCKE KD, Kahlert J, Damgaard RK, Eriksen DO, et al
    Clinical course of cervical intraepithelial neoplasia grade 2: a population-based cohort study.
    Am J Obstet Gynecol. 2023;229:656.
    Abstract

  2337. OYA K, Kondo Y, Kishino M, Toyosawa S, et al
    Cytological features of oral malignant lymphoma in scraping liquid-based cytology: Cases of plasmablastic lymphoma and anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Ann Diagn Pathol. 2023;67:152180.
    Abstract

  2338. PETRAS M, Dvorak V, Lomozova D, Macalik R, et al
    Timing of HPV vaccination as adjuvant treatment of CIN2+ recurrence in women undergoing surgical excision: a meta-analysis and meta-regression.
    Sex Transm Infect. 2023 Aug 8:sextrans-2023-055793.
    Abstract

  2339. GUNN CM, Berrian K, Weiss JE, Tosteson AAN, et al
    A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Prev Med. 2023;175:107649.
    Abstract

  2340. NAMBA M, Kaneda Y, Kotera Y
    Breaking down the stigma: reviving the HPV vaccination trust in Japan.
    QJM. 2023;116:895-896.
    Abstract

  2341. KASHOFER K, Reich O, Regauer S
    Acquisition of Genetic Aberrations During the Progression of High-Grade Intraepithelial Lesions/Micro-Invasive Squamous Cancers to Widely Invasive Cervical Squamous Cell Cancer.
    Arch Pathol Lab Med. 2023;147:1438-1445.
    Abstract

  2342. LOPEZ-CARDENAS MT, Jimenez A, Espinosa-Montesinos A, Maldonado-Alvarado E, et al
    Elimination of Human Papillomavirus and Cervical Pathological Microbiota with Photodynamic Therapy in Women from Mexico City with Cervical Intraepithelial Neoplasia I.
    Photochem Photobiol. 2023;99:1468-1475.
    Abstract

  2343. KULAKSIZ D, Bayoglu Tekin Y, Deger O, Baki Erin K, et al
    Investigating the relationship between the cervical mucoprotein levels and cervical intraepithelial neoplasia.
    Minerva Obstet Gynecol. 2023;75:559-564.
    Abstract

  2344. XIANG X, Ding J
    Anoikis Patterns in Cervical Cancer: Identification of Subgroups and Construction of a Novel Risk Model for Predicting Prognosis and Immune Response.
    Front Biosci (Landmark Ed). 2023;28:287.
    Abstract

  2345. TAO W, Wang W, Zhai J, Guo L, et al
    Efficacy Analysis of Neoadjuvant versus Adjuvant Cisplatin-Paclitaxel Regimens for Initial Treatment of FIGO Stages IB3 and IIA2 Cervical Cancer.
    Med Sci Monit. 2023;29:e940545.
    Abstract

  2346. CAO DM, Liu T
    Exploration of the Mechanism of Kaempferol in the Treatment of Cervical Cancer-based on Metabolomics and Network Pharmacology.
    Curr Pharm Des. 2023 Dec 7. doi: 10.2174/0113816128268061231012073704.
    Abstract


  2347. Human papillomavirus vaccination and cervical cancer risk.
    BMJ. 2023;383:p2901.
    Abstract

  2348. NI S, Wei Z, Li D
    Effect of lncRNA LINC00324 on cervical cancer progression through down-regulation of miR-195-5p.
    J Obstet Gynaecol. 2023;43:2285384.
    Abstract

  2349. HERNANDEZ-ESPARZA MJ, Fratoddi I, Cerra S, Juarez-Moreno K, et al
    Hybrid AuNPs-3MPS-MTX nanosystem and its evaluation for treating cervical cancer and melanoma.
    Nanoscale Adv. 2023;5:7077-7085.
    Abstract

  2350. ZHOU T, Xiao Z, Lu J, Zhang L, et al
    IGF2BP3-mediated regulation of GLS and GLUD1 gene expression promotes treg-induced immune escape in human cervical cancer.
    Am J Cancer Res. 2023;13:5289-5305.
    Abstract

  2351. KALBHOR M, Shinde S, Wajire P, Jude H, et al
    CerviCell-detector: An object detection approach for identifying the cancerous cells in pap smear images of cervical cancer.
    Heliyon. 2023;9:e22324.
    Abstract

  2352. LI S, Shen H, Wan Q, Chen P, et al
    Downregulation of HS6ST2 Inhibits Cervical Cancer Cell Migration and Invasion in Vivo and in Vitro.
    Discov Med. 2023;35:1147-1159.
    Abstract

  2353. TAN B, Wikan N, Lin S, Thaklaewphan P, et al
    Inhibitory actions of oxyresveratrol on the PI3K/AKT signaling cascade in cervical cancer cells.
    Biomed Pharmacother. 2023;170:115982.
    Abstract

  2354. BRUNO M, Bizzarri N, Teodorico E, Certelli C, et al
    The potential role of systemic inflammatory markers in predicting recurrence in early-stage cervical cancer.
    Eur J Surg Oncol. 2023;50:107311.
    Abstract

  2355. PANAYIOTOU T, Eftychiou M, Patera E, Promponas VJ, et al
    A paradigm for post-embryonic Oct4 re-expression: E7-induced hydroxymethylation regulates Oct4 expression in cervical cancer.
    J Med Virol. 2023;95:e29264.
    Abstract

  2356. HEBER N, Kuhn BJ, Strobel TD, Lohrey C, et al
    The impact of cycling hypoxia on the phenotype of HPV-positive cervical cancer cells.
    J Med Virol. 2023;95:e29280.
    Abstract

  2357. SCOTT-WILLIAMS J, Hosein A, Akpaka P, Adidam Venkata CR, et al
    Epidemiology of Cervical Cancer in the Caribbean.
    Cureus. 2023;15:e48198.
    Abstract

  2358. HACISEYITOGLU AO, Dogan TC, Dilsiz SA, Canpinar H, et al
    Pitavastatin induces caspase-mediated apoptotic death through oxidative stress and DNA damage in combined with cisplatin in human cervical cancer cell line.
    J Appl Toxicol. 2023 Dec 6. doi: 10.1002/jat.4565.
    Abstract

  2359. ZHANG P, Tang Y, Zhao J, Yang J, et al
    TRIM11 regulated by m6A modification promotes the progression of cervical cancer by PHLPP1 ubiquitination.
    Neoplasma. 2023;70:659-669.
    Abstract

  2360. BRAKEBILL A, Morgan A, Lieberman RW
    Primary HPV Screening vs Cotesting for Cervical Cancer.
    JAMA. 2023;330:2121.
    Abstract

  2361. PERKINS RB, Wentzensen N, Schiffman M
    Primary HPV Screening vs Cotesting for Cervical Cancer-Reply.
    JAMA. 2023;330:2121-2122.
    Abstract

  2362. ZHANG H, Cai S, Xia Y, Lin Y, et al
    Association between human herpesvirus infection and cervical carcinoma: a systematic review and meta-analysis.
    Virol J. 2023;20:288.
    Abstract

  2363. SMAHEL M, Nunvar J
    Bioinformatics analysis of immune characteristics in tumors with alternative carcinogenesis pathways induced by human papillomaviruses.
    Virol J. 2023;20:287.
    Abstract

  2364. KOSITAMONGKOL C, Kanchanasurakit S, Mepramoon E, Talungchit P, et al
    Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand.
    BMC Public Health. 2023;23:2413.
    Abstract

  2365. BEL HAJ RHOUMA R, Ardhaoui M, Othman H, Ben Jemia Z, et al
    The E6 gene polymorphism of Human papillomavirus 16 in relation to the risk of cervical cancer in Tunisian women.
    Infect Genet Evol. 2023;116:105536.
    Abstract

  2366. LI K, Chen J, Hu Y, Wang YZ, et al
    Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial.
    Lancet Oncol. 2023 Dec 1:S1470-2045(23)00531.
    Abstract

  2367. PAUTIER P
    Is there finally a place for neoadjuvant treatment in locally advanced cervical cancer?
    Lancet Oncol. 2023 Dec 1:S1470-2045(23)00576.
    Abstract

  2368. OAKNIN A, Gladieff L, Martinez-Garcia J, Villacampa G, et al
    Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
    Lancet. 2023 Dec 1:S0140-6736(23)02405-4. doi: 10.1016/S0140-6736(23)02405.
    Abstract

  2369. MILESHKIN LR, Manoharan S
    Improving survival from metastatic, recurrent, or persistent cervical cancer.
    Lancet. 2023 Dec 1:S0140-6736(23)02690-9. doi: 10.1016/S0140-6736(23)02690.
    Abstract

  2370. WILDING S, O'Connor DB, Conner M
    Social Norms in Cervical Cancer Screening.
    Psychol Rep. 2023 Dec 4:332941231219943. doi: 10.1177/00332941231219943.
    Abstract

  2371. YADAV S, Jayaseelan V, Pandjatcharam J, Roy G, et al
    Facilitators and Challenges in Patient's Satisfaction with Quality of Cervical Cancer Care in a Tertiary Care Hospital, Puducherry, India: A Qualitative Study.
    South Asian J Cancer. 2023;12:250-255.
    Abstract

  2372. TIE W, Ge F
    Lymphoid-specific helicase inhibits cervical cancer cells ferroptosis by promoting Nrf2 expression.
    PeerJ. 2023;11:e16451.
    Abstract

  2373. ZHANG Q, Zhang J, Liu Z, Wang J, et al
    Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy.
    Drug Des Devel Ther. 2023;17:3507-3522.
    Abstract

  2374. SUDHAKAR K, Saravanan D, Hariharan G, Sanaj MS, et al
    Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer.
    Open Life Sci. 2023;18:20220770.
    Abstract

  2375. NHANGAVE AV, Evaristo B, Osorio D, Muhiwa A, et al
    Knowledge about Cervical Cancer Prevention and Screening in Women with Cervical Cancer Attending Gynecological Services in Southern Mozambique.
    Niger J Clin Pract. 2023;26:1616-1620.
    Abstract

  2376. FENG S, Wang Z, Zhang H, Hou B, et al
    Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
    J Gene Med. 2023 Dec 4:e3643. doi: 10.1002/jgm.3643.
    Abstract

  2377. ELLIS SJ
    Are women-who-have-sex-with-women an 'at-risk' group for cervical cancer? An exploratory study of women in Aotearoa New Zealand.
    Sex Health. 2023 Dec 4. doi: 10.1071/SH23145.
    Abstract

  2378. BELANGER C, Aubin S, Lavallee MC, Beaulieu L, et al
    Simultaneous catheter and multicriteria optimization for HDR cervical cancer brachytherapy with a complex intracavity/interstitial applicator.
    Med Phys. 2023 Dec 3. doi: 10.1002/mp.16874.
    Abstract

  2379. MORSE RM, Brown J, Gage JC, Prieto BA, et al
    "Easy women get it": pre-existing stigma associated with HPV and cervical cancer in a low-resource setting prior to implementation of an HPV screen-and-treat program.
    BMC Public Health. 2023;23:2396.
    Abstract

  2380. KIENDREBEOGO JA, Sidibe ARO, Compaore GB, Nacanabo R, et al
    Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study.
    BMC Health Serv Res. 2023;23:1338.
    Abstract

  2381. WU Q, Qian M, Welby S, Guignard A, et al
    Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018-2020.
    Hum Vaccin Immunother. 2023;19:2283912.
    Abstract

  2382. WANG Y, Gong Y, Zhou Q, Qu W, et al
    Genetic variability analysis of human papillomavirus 58: Novel sublineage identification and persistent infection association.
    J Med Virol. 2023;95:e29262.
    Abstract

  2383. DESAI KT, de Sanjose S, Schiffman M
    Treatment of Cervical Precancers is the Major Remaining Challenge in Cervical Screening Research.
    Cancer Prev Res (Phila). 2023;16:649-651.
    Abstract

  2384. XU D, Feng H, Ren Z, Li X, et al
    SNHG3/WISP2 Axis Promotes Hela Cell Migration and Invasion via Activating Wnt/beta-Catenin Signaling.
    Cancer Genomics Proteomics. 2023;20.
    Abstract

  2385. CHENG G, Wang M, Sun H, Lai J, et al
    Age at menopause is inversely related to the prevalence of common gynecologic cancers: a study based on NHANES.
    Front Endocrinol (Lausanne). 2023;14:1218045.
    Abstract

  2386. SHANKAR B, Singh T, Kumar B, Arora A, et al
    Solvent-free synthesis and in-silico molecular docking study of (E)-3-(beta-C-glycosylmethylidene)-N-aryl/alkyl succinimides.
    Org Biomol Chem. 2023;21:9398-9409.
    Abstract

  2387. CAI H, Chen S, Wu Z, Wang F, et al
    Comprehensive analysis of ZNF692 as a potential biomarker associated with immune infiltration in a pan cancer analysis and validation in hepatocellular carcinoma.
    Aging (Albany NY). 2023;15:13041-13058.
    Abstract

  2388. MAKONI M
    HPV vaccine roll-out in Nigeria and Bangladesh.
    Lancet Oncol. 2023;24:1311-1312.
    Abstract

  2389. SKOLNIK JM, Morrow MP
    Vaccines for HPV-associated diseases.
    Mol Aspects Med. 2023;94:101224.
    Abstract

  2390. MORCET-DELATTRE R, Espenel S, Tas P, Chargari C, et al
    Role of radiotherapy in the management of rare gynaecological cancers.
    Cancer Radiother. 2023;27:778-788.
    Abstract

  2391. KING J, Flores YN, Meneses-Leon J, Hernandez-Salazar S, et al
    Clinical Performance of hrHPV Primary Screening Using Vaginal versus Cervical Samples to Detect High-grade Intraepithelial Lesions.
    Cancer Prev Res (Phila). 2023;16:681-687.
    Abstract

  2392. GAY SS, Kisling KD, Anderson BM, Zhang L, et al
    Identifying the optimal deep learning architecture and parameters for automatic beam aperture definition in 3D radiotherapy.
    J Appl Clin Med Phys. 2023;24:e14131.
    Abstract

  2393. KOTAKA S, Kondo E, Kawai Y, Okamoto K, et al
    Paclitaxel-carboplatin plus bevacizumab therapy for advanced neuroendocrine carcinoma of the uterine cervix: A retrospective case series.
    J Obstet Gynaecol Res. 2023;49:2868-2874.
    Abstract

  2394. YIN Z, Cui Z, Kang S, Ji M, et al
    Laparoscopic versus open radical hysterectomy in FIGO 2018 early-stage cervical adenocarcinoma: Long-term survival outcomes after propensity score matching.
    J Obstet Gynaecol Res. 2023;49:2849-2859.
    Abstract

  2395. STOLNICU S, Allison D, Patrichi A, Flynn J, et al
    Invasive Squamous Cell Carcinoma of the Cervix: A Review of Morphological Appearances Encountered in Human Papillomavirus-associated and Papillomavirus-independent Tumors and Precursor Lesions.
    Adv Anat Pathol. 2024;31:1-14.
    Abstract

  2396. WANG H, Shi Y, Sun Y, Zhang A, et al
    E7 as a Promising Biomarker for Monitoring the Progression of Cervical Lesions in Patients with HPV 16/18 Infections.
    Altern Ther Health Med. 2023;29:310-314.
    Abstract

  2397. CHEN M, Xue P, Li Q, Shen Y, et al
    Enhancing colposcopy training using a widely accessible digital education tool in China.
    Am J Obstet Gynecol. 2023;229:538.
    Abstract

  2398. MICHALEK IM, Manczuk M, Caetano Dos Santos FL, Macios A, et al
    Self-reported participation in cervical cancer screening among Polish women in 2004-2019.
    Ginekol Pol. 2023 Dec 15. doi: 10.5603/gpl.96634.
    Abstract

  2399. NOWAKOWSKI A
    Cervical cancer - a preventable (?) disease in Poland.
    Ginekol Pol. 2023 Dec 15. doi: 10.5603/gpl.98540.
    Abstract

  2400. GOVAHI A, Zahmatkesh N, Pourbagherian O, Khas NM, et al
    Antitumor Effects of Curcumin on Cervical Cancer with the Focus on Molecular Mechanisms: An Exegesis.
    Curr Pharm Des. 2023 Dec 8. doi: 10.2174/0113816128279330231129180250.
    Abstract

  2401. VALI M, Maleki Z, Nikbakht HA, Hassanipour S, et al
    Survival rate of cervical cancer in Asian countries: a systematic review and meta-analysis.
    BMC Womens Health. 2023;23:671.
    Abstract

  2402. XIANG H, Tang H, He Q, Sun J, et al
    NDUFA8 is transcriptionally regulated by EP300/H3K27ac and promotes mitochondrial respiration to support proliferation and inhibit apoptosis in cervical cancer.
    Biochem Biophys Res Commun. 2023;693:149374.
    Abstract

  2403. YAMAGUCHI S, Koizumi M, Kakuda M, Yamamoto T, et al
    Uncommon Hematogenous Metastasis: Orbital Involvement in Uterine Cervical Cancer.
    Am J Case Rep. 2023;24:e941076.
    Abstract

  2404. TEWARI KS, Colombo N, Monk BJ, Dubot C, et al
    Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses from the KEYNOTE-826 Randomized Clinical Trial.
    JAMA Oncol. 2023 Dec 14. doi: 10.1001/jamaoncol.2023.5410.
    Abstract

  2405. HU XX, Zhou LY, Lin RY
    The association between the serum concentration of CXC subfamily chemokine 13 and post-surgical clinical outcomes in cervical cancer patients.
    Eur Rev Med Pharmacol Sci. 2023;27:11635-11642.
    Abstract

  2406. IMPELIDO ML, Brewer K, Burgess P, Curtis J, et al
    Age-specific differences in cervical cancer screening rates in women using mental health services in New South Wales, Australia.
    Aust N Z J Psychiatry. 2023 Dec 14:48674231217415.
    Abstract

  2407. AND ALTERNATIVE MEDICINE EC
    Retracted: Analysis of the Effect of Fast Recovery Surgery Concept on Perioperative Nursing Care of Patients with Radical Resection of Cervical Cancer and Its Influence on Psychological Status.
    Evid Based Complement Alternat Med. 2023;2023:9841487.
    Abstract

  2408. SCANNING
    Retracted: The Application Value of CT Three-Dimensional Microscope Reconstruction Technology in the Diagnosis of Cervical Cancer.
    Scanning. 2023;2023:9786383.
    Abstract

  2409. JIA Y, Zou K, Zou L
    Research progress of metabolomics in cervical cancer.
    Eur J Med Res. 2023;28:586.
    Abstract

  2410. FURUKAWA Y, Ishii M, Ando J, Ikeda K, et al
    iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer.
    Cell Rep Med. 2023 Dec 8:101327. doi: 10.1016/j.xcrm.2023.101327.
    Abstract

  2411. HIMOTO Y, Yamanoi K, Kurata Y
    Survival impact of the degree of parametrial invasion on MRI in locally advanced cervical cancer.
    Eur Radiol. 2023 Dec 13. doi: 10.1007/s00330-023-10480.
    Abstract

  2412. KOMURA N, Mabuchi S, Sasano T, Kamiura S, et al
    Twenty-five-year mortality trends of four major histological subtypes of cervical cancer: a population-based study using the Osaka cancer registry data.
    Front Oncol. 2023;13:1233354.
    Abstract

  2413. PRIYA A, Bhatia P, Singh N
    Study on Sociodemographic Profiles and Health-Seeking Behaviour in Cervical Cancer Patients in a Tertiary Healthcare Centre in Central India.
    Cureus. 2023;15:e48635.
    Abstract

  2414. LUO Y, Ma X
    An Energy-Efficient Test and Predictive Model for Recurrence After Radiotherapy in Localized Intermediate and Advanced Cervical Cancer Were Created Using Thymidine Kinase 1 in Conjunction with Inflammatory Markers and Tumor Markers.
    Int J Gen Med. 2023;16:5789-5797.
    Abstract

  2415. WANG J, Wang S, Wang J, Huang J, et al
    Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer.
    Cancer Med. 2023 Dec 12. doi: 10.1002/cam4.6734.
    Abstract

  2416. BELLO ROUFAI D
    [Place of innovative therapies in the management of cervical cancer].
    Bull Cancer. 2023 Dec 11:S0007-4551(23)00429.
    Abstract

  2417. VALE DB, Teixeira JC
    Implementing plans for global elimination of cervical cancer.
    Nat Med. 2023;29:3004-3005.
    Abstract

  2418. DU NH, Ngoc TTB, Cang HQ, Luyen NTT, et al
    KTt-45, a T-type calcium channel blocker, acts as an anticancer agent by inducing apoptosis on HeLa cervical cancer cell line.
    Sci Rep. 2023;13:22092.
    Abstract

  2419. ELFSTROM M, Gray PG, Dillner J
    Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic.
    Elife. 2023;12:e80905.
    Abstract

  2420. YANG C, Zhang Y, Wang R, Cheng B, et al
    IL-10(+)CD19(+) regulatory B cells induce CD4(+)Foxp3(+)regulatory T cells in serum of cervical cancer patients.
    Autoimmunity. 2024;57:2290909.
    Abstract

  2421. SAUL H, Cassidy S, Imison C, Athanasiou A, et al
    Preventing cervical cancer: what are the risks and benefits of different treatments?
    BMJ. 2023;383:p2802.
    Abstract

  2422. TEIXEIRA AR, Abreu MH
    Metastatic Cervical Cancer: A Case That Recalls the Importance of a Multidisciplinary Approach.
    Cureus. 2023;15:e48626.
    Abstract

  2423. TOFT MOREN A, Bull C, Bergmark K
    Remarkable effects of infliximab on severe radiation-induced side effects in a patient with uterine cervical cancer: a case report.
    J Int Med Res. 2023;51:3000605231208596.
    Abstract

  2424. SHA Y, Liu Y, Yang X, Wang J, et al
    Exploring the diagnostic potential of EPB41L3 methylation in cervical cancer and precancerous lesions: A systematic review and meta-analysis.
    Gynecol Obstet Invest. 2023 Dec 11. doi: 10.1159/000535563.
    Abstract

  2425. ABU-RUSTUM NR, Yashar CM, Arend R, Barber E, et al
    NCCN Guidelines(R) Insights: Cervical Cancer, Version 1.2024.
    J Natl Compr Canc Netw. 2023;21:1224-1233.
    Abstract

  2426. ASADZADEH A, Ghorbani N, Dastan K
    Identification of druggable hub genes and key pathways associated with cervical cancer by protein-protein interaction analysis: An in silico study.
    Int J Reprod Biomed. 2023;21:809-818.
    Abstract

  2427. SAITO T, Murakami M, Sumiya T, Kobayashi D, et al
    Multimodal treatment with chemoradiotherapy, regional hyperthermia and interstitial brachytherapy for a huge locally advanced cervical cancer: A case report.
    Tech Innov Patient Support Radiat Oncol. 2023;28:100222.
    Abstract

  2428. LIN C, Yang F, Guo B, Xiao N, et al
    Development of a combined model incorporating clinical characteristics and magnetic resonance imaging features to enhance the predictive value of a prognostic model for locally advanced cervical cancer.
    Front Oncol. 2023;13:1284493.
    Abstract

  2429. LIU X, Zhu Y, Huang S, Shi T, et al
    Multiomics analysis of metabolic heterogeneity in cervical cancer cell lines with or without HPV.
    Front Oncol. 2023;13:1194462.
    Abstract

  2430. SAKRAWAL K, Meena G, Gupta A, Malav K, et al
    Knowledge, attitude, and practice about cervical cancer among adult women in rural Jaipur: An observational analysis.
    J Family Med Prim Care. 2023;12:2379-2384.
    Abstract

  2431. LIAO L, Huang P, Zhao J, Wang Z, et al
    lncRNA799/TBL1XR1/ZEB1 Axis Forms a Feedback Loop to Promote the Epithelial-Mesenchymal Transition of Cervical Cancer Cells.
    Crit Rev Eukaryot Gene Expr. 2024;34:33-43.
    Abstract

  2432. AVISHA M, Pelupessy NU, Rahman A, Rauf S, et al
    Pre-treatment inflammatory and immune system parameters predicting cervical cancer metastasis.
    Turk J Obstet Gynecol. 2023;20:285-292.
    Abstract

  2433. FELTRI G, Valenti G, Isidoro E, Kaur J, et al
    Evaluation of self-sampling-based cervical cancer screening strategy using HPV Selfy CE-IVD test coupled with home-collection kit: a clinical study in Italy.
    Eur J Med Res. 2023;28:582.
    Abstract

  2434. GARCIA E, Ayoub N, Tewari KS
    Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer.
    J Gynecol Oncol. 2023 Nov 30. doi: 10.3802/jgo.2024.
    Abstract

  2435. PAVONE M, Goglia M, Scambia G, Querleu D, et al
    Laparoscopic-Assisted Vaginal Trachelectomy with Prophylactic Cerclage: A Safe Fertility-Sparing Treatment for Early Stage Cervical Cancer.
    Ann Surg Oncol. 2023 Dec 10. doi: 10.1245/s10434-023-14737.
    Abstract

  2436. LIAO YQ, Fang BB, Wu QX, Dong WY, et al
    Verapamil modulates NFAT2 to inhibit tumor growth and potentiates PD1ab immune checkpoint inhibitor therapy in cervical cancer treatment.
    J Recept Signal Transduct Res. 2023.
    Abstract

  2437. SONG H, Qiu J, Hua K
    USP14 promotes the proliferation of cervical cancer via upregulating beta-catenin.
    Environ Toxicol. 2023 Dec 9. doi: 10.1002/tox.23990.
    Abstract

  2438. ZHANG J, Zhou Y, Ye H, Chen C, et al
    Effect of laparoscopic-assisted transvaginal hysterectomy on wound complications in patients with early stage cervical cancer: A meta-analysis.
    Int Wound J. 2023 Dec 8. doi: 10.1111/iwj.14529.
    Abstract

  2439. DAU H, Zhou C, Nankya E, Naguti P, et al
    The burden of travelling for cervical cancer treatment in Uganda: A mixed-method study.
    Trop Med Int Health. 2023 Dec 8. doi: 10.1111/tmi.13958.
    Abstract

  2440. ZHANG S, Chen M, Geng Z, Liu T, et al
    Potential Application of Self-Assembled Peptides and Proteins in Breast Cancer and Cervical Cancer.
    Int J Mol Sci. 2023;24:17056.
    Abstract

  2441. MENESES-URREA LA, Vaquero-Abellan M, Villegas Arenas D, Benachi Sandoval N, et al
    Association between Cervical Cancer and Dietary Patterns in Colombia.
    Nutrients. 2023;15:4889.
    Abstract

  2442. YANG Z, Liu Z, Ablise M, Maimaiti A, et al
    Design and Synthesis of Novel alpha-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP Cells.
    Molecules. 2023;28:7697.
    Abstract

  2443. YE M, Liu T, Miao L, Zou S, et al
    The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models.
    Cancers (Basel). 2023;15:5625.
    Abstract

  2444. MOHAMMED FA, Tune KK, Jett M, Muhie S, et al
    Cervical Cancer Stages, Human Papillomavirus Integration, and Malignant Genetic Mutations: Integrative Analysis of Datasets from Four Different Cohorts.
    Cancers (Basel). 2023;15:5595.
    Abstract

  2445. MONTOYA-GOMEZ A, Tonello F, Spolaore B, Massimino ML, et al
    Pllans-II: Unveiling the Action Mechanism of a Promising Chemotherapeutic Agent Targeting Cervical Cancer Cell Adhesion and Survival Pathways.
    Cells. 2023;12:2715.
    Abstract

  2446. MALI ME, Sanyang O, Harris KL, Sorensen J, et al
    Capacity assessment and spatial analysis of cervical cancer services in The Gambia.
    BMC Womens Health. 2023;23:660.
    Abstract

  2447. KANG M, Qiu J, Wei H, Li J, et al
    A bibliometric analysis of global research trends of inflammation in cervical cancer: A review.
    Medicine (Baltimore). 2023;102:e36598.
    Abstract

  2448. WU J, Wang X, Xiao L
    Nodular fasciitis of the abdominal wall complicating radiotherapy for cervical cancer: A case report.
    Asian J Surg. 2023 Dec 7:S1015-9584(23)01931.
    Abstract

  2449. BRAVO CA, Walker MJ, Papadopoulos A, McWhirter JE, et al
    Social media use in HPV-, cervical cancer-, and cervical screening-related research: A scoping review.
    Prev Med. 2023 Dec 6:107798. doi: 10.1016/j.ypmed.2023.107798.
    Abstract

  2450. YE Y, Li M, Pan Q, Fang X, et al
    Machine learning-based classification of deubiquitinase USP26 and its cell proliferation inhibition through stabilizing KLF6 in cervical cancer.
    Comput Biol Med. 2023;168:107745.
    Abstract


  2451. HPV ctDNA Allows for the Detection of Residual Disease in Cervical Cancer.
    Cancer Discov. 2023 Dec 8:OF1. doi: 10.1158/2159-8290.CD-RW2023.
    Abstract

  2452. VAHABI M, Shahil-Feroz A, Lofters A, Wong JP, et al
    Surviving the Storm: The Impact of COVID-19 on Cervical Cancer Screening in Low- and Middle-Income Countries.
    Healthcare (Basel). 2023;11:3079.
    Abstract

  2453. KHADRAOUI W, Meade CE, Backes FJ, Felix AS, et al
    Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic Cancer.
    JAMA Netw Open. 2023;6:e2346494.
    Abstract

  2454. OUEDRAOGO RA, Kande A, Nadembega WMC, Ouermi D, et al
    Distribution of high- and low-risk human papillomavirus genotypes and their prophylactic vaccination coverage among West African women: systematic review.
    J Egypt Natl Canc Inst. 2023;35:39.
    Abstract

  2455. BITTENCOURT DD, Zanine RM, Sebastiao APM, Ribas CM, et al
    Risk Factors for Persistence or Recurrence of High-Grade Cervical Squamous Intraepithelial Lesions.
    Rev Col Bras Cir. 2023;50:e20233537.
    Abstract

  2456. ATIGAN A, Kilic D, Karakaya YA, Gok S, et al
    The relationship of immunohistochemical SOX-2 staining with histopathological diagnosis in patients with abnormal colposcopic findings.
    Histochem Cell Biol. 2023;160:555-561.
    Abstract

  2457. GRADISSIMO A, Clarke MA, Xue X, Castle PE, et al
    A Novel HPV/Host DNA Methylation-Score and Detection of Cervical Adenocarcinoma.
    J Natl Cancer Inst. 2023 Jul 19:djad134. doi: 10.1093.
    Abstract

  2458. WANG J, Zhang B, Gong S, Liu Y, et al
    Cancer susceptibility 18 positively regulates NUAK Family Kinase 1 expression to promote migration and invasion via sponging of miR-5586-5p in cervical cancer cells.
    Int J Immunopathol Pharmacol. 2023;37:3946320231223310.
    Abstract

  2459. BONUCK KJ, Angier H, McCrimmon S, Holderness H, et al
    A Scoping Literature Review on Evidence-Based Strategies to Increase Cervical Cancer Screening.
    J Prim Care Community Health. 2023;14:21501319231220994.
    Abstract

  2460. WANG X, Li H, Li N, Yang H, et al
    LncRNA BCRT1 depletion suppresses cervical cancer cell growth via sponging miR-432-5p/CCR7 axis.
    3 Biotech. 2024;14:17.
    Abstract

  2461. LESSELIERS T, Van Trappen P
    Robotic Vaginal Cuff Closure During Radical Hysterectomy for Early-Stage Cervical Cancer: The Bruges Method.
    Cureus. 2023;15:e49149.
    Abstract

  2462. MOLIKA P, Leetanaporn K, Rungkamoltip P, Roytrakul S, et al
    Proteomic analysis of small extracellular vesicles unique to cervical cancer.
    Transl Cancer Res. 2023;12:3113-3128.
    Abstract

  2463. WANG G, Wang J, Momeni MR
    Epigallocatechin-3-gallate and its nanoformulation in cervical cancer therapy: the role of genes, MicroRNA and DNA methylation patterns.
    Cancer Cell Int. 2023;23:335.
    Abstract

  2464. HSIEH HY, Lu CH, Wang L
    Response to Dr. Liu 's comments on definite chemoradiotherapy for early-stage "bulky" cervical cancer.
    J Formos Med Assoc. 2023 Dec 20:S0929-6646(23)00438.
    Abstract

  2465. KYEI KA, Daniels J, Broni R, Anim-Sampong S, et al
    The sexuality of women with cervical cancer undergoing definitive radiotherapy in Ghana.
    Radiography (Lond). 2023;30:332-339.
    Abstract

  2466. GHAZI AA, Alturkistani HM, Alturkistani AM Jr, Alhajuj HY, et al
    Cervical Cancer Screening Barriers Among Citizens of Jeddah.
    Cureus. 2023;15:e50797.
    Abstract

  2467. AND ALTERNATIVE MEDICINE EC
    Retracted: Effect of MiR-375 Regulates YAP1 on the Invasion, Apoptosis, and Epithelial-Mesenchymal Transition of Cervical Cancer HeLa Cells.
    Evid Based Complement Alternat Med. 2023;2023:9787136.
    Abstract

  2468. SCANNING
    Retracted: Evaluation of Pelvic Floor Dysfunction by Pelvic Floor Ultrasonography after Total Hysterectomy for Cervical Cancer.
    Scanning. 2023;2023:9853252.
    Abstract

  2469. METHODS IN MEDICINE CAM
    Retracted: Expression of GMFB in High-Grade Cervical Intraepithelial Neoplasia and Its Role in Cervical Cancer.
    Comput Math Methods Med. 2023;2023:9834985.
    Abstract

  2470. LIN CL, Ying TH, Yang SF, Lin CL, et al
    Magnolin targeting of the JNK/Sp1/MMP15 signaling axis suppresses cervical cancer microenvironment and metastasis via microbiota modulation.
    Cancer Lett. 2023 Dec 18:216584. doi: 10.1016/j.canlet.2023.216584.
    Abstract

  2471. KUSHWAH AS, Masood S, Mishra R, Banerjee M, et al
    Genetic and epigenetic alterations in DNA repair genes and treatment outcome of Chemoradiotherapy in Cervical cancer.
    Crit Rev Oncol Hematol. 2023 Dec 18:104240.
    Abstract

  2472. MUDRINICH SM, Nguyen MLT, Blemur DM, Wang X, et al
    An Alternative to Cytology in Triaging Cisgender Men and Transgender Women With HIV for High-Resolution Anoscopy.
    J Low Genit Tract Dis. 2024;28:101-106.
    Abstract

  2473. PERKINS RB, Guido RS, Castle PE, Chelmow D, et al
    2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023.
    J Low Genit Tract Dis. 2024;28:3-6.
    Abstract

  2474. AN L, Dong K, Chi S, Wei S, et al
    lncRNA UCA1 promotes tumor progression by targeting SMARCD3 in cervical cancer.
    Mol Carcinog. 2023 Dec 20. doi: 10.1002/mc.23659.
    Abstract

  2475. HOLT HK, Flores R, James JE, Waters C, et al
    A qualitative study of primary care clinician's approach to ending cervical cancer screening in older women in the United States.
    Prev Med Rep. 2023;36:102500.
    Abstract

  2476. BENJAMIN KA, Lamberti N, Cooke M
    Predictors of non-adherence to cervical cancer screening among immigrant women in Ontario, Canada.
    Prev Med Rep. 2023;36:102524.
    Abstract

  2477. ZHANG F, Yu P, Xu L, Chen X, et al
    Differences of characteristics, influencing factors, and treatment effects on the survival in patients with first and second primary cervical cancer.
    Prev Med Rep. 2023;36:102504.
    Abstract

  2478. ARROYO MUHR LS, Lagheden C, Hassan SS, Eklund C, et al
    The International Human Papillomavirus Reference Center: Standardization, collaboration, and quality assurance in HPV research and diagnostics.
    J Med Virol. 2023;95:e29332.
    Abstract

  2479. YILMAZ A, Gulbahar A, Sen S
    Comparison of the efficacy of 5% versus 8% acetic acid concentrations for detecting premalignant and malignant lesions in colposcopy.
    Medicine (Baltimore). 2023;102:e36341.
    Abstract

  2480. HUANG Y, Qin T, Yang M, Liu Z, et al
    Impact of ovary-sparing treatment planning on plan quality, treatment time and gamma passing rates in intensity-modulated radiotherapy for stage I/II cervical cancer.
    Medicine (Baltimore). 2023;102:e36373.
    Abstract

  2481. SKELIN J, Luk HY, Butorac D, Boon SS, et al
    The effects of HPV oncoproteins on host communication networks: Therapeutic connotations.
    J Med Virol. 2023;95:e29315.
    Abstract

  2482. ROCHA MARTINS P, Luciano Pereira Morais K, de Lima Galdino NA, Jacauna A, et al
    Linking tumor immune infiltrate and systemic immune mediators to treatment response and prognosis in advanced cervical cancer.
    Sci Rep. 2023;13:22634.
    Abstract

  2483. LI Q, Zhu G, Zhang L, Zeng B, et al
    Mutational landscape of head and neck cancer and cervical cancer in Chinese and Western population.
    Head Neck. 2023 Dec 18. doi: 10.1002/hed.27603.
    Abstract

  2484. YAN J, Wu T, Zhang J, Gao Y, et al
    Revolutionizing the female reproductive system research using microfluidic chip platform.
    J Nanobiotechnology. 2023;21:490.
    Abstract

  2485. LI L, Tong Y, Wu J, Xu X, et al
    Clinical applications and utility of ctDNA in cervical cancer and its precursor lesions: from screening to predictive biomarker.
    Cancer Cell Int. 2023;23:329.
    Abstract

  2486. ROMERO D
    Neoadjuvant chemoimmunotherapy is effective in locally advanced cervical cancer.
    Nat Rev Clin Oncol. 2023 Dec 18. doi: 10.1038/s41571-023-00855.
    Abstract

  2487. YAO S, Xiong B, Tuo JY, Qin Y, et al
    [Survival analysis of malignant tumors in cancer registration areas of Hubei province in China, 2013 to 2015].
    Zhonghua Zhong Liu Za Zhi. 2023;45:1051-1056.
    Abstract

  2488. CHEN Y, Chen Q, Xue H, Zheng J, et al
    Clinical Characteristics and Detection Sensitivity of Cervical Cancer Screening in Vaginal Intraepithelial Neoplasia.
    J Low Genit Tract Dis. 2023 Dec 18. doi: 10.1097/LGT.0000000000000793.
    Abstract

  2489. ZHAO J, Li B, Shu C, Ma Y, et al
    [Retracted] Downregulation of miR?30a is associated with proliferation and invasion via targeting MEF2D in cervical cancer.
    Oncol Lett. 2023;27:35.
    Abstract

  2490. TIE H, Shi L, Wang L, Hao X, et al
    Symptom clusters and characteristics of cervical cancer patients receiving concurrent chemoradiotherapy: A cross-sectional study.
    Heliyon. 2023;9:e22407.
    Abstract

  2491. PIRANI N, Jafari M, Bagherzadeh R, Keikhosravi M, et al
    Cervical Cancer Prevention, Its Challenges and Solutions in Iran and Worldwide: A Systematic Review.
    Iran J Public Health. 2023;52:2313-2324.
    Abstract

  2492. WANG Y, Zhao J, Liang H, Liu J, et al
    Efficacy and safety of sintilimab plus albumin-bound-paclitaxel in recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trial.
    EClinicalMedicine. 2023;65:102274.
    Abstract

  2493. LI S, Liu J, Zhang Z, Wang W, et al
    Added-value of 3D amide proton transfer MRI in assessing prognostic factors of cervical cancer: a comparative study with multiple model diffusion-weighted imaging.
    Quant Imaging Med Surg. 2023;13:8157-8172.
    Abstract

  2494. SHARMA P, Khanna D, Pradhan S, Birur P, et al
    Community cancer screening at primary care level in Northern India: determinants and policy implications for cancer prevention.
    Fam Med Community Health. 2023;11.
    Abstract

  2495. AMPOFO AG, Mackenzie LJ, Osei Asibey S, Oldmeadow C, et al
    Prevalence and Correlates of Cervical Cancer Prevention Knowledge Among High School Students in Ghana.
    Health Educ Behav. 2023 Dec 17:10901981231217978. doi: 10.1177/10901981231217978
    Abstract

  2496. ANNEDE P, Robert C, Espenel S, Dumas I, et al
    Redefining the role of pulsed-dose-rate brachytherapy in cervical cancer treatment using a preplanned approach.
    Brachytherapy. 2023 Dec 16:S1538-4721(23)01677.
    Abstract

  2497. ZHANG C, Liu L, Li W, Li M, et al
    Upregulation of FAM83F by c-Myc promotes cervical cancer growth and aerobic glycolysis via Wnt/beta-catenin signaling activation.
    Cell Death Dis. 2023;14:837.
    Abstract

  2498. SOLEYMANI MAJD H, Yancheva S, Abdul B, Hellner K, et al
    Emergency hysterectomy following iatrogenic injury to the descending branch of the uterine artery during colposcopy.
    BMJ Case Rep. 2023;16:e255202.
    Abstract

  2499. NEHA, Ranjan P, Das P
    Calcimycin mediates apoptosis in breast and cervical cancer cell lines by inducing intracellular calcium levels in a P2RX4-dependent manner.
    Biochim Biophys Acta Gen Subj. 2023;1868:130535.
    Abstract

  2500. LIU S, Mei B, Ouyang Y, Li C, et al
    Prevalence and genotype distribution of human papillomavirus infection among women in Jingzhou, China: a population-based study of 51,720 women.
    Virol J. 2023;20:297.
    Abstract

  2501. XU Q, Song Q, Wang Y, Lin L, et al
    Amide proton transfer weighted combined with diffusion kurtosis imaging for predicting lymph node metastasis in cervical cancer.
    Magn Reson Imaging. 2023;106:85-90.
    Abstract

  2502. LEE S, Yoon H, Hong SH, Kwon SP, et al
    mRNA-HPV vaccine encoding E6 and E7 improves therapeutic potential for HPV-mediated cancers via subcutaneous immunization.
    J Med Virol. 2023;95:e29309.
    Abstract

  2503. OKODO M, Okayama K, Teruya K, Shinohara R, et al
    Cytological features of human papillomavirus-infected immature squamous metaplastic cells from cervical intraepithelial neoplasia grade 2.
    J Med Virol. 2023;95:e29311.
    Abstract

  2504. PARRA-LARA LG, Arango-Ibanez JP, Martinez-Arboleda JJ, Bravo JC, et al
    Survival of patients living with HIV and cancer in Cali, Colombia.
    Colomb Med (Cali). 2023;54:e2015558.
    Abstract

  2505. WEI X, Zhang J, Mei Y, Dai Q, et al
    Prevalence and genotype distribution of HPV6/11/16/18 infections among 180,276 outpatient females from a Women's and Children's Central Hospital, 2015-2021, Chengdu, China.
    Sci Rep. 2023;13:22249.
    Abstract

  2506. DONG J, Holthaus D, Peters C, Koster S, et al
    gammadelta T cell-mediated cytotoxicity against patient-derived healthy and cancer cervical organoids.
    Front Immunol. 2023;14:1281646.
    Abstract

  2507. PASQUIER C, Raymond S, Duchanois D, Saune K, et al
    Human papillomavirus testing using HPV APTIMA(R) assay and an external cellularity control in self-collected samples.
    J Med Virol. 2023;95:e29283.
    Abstract

  2508. HALL MT, Simms KT, Murray JM, Keane A, et al
    Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV.
    Nat Med. 2023;29:3059-3066.
    Abstract

  2509. SIMMS KT, Keane A, Nguyen DTN, Caruana M, et al
    Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population.
    Nat Med. 2023;29:3050-3058.
    Abstract

  2510. SHAFIQUE M, Shoaib I, Aslam B, Khalid R, et al
    Detection of high-risk human papillomavirus infected cervical biopsies samples by immunohistochemical expression of the p16 tumor marker.
    Arch Microbiol. 2023;206:17.
    Abstract

  2511. SHU T, Shi J, Zheng Y, Jiang Z, et al
    A Key-Points Based Anchor-Free Cervical Cell Detector.
    Annu Int Conf IEEE Eng Med Biol Soc. 2023;2023:1-5.
    Abstract

  2512. YE Y, Li M, Yang W, Xu J, et al
    Characteristics of high-risk HPV infection in women with vaginal intraepithelial neoplasia in Beijing, China.
    J Med Virol. 2023;95:e29267.
    Abstract

  2513. MANTINA NM, Nakayima Miiro F, Smith J, McClelland DJ, et al
    Perspectives of HPV vaccination among young adults: a qualitative systematic review and evidence synthesis protocol.
    BMJ Open. 2023;13:e076234.
    Abstract

  2514. AHMED SR, Befano B, Lemay A, Egemen D, et al
    Reproducible and clinically translatable deep neural networks for cervical screening.
    Sci Rep. 2023;13:21772.
    Abstract

  2515. RAMIREZ-LOPEZ LX, Carnalla-Cortes M, Barrientos-Gutierrez T, Coursaget P, et al
    Prophylactic cancer vaccines: development and challenges for HBV and HPV vaccines in Latin America.
    Salud Publica Mex. 2023;66.
    Abstract

  2516. ADEBOLA A, Kehinde O, Glory O, Oluwafikunayomi A, et al
    MOTHERS WILLINGNESS TO VACCINATE THEIR IN-SCHOOL ADOLESCENTS AGAINST HPV INFECTION IN LAGOS STATE NIGERIA.
    West Afr J Med. 2023;40.
    Abstract

  2517. RAJKHOWA P, Patil DS, Dsouza SM, Narayanan P, et al
    Evidence on factors influencing HPV vaccine implementation in South Asia: A scoping review.
    Glob Public Health. 2023;18:2288269.
    Abstract

  2518. YANG X, He L, Xiao X, Yan L, et al
    Effectiveness of TruScreen for detecting CIN2+ in women with ThinPrep cytologic test results indicating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
    Future Oncol. 2023;19:2493-2504.
    Abstract

  2519. YU J, Sun X, Yu Y, Cui X, et al
    The cadherin protein CDH19 mediates cervical carcinoma progression by regulating AKT/NF-kappaB signaling.
    Acta Biochim Pol. 2023;70:955-961.
    Abstract

  2520. BARNABAS RV, Brown ER, Onono MA, Bukusi EA, et al
    Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results.
    Nat Med. 2023 Dec 4. doi: 10.1038/s41591-023-02658.
    Abstract

  2521. KIM MJ, Lee GJ, Lee EJ, Lee S, et al
    Lugol's Solution Reduces Positive Margins and Residual Disease After the Large Loop Excision of Transformation Zone.
    J Low Genit Tract Dis. 2024;28:12-17.
    Abstract

  2522. MENESES-LEON J, Hernandez-Lopez R, Hernandez-Salazar S, Torres-Ibarra L, et al
    Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections in Tlaxcala, Mexico.
    Epidemiol Infect. 2023;151:e198.
    Abstract

  2523. AGGARWAL S, Agarwal P, Singh AK
    Human papilloma virus vaccines: A comprehensive narrative review.
    Cancer Treat Res Commun. 2023;37:100780.
    Abstract

  2524. FAN J, Lu F, Qin T, Peng W, et al
    Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance.
    Nat Genet. 2023;55:2175-2188.
    Abstract

  2525. BI Y, Hu J, Zeng L, Chen G, et al
    Characteristics of HPV integration in cervical adenocarcinoma and squamous carcinoma.
    J Cancer Res Clin Oncol. 2023;149:17973-17986.
    Abstract

  2526. SGAYER I, Shmueli M, Lowenstein L, Frank Wolf M, et al
    Colposcopy-A Valuable Diagnostic Tool for Pregnant Women With Unexplained Vaginal Bleeding.
    J Low Genit Tract Dis. 2024;28:32-36.
    Abstract

  2527. LYCKE KD, Kalpathy-Cramer J, Jeronimo J, de Sanjose S, et al
    Agreement on Lesion Presence and Location at Colposcopy.
    J Low Genit Tract Dis. 2024;28:37-42.
    Abstract

  2528. XU J, He J, Zhou YL, Weng Z, et al
    Von Willebrand factor promotes radiation-induced intestinal injury (RIII) development and its cleavage enzyme rhADAMTS13 protects against RIII by reducing inflammation and oxidative stress.
    Free Radic Biol Med. 2024;210:1-12.
    Abstract

  2529. ZHANG Z, Li Y, Wu Y, Bi R, et al
    Identifying tumor markers-stratified subtypes (CA-125/CA19-9/carcinoembryonic antigen) in cervical adenocarcinoma.
    Int J Biol Markers. 2023;38.
    Abstract

  2530. VIVEROS-CARRENO D, Mora-Soto N, Rodriguez J, Rauh-Hain JA, et al
    Recurrence After Biopsy-Confirmed Cervical High-Grade Intraepithelial Lesion Followed by Negative Conization: A Systematic Review and Meta-analysis.
    J Low Genit Tract Dis. 2024;28:26-31.
    Abstract

  2531. SWIECKI-SIKORA AL, Lauder A, Harris A, Tagai EK, et al
    Attitudes About the Human Papillomavirus Vaccine Among Patients With and Without Cervical Dysplasia.
    J Low Genit Tract Dis. 2024;28:18-25.
    Abstract

  2532. NEIL AJ, Li YY, Hakam A, Nucci MR, et al
    Pattern A endocervical adenocarcinomas with ovarian metastasis are indolent and molecularly distinct from destructively invasive adenocarcinomas.
    Histopathology. 2024;84:369-380.
    Abstract

  2533. PIEDIMONTE S, Tsang K, Jembere N, Murphy J, et al
    Defining the Longitudinal Risk of CIN 3+ for
    J Low Genit Tract Dis. 2024;28:7-11.
    Abstract

  2534. BABAN FS, Henry MR, Long ME, VandeHaar MA, et al
    Women 50 Years and Older With Negative Pap Test and Positive Human Papillomavirus Test for Genotypes Other Than 16 and 18-Follow-up Outcomes.
    J Low Genit Tract Dis. 2024;28:43-47.
    Abstract

  2535. SONG Y, Zhang M, Zhang C, Du S, et al
    HPV E6/E7 mRNA combined with thin-prep cytology test for the diagnosis of residual/recurrence after loop electrosurgical excision procedure in patients with cervical intraepithelial neoplasia.
    Diagn Microbiol Infect Dis. 2024;108:116119.
    Abstract

  2536. KUMARI N, Antil H, Kumari S, Raghavan SC, et al
    Deficiency of ligase IV leads to reduced NHEJ, accumulation of DNA damage, and can sensitize cells to cancer therapeutics.
    Genomics. 2023;115:110731.
    Abstract

  2537. SOUID M, Bday J, Souissi S, Ghedira R, et al
    Arginase is upregulated in healthy women infected by oncogenic HPV types.
    Biomarkers. 2023;28:628-636.
    Abstract

  2538. SHU X, Su J, Zhao Y, Liu C, et al
    Regulation of HeLa cell proliferation and apoptosis by bovine lactoferrin.
    Cell Biochem Funct. 2023;41:1395-1402.
    Abstract

  2539. TONINI F, Forret A, Lanta S, Gagneur O, et al
    How to make a LLETZ simulator: LLETZ Simulator.
    J Gynecol Obstet Hum Reprod. 2023;52:102676.
    Abstract

  2540. YING J, Mao L, Tang Y, Fassatoui M, et al
    Development and validation of real-time recombinase polymerase amplification-based assays for detecting HPV16 and HPV18 DNA.
    Microbiol Spectr. 2023;11:e0120723.
    Abstract

  2541. YUAN LJ, He K, Zhu CX, Cao TF, et al
    Rational of topical photodynamic therapy (PDT) with 5-aminolevulinic acid (5-ALA) for treatment of endocervical canal low-grade squamous intraepithelial lesion with high-risk human papillomavirus infection.
    Lasers Surg Med. 2023;55:880-885.
    Abstract

  2542. RAWL SM, Baltic R, Monahan PO, Stump TE, et al
    Receipt, uptake, and satisfaction with tailored DVD and patient navigation interventions to promote cancer screening among rural women.
    Transl Behav Med. 2023;13:879-890.
    Abstract

  2543. ZHANG Z, Wang J, Yuan S
    Cervical perineural cyst: A case report.
    Asian J Surg. 2023;46:5809-5810.
    Abstract

  2544. ZHENG LL, Zheng LY, Chen C, Wang YT, et al
    High-risk human papillomavirus distribution in different cytological classification women.
    Microbes Infect. 2023;25:105214.
    Abstract

  2545. MOAZZAM Z, Woldesenbet S, Endo Y, Alaimo L, et al
    Association of Historical Redlining and Present-Day Social Vulnerability with Cancer Screening.
    J Am Coll Surg. 2023;237:454-464.
    Abstract

  2546. IKIROMA A, Santin O, Camanda J, Chocolate F, et al
    Evaluation of human papillomavirus (HPV) knowledge among healthcare professionals: A study of conference attendees in Angola.
    Glob Public Health. 2023;18:2099931.
    Abstract

  2547. THRALL MJ
    A Practical Approach to Squamous Abnormalities on Cervical Cytology: Overview of Interpretive Criteria and Guidance for Altering Thresholds in Response to Quality Assurance Findings.
    Acta Cytol. 2023;67:129-142.
    Abstract

  2548. HOPP AM, Puzyrenko A, Giorgadze T
    Comprehensive Review of Anal Cytology.
    Acta Cytol. 2023;67:185-194.
    Abstract

  2549. BARROETA JE, Lastra RR
    Cytopathology in Gynecology and Gynecologic Oncology: Updates, Recent Advances, and Practical Considerations.
    Acta Cytol. 2023;67:109-110.
    Abstract

  2550. OLIVAS AD, Barroeta JE, Lastra RR
    Overview of Ancillary Techniques in Cervical Cytology.
    Acta Cytol. 2023;67:119-128.
    Abstract

  2551. OKUNADE KS, Badmos KB, Soibi-Harry AP, Garba SR, et al
    Cervical Epithelial Abnormalities and Associated Factors among HIV-Infected Women in Lagos, Nigeria: A Cytology-Based Study.
    Acta Cytol. 2023;67:248-256.
    Abstract

  2552. KIR G, Dokmeci Guney D, Seneldir H
    Comparison of the Clinical Performance of Aptima HPV Assay and the Cobas 4800 Platform in Women with Normal Cytology and Positive High-Risk HPV.
    Acta Cytol. 2023;67:395-402.
    Abstract

  2553. KIMURA F, Ohshima K, Shirai K, Kanai R, et al
    Discriminant Analysis Using Gabor Filter Sets for Lobular Endocervical Glandular Hyperplasia: Numerical Interpretation of Nuclear Atypia by Gabor Filter Features.
    Acta Cytol. 2023;67:539-549.
    Abstract

  2554. KIR G, Ozen S
    Histopathologic Follow-Up of Women with Inadequate ThinPrep Cervical Pap Tests and Positive High-Risk Human Papillomavirus Test Results.
    Acta Cytol. 2023;67:533-538.
    Abstract

  2555. CANNISTRA S, Carozzi F, Di Stefano C, Matucci M, et al
    Accuracy and Reproducibility of Cytology Triage in a HPV-Based Primary Screening Setting: A Revision of 384 Pap Tests.
    Acta Cytol. 2023;67:618-628.
    Abstract

  2556. PULKKINEN J, Huhtala H, Kholova I
    False-Positive Atypical Endocervical Cells in Conventional Pap Smears: Cyto-Histological Correlation and Analysis.
    Acta Cytol. 2023;67:604-617.
    Abstract

  2557. ALFONZO E, Zhang C, Daneshpip F, Strander B, et al
    Accuracy of colposcopy in the Swedish screening program.
    Acta Obstet Gynecol Scand. 2023;102:549-555.
    Abstract

  2558. SKORSTENGAARD M, Viborg PH, Telen Andersen AB, Andersen B, et al
    A cervical screening initiative for elderly women in Denmark.
    Acta Obstet Gynecol Scand. 2023;102:791-800.
    Abstract

  2559. DUAN H, Li H, Kang S, Zhao H, et al
    Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.
    Acta Obstet Gynecol Scand. 2023 Jun 20. doi: 10.1111/aogs.14612.
    Abstract

  2560. XUE P, Xu HM, Tang HP, Wu WQ, et al
    Assessing artificial intelligence enabled liquid-based cytology for triaging HPV-positive women: a population-based cross-sectional study.
    Acta Obstet Gynecol Scand. 2023;102:1026-1033.
    Abstract

  2561. DAMGAARD RK, Jenkins D, Stoler MH, van de Sandt MM, et al
    High prevalence of HPV16 and high-grade cytology in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
    Acta Obstet Gynecol Scand. 2023;102:1227-1235.
    Abstract

  2562. SOARES LC, de Souza RJ, Oliveira MAP
    Reviewing FIGO 2018 cervical cancer staging.
    Acta Obstet Gynecol Scand. 2023 Aug 17. doi: 10.1111/aogs.14667.
    Abstract

  2563. HELLSTEN C, Holmberg A, Astrom J, Forslund O, et al
    Cervical cancer in Region Skane, Sweden 2017-2020 after the implementation of primary HPV screening: A quality assurance audit.
    Acta Obstet Gynecol Scand. 2023 Oct 10. doi: 10.1111/aogs.14691.
    Abstract

  2564. STOLNICU S, Allison D, Praiss AM, Tessier-Cloutier B, et al
    Incidence and Clinicopathologic Characteristics of Human Papillomavirus-independent Invasive Squamous Cell Carcinomas of the Cervix: A Morphologic, Immunohistochemical, and Human Papilloma-Virologic Study of 670 Cases.
    Am J Surg Pathol. 2023;47:1376-1389.
    Abstract

  2565. GILHAM C, Sargent A, Crosbie EJ, Peto J, et al
    Long-term risks of invasive cervical cancer following HPV infection: follow-up of two screening cohorts in Manchester.
    Br J Cancer. 2023 Mar 23. doi: 10.1038/s41416-023-02227.
    Abstract

  2566. MITTELSTADT S, Kelemen O, Admard J, Gschwind A, et al
    Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse.
    Br J Cancer. 2023 Mar 27. doi: 10.1038/s41416-023-02233.
    Abstract

  2567. KAMAL M, Lameiras S, Deloger M, Morel A, et al
    Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
    Br J Cancer. 2023 Apr 13. doi: 10.1038/s41416-023-02261.
    Abstract

  2568. KERRISON RS, Jones A, Peng J, Price G, et al
    Inequalities in cancer screening participation between adults with and without severe mental illness: results from a cross-sectional analysis of primary care data on English Screening Programmes.
    Br J Cancer. 2023;129:81-93.
    Abstract

  2569. VERHOEF L, Bleeker MCG, Polman N, Steenbergen RDM, et al
    Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.
    Br J Cancer. 2023 Apr 26:1-8. doi: 10.1038/s41416-023-02277.
    Abstract

  2570. CUSCHIERI K, Palmer T, Graham C, Cameron R, et al
    The changing nature of HPV associated with high grade cervical lesions in vaccinated populations, a retrospective study of over 1700 cases in Scotland.
    Br J Cancer. 2023 Aug 10. doi: 10.1038/s41416-023-02386.
    Abstract

  2571. NIERENGARTEN MB
    Balancing the benefits and harms of cervical cancer screening in older women.
    Cancer. 2023;129:979-980.
    Abstract

  2572. AYALA-PEACOCK DN, Chino JP
    Is it time for bone marrow sparing radiation therapy to be standard of care in cervical cancer?
    Cancer. 2023 Apr 12. doi: 10.1002/cncr.34769.
    Abstract

  2573. WANG S, Liu J, Lei K, Jia Y, et al
    Single-photon emission computed tomography-defined active bone marrow-sparing volumetric-modulated arc therapy reduces the incidence of acute hematologic toxicity in locally advanced cervical cancer patients who receive chemoradiotherapy: A single-cen
    Cancer. 2023 Apr 12. doi: 10.1002/cncr.34771.
    Abstract

  2574. SPENCER JC, Noel L, Shokar NK, Pignone MP, et al
    Understanding the role of access in Hispanic cancer screening disparities.
    Cancer. 2023;129:1569-1578.
    Abstract

  2575. FRANCO EL
    The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
    Cancer. 2023 Jun 22. doi: 10.1002/cncr.34899.
    Abstract

  2576. VADAPARAMPIL ST, Fuzzell LN, Brownstein NC, Fontenot HB, et al
    A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
    Cancer. 2023;129:2671-2684.
    Abstract

  2577. MACKINNON KM, Risica PM, von Ash T, Scharf AL, et al
    Barriers and motivators to women's cancer screening: A qualitative study of a sample of diverse women.
    Cancer. 2023;129.
    Abstract


  2578. HPV testing in older women may improve cervical cancer prevention.
    Cancer. 2023;129:3518.
    Abstract

  2579. ROSSI NM, Dai J, Xie Y, Wangsa D, et al
    Extrachromosomal Amplification of Human Papillomavirus Episomes Is a Mechanism of Cervical Carcinogenesis.
    Cancer Res. 2023;83:1768-1781.
    Abstract

  2580. LI QS, Zheng PS
    ESRRB inhibits the TGF-beta signaling pathway to drive cell proliferation in cervical cancer.
    Cancer Res. 2023 Jun 23:CAN-23-0067. doi: 10.1158/0008-5472.CAN-23-0067.
    Abstract

  2581. FRIEDMAN CF, Ravichandran V, Miller K, Vanderbilt C, et al
    Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.
    Clin Cancer Res. 2023 Aug 29:CCR-23-1078. doi: 10.1158/1078-0432.CCR-23-1078.
    Abstract

  2582. TOYODA S, Morita K, Ishida E, Sado T, et al
    Spindle-nucleated cells in cervical liquid-based cytology: Difficulties in distinguishing between epithelial and non-epithelial tumours based on morphology.
    Cytopathology. 2023;34:271-274.
    Abstract

  2583. BASCIO LS, Chiappa V, Paolini B, Chiarello G, et al
    Urothelial bladder carcinoma recurrence in the uterine cervix: Cytological findings on a cervical cytology test.
    Cytopathology. 2023;34:645-648.
    Abstract

  2584. NG JKM, Li JJX
    Keratinization in atypical glandular cell clusters as a cytological clue to endometrioid carcinoma on cervical cytology.
    Cytopathology. 2024;35:131-135.
    Abstract

  2585. POGERE A, Costa AF, Pasinato APBF, Machado MJ, et al
    Role of DNA ploidy in diagnosis and prognosis of high-grade cervical intraepithelial neoplasia: A prospective cohort study.
    Cytopathology. 2024;35:122-130.
    Abstract

  2586. TOROUS VF
    Challenging lesions in cervical cytology: The elusive HSIL.
    Cytopathology. 2024;35:48-59.
    Abstract

  2587. SEO Y, Park E, Kim HS
    Cytological features of mesonephric-like adenocarcinoma of the uterine corpus.
    Diagn Cytopathol. 2023 Feb 8. doi: 10.1002/dc.25111.
    Abstract

  2588. XU H, Chen Y, Zhao C, Wang Q, et al
    Bethesda system reporting rates, histological follow-up and HPV genotypes distribution of abnormal cytology in Anhui province of China: Analysis of 93,168 cervical liquid-based cytology test reports.
    Diagn Cytopathol. 2023;51:501-510.
    Abstract

  2589. AGOFF SN, Brockmeyer AD, Barrie AM, Larson J, et al
    High-grade squamous intraepithelial lesion cervicovaginal paps with negative high-risk HPV testing, a prospective study with histological follow-up.
    Diagn Cytopathol. 2023;51:475-479.
    Abstract

  2590. KIR G, Gunel H, Cicek T, Seneldir H, et al
    Immediate histopathologic correlation in Turkish population with negative cytology and high-risk human papillomavirus positivity: A retrospective analysis of high-risk human papillomavirus genotype and stratified by age.
    Diagn Cytopathol. 2023;51:605-611.
    Abstract

  2591. GOEL A, Kapatia G, Parwaiz A, Gupta S, et al
    Commentary on "Comparison of glass and digital slides for cervical cytopathology screening and interpretation".
    Diagn Cytopathol. 2023;51:791-792.
    Abstract

  2592. DE SOUSA VELOZO G, Cordeiro J, Sousa J, Holanda AC, et al
    Comparison of glass and digital slides for cervical cytopathology screening and interpretation.
    Diagn Cytopathol. 2023;51:790.
    Abstract

  2593. DE VELOZO G, Cordeiro J, Sousa J, Holanda AC, et al
    Comparison of glass and digital slides for cervical cytopathology screening and interpretation.
    Diagn Cytopathol. 2023;51:735-743.
    Abstract

  2594. CHEN L, Zhu K, Chen H, Liu Q, et al
    Correlation of immediate prevalence of cervical squamous cell precancers and cancers with HPV genotype and age in women with LSIL cytology: A retrospective analysis of 1617 cases.
    Diagn Cytopathol. 2024;52:10-15.
    Abstract

  2595. WENZEL HHB, Hardie AN, Moncada-Torres A, Hogdall CK, et al
    A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases.
    Eur J Cancer. 2023;185:61-68.
    Abstract

  2596. DING S, Li H
    Re: A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases.
    Eur J Cancer. 2023 Aug 1:112978. doi: 10.1016/j.ejca.2023.112978.
    Abstract

  2597. CHEN M, Li C, Cui Q, Zhou C, et al
    The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: A prospective observational study in China.
    Eur J Obstet Gynecol Reprod Biol. 2023;286:10-15.
    Abstract

  2598. DONG H, Li H, Wang L, Yuan Y, et al
    Clinical analysis of 175 cases of vaginal intraepithelial neoplasia.
    Eur J Obstet Gynecol Reprod Biol. 2023;287:232-236.
    Abstract

  2599. KHAN A, Hussain S, Iyer JK, Kaul A, et al
    Human papillomavirus-mediated expression of complement regulatory proteins in human cervical cancer cells.
    Eur J Obstet Gynecol Reprod Biol. 2023;288:222-228.
    Abstract

  2600. MARCHAND G, Taher Masoud A, Abdelsattar A, King A, et al
    Systematic Review and Meta-analysis of laparoscopic radical hysterectomy vs. Robotic assisted radical hysterectomy for early stage cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2023;289:190-202.
    Abstract

  2601. VIEIRA-COIMBRA M, Nogueira-Martins N, Zadykowicz R, Gaspar HR, et al
    EBCOG position statement on Inequalities in screening for cervical and breast cancer.
    Eur J Obstet Gynecol Reprod Biol. 2023;289:217-218.
    Abstract

  2602. VIEIRA-COIMBRA M, Nogueira-Martins N, Zadykowicz R, Rodrigues Gaspar H, et al
    Provision of screening services for cervical and breast cancer - A scientific study commissioned by the European Board & College of Obstetrics and Gynaecology (EBCOG).
    Eur J Obstet Gynecol Reprod Biol. 2023 Aug 30:S0301-2115(23)00691.
    Abstract

  2603. GHELMAN F, Cristina Cruz Silva N, Cristina Brollo Soares L
    Relation between naked eye Swede score and the outcomes of atypias of undetermined significance.
    Eur J Obstet Gynecol Reprod Biol. 2023;289:158-162.
    Abstract

  2604. AISSAOUI O, Phalippou J, Cordoba A, Azais H, et al
    Brachytherapy and surgery versus surgery alone for IB2 (FIGO 2018) cervical cancers: A FRANCOGYN study.
    Eur J Obstet Gynecol Reprod Biol. 2023;290:128-134.
    Abstract

  2605. MCGEE AE, Alibegashvili T, Elfgren K, Frey B, et al
    European consensus statement on expert colposcopy.
    Eur J Obstet Gynecol Reprod Biol. 2023;290:27-37.
    Abstract

  2606. MONTI E, Salmaso M, Alberico D, Emily Cetera G, et al
    Prevalence of high-grade anal intraepithelial neoplasia in immunocompetent women treated for high-grade cervical intraepithelial neoplasia.
    Eur J Obstet Gynecol Reprod Biol. 2023;291:82-87.
    Abstract

  2607. BENBROOK DM, Deng W, Gold MA, Rai R, et al
    Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study.
    Gynecol Oncol. 2023;171:67-75.
    Abstract

  2608. TEWARI KS, Sill MW, Birrer MJ, Penson RT, et al
    Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical Cancer: A NRG oncology randomized study.
    Gynecol Oncol. 2023;171:141-150.
    Abstract

  2609. KIM C, Salvo G, Ishikawa M, Chen TC, et al
    The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis.
    Gynecol Oncol. 2023;170:328-332.
    Abstract

  2610. KAUR A, Wang S, Kumar A
    Impact of racial disparities on potential years of life lost due to gynecologic cancer in the United States: Trends from 1975 to 2017 based on SEER database.
    Gynecol Oncol. 2023;170:266-272.
    Abstract

  2611. HOLLOWAY SB, Mercadel AJ, Miller DS, Lea JS, et al
    Isolated para-aortic nodal recurrence after treatment of early stage cervical carcinoma.
    Gynecol Oncol. 2023;170:248-253.
    Abstract

  2612. STOLER MH, Wright TC Jr, Parvu V, Yanson K, et al
    Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trial.
    Gynecol Oncol. 2023;170:143-152.
    Abstract

  2613. LU L, Liu T, Wang S, Li J, et al
    Joint detection of multiple HPV-testing technologies and evaluation of clinicopathological characteristics discriminate between HPV-independent and low-copy HPV-associated cervical squamous cell carcinoma (CSCC) -an analysis of 3869 cases.
    Gynecol Oncol. 2023;170:59-69.
    Abstract

  2614. MOOLENAAR LR, van Rangelrooij LE, van Poelgeest MIE, van Beurden M, et al
    Clinical outcomes of pelvic exenteration for gynecologic malignancies.
    Gynecol Oncol. 2023;171:114-120.
    Abstract

  2615. GARCIA-SAYRE J, Lin YG, Matuso K, Tsao-Wei DD, et al
    Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancer.
    Gynecol Oncol. 2023;173:49-57.
    Abstract

  2616. CIBULA D
    The group with the most heterogenous treatment among patients with cervical cancer.
    Gynecol Oncol. 2023 Apr 17:S0090-8258(23)00169.
    Abstract

  2617. KIM SI, Nam SH, Hwangbo S, Kim Y, et al
    Conization before radical hysterectomy in patients with early-stage cervical cancer: A Korean multicenter study (COBRA-R).
    Gynecol Oncol. 2023;173:88-97.
    Abstract

  2618. FUREY KB, Anderson ZS, Kuznicki ML, Klar M, et al
    Increasing trends of cervical conization with lymph node evaluation for fertility-sparing surgery in early cervical cancer.
    Gynecol Oncol. 2023;173:122-129.
    Abstract

  2619. VERGOTE I, Van Nieuwenhuysen E, Casado A, Laenen A, et al
    Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer.
    Gynecol Oncol. 2023;174:80-88.
    Abstract

  2620. ROBOVA H, Rob L, Halaska MJ, Drozenova J, et al
    Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer: Pregnancy outcomes.
    Gynecol Oncol. 2023;174:76-79.
    Abstract

  2621. DI DONATO V, Bogani G, Casarin J, Ghezzi F, et al
    Ten-year outcomes following laparoscopic and open abdominal radical hysterectomy for "low-risk" early-stage cervical cancer: A propensity-score based analysis.
    Gynecol Oncol. 2023;174:49-54.
    Abstract

  2622. PIEDIMONTE S, Helpman L, Pond G, Nelson G, et al
    Surgical margin status in relation to surgical approach in the management of early-stage cervical Cancer: A Canadian cervical Cancer collaborative (4C) study.
    Gynecol Oncol. 2023;174:21-27.
    Abstract

  2623. HAN L, Chen Y, Zheng A, Chen H, et al
    Effect of preoperative cervical conization before hysterectomy on survival and recurrence of patients with cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2023;174:167-174.
    Abstract

  2624. KIM NR, Kim SI, Suh DH, Kim HS, et al
    Survival outcomes of laparoscopic versus open radical hysterectomy in early cervical cancer with incidentally identified high-risk factors.
    Gynecol Oncol. 2023;174:224-230.
    Abstract

  2625. LEVINE MD, Barrington DA, Meade CE, Lammers SM, et al
    Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes.
    Gynecol Oncol. 2023;173:15-21.
    Abstract

  2626. KULKARNI A, Chen L, Gockley A, Khoury-Collado F, et al
    Patterns of cervical cancer screening follow-up in the era of prolonged screening intervals.
    Gynecol Oncol. 2023;175:53-59.
    Abstract

  2627. LI J, Xue X, Zhang Y, Ding F, et al
    The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
    Gynecol Oncol. 2023;175:133-141.
    Abstract

  2628. SCHIFFMAN M, Mirabello L, Egemen D, Befano B, et al
    The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma.
    Gynecol Oncol. 2023;174:253-261.
    Abstract

  2629. STOLER MH, Parvu V, Yanson K, Andrews J, et al
    Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial.
    Gynecol Oncol. 2023;174:68-75.
    Abstract

  2630. KAHVECIOGLU A, Gurlek E, Yedekci FY, Sari SY, et al
    Simultaneous integrated or sequential boost to clinically involved lymph nodes in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy.
    Gynecol Oncol. 2023;176:10-15.
    Abstract

  2631. EIDE AJ, Halle MK, Lura N, Fasmer KE, et al
    Visceral fat percentage for prediction of outcome in uterine cervical cancer.
    Gynecol Oncol. 2023;176:62-68.
    Abstract

  2632. KONSKI A, Deshmukh S, Klopp AH, Yeung AR, et al
    Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203.
    Gynecol Oncol. 2023;175:176-181.
    Abstract

  2633. MAH SJ, Carter Ramirez DM, Eiriksson LR, Schnarr K, et al
    Palliative care utilization across health sectors for patients with gynecologic malignancies in Ontario, Canada from 2006 to 2018.
    Gynecol Oncol. 2023;175:169-175.
    Abstract

  2634. KONG TW, Kim J, Son JH, Lee AJ, et al
    Is minimally invasive radical surgery safe for patients with cervical cancer
    Gynecol Oncol. 2023;176:122-129.
    Abstract

  2635. KOROMPELIS P, Rundle S, Cassar V, Ratnavelu N, et al
    "Conservative surgical approaches for small volume FIGO stage IB1 cervical cancer. Updated survival and obstetric outcomes of an expanded cohort".
    Gynecol Oncol. 2023;176:155-161.
    Abstract

  2636. PRAISS AM, Allison D, Tessier-Cloutier B, Flynn J, et al
    Extensive versus focal lymphovascular invasion in squamous cell carcinoma of the cervix: A comprehensive international, multicenter, retrospective clinicopathologic study.
    Gynecol Oncol. 2023;176:147-154.
    Abstract

  2637. AGUSTI N, Viveros-Carreno D, Mora-Soto N, Ramirez PT, et al
    Diagnostic accuracy of sentinel lymph node frozen section analysis in patients with early-stage cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2023;177:157-164.
    Abstract

  2638. LEE HC, Jeong JW, Lee JH, Kim SH, et al
    High-dose (60 Gy) intensity-modulated radiotherapy with concurrent weekly cisplatin followed by intracavitary radiation in locally advanced cervical cancer: A phase II prospective clinical trial.
    Gynecol Oncol. 2023;177:142-149.
    Abstract

  2639. BAETEN IGT, Hoogendam JP, Schreuder HWR, Jurgenliemk-Schulz IM, et al
    Introducing a novice surgeon to an experienced robotic gynaecological oncology team: An observational cohort study on the impact of a structured curriculum on outcomes of cervical cancer surgery.
    Gynecol Oncol. 2023;178:153-160.
    Abstract

  2640. MORTON M, Haight PJ, Khadraoui W, Backes F, et al
    "More than a song and dance": Exploration of patient perspectives and educational quality of gynecologic cancer content on TikTok.
    Gynecol Oncol. 2023;175:81-87.
    Abstract

  2641. HOLM J, Gerke O, Vilstrup MH, Spasojevic D, et al
    Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
    Gynecol Oncol. 2022 Sep 28. pii: S0090-8258(22)01841.
    Abstract

  2642. KUMAR R, Sherwani Z, Lopez M, Vergalasova I, et al
    Disparities in brachytherapy utilization in cervical cancer in the United States: A comprehensive literature review.
    Gynecol Oncol. 2023;179:79-84.
    Abstract

  2643. WICKENHEISSER NE, Dillon M, Broadwater G, Zacherl K, et al
    Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Cancer Centers.
    Gynecol Oncol. 2023;179:70-78.
    Abstract

  2644. SUMMEY R, Benoit M, Williams-Brown MY
    Survival differences by race and surgical approach in early-stage operable cervical Cancer.
    Gynecol Oncol. 2023;179:63-69.
    Abstract

  2645. HERMANN CE, Patel JM, Boyd L, Growdon WB, et al
    Let's chat about cervical cancer: Assessing the accuracy of ChatGPT responses to cervical cancer questions.
    Gynecol Oncol. 2023;179:164-168.
    Abstract

  2646. GIRDA E, Randall LM, Chino F, Monk BJ, et al
    Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement.
    Gynecol Oncol. 2023;179:115-122.
    Abstract

  2647. CHAPMAN GC, Smrz SA, Gordon JC, Lynam SK, et al
    Gynecologic cancer care in the first year of the COVID-19 pandemic.
    Gynecol Oncol. 2023;178:138-144.
    Abstract

  2648. CHEN F, Zhang GN, Lei W, Zhou SG, et al
    Effectiveness and safety of REBACIN as a non-invasive intervention for persistent high-risk human papillomavirus infection: A real-world prospective multicenter cohort study.
    Gynecol Oncol. 2023;178:8-13.
    Abstract

  2649. HSIEH K, Bloom JR, Dickstein DR, Hsieh C, et al
    Dose and fractionation regimen for brachytherapy boost in cervical cancer in the US.
    Gynecol Oncol. 2023;180:55-62.
    Abstract

  2650. RAI R, Lightfoot S, Benbrook DM
    Manipulation of metabolic responses enhances SHetA2 efficacy without toxicity in cervical cancer cell lines and xenografts.
    Gynecol Oncol. 2023;180:44-54.
    Abstract

  2651. SAMMOURI J, Venkatesan AM, Lin LL, Jhingran A, et al
    Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement.
    Gynecol Oncol. 2023;180:24-34.
    Abstract

  2652. VAHTERISTO M, Leinonen MK, Sarkeala T, Anttila A, et al
    Similar effectiveness with primary HPV and cytology screening - Long-term follow-up of randomized cervical cancer screening trial.
    Gynecol Oncol. 2023;180:146-151.
    Abstract

  2653. URBUTE A, Frederiksen K, Thomsen LT, Kesmodel US, et al
    Overweight and obesity as risk factors for cervical cancer and detection of precancers among screened women: A nationwide, population-based cohort study.
    Gynecol Oncol. 2023;181:20-27.
    Abstract

  2654. LONG E, Macdonald MC, Parker VL, Lyon R, et al
    Factors associated with failed 'test of cure' in the NHS Cervical Screening Programme: A retrospective cohort study.
    Gynecol Oncol. 2023;179:158-163.
    Abstract

  2655. BARRETT JE, Jones A, Evans I, Herzog C, et al
    The WID-EC test for the detection and risk prediction of endometrial cancer.
    Int J Cancer. 2022 Dec 19. doi: 10.1002/ijc.34406.
    Abstract

  2656. PESOLA F, Rebolj M, Sasieni P
    Managing an extension of screening intervals: Avoiding boom and bust in health care workloads.
    Int J Cancer. 2023;152:2061-2068.
    Abstract

  2657. HERZOG C, Vavourakis CD, Barrett JE, Karbon G, et al
    HPV-induced host epigenetic reprogramming is lost upon progression to high-grade cervical intraepithelial neoplasia.
    Int J Cancer. 2023 Feb 21. doi: 10.1002/ijc.34477.
    Abstract

  2658. TISLER A, Nygard M, Kivite-Urtane A, Berza N, et al
    Comment on "The European response to the WHO call to eliminate cervical cancer as a public health problem".
    Int J Cancer. 2023 Apr 19. doi: 10.1002/ijc.34540.
    Abstract

  2659. CUZICK J, Adcock R, Kinney W, Castle PE, et al
    Impact of HPV testing in Opportunistic Cervical Screening: Support for Primary HPV Screening in the United States.
    Int J Cancer. 2023 Mar 22. doi: 10.1002/ijc.34519.
    Abstract

  2660. REBOLJ M, Sargent A, Njor SH, Cuschieri K, et al
    Widening the offer of human papillomavirus self-sampling to all women eligible for cervical screening: Make haste slowly.
    Int J Cancer. 2023;153:8-19.
    Abstract

  2661. WEVER BMM, van den Helder R, van Splunter AP, van Gent MDJM, et al
    DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self-samples, and cervical scrapes.
    Int J Cancer. 2023 Mar 13. doi: 10.1002/ijc.34504.
    Abstract

  2662. DONG L, Nygard M, Stoer NC, Klungsoyr O, et al
    Real-World Effectiveness of Hpv Vaccination Against Cervical Neoplasia Among Birth Cohorts Ineligible for Routine Vaccination.
    Int J Cancer. 2023 Mar 3. doi: 10.1002/ijc.34489.
    Abstract

  2663. QI L, Wang M, Jia Y, Wang Y, et al
    Impact of the COVID-19 pandemic on the hospital attendance of patients with primary cervical cancer in Heilongjiang, China.
    Int J Cancer. 2023 Jun 1. doi: 10.1002/ijc.34617.
    Abstract

  2664. WANG J, Edvardsson H, Strander B, Andrae B, et al
    Long-term follow-up of cervical cancer incidence after normal cytological findings.
    Int J Cancer. 2023 Sep 11. doi: 10.1002/ijc.34723.
    Abstract

  2665. INTURRISI F, de Sanjose S, Desai KT, Dagnall C, et al
    A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.
    Int J Cancer. 2023 Sep 29. doi: 10.1002/ijc.34698.
    Abstract

  2666. MUNGO C, Osongo CO, Ambaka J, Omoto J, et al
    Efficacy of thermal ablation for treatment of biopsy-confirmed high-grade cervical precancer among women living with HIV in Kenya.
    Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34737.
    Abstract


  2667. Harald zur Hausen 1936-2023.
    Int J Cancer. 2023;153:1937-1939.
    Abstract

  2668. DICK S, Heideman DAM, Mom CH, Meijer CJLM, et al
    Methylation testing for the detection of recurrent cervical intraepithelial neoplasia.
    Int J Cancer. 2023;153:2011-2018.
    Abstract


  2669. Correction to "Randomized multicenter phase II trial of prophylactic irradiation of para-aortic lymph nodes in advanced cervical cancer according to tumor hypoxia: Korean Radiation Oncology Group (KROG 07-01) study".
    Int J Cancer. 2023 Oct 31. doi: 10.1002/ijc.34775.
    Abstract

  2670. BONI SP, Tenet V, Horo A, Heideman DAM, et al
    High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Cote d'Ivoire, 2018 to 2020.
    Int J Cancer. 2023 Nov 9. doi: 10.1002/ijc.34774.
    Abstract

  2671. TULSIDAS S, Fontes F, Monteiro K, Mussa M, et al
    Cervical cancer in Mozambique: Clinical characteristics, treatment and survival of incident cases admitted to the Oncology Service of Maputo Central Hospital in 2016-2018.
    Int J Cancer. 2023 Nov 14. doi: 10.1002/ijc.34779.
    Abstract

  2672. WHITE C, Reynolds S, Murphy K, Keegan H, et al
    Performance of the HPV E6/E7 mRNA Aptima HPV assay combined with partial genotyping compared with the HPV DNA Cobas 4800 HPV test for use in primary screening: Results from the CERVIVA HPV primary screening study in Ireland.
    Int J Cancer. 2023 Aug 26. doi: 10.1002/ijc.34685.
    Abstract

  2673. EL-ZEIN M, Cheishvili D, Szyf M, Franco EL, et al
    Validation of novel DNA methylation markers in cervical precancer and cancer.
    Int J Cancer. 2024;154:104-113.
    Abstract

  2674. DHOKOTERA TG, Muchengeti M, Davidovic M, Rohner E, et al
    Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study.
    Int J Cancer. 2023 Sep 8. doi: 10.1002/ijc.34712.
    Abstract

  2675. FERNANDEZ VILLALOBOS NV, Ruffieux Y, Haas AD, Chinogurei C, et al
    Cervical precancer and cancer incidence among insured women with and without HIV in South Africa.
    Int J Cancer. 2023 Sep 2. doi: 10.1002/ijc.34707.
    Abstract

  2676. COCUZZA CE, Dhillon SK, Martinelli M, Giubbi C, et al
    Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.
    Int J Cancer. 2023 Oct 19. doi: 10.1002/ijc.34754.
    Abstract

  2677. BAO H, Zhao Y, Zhang X, Bi H, et al
    HPV-negative high-grade cervical precancerous lesions or invasive cancer in China: A post hoc analysis of a multicentric clinical study.
    Int J Gynaecol Obstet. 2022 Nov 29. doi: 10.1002/ijgo.14598.
    Abstract

  2678. GIANNELLA L, Delli Carpini G, Di Giuseppe J, Gardella B, et al
    Should attention be paid to the cone depth in the fully visible transformation zone? Retrospective analysis of 517 patients with cervical intraepithelial neoplasia grade 3.
    Int J Gynaecol Obstet. 2023;161:137-143.
    Abstract

  2679. JOHN JH, Halder A, Purwar S, Pushpalatha K, et al
    Study to determine efficacy of Urinary HPV 16 &18 detection in predicting premalignant and malignant lesions of Uterine Cervix.
    Int J Gynaecol Obstet. 2022 Oct 2. doi: 10.1002/ijgo.14486.
    Abstract

  2680. TEHRANIAN A, Ghahghaei-Nezamabadi A, Seifollahi A, Mansouri P, et al
    Concurrent anorectal and cervical cytology in women with positive and negative cervical smear test results: A cross-sectional study.
    Int J Gynaecol Obstet. 2023;161:100-105.
    Abstract

  2681. MATSUO K, Violette CJ, Mandelbaum RS, Shoupe D, et al
    Utilizations and characteristics of ovarian conservation at hysterectomy for cervical carcinoma in-situ.
    Int J Gynaecol Obstet. 2022 Dec 1. doi: 10.1002/ijgo.14604.
    Abstract

  2682. BONI SP, Horo A, Didi-Kouko-Coulibaly J, Tanon A, et al
    Impact of HIV infection on access to cancer care and survival among women with invasive cervical cancer in Cote d'Ivoire: A prospective cohort study.
    Int J Gynaecol Obstet. 2023 Jun 22. doi: 10.1002/ijgo.14925.
    Abstract

  2683. KASUGA Y, Hasegawa K, Hamuro A, Fukuma Y, et al
    Pregnancy outcomes following radical trachelectomy for early-stage cervical cancer: A retrospective observational study in the Kanto area, Japan.
    Int J Gynaecol Obstet. 2023 Jun 21. doi: 10.1002/ijgo.14935.
    Abstract

  2684. TOGAMI S, Tokudome A, Fukuda M, Mizuno M, et al
    Validation of single-photon emission computed tomography with computed tomography and lymphoscintigraphy for sentinel lymph node identification in cervical cancer.
    Int J Gynaecol Obstet. 2023 Jun 18. doi: 10.1002/ijgo.14917.
    Abstract

  2685. DE LA CRUZ-RAMIREZ YM, Olaza-Maguina AF
    Barriers to HPV vaccine uptake in adolescents of the indigenous Andean community of Peru.
    Int J Gynaecol Obstet. 2023 May 5. doi: 10.1002/ijgo.14844.
    Abstract

  2686. MCCLYMONT E, Money D
    The shift to one-dose HPV vaccination: Where does this leave women living with HIV?
    Int J Gynaecol Obstet. 2023 Feb 20. doi: 10.1002/ijgo.14713.
    Abstract

  2687. VORA KS, Saiyed S, Joshi R, Natesan S, et al
    Prevalence of High Risk HPV amongst marginalized urban women in India and its implications on vaccination: A cross sectional study.
    Int J Gynaecol Obstet. 2022 Sep 1. doi: 10.1002/ijgo.14428.
    Abstract

  2688. AMARAL E, Cain JM, Hearing F, Lumsden MA, et al
    FIGO guidance for sustainable implementation of vaccination programs for women: Pregnancy and HPV.
    Int J Gynaecol Obstet. 2023;162 Suppl 1:3-23.
    Abstract

  2689. LIU Y, He J, Liu P, Chen C, et al
    Postoperative management of FIGO 2018 stage IIA1 cervical squamous cell carcinoma with only one intermediate-risk factor: Is radiotherapy needed?
    Int J Gynaecol Obstet. 2023;162:1098-1105.
    Abstract

  2690. ZHOU Y, Wang C, Li W, Lu W, et al
    Fluorescence colposcope with TMTP1-PEG4-ICG is comparable to the conventional colposcope in identifying cervical precancerous lesions: A randomized controlled trial.
    Int J Gynaecol Obstet. 2023;162:969-976.
    Abstract

  2691. REIJNTJES B, Eising M, Kleppe M, Geuken E, et al
    The clinical relevance of excisional margins after large loop excision of the transformation zone for the persistence of cervical dysplasia.
    Int J Gynaecol Obstet. 2023;163:140-147.
    Abstract

  2692. HAMAR B, Teutsch B, Hoffmann E, Hegyi P, et al
    Trichomonas vaginalis infection is associated with increased risk of cervical carcinogenesis: A systematic review and meta-analysis of 470 000 patients.
    Int J Gynaecol Obstet. 2023;163:31-43.
    Abstract

  2693. VARGAS-CARDONA HD, Rodriguez-Lopez M, Arrivillaga M, Vergara-Sanchez C, et al
    Artificial intelligence for cervical cancer screening: Scoping review, 2009-2022.
    Int J Gynaecol Obstet. 2023 Oct 9. doi: 10.1002/ijgo.15179.
    Abstract

  2694. RAMESAN CK, Calvin JD, Thomas A, Fletcher J, et al
    Diagnostic study of human papillomavirus DNA detection in cervical and vaginal samples using the filter paper card.
    Int J Gynaecol Obstet. 2023;163:660-666.
    Abstract

  2695. ZHANG Y, Wang C, Zhao Z, Cheng L, et al
    Survival outcomes of 2018 FIGO stage IIIC versus stages IIIA and IIIB in cervical cancer: A systematic review with meta-analysis.
    Int J Gynaecol Obstet. 2023 Nov 11. doi: 10.1002/ijgo.15218.
    Abstract

  2696. DESRAVINES N, Hsu CH, Mohnot S, Sahasrabuddhe V, et al
    Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
    Int J Gynaecol Obstet. 2023;163:862-867.
    Abstract

  2697. VAN DE SANDE AJM, Kengsakul M, Koeneman MM, Jozwiak M, et al
    The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2024;164:66-74.
    Abstract

  2698. VIVEROS-CARRENO D, Fernandes A, Pareja R
    Updates on cervical cancer prevention.
    Int J Gynecol Cancer. 2023;33:394-402.
    Abstract

  2699. GRAU JF, Farinas-Madrid L, Garcia-Duran C, Garcia-Illescas D, et al
    Advances in immunotherapy in cervical cancer.
    Int J Gynecol Cancer. 2023;33:403-413.
    Abstract

  2700. CHELARIU-RAICU A, Mahner S, Moore KN, Lorusso D, et al
    Integrating antibody drug conjugates in the management of gynecologic cancers.
    Int J Gynecol Cancer. 2023;33:420-429.
    Abstract

  2701. OBERMAIR A, Pareja R
    Can simple hysterectomy replace radical hysterectomy as treatment of early-stage cervical cancer?
    Int J Gynecol Cancer. 2023 Mar 10:ijgc-2023-004372.
    Abstract

  2702. CAPOZZI VA, Rotondella I, De Finis A, Scarpelli E, et al
    Rectovaginal fistula repair by Martius flap after exclusive chemoradiation in a patient with advanced cervical cancer.
    Int J Gynecol Cancer. 2023 Mar 23:ijgc-2023-004365.
    Abstract

  2703. TOUHAMI O, Plante M, St-Gelais J, Frumovitz M, et al
    Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix.
    Int J Gynecol Cancer. 2023;33:623-627.
    Abstract

  2704. SOOCHIT A, Zhang C, Feng Y, Luo X, et al
    Impact of different post-operative treatment modalities on long-term outcomes in International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIICp cervical cancer.
    Int J Gynecol Cancer. 2023 Mar 31:ijgc-2022-004234.
    Abstract

  2705. KESIC V, Carcopino X, Preti M, Vieira-Baptista P, et al
    The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus s
    Int J Gynecol Cancer. 2023;33:446-461.
    Abstract

  2706. KAMANI MO, Kyrgiou M, Joura E, Zapardiel I, et al
    ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?
    Int J Gynecol Cancer. 2023;33:462-464.
    Abstract

  2707. GOMEZ CHEREY JF, Payalef SN, Fleider L, Reyes AP, et al
    Microbiota unbalance in relation to high-risk human papillomavirus cervical infection.
    Int J Gynecol Cancer. 2023;33:482-488.
    Abstract

  2708. BOCCIOLONE L, Candotti G, Cioffi R, Rabaiotti E, et al
    Sentinel lymph node biopsy in open surgery for gynecological malignancies.
    Int J Gynecol Cancer. 2023;33:636-637.
    Abstract

  2709. RAMIREZ PT
    ESGO/ESTRO/ESP updated guidelines in cervical cancer.
    Int J Gynecol Cancer. 2023 Apr 13:ijgc-2023-004523.
    Abstract

  2710. SAGAE S, Toita T, Matsuura M, Saito M, et al
    Improvement in radiation techniques for locally advanced cervical cancer during the last two decades.
    Int J Gynecol Cancer. 2023 Apr 11:ijgc-2022-004230.
    Abstract

  2711. CIBULA D, Raspollini MR, Planchamp F, Centeno C, et al
    ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
    Int J Gynecol Cancer. 2023;33:649-666.
    Abstract

  2712. ISHIKAWA M, Shibata T, Kataoka T, Takekuma M, et al
    Final analysis of a randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinom
    Int J Gynecol Cancer. 2023;33:692-700.
    Abstract

  2713. PELEG HASSON S, Felder S, Helpman L, Taylor A, et al
    Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix.
    Int J Gynecol Cancer. 2023;33:683-691.
    Abstract

  2714. CUSCHIERI K, Fellner MD, Arroyo Muhr LS, Padalko E, et al
    Quality assurance in human papillomavirus testing for primary cervical screening.
    Int J Gynecol Cancer. 2023;33:802-811.
    Abstract

  2715. LEVYTSKA K, Pena SR, Brown J, Yu Z, et al
    Opioid and benzodiazepine use in gynecologic oncology patients.
    Int J Gynecol Cancer. 2023;33:786-791.
    Abstract

  2716. ZHANG X, Wang Y, Lv X, Wang F, et al
    Intratumoral injection of oncolytic virus (H101) in combination with concurrent chemoradiotherapy for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2023 May 19:ijgc-2022-003914.
    Abstract

  2717. VIVEROS-CARRENO D, Vieira-Serna S, Grillo-Ardila CF, Rodriguez J, et al
    Definitive pelvic radiotherapy for patients with newly diagnosed stage IVB cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2023 May 16:ijgc-2023-004465.
    Abstract

  2718. BUDA A, Fanfani F
    The patterns of growth of cervical cancer: a challenge to personalized radical surgery.
    Int J Gynecol Cancer. 2023 Apr 25:ijgc-2023-004556.
    Abstract

  2719. CHARGARI C, Tanderup K, Planchamp F, Chiva L, et al
    ESGO/ESTRO quality indicators for radiation therapy of cervical cancer.
    Int J Gynecol Cancer. 2023 May 31:ijgc-2022-004180.
    Abstract

  2720. NGUYEN CGT, Phillips S, Chen A, Harrison R, et al
    Isolated tumor cells in a patient with early-stage cervical cancer.
    Int J Gynecol Cancer. 2023 Jun 2:ijgc-2022-004115. doi: 10.1136/ijgc-2022-004115
    Abstract

  2721. KOBAYASHI E, Takekuma M, Enomoto T, Okamoto A, et al
    Response to: Commentary on "Surgical skill and oncological outcome of laparoscopic radical hysterectomy: JGOG1081S-A1, an ancillary analysis of the Japanese Gynecologic Oncology Group Study JGOG1081" by Ramirez et al.
    Int J Gynecol Cancer. 2023;33:1012.
    Abstract

  2722. CORDOBA A, El Hajj H, Martinez-Gomez C, Hudry D, et al
    Should the cut-off for concomitant radiochemotherapy and intracavitary 3D adaptive uterovaginal brachytherapy be 3 cm?
    Int J Gynecol Cancer. 2023;33:1010-1011.
    Abstract

  2723. CASTILLO MH, Rodriguez R, Chavez C, Baltazar D, et al
    Control and management of gynecological cancer in Peru.
    Int J Gynecol Cancer. 2023;33:995-996.
    Abstract

  2724. OBERMAIR A, Leitao M
    Correspondence on "ESGO/ESTRO/ESP guidelines fpr the management of patients with cervical cancer: update 2023" by Cibula et al.
    Int J Gynecol Cancer. 2023 Jun 15:ijgc-2023-004645.
    Abstract

  2725. PAREJA R, Heredia F, Leitao M
    Correspondence on 'ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023*'.
    Int J Gynecol Cancer. 2023 Jun 9:ijgc-2023-004656. doi: 10.1136/ijgc-2023-004656
    Abstract

  2726. BOGANI G, Ghelardi A, Sopracordevole F, Annoni M, et al
    Human papillomavirus (HPV) vaccination: a call for action in Italy.
    Int J Gynecol Cancer. 2023;33:1132-1139.
    Abstract

  2727. GONZALEZ-OCHOA E, Milosevic M, Corr B, Abbruzzese JL, et al
    A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.
    Int J Gynecol Cancer. 2023;33:1208-1214.
    Abstract

  2728. MAURO J, Viveros-Carreno D, Vizzielli G, De Ponti E, et al
    Survival after sentinel node biopsy alone in early-stage cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2023 Aug 16:ijgc-2023-004692.
    Abstract

  2729. TURCO LC, Pedone Anchora L, Scambia G, Ferrandina G, et al
    Response to: Correspondence on "Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery" by Yuce Sari et al.
    Int J Gynecol Cancer. 2023;33:1491-1492.
    Abstract

  2730. YUCE SARI S, Bay M, Gultekin M
    Correspondence on 'Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery' by Turco et al.
    Int J Gynecol Cancer. 2023;33:1490.
    Abstract

  2731. NAKISIGE C, de Fouw M, Kabukye J, Sultanov M, et al
    Artificial intelligence and visual inspection in cervical cancer screening.
    Int J Gynecol Cancer. 2023 Sep 4:ijgc-2023-004397. doi: 10.1136/ijgc-2023-004397
    Abstract

  2732. MICHAAN N, Wenkert A, Even-Sapir E, Kerzhner K, et al
    Prognostic significance of delayed complete metabolic response on PET/CT after primary chemoradiation treatment of cervical cancer.
    Int J Gynecol Cancer. 2023 Sep 1:ijgc-2023-004703. doi: 10.1136/ijgc-2023-004703
    Abstract

  2733. SALVO G, Flores Legarreta A, Ramalingam P, Jhingran A, et al
    Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study.
    Int J Gynecol Cancer. 2023;33:1359-1369.
    Abstract

  2734. PLAIKNER A, Siegler K, Hertel H, Jacob A, et al
    Fertility sparing therapy in women with lymph node negative cervical cancer >2cm - oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy.
    Int J Gynecol Cancer. 2023 Sep 11:ijgc-2023-004669.
    Abstract

  2735. BIZZARRI N, Russo L, Dolciami M, Zormpas-Petridis K, et al
    Radiomics systematic review in cervical cancer: gynecological oncologists' perspective.
    Int J Gynecol Cancer. 2023 Sep 15:ijgc-2023-004589.
    Abstract

  2736. MBURU A, Shaffi AF
    Pathological pelvic fracture due to metastatic cervical cancer in a young immunosuppressed woman.
    Int J Gynecol Cancer. 2023 Oct 19:ijgc-2023-004479.
    Abstract

  2737. XIA L, Wang J, Wang C, Zhang Q, et al
    Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study.
    Int J Gynecol Cancer. 2023 Oct 24:ijgc-2023-004705.
    Abstract

  2738. FRUMOVITZ M, Morani AC, Aziz A, Jhingran A, et al
    PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study.
    Int J Gynecol Cancer. 2023 Oct 24:ijgc-2023-004907.
    Abstract

  2739. SALCEDO MP, Lathrop E, Osman N, Neves A, et al
    The Mulher Study: cervical cancer screening with primary HPV testing in Mozambique.
    Int J Gynecol Cancer. 2023 Oct 31:ijgc-2023-004958.
    Abstract

  2740. KOUHEN F, El Ghanmi A
    Breaking the silence: the taboo surrounding HPV vaccination in Morocco.
    Int J Gynecol Cancer. 2023;33:1835.
    Abstract

  2741. NITECKI R, Ramirez PT, Dundr P, Nemejcova K, et al
    MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?
    Int J Gynecol Cancer. 2023;33:1684-1689.
    Abstract

  2742. ALLANSON ER, Burling M, Simcock B, Nicklin J, et al
    The Australian Society of Gynaecological Oncology Western Pacific Liaison group.
    Int J Gynecol Cancer. 2023;33:1819-1820.
    Abstract

  2743. CARUSO G, Bruni S, Lapresa M, De Vitis LA, et al
    Dose-dense neoadjuvant chemotherapy before radical surgery in cervical cancer: a retrospective cohort study and systematic literature review.
    Int J Gynecol Cancer. 2023 Nov 10:ijgc-2023-004928.
    Abstract

  2744. PARIDA P, Baburaj G, Rao M, Lewis S, et al
    Circulating cell-free DNA as a diagnostic and prognostic marker for cervical cancer.
    Int J Gynecol Cancer. 2023 Nov 10:ijgc-2023-004873.
    Abstract

  2745. BORGHI C, Biagioli E, Mauro J, Roberto A, et al
    Neoadjuvant chemotherapy prior to radical hysterectomy in locally advanced cervical cancer: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2023 Nov 27:ijgc-2023-004863.
    Abstract

  2746. RIBEIRO R, Baiocchi G, Moretti-Marques R, Linhares JC, et al
    Uterine transposition for fertility and ovarian function preservation after radiotherapy.
    Int J Gynecol Cancer. 2023;33:1837-1842.
    Abstract

  2747. PARPINEL G, Laas-Faron E, Balaya V, Guani B, et al
    Survival after sentinel lymph node biopsy for early cervical cancers: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2023;33:1853-1860.
    Abstract

  2748. PLAIKNER A, Siegler K, Kohler C
    Surgical steps of laparoscopic-assisted simple vaginal trachelectomy.
    Int J Gynecol Cancer. 2023;33:1972-1973.
    Abstract

  2749. KOK HP, Herrera TD, Crezee J
    The Relevance of High Temperatures and Short Time Intervals Between Radiation Therapy and Hyperthermia: Insights in Terms of Predicted Equivalent Enhanced Radiation Dose.
    Int J Radiat Oncol Biol Phys. 2023;115:994-1003.
    Abstract

  2750. LI B, Hirata E, Trejo JM, Garcia B, et al
    Exploring the Cost of Radiation Therapy Delivery for Locally Advanced Cervical Cancer in a Public and a Private Center in Latin America Using Time-Driven Activity-Based Costing.
    Int J Radiat Oncol Biol Phys. 2023;115:1205-1216.
    Abstract

  2751. MARAR M, Niedermayr T, Kidd E
    Developing next generation 3D-printing for cervical cancer hybrid brachytherapy: a guided interstitial technique enabling improved flexibility, dosimetry, and efficiency.
    Int J Radiat Oncol Biol Phys. 2023 Apr 12:S0360-3016(23)00364.
    Abstract

  2752. LIN LL, Msadabwe SC, Chiao E
    Improving Access to Radiation Therapy Globally To Meet World Health Organization Goals To Eliminate Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2023;116:459-462.
    Abstract

  2753. LIN LL, Ndlovu N, Lowenstein J, Wirth M, et al
    Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan Africa.
    Int J Radiat Oncol Biol Phys. 2023;116:439-447.
    Abstract

  2754. KUMAR A, Gurram L, Nayak P, Mulye G, et al
    Correlation of haematological parameters with clinical outcomes in cervical cancer patients treated with radical radio (chemo) therapy - A retrospective study.
    Int J Radiat Oncol Biol Phys. 2023 Jul 26:S0360-3016(23)07677.
    Abstract

  2755. LAVILLE A, Ka K, El-Ayachi R, Achkar S, et al
    Locoregional treatment in patients with metastatic cervical cancer: benefit of dose escalation strategies.
    Int J Radiat Oncol Biol Phys. 2023 Aug 14:S0360-3016(23)07744.
    Abstract

  2756. CHO WK, Kim HS, Park W, Kim YS, et al
    The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07).
    Int J Radiat Oncol Biol Phys. 2023;117:154-163.
    Abstract

  2757. GHOSH DS, Gurram DL, Kumar DA, Mulye DG, et al
    Clinical implementation of 'plan of the day' strategy in definitive radiotherapy of cervical cancer: Online adaptation to address the challenge of organ filling reproducibility.
    Int J Radiat Oncol Biol Phys. 2023 Oct 8:S0360-3016(23)07956.
    Abstract

  2758. HAN K, Colson-Fearon D, Liu ZA, Viswanathan A, et al
    Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the U.S.: A Surveillance, Epidemiology, and End-Results Study.
    Int J Radiat Oncol Biol Phys. 2023 Nov 9:S0360-3016(23)08132.
    Abstract

  2759. MANTZ C
    Comments on "Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy".
    Int J Radiat Oncol Biol Phys. 2023;117:1143-1144.
    Abstract

  2760. FIELDS EC, Erickson B, Chino J, Small C, et al
    Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2023;117:1138-1142.
    Abstract

  2761. AKINFENWA CA, Allanson E, Ewongwo A, Lumley C, et al
    Mapping of radiation oncology and gynecologic oncology services available to treat the growing burden of cervical cancer in Africa.
    Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08043.
    Abstract

  2762. CORBEAU A, Heemsbergen WD, Kuipers SC, Godart J, et al
    Predictive factors for toxicity after primary chemoradiation for locally advanced cervical cancer: a systematic review.
    Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08133.
    Abstract

  2763. BHATIA R, Alcaniz Boada E, Bonde JH, Quint WGV, et al
    Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
    J Clin Pathol. 2021 Nov 15. pii: jclinpath-2021-207864.
    Abstract

  2764. ALCANIZ BOADA E, Cuschieri K, Graham C, Moncur S, et al
    Agreement between L1 and E6/E7-based assays for detection of high-risk HPV in cervical, oropharyngeal and penile cancers.
    J Clin Pathol. 2022 Feb 8. pii: jclinpath-2021-208054.
    Abstract

  2765. MONTERO-MACIAS R, Veyer D, Bruneau T, Robillard N, et al
    TRANSLACOL project: Nodal human papillomavirus tumoral DNA detection by ddPCR for survival prediction in early cervical cancer patients without pelvic lymph node invasion.
    J Clin Virol. 2023;161:105418.
    Abstract

  2766. ELASIFER H, Amukwaya MMN, Bhatia R, Cuschieri K, et al
    The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis.
    J Clin Virol. 2023;164:105469.
    Abstract

  2767. YILMAZ E, Eklund C, Lagheden C, Robertsson KD, et al
    First international proficiency study on human papillomavirus testing in cervical cancer screening.
    J Clin Virol. 2023;167:105581.
    Abstract

  2768. CHAIKEN SR, Bruegl AS, Caughey AB, Emerson J, et al
    Adjuvant Human Papillomavirus Vaccination After Excisional Procedure for Cervical Intraepithelial Neoplasia: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2023;141:756-763.
    Abstract

  2769. MORTON M, Marcu I, Levine M, Cosgrove C, et al
    Evaluation of Efficacy and Adverse Events After Second Immunotherapy Exposure in Endometrial and Cervical Carcinoma.
    Obstet Gynecol. 2023 Jul 6. doi: 10.1097/AOG.0000000000005243.
    Abstract

  2770. ALIMENA S, Lykken JM, Tiro JA, Chubak J, et al
    Timing of Colposcopy and Risk of Cervical Cancer.
    Obstet Gynecol. 2023 Aug 22. doi: 10.1097/AOG.0000000000005313.
    Abstract

  2771. SINHA N, McDonald A, Barry D, Barber EL, et al
    Large Publication Gap for Gynecologic Cancers in High-Impact Factor Journals.
    Obstet Gynecol. 2023 Aug 3. doi: 10.1097/AOG.0000000000005301.
    Abstract

  2772. YILMAZ E, Lagheden C, Ghaderi M, Wang J, et al
    Assessment of Human Papillomavirus Non-16/18, Type-Specific Risk for Cervical Intraepithelial Neoplasia Grade 3 or Worse Among Women With Cervical Atypical Glandular Cells.
    Obstet Gynecol. 2023;142:679-687.
    Abstract

  2773. EINSTEIN MH, Zhou N, Gabor L, Sahasrabuddhe VV, et al
    Primary Human Papillomavirus Testing and Other New Technologies for Cervical Cancer Screening.
    Obstet Gynecol. 2023 Sep 14. doi: 10.1097/AOG.0000000000005393.
    Abstract

  2774. VOLESKY-AVELLANEDA KD, Laurie C, Tsyruk-Romano O, El-Zein M, et al
    Human Papillomavirus Detectability and Cervical Cancer Prognosis: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Sep 14. doi: 10.1097/AOG.0000000000005370.
    Abstract

  2775. BOITANO TKL, Kako T, Leath CA 3rd
    Improving Therapies for Cervical Cancer While Working Toward Eradication.
    Obstet Gynecol. 2023 Oct 12. doi: 10.1097/AOG.0000000000005413.
    Abstract

  2776. VOLESKY-AVELLANEDA KD, Laurie C, Tsyruk-Romano O, El-Zein M, et al
    Human Papillomavirus Detectability and Cervical Cancer Prognosis: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023;142:1055-1067.
    Abstract

  2777. NANDWANA D, Hawes K, Zuend CF, Pope R, et al
    Neovaginal Human Papillomavirus Prevalence in Transfeminine Individuals: A Systematic Review.
    Obstet Gynecol. 2023;142:296-306.
    Abstract

  2778. INAYAMA Y, Takamatsu S, Hamanishi J, Mizuno K, et al
    Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023;142:307-318.
    Abstract


  2779. Association of Radical Hysterectomy Surgical Volume and Survival for Early-Stage Cervical Cancer: Correction.
    Obstet Gynecol. 2024;143:e21.
    Abstract

  2780. QIN K, Jian D, Xue Y, Cheng Y, et al
    DDX41 regulates the expression and alternative splicing of genes involved in tumorigenesis and immune response.
    Oncol Rep. 2021;45:1213-1225.
    Abstract

  2781. CAUSIN RL, Van Helvoort Lengert A, Gomes INF, De Freitas AJA, et al
    MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression.
    Oncol Rep. 2023;49:109.
    Abstract

  2782. YANG J, Gao Y, Yao S, Wan S, et al
    TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1.
    Oncol Rep. 2023;49:114.
    Abstract

  2783. NDIAYE M, Diop G, Derbois C, Spadoni JL, et al
    Gene expression profiling of peripheral blood mononuclear cells from women with cervical lesions reveals new markers of cancer.
    Oncol Rep. 2023;49:118.
    Abstract

  2784. LI M, Gao Z, Wang S, Zhao Y, et al
    miR‑27a‑3p upregulation by p65 facilitates cervical tumorigenesis by increasing TAB3 expression and is involved in the positive feedback loop of NF‑kappaB signaling.
    Oncol Rep. 2023;50:132.
    Abstract

  2785. LIANG H, Luo R, Chen X, Zhao Y, et al
    [Retracted] miR?187 inhibits the growth of cervical cancer cells by targeting FGF9.
    Oncol Rep. 2023;50:195.
    Abstract

  2786. LIU Z, Zhang H, Hu X
    Analysis of the expression and mechanism of follistatin?like protein 1 in cervical cancer.
    Oncol Rep. 2023;50:215.
    Abstract

  2787. OKAMOTO H, Murakami N, Isohashi F, Kasamatsu T, et al
    Plan quality association between dummy run and individual case review in a prospective multi-institutional clinical trial of postoperative cervical cancer patients treated with intensity-modulated radiotherapy: Japan Clinical Oncology Group study (JCO
    Radiother Oncol. 2023 Mar 17:109630. doi: 10.1016/j.radonc.2023.109630.
    Abstract

  2788. CHARGARI C, Tanderup K, Planchamp F, Chiva L, et al
    ESGO/ESTRO quality indicators for radiation therapy of cervical cancer.
    Radiother Oncol. 2023;183:109589.
    Abstract

  2789. CIBULA D, Rosaria Raspollini M, Planchamp F, Centeno C, et al
    ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
    Radiother Oncol. 2023;184:109682.
    Abstract

  2790. ECKER S, Kirisits C, Schmid M, Knoth J, et al
    EviGUIDE - A tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer.
    Radiother Oncol. 2023 Jun 15:109748. doi: 10.1016/j.radonc.2023.109748.
    Abstract

  2791. NOUT R, Calaminus G, Planchamp F, Chargari C, et al
    ESTRO/ESGO/SIOPe guidelines for the management of patients with vaginal cancer.
    Radiother Oncol. 2023;186:109662.
    Abstract

  2792. REIJTENBAGH D, Godart J, Penninkhof J, Quint S, et al
    Nine years of plan of the day for cervical cancer: Plan library remains effective compared to fully online-adaptive techniques.
    Radiother Oncol. 2023;190:110009.
    Abstract

  2793. QIN D, Bai A, Xue P, Seery S, et al
    Colposcopic accuracy in diagnosing squamous intraepithelial lesions: a systematic review and meta-analysis of the International Federation of Cervical Pathology and Colposcopy 2011 terminology.
    BMC Cancer. 2023;23:187.
    Abstract

  2794. ZHANG H, Wang X, Li Y, Bai Y, et al
    The hsa_circ_0000276-ceRNA regulatory network and immune infiltration in cervical cancer.
    BMC Cancer. 2023;23:222.
    Abstract

  2795. RAHIMI M, Akbari A, Asadi F, Emami H, et al
    Cervical cancer survival prediction by machine learning algorithms: a systematic review.
    BMC Cancer. 2023;23:341.
    Abstract

  2796. GAN Q, Huang X, Zhao W, Liu H, et al
    AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway.
    BMC Cancer. 2023;23:364.
    Abstract

  2797. ZHANG HW, Zhong XM, Zhang ZH, Pang HW, et al
    Dose prediction of organs at risk in patients with cervical cancer receiving brachytherapy using needle insertion based on a neural network method.
    BMC Cancer. 2023;23:385.
    Abstract

  2798. MATOVU JK, Wagner GJ, Juncker M, Namisango E, et al
    Mediators and moderators of the effect of the game changers for cervical cancer prevention intervention on cervical cancer screening among previously unscreened social network members in Uganda.
    BMC Cancer. 2023;23:428.
    Abstract

  2799. YE Y, Li Z, Kang S, Yang Y, et al
    Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
    BMC Cancer. 2023;23:421.
    Abstract

  2800. BOOTH BB, Tranberg M, Gustafson LW, Christiansen AG, et al
    Risk of cervical intraepithelial neoplasia grade 2 or worse in women aged >/= 69 referred to colposcopy due to an HPV-positive screening test.
    BMC Cancer. 2023;23:405.
    Abstract

  2801. BELAY AS, Asmare WN, Kassie A
    Cervical cancer screening utilization and its predictors among women in bench Sheko Zone, Southwest Ethiopia: using health belief model.
    BMC Cancer. 2023;23:472.
    Abstract

  2802. LEONG E, Ong SK, Si-Ramlee KA, Naing L, et al
    Cancer incidence and mortality in Brunei Darussalam, 2011 to 2020.
    BMC Cancer. 2023;23:466.
    Abstract

  2803. WU J, Guo Q, Zhu J, Wu Y, et al
    Developing a nomogram for preoperative prediction of cervical cancer lymph node metastasis by multiplex immunofluorescence.
    BMC Cancer. 2023;23:485.
    Abstract

  2804. JIANG Y, Wang J, Jiang P, Wang X, et al
    Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer.
    BMC Cancer. 2023;23:481.
    Abstract

  2805. PENG H, Zhang J, Xu N, Zhou Y, et al
    Fan beam CT-guided online adaptive external radiotherapy of uterine cervical cancer: a dosimetric evaluation.
    BMC Cancer. 2023;23:588.
    Abstract

  2806. NAJJEMBA JI, Ndagire R, Mulamira P, Kibudde S, et al
    Treatment compliance among adult cervical cancer patients receiving care at Uganda cancer institute, Uganda: a retrospective data review.
    BMC Cancer. 2023;23:631.
    Abstract

  2807. MARTINEZ-GUTIERREZ J, Chima S, Boyd L, Sherwani A, et al
    Failure to follow up abnormal test results associated with cervical cancer in primary and ambulatory care: a systematic review.
    BMC Cancer. 2023;23:653.
    Abstract

  2808. ZHANG C, Gu L, Xiao J, Jin F, et al
    Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
    BMC Cancer. 2023;23:684.
    Abstract

  2809. MUSA J, Maiga M, Green SJ, Magaji FA, et al
    Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria.
    BMC Cancer. 2023;23:683.
    Abstract

  2810. DADIPOOR S, Alavi A, Kader Z, Mohseni S, et al
    Predictive power of PEN-3 cultural model in cervical cancer screening among women: a cross- sectional study in South of Iran.
    BMC Cancer. 2023;23:730.
    Abstract

  2811. SAMADI M, Mokhtari-Azad T, Nejati A, Norooz-Babaei Z, et al
    The antitumor effect of oncolytic respiratory syncytial virus via the tumor necrosis factor-alpha induction and ROS-bax-mediated mechanisms.
    BMC Cancer. 2023;23:803.
    Abstract

  2812. CHETTY-SEBASTIAN D, Assounga AG
    Regulatory T cell frequency in peripheral blood of women with advanced cervical Cancer including women living with HIV.
    BMC Cancer. 2023;23:830.
    Abstract

  2813. O'DOWD EL, Merriel SWD, Cheng VWT, Khan S, et al
    Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review.
    BMC Cancer. 2023;23:820.
    Abstract

  2814. ZAFAR S, Khan K, Badshah Y, Shahid K, et al
    Exploring the prognostic significance of PKCepsilon variants in cervical cancer.
    BMC Cancer. 2023;23:819.
    Abstract

  2815. HE C, Pei C, Ma J
    Developing an evaluation indicators of health literacy for cervical cancer among Chinese women: a modified Delphi method study.
    BMC Cancer. 2023;23:863.
    Abstract

  2816. WANG F, Song S, Guo B, Li Y, et al
    Increased TCP11 gene expression can inhibit the proliferation, migration and promote apoptosis of cervical cancer cells.
    BMC Cancer. 2023;23:853.
    Abstract

  2817. ZHU M, Li X, Feng Y, Jia T, et al
    Impact of CD40 gene polymorphisms on the risk of cervical squamous cell carcinoma: a case-control study.
    BMC Cancer. 2023;23:845.
    Abstract

  2818. SHAN M, Deng Y, Zou W, Fan S, et al
    Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis.
    BMC Cancer. 2023;23:905.
    Abstract

  2819. WANG J, Huang J, Ding H, Ma J, et al
    Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
    BMC Cancer. 2023;23:929.
    Abstract

  2820. ZAFAR S, Khan K, Badshah Y, Shahid K, et al
    Correction: Exploring the prognostic significance of PKCepsilon variants in cervical cancer.
    BMC Cancer. 2023;23:963.
    Abstract

  2821. MISGUN T, Demissie DB
    Knowledge, practice of cervical cancer screening and associated factors among women police members of Addis Ababa police commission Ethiopia.
    BMC Cancer. 2023;23:961.
    Abstract

  2822. TSEGAYE K, Hagos A, Kindie H, Minyihun A, et al
    Evaluation of cervical cancer screening program in Gondar city administration public health facilities, Northwest Ethiopia, 2021: mixed method approach.
    BMC Cancer. 2023;23:1034.
    Abstract

  2823. LV N, Zhao Y, Song Y, Ji M, et al
    Development of a sensitive droplet digital PCR according to the HPV infection specificity in Chinese population.
    BMC Cancer. 2023;23:1022.
    Abstract

  2824. LI X, Wei X, Liu X, Wang N, et al
    The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapy.
    BMC Cancer. 2023;23:1052.
    Abstract

  2825. BUKOWSKI A, Hoyo C, Vielot NA, Graff M, et al
    Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States.
    BMC Cancer. 2023;23:1072.
    Abstract

  2826. MWALIKO E, Itsura P, Keter A, De Bacquer D, et al
    Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya.
    BMC Cancer. 2023;23:1104.
    Abstract

  2827. CHENG Z, Wang H, Yang Z, Li J, et al
    LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/beta-catenin signaling pathway and EMT in cervical cancer.
    BMC Cancer. 2023;23:1128.
    Abstract

  2828. ZHANG H, Yang Y, Xing W, Li Y, et al
    Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
    BMC Cancer. 2023;23:1124.
    Abstract

  2829. GLINSKA P, Komerska K, Janik B, Olkowicz J, et al
    HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
    BMC Cancer. 2023;23:1118.
    Abstract

  2830. ZEWDIE A, Shitu S, Kebede N, Gashaw A, et al
    Determinants of late-stage cervical cancer presentation in Ethiopia: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:1228.
    Abstract

  2831. VIGNESHWARAN E, Goruntla N, Bommireddy BR, Mantargi MJS, et al
    Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
    BMC Cancer. 2023;23:1216.
    Abstract

  2832. KONG L, Xiao X, Xu T, Wan R, et al
    Immediate histologic correlation in patients with different HPV genotypes and ages: a single center analysis in China.
    BMC Cancer. 2023;23:1211.
    Abstract

  2833. TRANBERG M, Petersen LK, Hammer A, Elfstrom M, et al
    Value of a catch-up HPV test in women aged 65 and above: A Danish population-based nonrandomized intervention study.
    PLoS Med. 2023;20:e1004253.
    Abstract

  2834. WANG J, Elfstrom KM, Lagheden C, Eklund C, et al
    Impact of cervical screening by human papillomavirus genotype: Population-based estimations.
    PLoS Med. 2023;20:e1004304.
    Abstract

  2835. RODRIGUEZ NM, Brennan LP, Claure L, Balian LN, et al
    Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
    PLoS One. 2023;18:e0282853.
    Abstract

  2836. YAN L, Xiao X, He L, Shi L, et al
    Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy.
    PLoS One. 2023;18:e0282833.
    Abstract

  2837. CHOI J, Markham C, Tami-Maury I, Kim S, et al
    Maternal perceptions of vaccinating boys against human papillomavirus (HPV) in Seoul, South Korea: A descriptive exploratory qualitative study.
    PLoS One. 2023;18:e0282811.
    Abstract

  2838. GIBSON-HELM M, Slater T, MacDonald EJ, Stevenson K, et al
    Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
    PLoS One. 2023;18:e0280643.
    Abstract

  2839. SMITH JS, Vaz OM, Gaber CE, Des Marais AC, et al
    Recruitment strategies and HPV self-collection return rates for under-screened women for cervical cancer prevention.
    PLoS One. 2023;18:e0280638.
    Abstract

  2840. TAKADA A, Yokota H, Nemoto MW, Horikoshi T, et al
    Prognosis prediction of uterine cervical cancer using changes in the histogram and texture features of apparent diffusion coefficient during definitive chemoradiotherapy.
    PLoS One. 2023;18:e0282710.
    Abstract

  2841. PAKEN J, Govender CD, Pillay M, Feyasa M, et al
    Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.
    PLoS One. 2023;18:e0283639.
    Abstract

  2842. LIVESEY M, Rossouw SC, Blignaut R, Christoffels A, et al
    Transforming RNA-Seq gene expression to track cancer progression in the multi-stage early to advanced-stage cancer development.
    PLoS One. 2023;18:e0284458.
    Abstract


  2843. Expression of Concern: Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis.
    PLoS One. 2023;18:e0285579.
    Abstract

  2844. HOLOPAINEN E, Lahtinen O, Kononen M, Anttila M, et al
    Greater increases in intratumoral apparent diffusion coefficients after chemoradiotherapy predict better overall survival of patients with cervical cancer.
    PLoS One. 2023;18:e0285786.
    Abstract

  2845. OKAFOR IP, Kukoyi FO, Kanma-Okafor OJ, Izuka MO, et al
    Male involvement in female partners' screening for breast and cervical cancers in Southwest Nigeria.
    PLoS One. 2023;18:e0284141.
    Abstract

  2846. MITI S, Shato T, Asante C, Baumann A, et al
    Leveraging health infrastructure to optimize HPV vaccination for adolescents in Zambia: Protocol for an implementation study.
    PLoS One. 2023;18:e0285031.
    Abstract

  2847. KHOMPHAIBOONKIJ U, Sreamsukcharoenchai N, Pitakkarnkul S, Rittiluechai K, et al
    Knowledge of Thai women in cervical cancer etiology and screening.
    PLoS One. 2023;18:e0286011.
    Abstract

  2848. KURITA Y, Meguro S, Tsuyama N, Kosugi I, et al
    Accurate deep learning model using semi-supervised learning and Noisy Student for cervical cancer screening in low magnification images.
    PLoS One. 2023;18:e0285996.
    Abstract

  2849. PANERU B, Karmacharya A, Bharati A, Makaju S, et al
    Association between cancer stigma and cervical cancer screening uptake among women of Dhulikhel and Banepa, Nepal.
    PLoS One. 2023;18:e0285771.
    Abstract

  2850. JEMAL Z, Chea N, Hasen H, Tesfaye T, et al
    Cervical cancer screening utilization and associated factors among female health workers in public health facilities of Hossana town, southern Ethiopia: A mixed method approach.
    PLoS One. 2023;18:e0286262.
    Abstract

  2851. MWENDA V, Bor JP, Nyangasi M, Njeru J, et al
    Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
    PLoS One. 2023;18:e0286202.
    Abstract

  2852. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
    Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.
    PLoS One. 2023;18:e0286909.
    Abstract

  2853. ALAM Z, Cairns JM, Scott M, Dean JA, et al
    Interventions to increase cervical screening uptake among immigrant women: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0281976.
    Abstract

  2854. VAINER G, Huang L, Emancipator K, Nuti S, et al
    Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications.
    PLoS One. 2023;18:e0285764.
    Abstract

  2855. JONSDOTTIR B, Wikman A, Sundstrom Poromaa I, Stalberg K, et al
    Advanced gynecological cancer: Quality of life one year after diagnosis.
    PLoS One. 2023;18:e0287562.
    Abstract

  2856. STRBAC M, Vukovic V, Pustahija T, Nikolic N, et al
    Motives and attitudes of parents toward HPV vaccination: Results from the initial period of HPV vaccine rollout in Serbia.
    PLoS One. 2023;18:e0287295.
    Abstract

  2857. WULANDARI D, Meidyandra RW, Andrijono
    Genotype profiles of high-risk human papillomavirus in women of reproductive age: A community-based study.
    PLoS One. 2023;18:e0287399.
    Abstract

  2858. MAHAJAN H, Reddy N, Devi NGM, Poli UR, et al
    Projected cancer burden, challenges, and barriers to cancer prevention and control activities in the state of Telangana.
    PLoS One. 2023;18:e0278357.
    Abstract

  2859. FAZLOLLAHPOUR-NAGHIBI A, Bagheri K, Almukhtar M, Taha SR, et al
    Trichomonas vaginalis infection and risk of cervical neoplasia: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0288443.
    Abstract

  2860. BAS S, Sijben J, Bischoff EWMA, Bekkers RLM, et al
    Acceptability of risk-based triage in cervical cancer screening: A focus group study.
    PLoS One. 2023;18:e0289647.
    Abstract

  2861. CONTRERAS NE, Roldan JS, Castillo DS
    Novel competitive enzyme-linked immunosorbent assay for the detection of the high-risk Human Papillomavirus 18 E6 oncoprotein.
    PLoS One. 2023;18:e0290088.
    Abstract

  2862. CHONA EZ, Msengi EA, Gosse RA, Ambikile JS, et al
    The lived experiences and caring needs of women diagnosed with cervical cancer: A qualitative study in Dar es Salaam, Tanzania.
    PLoS One. 2023;18:e0289925.
    Abstract

  2863. OKYERE ASANTE PG, Owusu AY, Oppong JR, Amegah KE, et al
    The psychosocial burden of women seeking treatment for breast and cervical cancers in Ghana's major cancer hospitals.
    PLoS One. 2023;18:e0289055.
    Abstract

  2864. GONG M, Shen F, Li Y, Ming L, et al
    MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
    PLoS One. 2023;18:e0290462.
    Abstract

  2865. URQUHART G, Maclennan SJ, Guntupalli AM
    Is there an association between intimate partner violence and the prevalence of cervical cancer screening in Jordan?
    PLoS One. 2023;18:e0290678.
    Abstract

  2866. SUNDARA RAJAN R S, Thomas J, Francis D, Daniel EC, et al
    Effective gene delivery using size dependant nano core-shell in human cervical cancer cell lines by magnetofection.
    PLoS One. 2023;18:e0289731.
    Abstract

  2867. ODEH HI, Al-Badi SR, Karima B, Saeed TA, et al
    Exploring the prevalence of Human Papillomavirus (HPV) genotypes in PAP smear samples of women in northern region of United Arab Emirates (UAE): HPV Direct Flow CHIP system-based pilot study.
    PLoS One. 2023;18:e0286889.
    Abstract

  2868. WANG S, Wang Y, Zhuang J, Wu Y, et al
    Prognostic significance of index (LANR) composed of preoperative lymphocytes, albumin, and neutrophils in patients with stage IB-IIA cervical cancer.
    PLoS One. 2023;18:e0290905.
    Abstract

  2869. MANTULA F, Toefy Y
    Women and health providers' perspectives on male support for cervical cancer screening in Gwanda district, Zimbabwe.
    PLoS One. 2023;18:e0282931.
    Abstract

  2870. IORDANISHVILI S, Metreveli T, Lipartia E, Gachechiladze K, et al
    The HPV-TP53-MALAT1 Axis: Unravelling interactions in cervical cancer development.
    PLoS One. 2023;18:e0291725.
    Abstract

  2871. FERREIRA HNC, Capistrano GN, Morais TNB, Costa KTDS, et al
    Screening and hospitalization of breast and cervical cancer in Brazil from 2010 to 2022: A time-series study.
    PLoS One. 2023;18:e0278011.
    Abstract

  2872. QAQISH A, Abdo N, Abbas MM, Saadeh N, et al
    Awareness and knowledge of physicians and residents on the non-sexual routes of human papilloma virus (HPV) infection and their perspectives on anti-HPV vaccination in Jordan.
    PLoS One. 2023;18:e0291643.
    Abstract

  2873. ZHAO X, Gopalappa C
    Joint modeling HIV and HPV using a new hybrid agent-based network and compartmental simulation technique.
    PLoS One. 2023;18:e0288141.
    Abstract

  2874. DESTA M, Getaneh T, Yeserah B, Worku Y, et al
    Correction: Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0294799.
    Abstract

  2875. TACHIWENYIKA E, Dhodho M, Muchedzi A, Sibanda TP, et al
    Prevalence of Cervical Cancer and Clinical Management of Women Screened positive using visual inspection with acetic acid and Cervicography in selected public sector health facilities of Manicaland and Midlands provinces of Zimbabwe, 2021.
    PLoS One. 2023;18:e0294115.
    Abstract

  2876. MAHUMUD RA, Alam K, Dunn J, Gow J, et al
    Correction: The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.
    PLoS One. 2023;18:e0295688.
    Abstract

  2877. QULU W, Mtshali A, Osman F, Ndlela N, et al
    High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV.
    PLoS One. 2023;18:e0294698.
    Abstract

  2878. ALMASOUDI HH, Nahari MH, Alhazmi AYM, Almasabi SHA, et al
    Delineating Pixantrone Maleate's adroit activity against cervical cancer proteins through multitargeted docking-based MM\GBSA, QM-DFT and MD simulation.
    PLoS One. 2023;18:e0295714.
    Abstract

  2879. RAZZAK MA, Islam MN, Aadeeb MS, Tasnim T, et al
    Digital health interventions for cervical cancer care: A systematic review and future research opportunities.
    PLoS One. 2023;18:e0296015.
    Abstract

  2880. AL-OSEELY S, Abdul Manaf R, Ismail S
    Factors affecting cervical cancer screening among Yemeni immigrant women in Klang Valley, Malaysia: A cross sectional study.
    PLoS One. 2023;18:e0290152.
    Abstract

  2881. GEBREMESKEL TG, Gebretatios MZ
    Determinants of cervical cancer screening utilization among HIV-positive women, in public general hospitals of Central Zone, Tigray, Ethiopia, 2020: Case-control study.
    PLoS One. 2023;18:e0289042.
    Abstract

  2882. NOVAIS IR, Coelho CO, Machado HC, Surita F, et al
    Cervical cancer screening in Brazilian Amazon Indigenous women: Towards the intensification of public policies for prevention.
    PLoS One. 2023;18:e0294956.
    Abstract

  2883. TOSADO-RODRIGUEZ E, Mendez LB, Espino AM, Dorta-Estremera S, et al
    Inflammatory cytokines and a diverse cervicovaginal microbiota associate with cervical dysplasia in a cohort of Hispanics living in Puerto Rico.
    PLoS One. 2023;18:e0284673.
    Abstract

  2884. MCDERMOTT A
    Microbiome insights open new avenues to treat HPV.
    Proc Natl Acad Sci U S A. 2023;120:e2304645120.
    Abstract


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;